[
    {
        "ticker": "pfe",
        "data": [
            [
                1682726400000,
                "XTANDI® (enzalutamide) plus Leuprolide Reduced the Risk of Metastasis by 58% in Non-Metastatic Hormone-Sensitive Prostate Cancer versus Placebo plus Leuprolide",
                0.1536133415
            ],
            [
                1682553600000,
                "U.S. FDA Approves PREVNAR 20®, Pfizer’s 20-valent Pneumococcal Conjugate Vaccine for Infants and Children",
                0.6942670661
            ],
            [
                1682553600000,
                "Pfizer Announces 2023 Shareholder Meeting Preliminary Results",
                0.6942670661
            ],
            [
                1682467200000,
                "Pfizer Declares Second-Quarter 2023 Dividend",
                -1.0841459751
            ],
            [
                1681344000000,
                "Pfizer Invites Shareholders to Attend Virtual-Only 2023 Annual Meeting of Shareholders on April 27",
                -0.8254434667
            ],
            [
                1680566400000,
                "FDA Accepts Pfizer’s Supplemental New Drug Applications for BRAFTOVI + MEKTOVI",
                0.2647427494
            ],
            [
                1679356800000,
                "Pfizer Invites Public to View and Listen to Webcast of May 2 Conference Call with Analysts",
                -2.1244746925
            ],
            [
                1678924800000,
                "Phase 3 Study Shows XTANDI® (enzalutamide) plus Leuprolide Significantly Improves Metastasis-Free Survival in Men with Non-Metastatic Prostate Cancer",
                0.0997433974
            ],
            [
                1678924800000,
                "FDA Advisory Committee Votes in Support of Favorable Benefit-Risk Profile for Pfizer’s PAXLOVID™",
                0.0997433974
            ],
            [
                1678752000000,
                "Pfizer and BioNTech Receive U.S. Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Booster in Children Under 5 Years",
                0.57100186
            ],
            [
                1678665600000,
                "Pfizer Invests $43 Billion to Battle Cancer",
                1.6040179947
            ],
            [
                1678406400000,
                "Pfizer’s ZAVZPRET™ (zavegepant) Migraine Nasal Spray Receives FDA Approval",
                1.43000423
            ],
            [
                1677628800000,
                "Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Booster in Children Under 5 Years",
                0.147704481
            ],
            [
                1677542400000,
                "Pfizer Receives Positive FDA Advisory Committee Votes Supporting Potential Approval for Vaccine Candidate to Help Combat RSV in Older Adults",
                -0.7964153619
            ],
            [
                1677456000000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference",
                -2.1444390891
            ],
            [
                1677196800000,
                "Pfizer and BioNTech Submit Supplemental Biologics License Application for U.S. FDA Approval of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine for Ages 12 Years and Older as Primary Series or Booster",
                -3.0652281447
            ],
            [
                1677024000000,
                "Pfizer’s Elranatamab Receives FDA and EMA Filing Acceptance",
                -0.9929125088
            ],
            [
                1676937600000,
                "U.S. FDA Accepts Biologics License Application for Pfizer’s Respiratory Syncytial Virus Maternal Vaccine Candidate for Priority Review",
                -1.0146302368
            ],
            [
                1676505600000,
                "Pfizer Announces Positive TALZENNA® and XTANDI® Combination Data from Phase 3 TALAPRO-2 Study",
                0.138851099
            ],
            [
                1676505600000,
                "Pfizer Announces The Lancet Neurology Has Published Phase 3 Data for Zavegepant for the Acute Treatment of Migraine in Adults",
                0.138851099
            ],
            [
                1675987200000,
                "FDA Approves Pfizer's Supplemental New Drug Application for CIBINQO® (abrocitinib)",
                1.1138932934
            ],
            [
                1675900800000,
                "Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference",
                -0.5469413353
            ],
            [
                1675123200000,
                "PFIZER REPORTS RECORD FULL-YEAR 2022 RESULTS AND PROVIDES FULL-YEAR 2023 FINANCIAL GUIDANCE",
                2.2060522942
            ],
            [
                1673913600000,
                "Pfizer Expands ‘An Accord for a Healthier World’ Product Offering to Include Full Portfolio for Greater Benefit to 1.2 Billion People in 45 Lower-Income Countries",
                -3.4222198706
            ],
            [
                1672963200000,
                "U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine in Infants and Children",
                -3.2858060169
            ],
            [
                1672963200000,
                "Longevity Biotech Gero Entered a Research Collaboration with Pfizer to Discover Potential Targets for Fibrotic Diseases",
                -3.2858060169
            ],
            [
                1672704000000,
                "Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference",
                -1.7554282618
            ],
            [
                1672272000000,
                "Pfizer Announces Positive Top-Line Results from Phase 3 Study of Hemophilia B Gene Therapy Candidate",
                0.4293572369
            ],
            [
                1672185600000,
                "U.S. FDA Accepts for Review the Biologics License Application for Pfizer’s Investigational Pentavalent Meningococcal Vaccine Candidate (MenABCWY) in Adolescents",
                0.5454943307
            ],
            [
                1671580800000,
                "Pfizer Announces FDA and EMA Acceptance of Etrasimod Regulatory Submissions for Ulcerative Colitis",
                0.0580944049
            ],
            [
                1671494400000,
                "Pfizer Invites Public to View and Listen to Webcast of January 31 Conference Call with Analysts",
                0.8710801879
            ],
            [
                1670630400000,
                "Pfizer Presents Updated Favorable Elranatamab Data from Pivotal Phase 2 MagnetisMM-3 Trial",
                1.7900906865
            ],
            [
                1670544000000,
                "Pfizer Declares First-Quarter 2023 Dividend",
                0.7860446748
            ],
            [
                1670457600000,
                "Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years",
                2.9775726785
            ],
            [
                1670371200000,
                "U.S. FDA Accepts for Priority Review the Biologics License Application for Pfizer’s Respiratory Syncytial Virus Vaccine Candidate for the Prevention of RSV Disease in Older Adults",
                3.9204264168
            ],
            [
                1670284800000,
                "Pfizer and Clear Creek Bio to Collaborate on a Research Program Targeting SARS-CoV-2 Papain-Like Protease",
                -0.8558854536
            ],
            [
                1670198400000,
                "Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years",
                -2.4139981751
            ],
            [
                1669852800000,
                "Pfizer Invites Public to Register for Webcast of Pfizer Near-Term Launches + High-Value Pipeline Day",
                1.1785443595
            ],
            [
                1669852800000,
                "Roivant and Pfizer Form New Vant Company Focused on Developing TL1A Drug Candidate for Inflammatory and Fibrotic Diseases",
                1.1785443595
            ],
            [
                1669852800000,
                "Valneva and Pfizer Report Six-Month Antibody Persistence Data in Children and Adults for Lyme Disease Vaccine Candidate",
                1.1785443595
            ],
            [
                1669593600000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference",
                0.6263936735
            ],
            [
                1668729600000,
                "Pfizer and BioNTech Report New Data on Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Improved Immune Response Against Emerging Omicron Sublineages",
                -0.9547529919
            ],
            [
                1668124800000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference",
                4.4069897684
            ],
            [
                1668038400000,
                "Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Children 5 Through 11 Years of Age in European Union",
                0.1470552156
            ],
            [
                1668038400000,
                "Fox Chase Cancer Center and Sylvester Comprehensive Cancer Center Collaborate with Pfizer’s Institute of Translational Equitable Medicine to Identify Novel Genetic Drivers of Cancer Disparities in African Ancestry Populations",
                0.1470552156
            ],
            [
                1667520000000,
                "Pfizer and BioNTech Announce Updated Clinical Data for Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Substantially Higher Immune Response in Adults Compared to the Original COVID-19 Vaccine",
                -0.8069677732
            ],
            [
                1667433600000,
                "Pfizer’s Elranatamab Granted FDA Breakthrough Therapy Designation for Relapsed or Refractory Multiple Myeloma",
                1.8212639502
            ],
            [
                1667260800000,
                "PFIZER REPORTS STRONG THIRD-QUARTER 2022 RESULTS AND RAISES 2022 OUTLOOK",
                -1.9757864005
            ],
            [
                1667260800000,
                "Pfizer Announces Positive Top-Line Data of Phase 3 Global Maternal Immunization Trial for its Bivalent Respiratory Syncytial Virus (RSV) Vaccine Candidate",
                -1.9757864005
            ],
            [
                1666051200000,
                "Pfizer Presents Scientific Advancements in Infectious Disease Prevention and Treatments at IDWeek 2022",
                -2.1804681799
            ],
            [
                1665619200000,
                "Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older",
                2.5665004169
            ],
            [
                1665532800000,
                "Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in Children 5 Through 11 Years of Age",
                2.0707339929
            ],
            [
                1664928000000,
                "Pfizer Completes Acquisition of Global Blood Therapeutics",
                -2.3903329546
            ],
            [
                1664841600000,
                "Voyager Therapeutics Announces Pfizer License of  Next-Generation AAV Capsid for Rare Neurologic Disease Target",
                -0.2946563087
            ],
            [
                1664841600000,
                "Pfizer Announces Positive Topline Results from Phase 3 TALAPRO-2 Trial",
                -0.2946563087
            ],
            [
                1664755200000,
                "Pfizer Completes Acquisition of Biohaven Pharmaceuticals",
                0.8771871522
            ],
            [
                1664150400000,
                "Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster in Children 5 Through 11 Years of Age",
                0.6350614464
            ],
            [
                1663804800000,
                "Pfizer Declares Fourth-Quarter 2022 Dividend",
                0.9301427954
            ],
            [
                1663804800000,
                "Pfizer to Supply Global Fund Up to 6 Million PAXLOVID™ Treatment Courses for Low-and-Middle-Income Countries",
                0.9301427954
            ],
            [
                1663632000000,
                "Pfizer Invites Public to View and Listen to Webcast of November 1 Conference Call with Analysts",
                -2.4590147449
            ],
            [
                1663632000000,
                "CytoReason Announces Expanded Collaboration Deal with Pfizer to Deliver AI for Drug Discovery and Development",
                -2.4590147449
            ],
            [
                1663545600000,
                "Pfizer Announces Positive Top-Line Results from Phase 3 Study in 20-Valent Pneumococcal Conjugate Vaccine in Infants in the European Union",
                -2.0326172023
            ],
            [
                1663200000000,
                "Pfizer Announces Positive Top-Line Results from Phase 3 Trial of Pentavalent Meningococcal Vaccine Candidate (MenABCWY) in Adolescents",
                -0.1738011985
            ],
            [
                1663113600000,
                "Pfizer Invites Public to View and Listen to Webcast of Analyst and Investor Call to Review Oral GLP-1 Data Presented at European Association for the Study of Diabetes (EASD) 2022",
                -0.5659548729
            ],
            [
                1663113600000,
                "Pfizer Initiates Phase 3 Study of mRNA-Based Influenza Vaccine",
                -0.5659548729
            ],
            [
                1662940800000,
                "Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in European Union",
                -4.0918074085
            ],
            [
                1662681600000,
                "FDA and EMA Accept Regulatory Submission for Pfizer’s Ritlecitinib for Individuals 12 Years and Older with Alopecia Areata",
                1.1725292267
            ],
            [
                1662508800000,
                "FDA Grants Breakthrough Therapy Designation to Pfizer’s Group B Streptococcus Vaccine Candidate to Help Prevent Infection in Infants Via Immunization of Pregnant Women",
                2.9311793431
            ],
            [
                1662422400000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference",
                0.3685288828
            ],
            [
                1662422400000,
                "Pfizer Invites Public to View and Listen to a Webcast of Pfizer Discussion on Climate Action",
                0.3685288828
            ],
            [
                1661990400000,
                "Pfizer Invites Public to View and Listen to Two Webcasts of Pfizer Discussions at Healthcare Conferences",
                1.2253801953
            ],
            [
                1661990400000,
                "Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union",
                1.2253801953
            ],
            [
                1661904000000,
                "Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older",
                1.3296218867
            ],
            [
                1661472000000,
                "Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5 Adapted Bivalent Vaccine",
                -3.0067074557
            ],
            [
                1661385600000,
                "Pfizer Announces Positive Top-Line Data from Phase 3 Trial of Older Adults for its Bivalent Respiratory Syncytial Virus (RSV) Vaccine Candidate",
                -1.4950934848
            ],
            [
                1661212800000,
                "Pfizer and BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years of Age",
                -2.0872855572
            ],
            [
                1661126400000,
                "Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine",
                -2.4994728747
            ],
            [
                1660867200000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference",
                0.1227019009
            ],
            [
                1660262400000,
                "Pfizer Announces Positive Top-Line Results from Phase 3 Study of 20-Valent Pneumococcal Conjugate Vaccine in Infants",
                2.4120605235
            ],
            [
                1659916800000,
                "Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15",
                0.7834486196
            ],
            [
                1659916800000,
                "Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology",
                0.7834486196
            ],
            [
                1659657600000,
                "Myovant Sciences and Pfizer Receive U.S. FDA Approval of MYFEMBREE®, a Once-Daily Treatment for the Management of Moderate to Severe Pain Associated With Endometriosis",
                -0.1412088088
            ],
            [
                1658966400000,
                "PFIZER REPORTS SECOND-QUARTER 2022 RESULTS",
                -0.6731371532
            ],
            [
                1656547200000,
                "Pfizer Announces Submission of New Drug Application to the U.S. FDA for PAXLOVID™",
                1.1852469002
            ],
            [
                1656460800000,
                "Pfizer and BioNTech Announce New Agreement with U.S. Government to Provide Additional Doses of COVID-19 Vaccine",
                3.2424131721
            ],
            [
                1656374400000,
                "Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus",
                -1.7471516019
            ],
            [
                1656115200000,
                "Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron",
                -1.6186394496
            ],
            [
                1656028800000,
                "Pfizer Invites Public to View and Listen to Webcast of July 28 Conference Call with Analysts",
                2.3708535384
            ],
            [
                1655942400000,
                "Valneva and Pfizer Announce Closing of Equity Investment",
                4.5745297198
            ],
            [
                1655942400000,
                "Pfizer Declares Third-Quarter 2022 Dividend",
                4.5745297198
            ],
            [
                1655769600000,
                "Truveta Announces Strategic Collaboration with Pfizer to Accelerate Safety Insights in Real Time",
                3.566327744
            ],
            [
                1655683200000,
                "Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15",
                3.566327744
            ],
            [
                1655424000000,
                "Pfizer-BioNTech COVID-19 Vaccine Receives FDA Emergency Use Authorization for Children 6 Months through 4 Years of Age",
                1.5173539699
            ],
            [
                1655424000000,
                "Myovant Sciences and Pfizer Announce Publication in The Lancet of Phase 3 SPIRIT 1 and SPIRIT 2 Studies of Once-Daily Relugolix Combination Therapy in Women With Endometriosis-Associated Pain",
                1.5173539699
            ],
            [
                1655164800000,
                "Pfizer Reports Additional Data on PAXLOVID™ Supporting Upcoming New Drug Application Submission to U.S. FDA",
                1.5666869445
            ],
            [
                1654732800000,
                "Pfizer Completes Acquisition of ReViral",
                -6.6039618264
            ],
            [
                1654732800000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference",
                -6.6039618264
            ],
            [
                1654646400000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference",
                -4.4032583317
            ],
            [
                1654473600000,
                "Pfizer to Invest $120 Million to Produce COVID-19 Oral Treatment in the U.S.",
                1.426988608
            ],
            [
                1654387200000,
                "Pfizer Presents First Data from Planned Interim Analysis of Pivotal Phase 2 MagnetisMM-3 Trial of BCMA-CD3 Bispecific Antibody Elranatamab Under Investigation for Relapsed/Refractory           Multiple Myeloma",
                1.426988608
            ],
            [
                1654300800000,
                "Pfizer Announces Overall Survival Results from Phase 3 PALOMA-2 Trial of IBRANCE® (palbociclib) for the First-Line Treatment of ER+, HER2- Metastatic Breast Cancer",
                1.426988608
            ],
            [
                1654128000000,
                "Myovant Sciences and Pfizer Announce FDA Acceptance of Supplemental New Drug Application for MYFEMBREE®",
                1.5601546747
            ],
            [
                1654041600000,
                "Annaliesa Anderson, Ph.D., Will Lead Pfizer’s Vaccine Research & Development",
                -1.0820090331
            ],
            [
                1654041600000,
                "Pfizer Provides Update on Ownership Interest in Haleon",
                -1.0820090331
            ],
            [
                1653955200000,
                "Pfizer Invites Public to View and Listen to a Webcast of Pfizer Discussion on Expanding Access & Affordability",
                -1.8140051871
            ],
            [
                1653523200000,
                "Pfizer Granted FDA Fast Track Designation for Ervogastat/Clesacostat Combination for the Treatment of Non-Alcoholic Steatohepatitis (NASH)",
                -0.2782518374
            ],
            [
                1653436800000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference",
                1.4632361419
            ],
            [
                1653436800000,
                "Pfizer Launches ‘An Accord for a Healthier World’ to Improve Health Equity for 1.2 Billion People Living in 45 Lower-Income Countries",
                1.4632361419
            ],
            [
                1653350400000,
                "Pfizer Presents ELEVATE Pivotal Findings Demonstrating Etrasimod’s Potentially Best-in-Class Profile in Ulcerative Colitis",
                1.8618475525
            ],
            [
                1653264000000,
                "Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose",
                1.554011326
            ],
            [
                1653004800000,
                "NetVation DL Medicine Announces Research Collaboration with Pfizer Inc.",
                3.0446364739
            ],
            [
                1652745600000,
                "Pfizer and BioNTech Granted U.S. Emergency Use Authorization for Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age",
                -1.0912658081
            ],
            [
                1652400000000,
                "Pfizer and BioNTech Provide Update on COVID-19 Vaccine Supply Agreement with European Commission",
                0.5723205785
            ],
            [
                1652140800000,
                "Pfizer to Acquire Biohaven Pharmaceuticals",
                0.8291223087
            ],
            [
                1651795200000,
                "Myovant Sciences and Pfizer Provide Update on Supplemental New Drug Application (sNDA) for MYFEMBREE® for the Management of Moderate to Severe Pain Associated With Endometriosis",
                1.13076282
            ],
            [
                1651622400000,
                "Pfizer Presents Positive Real-World Evidence for First-Line IBRANCE® (palbociclib) Combination Therapy in HR+, HER2- Metastatic Breast Cancer at ESMO Breast Cancer 2022",
                -0.9081451873
            ],
            [
                1651536000000,
                "Pfizer Reports First-Quarter 2022 Results",
                1.5908250716
            ],
            [
                1651190400000,
                "Pfizer Shares Top-Line Results from Phase 2/3 EPIC-PEP Study of PAXLOVID™ for Post-Exposure Prophylactic Use",
                -3.1650783865
            ],
            [
                1651104000000,
                "Pfizer Announces 2022 Shareholder Meeting Preliminary Results",
                -2.7919293713
            ],
            [
                1651104000000,
                "Pfizer Declares Second-Quarter 2022 Dividend",
                -2.7919293713
            ],
            [
                1651104000000,
                "Pfizer to Open First U.S. Sites in Phase 3 Trial of Investigational Gene Therapy for Ambulatory Patients with Duchenne Muscular Dystrophy",
                -2.7919293713
            ],
            [
                1651017600000,
                "Zentalis Pharmaceuticals Announces $25 Million Equity Investment from Pfizer",
                2.7717293379
            ],
            [
                1651017600000,
                "Pfizer and Biohaven’s VYDURA® (Rimegepant) Granted First Ever Marketing Authorization by European Commission for Both Acute Treatment of Migraine and Prophylaxis of Episodic Migraine",
                2.7717293379
            ],
            [
                1650931200000,
                "Pfizer and BioNTech Submit Application for U.S. Emergency Use Authorization for a COVID-19 Vaccine Booster Dose in Children 5 Through 11 Years of Age",
                1.5078344993
            ],
            [
                1650931200000,
                "Valneva and Pfizer Report Positive Phase 2 Pediatric Data for Lyme Disease Vaccine Candidate",
                1.5078344993
            ],
            [
                1650585600000,
                "Pfizer Voluntary Nationwide Recall of Lots of ACCUPRIL® (Quinapril HCl) Due to N-Nitroso-Quinapril Content",
                -1.0288e-06
            ],
            [
                1650326400000,
                "Pfizer Invites Shareholders to Attend Virtual-Only 2022 Annual Meeting of Shareholders on April 28",
                -3.8391898206
            ],
            [
                1649894400000,
                "Pfizer and BioNTech Announce Data Demonstrating High Immune Response Following a Booster Dose of their COVID-19 Vaccine in Children 5 Through 11 Years of Age",
                -3.0092573799
            ],
            [
                1649721600000,
                "Myovant Sciences and Pfizer Provide Update on Supplemental New Drug Application for MYFEMBREE® for the Management of Moderate to Severe Pain Associated with Endometriosis",
                -0.3766600454
            ],
            [
                1649635200000,
                "Pfizer Names David M. Denton Chief Financial Officer",
                -4.4247670118
            ],
            [
                1649376000000,
                "Three Year Follow-Up Data from Phase 3 CROWN Trial of Pfizer’s LORBRENA® (lorlatinib) Confirm Prolonged Progression-Free Survival in First-Line ALK-Positive Advanced Lung Cancer",
                -1.705916789
            ],
            [
                1649289600000,
                "Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates",
                4.8395863675
            ],
            [
                1648512000000,
                "Pfizer and BioNTech Receive Expanded U.S. Emergency Use Authorization for an Additional COVID-19 Vaccine Booster in Individuals Aged 50 Years and Older",
                -2.9748216612
            ],
            [
                1648512000000,
                "Pfizer Announces Positive Top-line Results from Yearlong Phase 3 Trial of Etrasimod in Ulcerative Colitis, Underscoring Best-in-Class Potential",
                -2.9748216612
            ],
            [
                1648080000000,
                "Pfizer Granted FDA Breakthrough Therapy Designation for Respiratory Syncytial Virus Vaccine Candidate for the Prevention of RSV in Older Adults",
                0.4547215937
            ],
            [
                1647993600000,
                "Pfizer Announces Positive Top-Line Results for Phase 3 Trial of Etrasimod in Ulcerative Colitis Patients",
                -0.8176387439
            ],
            [
                1647907200000,
                "Pfizer Invites Public to View and Listen to Webcast of May 3 Conference Call with Analysts",
                -3.8513257921
            ],
            [
                1647907200000,
                "Pfizer to Supply UNICEF up to 4 Million Treatment Courses of Novel COVID-19 Oral Treatment for Low- and Middle-Income Countries",
                -3.8513257921
            ],
            [
                1647820800000,
                "Pfizer Voluntary Nationwide Recall of Lots of ACCURETIC™ (quinapril HCl/hydrochlorothiazide), quinapril and hydrochlorothiazide Tablets, and quinapril HCl/hydrochlorothiazide Tablets Due to N-Nitroso- Quinapril Content",
                -2.2624438884
            ],
            [
                1647302400000,
                "Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults",
                0.5668859376
            ],
            [
                1647216000000,
                "Pfizer Updates Company Position in Russia",
                2.8538501742
            ],
            [
                1646956800000,
                "Pfizer Completes Acquisition of Arena Pharmaceuticals",
                5.9521628409
            ],
            [
                1646784000000,
                "Pfizer Initiates Phase 2/3 Study of Novel COVID-19 Oral Treatment in Pediatric Participants",
                2.1747972076
            ],
            [
                1646697600000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference",
                2.3999939481
            ],
            [
                1646179200000,
                "Pfizer Granted FDA Breakthrough Therapy Designation for Respiratory Syncytial Virus (RSV) Vaccine Candidate for the Prevention of RSV in Infants from Birth up to Six Months of Age by Active Immunization of Pregnant Women",
                3.5960760907
            ],
            [
                1646092800000,
                "Phase 3 CLOVER Trial for Pfizer’s Investigational Clostridioides Difficile Vaccine Indicates Strong Potential Effect in Reducing Duration and Severity of Disease Based on Secondary Endpoints",
                2.1174041211
            ],
            [
                1646006400000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference",
                -2.3387849294
            ],
            [
                1645747200000,
                "FDA Accepts for Review Pfizer’s Supplemental Application for ABRILADA™ (adalimumab-afzb) Interchangeability",
                2.4073129888
            ],
            [
                1645747200000,
                "Biohaven and Pfizer Receive Positive CHMP Opinion for Migraine Treatment",
                2.4073129888
            ],
            [
                1645660800000,
                "Pfizer and BioNTech Receive Positive CHMP Opinion for COVID-19 Vaccine Booster in Adolescents 12 through 17 Years of Age in the European Union",
                3.897728502
            ],
            [
                1645574400000,
                "CDC Advisory Committee on Immunization Practices Votes to Recommend TicoVac™, Pfizer’s Tick-Borne Encephalitis (TBE) Vaccine, For Those at Risk of Virus Exposure",
                -3.5465617285
            ],
            [
                1645488000000,
                "Pfizer Statement on Results of Third Annual Pay Equity Study Among Colleagues Worldwide",
                -1.4294820723
            ],
            [
                1645488000000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Keynote Presentation at Healthcare Conference",
                -1.4294820723
            ],
            [
                1644883200000,
                "Pfizer and OPKO’s Once-Weekly NGENLA™ (somatrogon) Injection Receives Marketing Authorization in European Union for Treatment of Pediatric Growth Hormone Deficiency",
                -0.2415412135
            ],
            [
                1644883200000,
                "European Medicines Agency Approves Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease and Pneumonia in Adults",
                -0.2415412135
            ],
            [
                1644796800000,
                "Pfizer joins the Open Targets consortium",
                -0.0602538651
            ],
            [
                1644796800000,
                "Biohaven and Pfizer Announce Positive Top-Line Results of Pivotal Trial of Rimegepant for the Acute Treatment of Migraine in China and South Korea",
                -0.0602538651
            ],
            [
                1644537600000,
                "Pfizer and BioNTech Provide Update on Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age",
                -1.0642595526
            ],
            [
                1644364800000,
                "Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference",
                -2.055345855
            ],
            [
                1644278400000,
                "Pfizer Reports Fourth-Quarter and Full-Year 2021 Results",
                1.612595079
            ],
            [
                1643932800000,
                "Valneva and Pfizer Report Further Positive Phase 2 Data for Lyme Disease Vaccine Candidate",
                0.3570725651
            ],
            [
                1643673600000,
                "Pfizer and BioNTech Initiate Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age Following Request From U.S. FDA",
                2.0794676173
            ],
            [
                1643673600000,
                "Pfizer Announces New Chief Development Officer",
                2.0794676173
            ],
            [
                1643673600000,
                "Pfizer Invites Public to View and Listen to a Webcast with Pfizer Director Joseph Echevarria to Discuss Board Oversight of ESG",
                2.0794676173
            ],
            [
                1643587200000,
                "Pfizer and Ionis Announce Discontinuation of Vupanorsen Clinical Development Program",
                -1.7524170119
            ],
            [
                1643328000000,
                "European Commission Approves LORVIQUA® (lorlatinib) as a First-Line Treatment for ALK-Positive Advanced Lung Cancer",
                -2.0497188346
            ],
            [
                1643241600000,
                "Pfizer Receives CHMP Positive Opinion for Novel COVID-19 Oral Treatment",
                2.4111921774
            ],
            [
                1643068800000,
                "Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age",
                3.1126160712
            ],
            [
                1642982400000,
                "Pfizer and BioNTech Publish Data from Two Laboratory Studies on COVID-19 Vaccine-induced Antibodies Ability to Neutralize SARS-CoV-2 Omicron Variant",
                1.5036133462
            ],
            [
                1642723200000,
                "Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency",
                -5.5878892023
            ],
            [
                1642464000000,
                "Sema4 to Acquire GeneDx, Strengthening its Market-Leading AI-Driven Genomic and Clinical Data Platform",
                -1.7930619484
            ],
            [
                1642464000000,
                "Pfizer Shares In Vitro Efficacy of Novel COVID-19 Oral Treatment Against Omicron Variant",
                -1.7930619484
            ],
            [
                1642118400000,
                "U.S. FDA Approves Pfizer’s CIBINQO® (abrocitinib) for Adults with Moderate-to-Severe Atopic Dermatitis",
                -1.6078303053
            ],
            [
                1641945600000,
                "Positive Top-Line Results of Pfizer’s Phase 3 Study Exploring Coadministration of PREVNAR 20™ With Pfizer-BioNTech COVID-19 Vaccine in Older Adults Released",
                -1.4404126053
            ],
            [
                1641859200000,
                "Dren Bio Announces Research Collaboration and License Agreement with Pfizer to Discover and Advance Multiple Therapeutic Antibodies Using its Targeted Myeloid Engager and Phagocytosis Platform for the Treatment of Cancer",
                -0.1765211035
            ],
            [
                1641772800000,
                "Pfizer Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in mRNA Vaccines and Therapeutics",
                1.728705328
            ],
            [
                1641772800000,
                "Pfizer and Beam Enter Exclusive Multi-Target Research Collaboration to Advance Novel In Vivo Base Editing Programs for a Range of Rare Diseases",
                1.728705328
            ],
            [
                1641340800000,
                "Biohaven and Pfizer Complete Collaboration Transaction for Commercialization of Rimegepant and Zavegepant Outside United States",
                -1.8234700945
            ],
            [
                1641340800000,
                "Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine",
                -1.8234700945
            ],
            [
                1641254400000,
                "Pfizer to Provide U.S. Government with an Additional 10 Million Treatment Courses of its Oral Therapy to Help Combat COVID-19",
                -1.0605866961
            ],
            [
                1641254400000,
                "Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference",
                -1.0605866961
            ],
            [
                1641168000000,
                "Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Older",
                -7.2804018264
            ],
            [
                1640822400000,
                "Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference",
                2.2015227477
            ],
            [
                1640649600000,
                "Pfizer Invites Public to View and Listen to Webcast of February 8 Conference Call with Analysts",
                -2.5529565548
            ],
            [
                1640217600000,
                "Pfizer and BioNTech Submit Updated Longer-Term Follow-Up Data of COMIRNATY® in Adolescents 12 Through 15 Years of Age to EMA",
                -1.0472943985
            ],
            [
                1640131200000,
                "Pfizer Receives U.S. FDA Emergency Use Authorization for Novel COVID-19 Oral Antiviral Treatment",
                -0.9197803106
            ],
            [
                1640131200000,
                "Pfizer to Provide the United Kingdom an Additional 2.5 Million Treatment Courses of Investigational Oral Antiviral Candidate to Help Combat COVID-19",
                -0.9197803106
            ],
            [
                1639958400000,
                "Pfizer’s VYNDAQEL®/VYNDAMAX® Reduced the Risk of All-Cause Mortality by 41% Among Patients with Transthyretin Amyloid Cardiomyopathy, Five-Year Follow-Up Data Demonstrate",
                -2.7989828259
            ],
            [
                1639958400000,
                "Pfizer and BioNTech to Provide European Union More Than 200 Million Additional Doses of COMIRNATY® to Help Meet Continued Need for Vaccine Supply",
                -2.7989828259
            ],
            [
                1639699200000,
                "Pfizer and BioNTech Provide Update on Ongoing Studies of COVID-19 Vaccine",
                1.7862952999
            ],
            [
                1639699200000,
                "EMA Adopts a Positive CHMP Opinion for Pfizer’s and OPKO’s Somatrogon, a Long-Acting Treatment for Pediatric Growth Hormone Deficiency",
                1.7862952999
            ],
            [
                1639699200000,
                "CHMP Issues Positive Opinion for Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine for the Prevention of Vaccine-Type Pneumococcal Pneumonia in Adults",
                1.7862952999
            ],
            [
                1639699200000,
                "Pfizer Receives Positive CHMP Opinion for LORVIQUA® (lorlatinib) as First-Line Treatment for ALK-Positive Advanced Lung Cancer",
                1.7862952999
            ],
            [
                1639612800000,
                "Pfizer and BioNTech Submit Supplemental Biologics License Application for U.S. FDA Approval of COMIRNATY® in Adolescents 12 Through 15 Years of Age",
                1.8829839212
            ],
            [
                1639612800000,
                "EMA Issues Advice for Potential Early Use of Pfizer’s Novel COVID-19 Oral Antiviral Candidate",
                1.8829839212
            ],
            [
                1639612800000,
                "Anaveon to raise CHF 110 million in oversubscribed Series B financing",
                1.8829839212
            ],
            [
                1639526400000,
                "Pfizer Invests $68.5 Million in New State-of-the-Art Facility in Durham, North Carolina to Further Advance Gene Therapy Capabilities",
                8.3918338065
            ],
            [
                1639440000000,
                "U.S. FDA Approves Pfizer’s XELJANZ® (tofacitinib) for the Treatment of Active Ankylosing Spondylitis",
                6.853749525
            ],
            [
                1639440000000,
                "Pfizer Announces Additional Phase 2/3 Study Results Confirming Robust Efficacy of Novel COVID-19 Oral Antiviral Treatment Candidate in Reducing Risk of Hospitalization or Death",
                6.853749525
            ],
            [
                1639353600000,
                "Pfizer to Acquire Arena Pharmaceuticals",
                3.7810547048
            ],
            [
                1639267200000,
                "Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Bleeding Control in Highest Dose Cohort Through Two Years Following Hemophilia A Gene Therapy",
                3.7810547048
            ],
            [
                1639094400000,
                "Pfizer Declares First-Quarter 2022 Dividend",
                7.2463700144
            ],
            [
                1639094400000,
                "European Commission Approves Pfizer’s Cibinqo® (abrocitinib) for the Treatment of Adults with Moderate-to-Severe Atopic Dermatitis",
                7.2463700144
            ],
            [
                1639094400000,
                "Arvinas and Pfizer Announce PROTAC® Protein Degrader ARV-471 Continues to Demonstrate Encouraging Clinical Benefit Rate in Patients with Locally Advanced or Metastatic ER+/HER2- Breast Cancer",
                7.2463700144
            ],
            [
                1639008000000,
                "Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 16 Years and Older",
                2.4062207704
            ],
            [
                1638921600000,
                "Pfizer and BioNTech Provide Update on Omicron Variant",
                -1.2864736131
            ],
            [
                1638835200000,
                "Pfizer Invites Public to Register for Webcast of Analyst and Investor Call to Discuss Pfizer-BioNTech COVID-19 Vaccine and Pfizer’s Novel COVID-19 Oral Antiviral Treatment Candidate",
                0.2918262275
            ],
            [
                1638489600000,
                "FDA Issues Update to XELJANZ® Prescribing Information in the United States",
                -4.3317748298
            ],
            [
                1638403200000,
                "AWS Helps Pfizer Accelerate Drug Development And Clinical Manufacturing",
                0.8291822881
            ],
            [
                1638144000000,
                "Ranok Therapeutics Announces Agreement with Pfizer on Targeted Protein Degradation",
                -2.642850325
            ],
            [
                1637798400000,
                "Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 5 to under 12 Years of Age in the European Union",
                -3.1297666552
            ],
            [
                1637712000000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference",
                2.3282438545
            ],
            [
                1637712000000,
                "Pfizer Announces Topline Results from Phase 2b Trial of Vupanorsen in Statin-treated Participants with Dyslipidemia",
                2.3282438545
            ],
            [
                1637625600000,
                "Important Update on EpiPen® (epinephrine injection, USP) 0.3 mg  Auto-Injectors",
                0.6091479853
            ],
            [
                1637539200000,
                "Follow-Up Data From Phase 3 Trial of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age",
                0.2545154128
            ],
            [
                1637280000000,
                "Arvinas And Pfizer Announce Updated Phase 1 Dose Escalation Data For ARV-471 To Be Presented In Spotlight Poster Session At 2021 San Antonio Breast Cancer Symposium",
                -1.4843623911
            ],
            [
                1637280000000,
                "Pfizer and BioNTech Receive Expanded U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster to Include Individuals 18 and Older",
                -1.4843623911
            ],
            [
                1637193600000,
                "Pfizer’s XELJANZ® (tofacitinib) Receives Marketing Authorization in the European Union for the Treatment of Active Ankylosing Spondylitis",
                -0.5905715317
            ],
            [
                1637193600000,
                "Cardiff Oncology Announces $15 Million Equity Investment from Pfizer through its Pfizer Breakthrough Growth Initiative",
                -0.5905715317
            ],
            [
                1637193600000,
                "Pfizer to Provide U.S. Government with 10 Million Treatment Courses of Investigational Oral Antiviral Candidate to Help Combat COVID-19",
                -0.5905715317
            ],
            [
                1637107200000,
                "Pfizer Completes Acquisition of Trillium Therapeutics",
                2.8593827127
            ],
            [
                1637107200000,
                "Pfizer Announces Retirement of Chief Financial Officer Frank D’Amelio",
                2.8593827127
            ],
            [
                1637020800000,
                "Pfizer Seeks Emergency Use Authorization for Novel COVID-19 Oral Antiviral Candidate",
                2.7521037864
            ],
            [
                1637020800000,
                "Pfizer and The Medicines Patent Pool (MPP) Sign Licensing Agreement for COVID-19 Oral Antiviral Treatment Candidate to Expand Access in Low- and Middle-Income Countries",
                2.7521037864
            ],
            [
                1636675200000,
                "Pfizer Names Bill Sessa, Ph.D., Chief Scientific Officer to Lead Internal Medicine Research",
                -1.5508443947
            ],
            [
                1636588800000,
                "Zipline, Pfizer and BioNTech Collaboration Paves the Way for Automated, On-Demand Delivery of First mRNA COVID-19 Vaccines in Ghana",
                1.0054141333
            ],
            [
                1636502400000,
                "Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference",
                5.5400626519
            ],
            [
                1636416000000,
                "Pfizer and BioNTech Submit Request to Amend U.S. FDA Emergency Use Authorization of Their COVID-19 Vaccine Booster to Include All Individuals 18 and Older",
                1.4075882103
            ],
            [
                1636416000000,
                "Biohaven and Pfizer Enter Strategic Collaboration for the Commercialization of Rimegepant Outside the United States",
                1.4075882103
            ],
            [
                1636070400000,
                "Pfizer’s Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89% in Interim Analysis of Phase 2/3 EPIC-HR Study",
                0.4965935716
            ],
            [
                1635811200000,
                "PFIZER REPORTS THIRD-QUARTER 2021 RESULTS",
                -0.5801125588
            ],
            [
                1635465600000,
                "Pfizer and BioNTech Receive First U.S. FDA Emergency Use Authorization of a COVID-19 Vaccine in Children Ages 5 Through 11 Years",
                1.2603145615
            ],
            [
                1635379200000,
                "Pfizer and BioNTech to Provide U.S. Government an Additional 50 Million Pediatric Doses of COVID-19 Vaccine to Support Further Preparedness for Future Needs",
                1.806128983
            ],
            [
                1635206400000,
                "FDA Advisory Committee Votes in Favor of Granting Emergency Use Authorization for the Pfizer-BioNTech COVID-19 Vaccine in Children 5 to <12 Years",
                -0.8378072325
            ],
            [
                1634774400000,
                "Pfizer and BioNTech Announce Phase 3 Trial Data Showing High Efficacy of a Booster Dose of Their COVID-19 Vaccine",
                0.2316864772
            ],
            [
                1634688000000,
                "Advisory Committee on Immunization Practices Votes to Recommend Routine Use of Pfizer’s PREVNAR 20™ (Pneumococcal 20-valent Conjugate Vaccine) in Adults",
                1.7265710131
            ],
            [
                1634601600000,
                "Myovant Sciences and Pfizer Present Data on Relugolix Combination Therapy from Studies in Uterine Fibroids and Endometriosis at the American Society for Reproductive Medicine Congress",
                2.803736816
            ],
            [
                1634515200000,
                "New Formulation of COMIRNATY® Receives Positive Opinion from CHMP",
                1.5205432993
            ],
            [
                1634256000000,
                "Pfizer and BioNTech Submit Data to EMA for the Vaccination of Children 5 to <12 Years of Age with COMIRNATY®",
                -1.4036791239
            ],
            [
                1634256000000,
                "Pfizer’s Abrocitinib Receives Positive CHMP Opinion for the Treatment of Adults with Moderate to Severe Atopic Dermatitis",
                -1.4036791239
            ],
            [
                1634083200000,
                "AION Labs, Biotech Innovation Lab Launched by Top Pharma, Tech and Investment Leaders",
                -0.1919973729
            ],
            [
                1633305600000,
                "Pfizer and BioNTech Receive CHMP Positive Opinion for COVID-19 Vaccine Booster in the European Union",
                -1.4413949209
            ],
            [
                1632960000000,
                "Japan’s MHLW Approves Pfizer’s CIBINQO® (abrocitinib) for Adults and Adolescents with Moderate to Severe Atopic Dermatitis",
                -2.003258152
            ],
            [
                1632873600000,
                "Positive Top-line Results of Pfizer’s Phase 3 Study Exploring Coadministration of Prevnar 20™ With Seasonal Flu Vaccine in Older Adults Released",
                -0.4882577422
            ],
            [
                1632787200000,
                "Valneva and Pfizer Report Further Positive Phase 2 Results, Including Booster Response, for Lyme Disease Vaccine Candidate",
                1.0567295447
            ],
            [
                1632787200000,
                "Pfizer and BioNTech Submit Initial Data to U.S. FDA From Pivotal Trial of COVID-19 Vaccine in Children 5 to <12 Years of Age",
                1.0567295447
            ],
            [
                1632700800000,
                "Pfizer Starts Study of mRNA-Based Next Generation Flu Vaccine Program",
                -2.0445995103
            ],
            [
                1632700800000,
                "Pfizer Starts Global Phase 2/3 EPIC-PEP Study of Novel COVID-19 Oral Antiviral Candidate for Post-Exposure Prophylaxis in Adults",
                -2.0445995103
            ],
            [
                1632441600000,
                "Pfizer and OPKO Announce Extension of U.S. FDA Review of Biologics License Application of Somatrogon for Pediatric Growth Hormone Deficiency",
                -1.1475830295
            ],
            [
                1632355200000,
                "Pfizer Declares Fourth-Quarter 2021 Dividend",
                -0.7737840848
            ],
            [
                1632268800000,
                "Pfizer and BioNTech Expand Collaboration with U.S. to Provide 500 Million Additional COVID-19 Vaccine Doses at Not-for-Profit Price for Donation to Poorest Countries",
                0.452581165
            ],
            [
                1632096000000,
                "Pfizer and BioNTech Announce Positive Topline Results From Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years",
                1.2067232117
            ],
            [
                1631836800000,
                "FDA Advisory Committee Votes Unanimously in Favor Of COMIRNATY® Booster for Emergency Use in People 65 and Older and Certain High-risk Populations",
                0.0678867223
            ],
            [
                1631836800000,
                "Astellas’ and Pfizer’s XTANDI® (enzalutamide) Reduced Risk of Death by 34% in Men with Metastatic Hormone-Sensitive Prostate Cancer in Phase 3 ARCHES Study",
                0.0678867223
            ],
            [
                1631836800000,
                "Pfizer Expands Voluntary Nationwide Recall to include All Lots of CHANTIX® (varenicline) Tablets Due to N-Nitroso Varenicline Content",
                0.0678867223
            ],
            [
                1631750400000,
                "Anjarium Biosciences Raises CHF 55.5M ($61M) Series A Financing to Develop Next-Generation Non-viral Gene Therapies",
                -2.2556417704
            ],
            [
                1631145600000,
                "Myovant Sciences and Pfizer Announce FDA Acceptance of Supplemental New Drug Application for MYFEMBREE® for the Management of Moderate to Severe Pain Associated With Endometriosis",
                -1.9302287473
            ],
            [
                1631145600000,
                "UK’s MHRA Grants Marketing Authorisation for Pfizer’s CIBINQO® (abrocitinib) for Adults and Adolescents With Moderate to Severe Atopic Dermatitis",
                -1.9302287473
            ],
            [
                1630972800000,
                "Pfizer Invites Public to Listen to Two Webcasts of Pfizer Discussions at Upcoming Healthcare Conferences",
                -1.0320409374
            ],
            [
                1630886400000,
                "Pfizer and BioNTech Submit a Variation to EMA with the Data in  Support of a Booster Dose of COMIRNATY®",
                -1.0320409374
            ],
            [
                1630627200000,
                "The Bristol-Myers Squibb-Pfizer Alliance is pleased with the decision by the U.S.  Court of Appeals for the Federal Circuit upholding the Eliquis®Patents",
                -0.3208589985
            ],
            [
                1630540800000,
                "Pfizer Announces Start of Phase 3 Clinical Trial in Adults for Its Investigational Vaccine Against Respiratory Syncytial Virus (RSV)",
                0.768575169
            ],
            [
                1630454400000,
                "FDA Issues Drug Safety Communication Related to Current XELJANZ® Label",
                1.3877030832
            ],
            [
                1630454400000,
                "First Participant Dosed in Phase 2/3 Study of Oral Antiviral Candidate  in Non-Hospitalized Adults with COVID-19 Who Are at Low Risk of  Severe Illness",
                1.3877030832
            ],
            [
                1630281600000,
                "Positive Top-Line Results From Pfizer’s Phase 3 JADE DARE Trial Comparing the Efficacy of Abrocitinib and Dupilumab for Moderate to Severe Atopic Dermatitis",
                -0.2821792975
            ],
            [
                1629936000000,
                "Pfizer Announces New Chief Business Innovation Officer",
                -2.3605357359
            ],
            [
                1629936000000,
                "Pfizer and BioNTech Announce Collaboration With Brazil’s Eurofarma to Manufacture COVID-19 Vaccine Doses for Latin America",
                -2.3605357359
            ],
            [
                1629849600000,
                "Pfizer and BioNTech Initiate Rolling Submission of Supplemental Biologics License Application to U.S. FDA for Booster Dose of COMIRNATY® in Individuals 16 and Older",
                -1.3929903917
            ],
            [
                1629676800000,
                "Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older",
                -3.9479041433
            ],
            [
                1629676800000,
                "Pfizer to Acquire Trillium Therapeutics Inc.",
                -3.9479041433
            ],
            [
                1629417600000,
                "XELJANZ® (tofacitinib citrate) Receives Marketing Authorization in the European Union for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis",
                1.9026485576
            ],
            [
                1629072000000,
                "Pfizer Prices $1.0 Billion Sustainability Bond",
                4.3435140567
            ],
            [
                1629072000000,
                "Pfizer and BioNTech Announce Submission of Initial Data to U.S. FDA to Support Booster Dose of COVID-19 Vaccine",
                4.3435140567
            ],
            [
                1628812800000,
                "U.S. FDA Approves TICOVAC™, Pfizer’s Tick-Borne Encephalitis (TBE) Vaccine",
                3.0668668806
            ],
            [
                1628812800000,
                "Pfizer Expands Voluntary Nationwide Recall to include Four  Additional Lots of CHANTIX® (varenicline) Tablets Due to N-Nitroso Varenicline Content",
                3.0668668806
            ],
            [
                1628726400000,
                "VTX-801 Receives U.S. FDA Fast Track Designation for the Treatment of Wilson Disease",
                4.0841434391
            ],
            [
                1628035200000,
                "Pfizer Announces Positive Top-Line Results from Phase 2b/3 Trial of Ritlecitinib in Alopecia Areata",
                -0.6435687599
            ],
            [
                1627430400000,
                "Pfizer and BioNTech Share Detailed Update to the Results from 6 Month Safety and  Efficacy Data Analysis of Landmark COVID-19 Vaccine Study",
                1.91663523
            ],
            [
                1627430400000,
                "PFIZER REPORTS SECOND-QUARTER 2021 RESULTS",
                1.91663523
            ],
            [
                1626998400000,
                "Pfizer and BioNTech to Provide U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S.",
                0.8371240577
            ],
            [
                1626912000000,
                "Arvinas And Pfizer Announce Global Collaboration To Develop And Commercialize Protac® Protein Degrader Arv-471",
                1.3435776188
            ],
            [
                1626912000000,
                "Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein Degrader ARV-471",
                1.3435776188
            ],
            [
                1626825600000,
                "Pfizer Provides Update on U.S. FDA Review of Abrocitinib and XELJANZ® Filings",
                0.5546110479
            ],
            [
                1626825600000,
                "Pfizer and BioNTech Announce Collaboration With Biovac to Manufacture and Distribute COVID-19 Vaccine Doses Within Africa",
                0.5546110479
            ],
            [
                1626652800000,
                "Valneva and Pfizer Complete Recruitment for Phase 2 Trial of Lyme Disease Vaccine Candidate",
                2.3873294263
            ],
            [
                1626652800000,
                "Pfizer Announces New Investor Relations Leader",
                2.3873294263
            ],
            [
                1626393600000,
                "Pfizer Issues A Voluntary Nationwide Recall for Twelve Lots of  CHANTIX® (varenicline) Tablets Due to N-Nitroso Varenicline  Content",
                0.0249261368
            ],
            [
                1626393600000,
                "U.S. FDA Grants Priority Review for the Biologics License Application for Pfizer-BioNTech COVID-19 Vaccine",
                0.0249261368
            ],
            [
                1625702400000,
                "Pfizer and BioNTech Provide Update on Booster Program in Light of the Delta-Variant",
                1.5400160343
            ],
            [
                1625702400000,
                "Newly Published Expert Opinion Article Details Evidence for Classifying Aging Immune System as a High-Risk Condition for Pneumococcal Vaccine Policy",
                1.5400160343
            ],
            [
                1625702400000,
                "Collaboration Between Abbvie, Biogen And Pfizer Creates World's Largest Browsable Resource Linking Rare Protein-Coding Genetic Variants To Human Health And Disease.",
                1.5400160343
            ],
            [
                1625702400000,
                "Collaboration Between Abbvie, Biogen and Pfizer Creates World's Largest Browsable Resource Linking Rare Protein-Coding Genetic Variants to Human Health and Disease",
                1.5400160343
            ],
            [
                1625011200000,
                "Spero Therapeutics Announces $40 Million Equity Investment from Pfizer Inc. and Licensing Agreement for SPR206",
                1.0616965092
            ],
            [
                1624492800000,
                "Pfizer Declares Third-Quarter 2021 Dividend",
                -0.4104503628
            ],
            [
                1624406400000,
                "First Participant Dosed in Pfizer’s Pivotal Phase 3 TALAPRO-3 Combination Study of Talazoparib and Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer (mCSPC)",
                -1.1227455039
            ],
            [
                1624320000000,
                "SVI announces collaboration with Pfizer",
                -0.9219026142
            ],
            [
                1623801600000,
                "Data Published in New England Journal of Medicine Shows Pfizer’s Tofacitinib Meets Primary Endpoint in Brazilian Study in Patients Hospitalized with COVID-19 Pneumonia",
                -0.3546189538
            ],
            [
                1623801600000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer July 28 Conference Call with Analysts",
                -0.3546189538
            ],
            [
                1623369600000,
                "XELJANZ® Safety Review Recommendation Issued in the European Union",
                -2.5990509524
            ],
            [
                1623283200000,
                "Pfizer and BioNTech to Provide 500 Million Doses of COVID-19 Vaccine to U.S. Government for Donation to Poorest Nations",
                0.6226744249
            ],
            [
                1623110400000,
                "U.S. FDA Approves PREVNAR 20™, Pfizer’s Pneumococcal 20-valent Conjugate Vaccine for Adults Ages 18 Years or Older",
                1.858842403
            ],
            [
                1622505600000,
                "IMI SOPHIA PARTNERS WITH MACCABI’S RESEARCH AND INNOVATION CENTER (KSM), PFIZER, AND LAUSANNE UNIVERSITY HOSPITAL TO IMPROVE OBESITY TREATMENT",
                -0.3866903036
            ],
            [
                1622160000000,
                "Pfizer and BioNTech Receive First Authorization in European Union for COVID-19 Vaccine in Adolescents",
                -0.6493729606
            ],
            [
                1622160000000,
                "Pfizer Colleagues to Mentor Veterans in Transition to Civilian Life",
                -0.6493729606
            ],
            [
                1622073600000,
                "RefleXion Announces New Additions to Board of Directors and Appoints Audit Committee Chair",
                -0.6196514216
            ],
            [
                1621987200000,
                "Myovant Sciences and Pfizer Receive FDA Approval for MYFEMBREE®, the First Once-Daily Treatment for Heavy Menstrual Bleeding Associated With Uterine Fibroids",
                -1.6559099687
            ],
            [
                1621987200000,
                "The Foundation for the NIH Announces a New Research Initiative to Find Integrated Treatments Across Common Metabolic Diseases",
                -1.6559099687
            ],
            [
                1621814400000,
                "Pfizer Initiates Study Exploring Coadministration of Its 20-valent Pneumococcal Conjugate Vaccine Candidate Along With a Third Dose of the Pfizer-BioNTech COVID-19 Vaccine in Older Adults",
                -1.9069506383
            ],
            [
                1621468800000,
                "Pfizer and BioNTech to Supply the European Union With up to 1.8 Billion Additional Doses of COMIRNATY®",
                0.5507003872
            ],
            [
                1621382400000,
                "Sosei Heptares announces that the third novel drug candidate from its multi-target drug discovery collaboration with Pfizer has started clinical trials",
                0.5483491948
            ],
            [
                1620691200000,
                "Pfizer’s Novel Prediction Model, Derived from Machine Learning, Shows Robust Performance for Identifying Heart Failure Patients At-Risk for Wild-Type Transthyretin Amyloid Cardiomyopathy, a Rare and Life-Threatening Condition",
                0.0251835472
            ],
            [
                1620604800000,
                "Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents",
                -1.2198247949
            ],
            [
                1620345600000,
                "Pfizer and BioNTech Initiate Rolling Submission of Biologics License Application for U.S. FDA Approval of Their COVID 19 Vaccine",
                2.0321184226
            ],
            [
                1620259200000,
                "Pfizer and BioNTech to Provide COVID-19 Vaccine Doses for Olympic Athletes at the 2020 Tokyo Games",
                2.7791918314
            ],
            [
                1620086400000,
                "Hospira Issues A Voluntary Nationwide Recall for One Lot of  0.5% Bupivacaine Hydrochloride Injection, USP and One Lot of 1%  Lidocaine HCl Injection, USP Due to Mislabeling",
                -0.0750542248
            ],
            [
                1620086400000,
                "Hospira Issues A Voluntary Nationwide Recall for One Lot of  Sterile Water for Injection, USP, Due to the Potential Presence of Visible Particulate",
                -0.0750542248
            ],
            [
                1620086400000,
                "PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS",
                -0.0750542248
            ],
            [
                1619654400000,
                "Pfizer Ventures' Barbara Dalton Appointed as AMRA Medical's Newest Board Member",
                -0.8797027835
            ],
            [
                1619568000000,
                "Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference",
                0.155445173
            ],
            [
                1619568000000,
                "Pfizer Acquires Amplyx Pharmaceuticals",
                0.155445173
            ],
            [
                1619568000000,
                "Pfizer Acquires Amplyx Pharmaceuticals",
                0.155445173
            ],
            [
                1619049600000,
                "Pfizer Announces 2021 Shareholder Meeting Results",
                -2.1210664141
            ],
            [
                1619049600000,
                "Pfizer Declares Second-Quarter 2021 Dividend",
                -2.1210664141
            ],
            [
                1618790400000,
                "Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®",
                1.1017117711
            ],
            [
                1618444800000,
                "Pfizer Invites Shareholders to Attend Virtual-Only 2021 Annual Meeting of Shareholders on April 22",
                3.3964457913
            ],
            [
                1618358400000,
                "AMRA Medical Generates Largest Imaging Dataset on Body Composition Profiling",
                1.1436044496
            ],
            [
                1618185600000,
                "Myovant Sciences and Pfizer Announce First Participant Dosed in Phase 3 SERENE Study Evaluating Contraceptive Efficacy of Once-Daily Relugolix Combination Tablet",
                1.829925252
            ],
            [
                1617926400000,
                "Pfizer and BioNTech Request Regulatory Agencies Expand  Emergency Use of Their COVID-19 Vaccine to Adolescents",
                2.8942496401
            ],
            [
                1617753600000,
                "Pfizer Announces Extension of Review of New Drug Application of Abrocitinib for the Treatment of Moderate to Severe Atopic Dermatitis",
                -0.1946402213
            ],
            [
                1617321600000,
                "Pfizer Invites Public to Register for Webcast of Analyst and Investor Call to Review Oncology Business on April 9, 2021",
                -1.0818153766
            ],
            [
                1617235200000,
                "Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study",
                -0.0551607636
            ],
            [
                1617148800000,
                "Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents",
                0.4132351097
            ],
            [
                1616716800000,
                "EMA Approves New Storage Option for Pfizer-BioNTech Vaccine, Easing Distribution and Storage of Doses Across European Union",
                2.5669110959
            ],
            [
                1616630400000,
                "Joint FDA Advisory Committee Votes on Application for Tanezumab for the Treatment of Osteoarthritis Pain",
                1.6551682929
            ],
            [
                1616630400000,
                "Results from Pfizer’s Phase 3 Jade Compare Study of Abrocitinib in Moderate to Severe Atopic Dermatitis Published in New England Journal of Medicine",
                1.6551682929
            ],
            [
                1616630400000,
                "Real-World Evidence Supports Effectiveness of First-line IBRANCE® (palbociclib) Combination Therapy in HR+, HER2- Metastatic Breast Cancer",
                1.6551682929
            ],
            [
                1616544000000,
                "Myovant Sciences and Pfizer Announce Positive Data from Phase 3 LIBERTY Randomized Withdrawal Study of Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids",
                0.5326526217
            ],
            [
                1616457600000,
                "Pfizer Initiates Phase 1 Study of Novel Oral Antiviral Therapeutic Agent Against SARS-CoV-2",
                -0.5897229625
            ],
            [
                1616457600000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer May 4 Conference Call with Analysts",
                -0.5897229625
            ],
            [
                1615939200000,
                "Mediar Therapeutics Adds New Investors As It Advances Anti-Fibrotic Treatments",
                -0.1677639439
            ],
            [
                1615420800000,
                "Real-World Evidence Confirms High Effectiveness of Pfizer-BioNTech COVID-19 Vaccine and Profound Public Health Impact of Vaccination One Year After Pandemic Declared",
                -0.3720719034
            ],
            [
                1615161600000,
                "Valneva and Pfizer Announce Initiation of Phase 2 Study for Lyme Disease Vaccine Candidate",
                -0.0870730596
            ],
            [
                1614816000000,
                "Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference",
                0.3780079242
            ],
            [
                1614729600000,
                "U.S. FDA Expands Approval of Pfizer’s LORBRENA® as First-Line Treatment for ALK-Positive Metastatic Lung Cancer",
                2.0175628086
            ],
            [
                1614729600000,
                "Pfizer-BioNTech’s COVID-19 Vaccine Arrives in Rwanda",
                2.0175628086
            ],
            [
                1614297600000,
                "European Medicines Agency Accepts Pfizer’s Marketing Authorization Application for Its Investigational 20-valent Pneumococcal Conjugate Vaccine for Adults 18 Years of Age or Older",
                -0.4452356296
            ],
            [
                1614297600000,
                "EMA Accepts Marketing Application for Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency",
                -0.4452356296
            ],
            [
                1614211200000,
                "Pfizer Statement on Results of Second Annual Pay Equity Study  Among Colleagues Worldwide",
                -0.9853535321
            ],
            [
                1614211200000,
                "Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants",
                -0.9853535321
            ],
            [
                1614038400000,
                "U.S. FDA Accepts for Priority Review Pfizer’s Application for TicoVac™ (Tick-borne Encephalitis Vaccine)",
                -0.7407426902
            ],
            [
                1613952000000,
                "Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference",
                -1.2385742185
            ],
            [
                1613692800000,
                "President Biden Visits Pfizer’s Kalamazoo Manufacturing Facility",
                -1.1675596167
            ],
            [
                1613692800000,
                "Pfizer and BioNTech Submit COVID-19 Vaccine Stability Data at Standard Freezer Temperature to the U.S. FDA",
                -1.1675596167
            ],
            [
                1613606400000,
                "Pfizer and BioNTech Commence Global Clinical Trial to Evaluate COVID-19 Vaccine in Pregnant Women",
                -0.9872057431
            ],
            [
                1613520000000,
                "Myovant Sciences and Pfizer Announce Publication in the New England Journal of Medicine of Phase 3 LIBERTY Studies of Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids",
                -0.028933215
            ],
            [
                1613520000000,
                "Imcyse Raises Additional EUR 21.3 Million in Series B Financing Round - Pfizer Joins as Newest Shareholder",
                -0.028933215
            ],
            [
                1613520000000,
                "Pfizer Initiates Pivotal Phase 2 MagnetisMM-3 Trial of BCMA-CD3 Bispecific Antibody Elranatamab (PF-06863135) in Multiple Myeloma",
                -0.028933215
            ],
            [
                1613520000000,
                "Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®",
                -0.028933215
            ],
            [
                1613520000000,
                "In Vitro Study Published in The New England Journal of Medicine Demonstrates Sera from Individuals Immunized with the Pfizer- BioNTech COVID-19 Vaccine Neutralize SARS-CoV-2 with South African Variant Spike Mutations",
                -0.028933215
            ],
            [
                1613088000000,
                "U.S. FDA Approves PANZYGA® for the Treatment of Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)",
                0.7206701206
            ],
            [
                1613088000000,
                "Pfizer and BioNTech to Supply the United States with 100 Million Additional Doses of COVID-19 Vaccine",
                0.7206701206
            ],
            [
                1612828800000,
                "Pfizer And Ida Foundation Partner To Expand Access To Essential Cancer Treatments In  70 Low-And Lower-Middle-Income Countries New Partnership Broadens Access To Oncology Treatments Across Latin America, Asia, Africa And The  Western Pacific.",
                -0.1727373083
            ],
            [
                1612828800000,
                "Pfizer and IDA Foundation Partner to Expand Access to Essential Cancer Treatments in 70 Low- and Lower-Middle-Income Countries",
                -0.1727373083
            ],
            [
                1612742400000,
                "Palleon Pharmaceuticals Appoints Nikola Trbovic to its Board of Directors",
                0.0286282912
            ],
            [
                1612742400000,
                "Pfizer and BioNTech Publish Data from In Vitro Studies in Nature Medicine Demonstrating COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with Key Mutations Present in U.K. and South African Variants",
                0.0286282912
            ],
            [
                1612483200000,
                "Pfizer Confirms U.S. Patent Term Extension for IBRANCE® (palbociclib) Until March 2027",
                -0.287192213
            ],
            [
                1612224000000,
                "PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2020 RESULTS AND RELEASES 5-YEAR PIPELINE METRICS",
                -2.6406526209
            ],
            [
                1612137600000,
                "Pfizer and BioNTech Publish Preclinical Data from Investigational COVID-19 Vaccine  Program in Nature",
                -2.6864745227
            ],
            [
                1611878400000,
                "Pfizer and BioNTech Publish Data on COVID-19 Vaccine-Induced Antibodies’ Ability to Neutralize SARS-CoV-2 U.K. Strain Pseudovirus in Cell Culture in Science",
                -3.0167592985
            ],
            [
                1611705600000,
                "Pfizer Shares Co-Primary Endpoint Results from Post-Marketing Required Safety Study of XELJANZ® (tofacitinib) in Subjects with Rheumatoid Arthritis (RA)",
                -2.0410903353
            ],
            [
                1611705600000,
                "In Vitro Studies Demonstrate Pfizer and BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with Key Mutations Present in U.K. and South African Variants",
                -2.0410903353
            ],
            [
                1611619200000,
                "Myovant Sciences and Pfizer Announce Positive One-Year Data from Phase 3 SPIRIT Extension Study of Once-Daily Relugolix Combination Therapy in Women with Endometriosis",
                -2.8421678167
            ],
            [
                1611619200000,
                "Statement on ATMI Ranking",
                -2.8421678167
            ],
            [
                1611532800000,
                "European Commission Approves BAVENCIO® (avelumab) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma",
                2.0369921016
            ],
            [
                1611273600000,
                "Pfizer and BioNTech Reach Agreement with COVAX for Advance Purchase of Vaccine to Help Combat COVID-19",
                2.5750930784
            ],
            [
                1611273600000,
                "Ten Leading BioPharma Companies Announce Formation of Accumulus Synergy to Develop Global Data Sharing Platform",
                2.5750930784
            ],
            [
                1611187200000,
                "Cerevel Therapeutics Announces the Appointments of Deval Patrick and Deborah Baron to its Board of Directors",
                0.4377786245
            ],
            [
                1611100800000,
                "Pfizer and BioNTech Publish Results of Study Showing COVID-19  Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the  SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture",
                -0.8498025442
            ],
            [
                1610668800000,
                "Statement by Pfizer Chairman and CEO Albert Bourla",
                0.136135812
            ],
            [
                1610668800000,
                "Statement on European Upscaling as well as Impact on Deliveries",
                0.136135812
            ],
            [
                1610582400000,
                "Pfizer’s XALKORI® (crizotinib) Approved by FDA for ALK-positive Anaplastic Large Cell Lymphoma in Children and Young Adults",
                -0.2179829491
            ],
            [
                1610409600000,
                "Vedanta Biosciences Announces $25 Million Investment from Pfizer Inc.",
                -2.2788840563
            ],
            [
                1610409600000,
                "Pfizer Invests $120 Million in Biotechnology Innovation Through the Pfizer Breakthrough Growth Initiative",
                -2.2788840563
            ],
            [
                1610236800000,
                "Codex DNA Signs Early Access Collaboration and Licensing Agreement with Pfizer to FurtherDevelop CodexDNA’s Novel Enzymatic DNA Synthesis Technology for Pfizer’s use in its Research and  Development ofmRNA-based Vaccines and Biotherapies",
                -0.1076083661
            ],
            [
                1610064000000,
                "An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission",
                1.6150435079
            ],
            [
                1609977600000,
                "Pfizer Doses First Participant in Phase 3 Study for Duchenne Muscular Dystrophy Investigational Gene Therapy",
                0.2423919985
            ],
            [
                1609804800000,
                "Pfizer Invites Public to Listen to Two Webcasts of Pfizer Discussions at Healthcare Conference",
                0.4068379283
            ],
            [
                1609718400000,
                "US FDA Accepts Regulatory Submission from Pfizer and OPKO for Review of Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency",
                0.8604437595
            ],
            [
                1609200000000,
                "Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®",
                -0.4355240597
            ],
            [
                1609113600000,
                "LORBRENA® (lorlatinib) sNDA in Previously Untreated ALK-Positive Lung Cancer Accepted for Priority Review by U.S. FDA",
                -0.8366931037
            ],
            [
                1609113600000,
                "Myovant Sciences and Pfizer Announce Collaboration to Develop and Commercialize Relugolix in Oncology and Women's Health",
                -0.8366931037
            ],
            [
                1608681600000,
                "Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine",
                0.6976195537
            ],
            [
                1608595200000,
                "Pfizer Invites Public to View and Listen to Webcast of February 2 Conference Call with Analysts",
                0.6143262212
            ],
            [
                1608508800000,
                "Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine",
                -1.4697948477
            ],
            [
                1608508800000,
                "Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine",
                -1.4697948477
            ],
            [
                1608163200000,
                "Pfizer COVID-19 Vaccine Production and Distribution Working Well",
                -0.3981042368
            ],
            [
                1607990400000,
                "Pfizer Doses First Participants as Part of Global Achondroplasia Phase 2 Development Program",
                -3.224092846
            ],
            [
                1607904000000,
                "Pfizer and BioNTech Provide Data from German Phase 1/2 Study Further Characterizing Immune Response Following Immunization with Lead COVID-19 Vaccine Candidate BNT162b2",
                -7.5174524339
            ],
            [
                1607731200000,
                "U.S. CDC Committee of Independent Health Experts Recommends Vaccination with Pfizer and BioNTech COVID-19 Vaccine for Persons Ages 16 Years and Older",
                -7.5174524339
            ],
            [
                1607644800000,
                "Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19",
                -7.0390128333
            ],
            [
                1607644800000,
                "BAVENCIO® (avelumab) Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma",
                -7.0390128333
            ],
            [
                1607644800000,
                "BAVENCIO® (avelumab) Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma",
                -7.0390128333
            ],
            [
                1607644800000,
                "Pfizer Declares First-Quarter 2021 Dividend",
                -7.0390128333
            ],
            [
                1607558400000,
                "Pfizer and BioNTech Receive FDA Advisory Committee Vote Supporting Potential First Emergency Use Authorization for Vaccine to Combat COVID-19 in the U.S.",
                -1.7023417382
            ],
            [
                1607558400000,
                "Pfizer and BioNTech Announce Publication of Results from Landmark Phase 3 Trial of BNT162b2 COVID-19 Vaccine Candidate in The New England Journal of Medicine",
                -1.7023417382
            ],
            [
                1607472000000,
                "Statement on EMA Cyberattack",
                -3.2111339719
            ],
            [
                1607385600000,
                "U.S. FDA Accepts for Priority Review the Biologics License Application for Pfizer’s Investigational 20-valent Pneumococcal Conjugate Vaccine for Adults 18 Years of Age and Older",
                1.075267324
            ],
            [
                1607299200000,
                "PostEra enters a multi-year strategic partnership with Pfizer Inc. to advance machine  learning for Drug Discovery",
                4.4642755563
            ],
            [
                1607299200000,
                "Pfizer Reports Positive Clinical Data for BCMA-CD3 Bispecific Antibody (PF-06863135) in Multiple Myeloma",
                4.4642755563
            ],
            [
                1607299200000,
                "Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Factor VIII Activity Levels in 3x10¹³ VG/KG Cohort Through One Year Following Hemophilia A Gene Therapy",
                4.4642755563
            ],
            [
                1606867200000,
                "Pfizer and BioNTech Achieve First Authorization in the World for a Vaccine to Combat COVID-19",
                -0.9478837376
            ],
            [
                1606780800000,
                "Pfizer and BioNTech Submitted Application for Conditional Marketing Authorization for COVID-19 Vaccine to the EMA",
                3.4313752468
            ],
            [
                1606780800000,
                "Pfizer and BioNTech Submitted Application for Conditional Marketing  Authorization for COVID-19 Vaccine to the EMA",
                3.4313752468
            ],
            [
                1606089600000,
                "Pfizer Doses First Participant in Phase 3 Study Evaluating anti-TFPI Investigational Therapy, Marstacimab, for People With Severe Hemophilia A and B With or Without Inhibitors",
                -1.1748727906
            ],
            [
                1605830400000,
                "Pfizer Receives European Approval for Oncology Supportive Care Biosimilar, NYVEPRIATM (pegfilgrastim)",
                -0.4928833262
            ],
            [
                1605830400000,
                "Pfizer and BioNTech to Submit Emergency Use Authorization Request Today to the U.S. FDA for COVID-19 Vaccine",
                -0.4928833262
            ],
            [
                1605744000000,
                "Pfizer and LianBio Announce Strategic Collaboration to Expand Development of Novel Therapeutics in Greater China",
                0.2725047072
            ],
            [
                1605744000000,
                "Results from Phase 3 CROWN Trial of Pfizer’s LORBRENA® (lorlatinib) in Previously Untreated ALK-Positive Lung Cancer Published in the New England Journal of Medicine",
                0.2725047072
            ],
            [
                1605657600000,
                "Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints",
                -2.0447772091
            ],
            [
                1605484800000,
                "PFIZER UPDATE ON OUR U.S. COVID-19 VACCINE CANDIDATE  DISTRIBUTION PREPAREDNESS",
                0.3321210481
            ],
            [
                1605484800000,
                "Pfizer Update On Our U.S. COVID-19 Vaccine Candidate Distribution Preparedness",
                0.3321210481
            ],
            [
                1605484800000,
                "Pfizer Completes Transaction to Combine Its Upjohn Business with Mylan",
                0.3321210481
            ],
            [
                1605139200000,
                "Analysis from Phase 3 ATTR-ACT and Its Long-Term Extension Study Demonstrates VYNDAQEL® 80 mg/VYNDAMAX® 61 mg Significantly Improved Survival in Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Compared to VYNDAQEL 20 mg",
                0.8803855623
            ],
            [
                1605052800000,
                "Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference",
                -3.5419498083
            ],
            [
                1605052800000,
                "Pfizer Announces Positive Results from Fifth Phase 3 Trial of Abrocitinib, Evaluating Safety and Efficacy Across Different Dosing Regimens",
                -3.5419498083
            ],
            [
                1605052800000,
                "Pfizer and BioNTech Reach an Agreement to Supply the EU With 200 Million Doses of Their BNT162b2 mRNA-Based Vaccine Candidate Against SARS-CoV-2",
                -3.5419498083
            ],
            [
                1604966400000,
                "Pfizer Statement on Geodon (ziprasidone) Trial Closure in the  United States",
                -5.0649133954
            ],
            [
                1604880000000,
                "Homology Medicines Announces $60 Million Equity Investment from Pfizer Inc.",
                -8.2213207267
            ],
            [
                1604880000000,
                "Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study",
                -8.2213207267
            ],
            [
                1604620800000,
                "Pfizer Announces Positive Phase 3 Study Results for XELJANZ ® (tofacitinib) in Ankylosing Spondylitis (AS)",
                7.1683754825
            ],
            [
                1604534400000,
                "Pfizer Announces Details for When-Issued and Ex-Distribution Trading of Viatris and Pfizer Common Stock",
                -2.335164689
            ],
            [
                1604016000000,
                "Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn",
                2.7325400548
            ],
            [
                1603929600000,
                "New Report Identifies Need for More Effective Policy Responses and Investment to Prevent Strokes in Europe",
                -9.975e-06
            ],
            [
                1603756800000,
                "FDA Grants Priority Review and EMA Accepts Regulatory Submission for Pfizer’s Abrocitinib, an Oral Once-Daily JAK1 Inhibitor, for Patients 12 and Up with Moderate to Severe Atopic Dermatitis",
                -4.4851831651
            ],
            [
                1603756800000,
                "PFIZER REPORTS THIRD-QUARTER 2020 RESULTS",
                -4.4851831651
            ],
            [
                1603238400000,
                "Data From Pfizer’s Adult and Pediatric Clinical Trial Programs for 20-Valent Pneumococcal Conjugate Vaccine Presented at IDWeek 2020",
                0.2137342664
            ],
            [
                1602633600000,
                "Pfizer and BioNTech Announce New England Journal of Medicine Publication of Phase 1 Data on Lead mRNA Vaccine Candidate  BNT162b2 Against COVID-19",
                -1.2585677887
            ],
            [
                1602201600000,
                "PENELOPE-B Trial of IBRANCE® (palbociclib) in Early Breast Cancer Did Not Meet Primary Endpoint",
                -0.0271494316
            ],
            [
                1602115200000,
                "Pfizer Announces Positive Phase 3 Top-line Results for Once-Weekly Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency",
                0.5164488358
            ],
            [
                1602028800000,
                "Pfizer and Sangamo Dose First Participant in Phase 3 Study Evaluating Hemophilia A Gene Therapy Treatment",
                1.7077885713
            ],
            [
                1601942400000,
                "BioNTech and Pfizer Initiate Rolling Submission to European Medicines Agency for SARS-CoV-2 Vaccine Candidate BNT162b2",
                -1.453238409
            ],
            [
                1601856000000,
                "SpringWorks Therapeutics Announces Clinical Collaboration with PfizerInc. to  Evaluate Nirogacestat in Combination with PF‐06863135 in Patients with Relapsed  or Refractory Multiple Myeloma",
                -0.9953165712
            ],
            [
                1601510400000,
                "Pfizer Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Investigational Gene Therapy",
                -1.4568318833
            ],
            [
                1601424000000,
                "BioNTech and Pfizer Announce Nature Publication of German Phase 1/2 Study Data from mRNA-based Vaccine Candidate BNT162b1 Against SARS-CoV-2",
                0.2749366445
            ],
            [
                1601251200000,
                "U.S. FDA Approves Pfizer’s XELJANZ® (tofacitinib) for the Treatment of Active Polyarticular Course Juvenile Idiopathic Arthritis",
                0.027633653
            ],
            [
                1600905600000,
                "Pfizer Declares Fourth-Quarter 2020 Dividend",
                0.2774347734
            ],
            [
                1600819200000,
                "Vivet Therapeutics and Pfizer Inc. Enter into Manufacturing Agreement for Vivet’s  Investigational Gene Therapy for Wilson Disease",
                -1.6219495306
            ],
            [
                1600819200000,
                "FDA Accepts Supplemental New Drug Application for Pfizer’s XALKORI® (crizotinib) for the Treatment of Pediatric ALK-positive Anaplastic Large Cell Lymphoma",
                -1.6219495306
            ],
            [
                1600732800000,
                "Pfizer Invites Public to View and Listen to Webcast of October 27 Conference Call with Analysts",
                0.5277925886
            ],
            [
                1600732800000,
                "Javelin Biotech Aims to Develop Industry-Leading “Organ-on-a-Chip” Predictive  Pharmacokinetics Platform in Collaboration with Pfizer Inc.",
                0.5277925886
            ],
            [
                1600387200000,
                "BAVENCIO Pivotal Phase III JAVELIN Bladder 100 Results Published in The New England Journal of Medicine",
                -2.1099601067
            ],
            [
                1600128000000,
                "Pfizer Investor Day Features Significant Number of Pipeline Advances for COVID-19 Programs and Across Numerous Therapeutic Areas",
                -1.1147162458
            ],
            [
                1600041600000,
                "Pfizer Hosts Virtual Investor Day",
                1.6233631716
            ],
            [
                1599868800000,
                "Pfizer and BioNTech Propose Expansion of Pivotal COVID-19 Vaccine Trial",
                1.6233631716
            ],
            [
                1599782400000,
                "Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference",
                3.4315078191
            ],
            [
                1599696000000,
                "Pfizer to Present Latest Scientific Advancements from Its Industry-Leading Portfolio at the ESMO Virtual Congress 2020",
                -0.3603922705
            ],
            [
                1599609600000,
                "Pfizer and BioNTech Announce Data from Preclinical Studies of mRNA-based Vaccine Candidate Against COVID-19",
                -1.7952387348
            ],
            [
                1599609600000,
                "Pfizer and BioNTech to Potentially Supply the EU with 200 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2",
                -1.7952387348
            ],
            [
                1599523200000,
                "Biopharma Leaders Unite To Stand With Science",
                -0.9673862624
            ],
            [
                1599091200000,
                "Pfizer Invites Public to Register for Webcast of Virtual Investor Day on September 14 and 15, 2020",
                -2.7777596874
            ],
            [
                1597881600000,
                "Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19",
                1.8004120835
            ],
            [
                1597622400000,
                "Pfizer Statement on Lyrica (Pregabalin) Patent Infringement  in Japan",
                0.8342148989
            ],
            [
                1597190400000,
                "Pfizer and BioNTech Announce Publication of Peer-Reviewed Data from Ongoing Phase 1/2 study of mRNA-based Vaccine Candidate, BNT162b1, Against SARSCoV-2 in Nature",
                0.8907511975
            ],
            [
                1596758400000,
                "Pfizer Announces Agreement with Gilead to Manufacture Remdesivir for Treatment of COVID-19",
                0.2344170526
            ],
            [
                1596672000000,
                "Pfizer Announces Times for Rescheduled Virtual Investor Day on September 14 and September 15, 2020",
                -0.8322543249
            ],
            [
                1596672000000,
                "Pfizer signs on to The Hispanic Promise further strengthening its ties and commitment to Hispanics in the workplace",
                -0.8322543249
            ],
            [
                1596585600000,
                "The Bristol-Myers Squibb-Pfizer Alliance is pleased with the U.S. District Court decision to uphold both the composition of matter (COM) patent (US 6,967,208) and formulation patent (US 9,326,945) covering Eliquis®.",
                -0.5225873635
            ],
            [
                1596585600000,
                "Pfizer and BioNTech to Supply Canada with their BNT162 mRNA- Based Vaccine Candidate",
                -0.5225873635
            ],
            [
                1596585600000,
                "LORBRENA® (lorlatinib) Significantly Improves Progression-Free Survival in First-Line ALK-Positive Lung Cancer",
                -0.5225873635
            ],
            [
                1596153600000,
                "Pfizer and BioNTech to Supply Japan with 120 Million Doses of their BNT162 mRNA-based Vaccine Candidate",
                0.1825385129
            ],
            [
                1595894400000,
                "Pfizer Reports Second-Quarter 2020 Results",
                1.8339415192
            ],
            [
                1595808000000,
                "Pfizer and BioNTech Choose Lead mRNA Vaccine Candidate Against COVID-19 and Commence Pivotal Phase 2/3 Global Study",
                4.254208283
            ],
            [
                1595376000000,
                "Pfizer Shares Pre-Clinical Data Updates on COVID-19 Antiviral Research Program",
                0.4686092458
            ],
            [
                1595376000000,
                "Pfizer and BioNTech Announce an Agreement with U.S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2",
                0.4686092458
            ],
            [
                1595203200000,
                "Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data",
                -2.1804473147
            ],
            [
                1595203200000,
                "Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate against SARS-CoV-2",
                -2.1804473147
            ],
            [
                1594598400000,
                "Pfizer and BioNTech Granted FDA Fast Track Designation for Two Investigational mRNA-based Vaccine Candidates Against SARS-CoV-2",
                1.4192342631
            ],
            [
                1594252800000,
                "Pfizer Pledges $100 Million to New Industry Fund to Help Fight Growing Threat of Antimicrobial Resistance",
                0.295609952
            ],
            [
                1593561600000,
                "Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 study of mRNA-based Vaccine Candidate Against SARS-CoV-2",
                -0.0869199611
            ],
            [
                1593475200000,
                "FDA Approves BAVENCIO as First-Line Maintenance Treatment for Patients with Locally Advanced or Metastatic Urothelial Carcinoma",
                3.5862543682
            ],
            [
                1593475200000,
                "European Commission Approves DAURISMO™ (glasdegib) for Certain Adult Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)",
                3.5862543682
            ],
            [
                1593388800000,
                "Pfizer Statement on Facebook Advertising Boycott",
                0.7339214106
            ],
            [
                1593043200000,
                "Pfizer Declares Third-Quarter 2020 Dividend",
                -0.2184662047
            ],
            [
                1592956800000,
                "Pfizer and Wellcome Launch Surveillance Program to Combat Growing Threat of Antimicrobial Resistance in Sub-Saharan Africa",
                -1.2066940972
            ],
            [
                1592870400000,
                "NEW DATA ON THE BURDEN OF EMERGING S. PNEUMONIAE SEROTYPES  PUBLISHED IN ISPPD 2020 ONLINE DIGITAL LIBRARY",
                -3.1376212493
            ],
            [
                1592784000000,
                "European Medicines Agency Validates Application for BAVENCIO® (avelumab) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma",
                -1.7088814229
            ],
            [
                1592784000000,
                "Pfizer Announces Start of Four Phase 3 Clinical Trials for Investigational Vaccines",
                -1.7088814229
            ],
            [
                1592784000000,
                "European Medicines Agency Validates Application for BAVENCIO® (avelumab) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma",
                -1.7088814229
            ],
            [
                1592438400000,
                "Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Factor VIII Activity Levels and No Bleeding Events or Factor Usage in 3e13 vg/kg Cohort Following giroctocogene fitelparvovec (SB-525) Gene Therapy",
                0.4488327547
            ],
            [
                1592438400000,
                "Upjohn Announces Pricing of Senior Notes in Connection with the Proposed Combination of Mylan and Upjohn",
                0.4488327547
            ],
            [
                1592265600000,
                "Merck and Pfizer’s SGLT2 Inhibitor STEGLATROTM (ertugliflozin) Meets Primary  Endpoint in VERTIS CV Trial for Patients with Type 2 Diabetes and  Atherosclerotic Cardiovascular Disease",
                -0.0893913764
            ],
            [
                1592265600000,
                "Pfizer Invites Public to View and Listen to Webcast of July 28 Conference Call with Analysts",
                -0.0893913764
            ],
            [
                1591920000000,
                "Pfizer Invites Public to View and Listen to Webcast of June 18 Conference Call with Analysts to Review Data Presentations at Scientific Conferences during the Week of June 15th",
                -2.1582811901
            ],
            [
                1591833600000,
                "FDA Approves Pfizer’s Oncology Supportive Care Biosimilar, NYVEPRIA™ (pegfilgrastim-apgf)",
                -5.481471388
            ],
            [
                1591747200000,
                "Pfizer Announces Positive Top-Line Results from JADE TEEN Trial of Abrocitinib in Adolescents with Moderate-to-Severe Atopic Dermatitis",
                -9.1892008577
            ],
            [
                1591142400000,
                "Complete Results from Second Pivotal Monotherapy Study of Abrocitinib Published in JAMA Dermatology",
                -0.7775611265
            ],
            [
                1591056000000,
                "Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference",
                1.7422512467
            ],
            [
                1591056000000,
                "Pfizer Establishes New Program to Support Continued Biotechnology Innovation",
                1.7422512467
            ],
            [
                1590710400000,
                "Pfizer Provides Update on Phase 3 PALLAS Trial of IBRANCE® (palbociclib) Plus Endocrine Therapy in HR+, HER2- Early Breast Cancer",
                -7.9243938083
            ],
            [
                1590710400000,
                "Final PROSPER Results Show XTANDI® (enzalutamide) Significantly Extends Overall Survival in Men with Non-Metastatic Castration-Resistant Prostate Cancer",
                -7.9243938083
            ],
            [
                1590624000000,
                "Corning and Pfizer Announce Supply Agreement for Corning Valor® Glass  Packaging",
                0.9164559276
            ],
            [
                1590624000000,
                "Corning and Pfizer Announce Supply Agreement for Corning Valor® Glass Packaging",
                0.9164559276
            ],
            [
                1590105600000,
                "Pfizer Inc. Recommends Rejection of Unsolicited Note Tender Offer by Huguenot Bond Liquidity, LLC",
                1.013609352
            ],
            [
                1589760000000,
                "Pfizer Prices $4,000,000,000 Debt Offering",
                -1.7515720136
            ],
            [
                1589500800000,
                "Pfizer’s New Phase 1b Results of Gene Therapy in Ambulatory Boys with Duchenne Muscular Dystrophy (DMD) Support Advancement into Pivotal Phase 3 Study",
                0.2889455982
            ],
            [
                1589414400000,
                "Pfizer Announces Positive Top-Line Results From Phase 3 Lot Consistency Study of 20-Valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naive Adults 18 Through 49 Years of Age",
                2.5423775515
            ],
            [
                1589328000000,
                "Save the Date: Pfizer Announces New Date of September 14, 2020 for Rescheduled Investor Day",
                1.6086563372
            ],
            [
                1589241600000,
                "New Data from 18 Approved and Investigational Pfizer Medicines to be Showcased at ASCO20 Virtual Scientific Program",
                -2.8880126931
            ],
            [
                1589241600000,
                "Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference",
                -2.8880126931
            ],
            [
                1588896000000,
                "Pfizer Invites Public to View and Listen to Webcast of May 15 Conference Call with Analysts to Review Duchenne Muscular Dystrophy (DMD) Data Presentation at ASGCT 2020 Annual Meeting",
                2.2309798065
            ],
            [
                1588636800000,
                "Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program",
                -0.7790179867
            ],
            [
                1588550400000,
                "New Data Suggest Burden of Group B Streptococcus (GBS) Infection in U.S. Adults Greater Than Previously Recognized",
                2.3630422625
            ],
            [
                1588291200000,
                "Pfizer Receives Positive CHMP Opinion for DAURISMO®(glasdegib)for Certain Adult Patients with Newly Diagnosed or Secondary Acute Myeloid Leukemia (AML)",
                -0.6113727799
            ],
            [
                1588291200000,
                "Pfizer Receives Positive CHMP Opinion for DAURISMOTM (glasdegib)for  Certain Adult Patients with Newly Diagnosed Acute Myeloid Leukemia  (AML)",
                -0.6113727799
            ],
            [
                1588204800000,
                "Valneva and Pfizer Announce Collaboration to Co-Develop and Commercialize Lyme Disease Vaccine, VLA15",
                -0.9564756443
            ],
            [
                1588204800000,
                "AMRA Medical renews collaboration with Pfizer Inc.  aiming to generate the world’s  largest imaging dataset on body  composition profiling",
                -0.9564756443
            ],
            [
                1588118400000,
                "BioNTech and Pfizer announce completion of dosing for first cohort of Phase 1/2 trial of COVID-19 vaccine candidates in Germany",
                -0.2606467737
            ],
            [
                1588032000000,
                "PFIZER REPORTS FIRST-QUARTER 2020 RESULTS",
                -2.4396662803
            ],
            [
                1587600000000,
                "Pfizer Hosts Virtual-Only Annual Meeting of Shareholders",
                2.9427743096
            ],
            [
                1587513600000,
                "FoRx Therapeutics AG Raises EUR 10 Million Seed Round to Develop a Pipeline  of Drugs Targeting DNA Replication Stress for Cancer",
                -0.735905966
            ],
            [
                1587513600000,
                "BioNTech and Pfizer announce regulatory approval from German authority Paul-Ehrlich-Institut to commence first clinical trial of COVID-19 vaccine candidates",
                -0.735905966
            ],
            [
                1587340800000,
                "Valneva Receives FDA Fast Track Designation for its Lyme Disease  Vaccine Candidate VLA15",
                -2.1336390039
            ],
            [
                1586390400000,
                "Pfizer Advances Battle Against COVID-19 on Multiple Fronts",
                0.3130224119
            ],
            [
                1586390400000,
                "Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development",
                0.3130224119
            ],
            [
                1586390400000,
                "EMD Serono and Pfizer Receive US FDA Breakthrough Therapy Designation and Submit Application for BAVENCIO® for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma",
                0.3130224119
            ],
            [
                1586304000000,
                "U.S. FDA Approves BRAFTOVI® (Encorafenib) in Combination with Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer (CRC) After Prior Therapy",
                3.955923944
            ],
            [
                1586217600000,
                "Pfizer to Hold Virtual-Only 2020 Annual Meeting of Shareholders",
                -1.1560851751
            ],
            [
                1586131200000,
                "Pfizer and The Pfizer Foundation Donate $40 Million in Charitable Grants, Expand Product Access and Mobilize Colleagues to Combat COVID-19 Pandemic",
                -0.9223289721
            ],
            [
                1585785600000,
                "Pfizer Receives European Approval for Oncology Biosimilar, RUXIENCE™ (rituximab)",
                5.1724263045
            ],
            [
                1585785600000,
                "Susan Desmond-Hellmann Elected to Pfizer’s Board of Directors",
                5.1724263045
            ],
            [
                1585699200000,
                "Medical Professionals Across Merck & Co., Inc., Pfizer Inc., and Eli Lilly and Company Activate to Support Health Systems, First Responders and Patients Amid COVID-19 Pandemic",
                2.8901644279
            ],
            [
                1585267200000,
                "Pfizer Completes $1.25 Billion Sustainability Bond for Social and Environmental Impact",
                5.7238885516
            ],
            [
                1585180800000,
                "Mylan and Pfizer Provide Update Regarding Proposed Combination of Mylan and Upjohn",
                3.2686209366
            ],
            [
                1585008000000,
                "U.S. FDA Approves Supplemental New Drug Application (sNDA) for Expanded Indication of EUCRISA® (Crisaborole) Ointment, 2%, in Children as Young as 3 Months of Age With Mild-to-Moderate Atopic Dermatitis",
                0.8067219305
            ],
            [
                1584489600000,
                "Pfizer Announces Top-Line Results from Phase 3 Study of 20-Valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults Aged 18 Years or Older",
                -1.1505512587
            ],
            [
                1584489600000,
                "Pfizer Announces Positive Top-Line Results from Third Phase 3 Trial of Abrocitinib for Moderate to Severe Atopic Dermatitis, Which Showed Improvements in Skin Clearance, Disease Extent and Severity, and Itch",
                -1.1505512587
            ],
            [
                1584489600000,
                "Pfizer Postpones Investor Day Scheduled for March 31, 2020 Due to Coronavirus Concerns",
                -1.1505512587
            ],
            [
                1584489600000,
                "Pfizer Announces Positive Top-Line Results from Third Phase 3 Trial of Abrocitinib for Moderate to Severe Atopic Dermatitis, Which Showed Improvements in Skin Clearance, Disease Extent and Severity, and Itch",
                -1.1505512587
            ],
            [
                1584403200000,
                "Pfizer Invites Public to View and Listen to Webcast of April 28 Conference Call with Analysts",
                2.224988915
            ],
            [
                1584403200000,
                "Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine",
                2.224988915
            ],
            [
                1584403200000,
                "Pfizer and BioNTech to Co-Develop Potential COVID-19 Vaccine",
                2.224988915
            ],
            [
                1584057600000,
                "Pfizer Outlines Five-Point Plan to Battle COVID-19",
                -3.6116782049
            ],
            [
                1584057600000,
                "EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study",
                -3.6116782049
            ],
            [
                1583280000000,
                "Susan Hockfield Elected to Pfizer’s Board of Directors",
                1.0152283707
            ],
            [
                1583107200000,
                "Pfizer Provides Comment on COVID-19 White House Meeting",
                1.1370122693
            ],
            [
                1583107200000,
                "U.S. FDA Accepts Regulatory Submission for Tanezumab, a Potential First-in-Class Treatment for Patients with Chronic Pain Due to Moderate-to-Severe Osteoarthritis",
                1.1370122693
            ],
            [
                1582761600000,
                "James Quincey Elected to Pfizer’s Board of Directors",
                -3.0520632249
            ],
            [
                1582761600000,
                "Mylan and Pfizer Announce Appointment of Viatris Chief Financial Officer",
                -3.0520632249
            ],
            [
                1582761600000,
                "Mylan and Pfizer Finalize Appointments to Viatris Board of Directors",
                -3.0520632249
            ],
            [
                1582761600000,
                "Mylan and Pfizer Announce Appointment of Viatris Chief Financial Officer",
                -3.0520632249
            ],
            [
                1582761600000,
                "Mylan and Pfizer Finalize Appointments to Viatris Board of Directors",
                -3.0520632249
            ],
            [
                1582588800000,
                "Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference",
                0.1152156035
            ],
            [
                1582156800000,
                "Montis Biosciences launched with €8,4 million seed financing and a novel  approach to immune-oncology",
                0.0280029646
            ],
            [
                1581984000000,
                "European Commission Approves VYNDAQEL®, the First Treatment in the EU for Transthyretin Amyloid Cardiomyopathy (ATTR-CM)",
                -0.883251132
            ],
            [
                1581984000000,
                "European Commission Approves VYNDAQEL®, the First Treatment in the EU for Transthyretin Amyloid Cardiomyopathy (ATTR-CM)",
                -0.883251132
            ],
            [
                1581379200000,
                "XTANDI® (enzalutamide) Demonstrates Significant Improvement in Overall Survival in Phase 3 PROSPER Trial of Patients with nmCRPC",
                -0.3974578679
            ],
            [
                1580428800000,
                "Pfizer Receives Positive CHMP Opinion for Oncology Biosimilar, RUXIENCE™ (rituximab)",
                1.5195649055
            ],
            [
                1580169600000,
                "PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2019 RESULTS",
                -4.6301109691
            ],
            [
                1579737600000,
                "Pfizer Vaccines Launches Global Centers of Excellence Network to Conduct Real-World Research on Vaccine-Preventable Diseases Affecting Adults",
                -0.9291909169
            ],
            [
                1579737600000,
                "Pfizer Brings Three New Biosimilars to U.S. Patients at Substantial  Discounts",
                -0.9291909169
            ],
            [
                1579737600000,
                "Pfizer’s Greenstone and Digital Men’s Health Clinic Roman Collaborate to Offer Patients Remote Access to the Only FDA-Approved Authorized Generic Version of Viagra® (sildenafil citrate)",
                -0.9291909169
            ],
            [
                1578960000000,
                "Insilico enters into research collaboration with Pfizer Inc. to explore novel data  and artificial intelligence system for potential therapeutic targets",
                3.0489414721
            ],
            [
                1578873600000,
                "Biogen to Acquire Novel Clinical Stage Asset with Application in Alzheimer’s Disease  and Parkinson’s Disease from Pfizer Inc.",
                1.123032391
            ],
            [
                1578873600000,
                "Axsome Therapeutics Enters into Exclusive License Agreement with Pfizer Inc. for Pfizer’s Reboxetine  Clinical and Nonclinical Data and for New Phase 3 Esreboxetine Product Candidate",
                1.123032391
            ],
            [
                1578355200000,
                "Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference",
                -0.1536288611
            ],
            [
                1578268800000,
                "BAVENCIO Significantly Improved Overall Survival in Patients With Locally Advanced or Metastatic Urothelial Carcinoma",
                -0.1806499127
            ],
            [
                1577059200000,
                "Theravance Biopharma and Pfizer Inc. Enter Global License Agreement for Skin-Targeted, Locally-Acting Pan-Janus Kinase (JAK) Inhibitor Program",
                -0.3308709891
            ],
            [
                1577059200000,
                "BioInvent announces selection of second target and extension of the research  collaboration and license agreement with Pfizer Inc.",
                -0.3308709891
            ],
            [
                1576627200000,
                "U.S. FDA Accepts and Grants Priority Review to sNDA for BRAFTOVI® (encorafenib) in Combination with ERBITUX® (cetuximab) (BRAFTOVI Doublet) for the Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer After Prior Therapy",
                -0.1026311826
            ],
            [
                1576627200000,
                "Pfizer and Mylan Announce Two Future Viatris Board Members",
                -0.1026311826
            ],
            [
                1576540800000,
                "Pfizer Invites Public to View and Listen to Webcast of January 28 Conference Call with Analysts",
                -1.4142311928
            ],
            [
                1576540800000,
                "Triplet Therapeutics Launches with $59 Million in Financing to Further its Development of  Transformative Treatments for Triplet Repeat Disorders",
                -1.4142311928
            ],
            [
                1576454400000,
                "XTANDI® (enzalutamide) Approved by U.S. FDA for the Treatment of Metastatic Castration-Sensitive Prostate Cancer",
                0.5141052399
            ],
            [
                1576454400000,
                "Pfizer Declares First-Quarter 2020 Dividend and Announces Upcoming Investor Day to Highlight Strength of Innovative R&D Pipeline",
                0.5141052399
            ],
            [
                1576195200000,
                "Pfizer Receives Positive CHMP Opinion for VYNDAQEL® for Use in Patients with Transthyretin Amyloid Cardiomyopathy, a Rare and Fatal Disease",
                1.5840482856
            ],
            [
                1576108800000,
                "FDA Approves XELJANZ® XR (tofacitinib) Extended-Release Tablets for the Treatment of Ulcerative Colitis",
                0.4174168161
            ],
            [
                1575936000000,
                "ImmunOs Therapeutics AG raises CHF 15M in Series A Financing, co-led by Pfizer Ventures and  BioMedPartners, to Advance a Novel Immunotherapy Agent For Cancer Into Human Trials",
                -0.1308321033
            ],
            [
                1575676800000,
                "Findings Released from Real-World Data Analysis of Eliquis (apixaban) for the Treatment of Venous Thromboembolism in Patients with Active Cancer",
                0.9875229969
            ],
            [
                1575676800000,
                "Sangamo and Pfizer Announce Updated Phase 1/2 Results Showing Sustained Increased Factor VIII Activity Through 44 Weeks Following SB-525 Gene Therapy Treatment",
                0.9875229969
            ],
            [
                1575417600000,
                "ImCheck Raises $53 Million Series B to Advance Clinical Pipeline of Novel  Gamma Delta T-Cell-Focused Antibodies for Cancer and Autoimmune Diseases",
                -0.5258922836
            ],
            [
                1574380800000,
                "CeMM enters into research collaboration on expanding the druggable proteome  with Pfizer Inc.",
                2.3009228929
            ],
            [
                1574035200000,
                "FDA Approves Pfizer’s Biosimilar, ABRILADA™ (adalimumab-afzb) for Multiple Inflammatory Conditions",
                0.7169452316
            ],
            [
                1573776000000,
                "Pfizer Announces CHMP Opinion for XELJANZ® (tofacitinib) in the European Union Related to Ongoing Review of the Product",
                1.5851279894
            ],
            [
                1573776000000,
                "Bristol-Myers Squibb and Pfizer Announce Randomized, Controlled Trial to Evaluate the Effect of Atrial Fibrillation Screening on Health Outcomes in Older Individuals",
                1.5851279894
            ],
            [
                1573603200000,
                "CENTOGENE Signs Data Access and Collaboration Agreement with Pfizer Inc.",
                -1.0943846609
            ],
            [
                1573516800000,
                "Mylan and Pfizer Announce Viatris as the New Company Name in the Planned Mylan-Upjohn Combination",
                -0.6284283276
            ],
            [
                1573516800000,
                "Pfizer Announces Results of Phase 3 Study for XELJANZ® (tofacitinib) in Juvenile Idiopathic Arthritis Ahead of Presentation at 2019 American College of Rheumatology/Association of Rheumatology Professionals Annual Meeting",
                -0.6284283276
            ],
            [
                1573171200000,
                "EMD Serono and Pfizer Provide Update on Phase III JAVELIN Gastric 100 Trial",
                0.1353998994
            ],
            [
                1572307200000,
                "PFIZER REPORTS THIRD-QUARTER 2019 RESULTS",
                1.2474039043
            ],
            [
                1572220800000,
                "European Commission Approves BAVENCIO® (avelumab) Plus Axitinib Combination for First-Line Treatment of Patients With Advanced Renal Cell Carcinoma",
                3.5331026916
            ],
            [
                1571616000000,
                "OPKO and Pfizer Announce Positive Phase 3 Top-Line Results for Somatrogon, an Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency",
                -0.6039218049
            ],
            [
                1571356800000,
                "Pfizer Statement on Vincristine Sulfate Injection, USP Supply in the United States",
                0.0822774976
            ],
            [
                1571270400000,
                "Pfizer Statement on Results of Pay Equity Study and  Opportunity Parity Among Colleagues Worldwide",
                -0.0822885253
            ],
            [
                1571270400000,
                "The Bristol-Myers Squibb-Pfizer Alliance and Fitbit Collaborate to Address Gaps in Atrial Fibrillation Detection with the Aim of Accelerating Diagnosis",
                -0.0822885253
            ],
            [
                1571011200000,
                "ImaginAb signs multi-party collaboration agreement with three global  pharmaceutical companies to help further develop company’s CD8  ImmunoPET technology",
                0.931494303
            ],
            [
                1570838400000,
                "Pfizer Presents Positive Phase 3 Data at the 28th Congress of the European Academy of Dermatology and Venereology for Abrocitinib in Moderate to Severe Atopic Dermatitis",
                0.931494303
            ],
            [
                1570406400000,
                "Akcea and Pfizer Inc. Announce Licensing Agreement for investigative antisense therapy AKCEA-ANGPTL3-LRx",
                -1.1007867139
            ],
            [
                1569715200000,
                "Pfizer Presents Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI® (Encorafenib), MEKTOVI® (Binimetinib) and Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer",
                -2.3991194565
            ],
            [
                1569542400000,
                "Ian Read to Retire as Executive Chairman of Pfizer’s Board of Directors; Chief Executive Officer Dr. Albert Bourla Named Chairman",
                0.1948008469
            ],
            [
                1569542400000,
                "Pfizer Announces Positive Top-Line Results from Second Pivotal Phase 3 Study of Investigational Oral JAK1 Candidate, Abrocitinib, in Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis",
                0.1948008469
            ],
            [
                1569542400000,
                "New Data for BAVENCIO® (avelumab) for Advanced Cancers to Be Presented at ESMO 2019",
                0.1948008469
            ],
            [
                1569283200000,
                "Pfizer Declares Fourth-Quarter 2019 Dividend",
                -1.0306508675
            ],
            [
                1569283200000,
                "Pfizer Presents New Evidence of IBRANCE® (palbociclib) Effectiveness in HR+, HER2- Metastatic Breast Cancer Patients in Four Real-World Studies at ESMO Congress 2019",
                -1.0306508675
            ],
            [
                1569283200000,
                "Pfizer and Flatiron Health Announce Expanded Strategic Collaboration to Unlock Power of Real-World Evidence in Oncology",
                -1.0306508675
            ],
            [
                1568937600000,
                "CHMP Adopts Positive Opinion for BAVENCIO® (avelumab) Plus Axitinib for First-Line Treatment of Patients with Advanced Renal Cell Carcinoma",
                -1.7936159896
            ],
            [
                1568851200000,
                "Pfizer Presents Scientific Advancements in Cancer Care at the ESMO Congress 2019 Highlighting Expanded Portfolio",
                0.7359122444
            ],
            [
                1568678400000,
                "TrialSpark and Pfizer collaborating to improve speed and access to clinical trials",
                -1.1269625326
            ],
            [
                1568678400000,
                "Terry Bradshaw and Pfizer Educate Boomers About the Risks of Pneumococcal Pneumonia and the Importance of Vaccination",
                -1.1269625326
            ],
            [
                1568678400000,
                "Pfizer Invites Public to View and Listen to Webcast of October 29 Conference Call With Analysts",
                -1.1269625326
            ],
            [
                1568246400000,
                "Catalia Health and Pfizer collaborate to better understand patient journeys using artificial intelligence and via robot wellness coach",
                -1.78813777
            ],
            [
                1567987200000,
                "Pfizer Announces Positive Preliminary Results from a Proof-of-Concept Phase 2 Study (B7471003) of its 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive Disease and Otitis Media in Healthy Infants",
                2.1134188903
            ],
            [
                1567728000000,
                "Hospira, Inc., Issues A Voluntary Nationwide Recall for one lot of BACTERIOSTATIC WATER for Injection, USP, due to a Potential Lack of Sterility Assurance",
                1.2761544519
            ],
            [
                1567296000000,
                "Findings Released from NAXOS, a French Real-World Data Analysis and the Largest Real-World  Data Analysis on Oral Anticoagulant Effectiveness and Safety in Europe Among Patients with Non-Valvular Atrial Fibrillation",
                0.6140068474
            ],
            [
                1566345600000,
                "U.S. FDA Grants XTANDI® (enzalutamide) Application Priority Review for the Treatment of Men with Metastatic Hormone-Sensitive Prostate Cancer",
                0.3990684761
            ],
            [
                1566345600000,
                "Pfizer Invests Half Billion Dollars to Advance State-of-the-Art Gene Therapy Facility in Sanford, North Carolina",
                0.3990684761
            ],
            [
                1566259200000,
                "The Pfizer Foundation Invests in 20 Organizations Tackling Infectious Diseases and Antimicrobial Resistance",
                -0.6596052593
            ],
            [
                1565740800000,
                "Pfizer Inc. Issues A Voluntary Nationwide Recall For 2 Lots of  RELPAX® (eletriptan hydrobromide) 40 mg Tablets Due to Potential  Microbiological Contamination of Non-Sterile Products",
                -1.3051001943
            ],
            [
                1564704000000,
                "Pfizer Announces Phase 3 Top-Line Results for Rivipansel in Patients with Sickle Cell Disease Experiencing a Vaso-Occlusive Crisis",
                -3.490244527
            ],
            [
                1564617600000,
                "Pfizer Announces Closing of Joint Venture With GlaxoSmithKline to Create a Premier Global Consumer Healthcare Company",
                -0.8157762755
            ],
            [
                1564531200000,
                "BioInvent announces selection of first target discovered by BioInvent’s  proprietary F.I.R.S.TTM technology platform under collaboration with Pfizer Inc.",
                0.0203089565
            ],
            [
                1564444800000,
                "Pfizer Completes Acquisition of Array Biopharma",
                -2.5489166132
            ],
            [
                1564358400000,
                "Pfizer Inc. Reschedules Second-Quarter 2019 Earnings Conference Call to July 29, 2019 at 10:30 a.m. EDT",
                -8.7135694712
            ],
            [
                1564358400000,
                "PFIZER REPORTS SECOND-QUARTER 2019 RESULTS",
                -8.7135694712
            ],
            [
                1564358400000,
                "Mylan and Upjohn, a Division of Pfizer, to Combine, Creating a New Champion for Global Health Uniquely Positioned to Fulfill the World’s Need for Medicine",
                -8.7135694712
            ],
            [
                1564099200000,
                "Pfizer Statement on Update to XELJANZ® (tofacitinib) Prescribing Information in the United States",
                -2.91918292
            ],
            [
                1563840000000,
                "FDA Approves Pfizer’s Biosimilar, RUXIENCE™ (rituximab-pvvr), for Certain Cancers and Autoimmune Conditions",
                0.0932841468
            ],
            [
                1562284800000,
                "Sangamo and Pfizer Announce Updated Phase 1/2 Results for SB-525 Investigational Hemophilia A Gene Therapy Showing Sustained Increased Factor VIII Levels",
                -2.332568242
            ],
            [
                1561939200000,
                "Pfizer Completes Acquisition of Therachon",
                1.6056368545
            ],
            [
                1561939200000,
                "Pfizer Announces Positive Top-Line Results from Phase 4 Study of Crisaborole Ointment, 2%, in Children Aged 3 Months to Less Than 24 Months with Mild to Moderate Atopic Dermatitis",
                1.6056368545
            ],
            [
                1561680000000,
                "Pfizer Announces Results from Phase 3 Trial of Revatio® (Sildenafil Citrate) in Newborns with Persistent Pulmonary Hypertension",
                0.7310836892
            ],
            [
                1561680000000,
                "Pfizer Presents Initial Clinical Data on Phase 1b Gene Therapy Study for Duchenne Muscular Dystrophy (DMD)",
                0.7310836892
            ],
            [
                1561680000000,
                "Pfizer Receives U.S. FDA Approval for Its Oncology Biosimilar, ZIRABEV™ (bevacizumab-bvzr)",
                0.7310836892
            ],
            [
                1561593600000,
                "Scott Gottlieb Elected to Pfizer’s Board of Directors",
                0.6925188493
            ],
            [
                1561593600000,
                "Pfizer Declares Third-Quarter 2019 Dividend",
                0.6925188493
            ],
            [
                1561075200000,
                "European Commission Approves TALZENNA® (talazoparib) for Patients with Inherited (Germline) BRCA-Mutated Locally Advanced or Metastatic Breast Cancer",
                0.4798937073
            ],
            [
                1560816000000,
                "Pfizer Invites Public to View and Listen to Webcast of July 30 Conference Call with Analysts",
                1.5631988051
            ],
            [
                1560729600000,
                "Pfizer to Acquire Array BioPharma",
                0.8590949703
            ],
            [
                1560297600000,
                "Pfizer Announces Results from XELJANZ® XR (tofacitinib) ORAL Shift Study, The First Phase 3b/4 Study to Evaluate Methotrexate Withdrawal with a JAK Inhibitor",
                0.0705656629
            ],
            [
                1559692800000,
                "Jeff Settleman, Ph.D., Joins Pfizer to Lead Oncology Research & Development",
                0.2575568102
            ],
            [
                1558656000000,
                "Pfizer Announces Top-Line Results from Phase 3 Trial of LYRICA® (pregabalin) in Primary Generalized Tonic-Clonic Seizures",
                -0.3818792352
            ],
            [
                1558051200000,
                "Pfizer confirms initiation of EU review of Tofacitinib with interim recommendations",
                0.6972694604
            ],
            [
                1557878400000,
                "Pfizer Oncology to Showcase New Data from Innovative Science That Address Patient Needs at ASCO 2019 Annual Meeting",
                1.8732003456
            ],
            [
                1557878400000,
                "Pfizer Announces Positive Top-Line Results from Phase 3 Study of Investigational Oral JAK1 Candidate, Abrocitinib (PF-04965842), in Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis",
                1.8732003456
            ],
            [
                1557792000000,
                "FDA Approves BAVENCIO® (avelumab) Plus INLYTA® (axitinib) Combination for Patients with Advanced Renal Cell Carcinoma",
                1.3608535868
            ],
            [
                1557360000000,
                "Pfizer Opens New State-Of-The-Art Biologics Clinical Manufacturing Facility In Andover, Massachusetts",
                1.031420722
            ],
            [
                1557273600000,
                "Pfizer Acquires Clinical-Stage Biotech Therachon",
                0.4888600033
            ],
            [
                1557187200000,
                "European Commission Approves LORVIQUA® (lorlatinib) for Certain Adult Patients with Previously-Treated ALK-Positive Advanced Non-Small Cell Lung Cancer",
                -1.074444006
            ],
            [
                1557100800000,
                "U.S. FDA Approves VYNDAQEL® and VYNDAMAX™ for Use in Patients with Transthyretin Amyloid Cardiomyopathy, a Rare and Fatal Disease",
                -0.1959604788
            ],
            [
                1556582400000,
                "PFIZER REPORTS FIRST-QUARTER 2019 RESULTS",
                0.9075371934
            ],
            [
                1556236800000,
                "Pfizer Inc. Issues A Voluntary Nationwide Consumer Level Recall of One Lot of ThermaCare® Back Pain Therapy HeatWraps, up to 16HR pain relief, Due To Out of Specification Results for  High Cell Temperature",
                -0.2020806816
            ],
            [
                1556236800000,
                "Pfizer Receives Positive CHMP Opinion for TALZENNA® (talazoparib) for Patients with Inherited (Germline) BRCA-Mutated Locally Advanced or Metastatic Breast Cancer",
                -0.2020806816
            ],
            [
                1556150400000,
                "Pfizer Hosts Annual Meeting of Shareholders",
                1.8013390177
            ],
            [
                1555545600000,
                "Pfizer and Lilly Announce Top-Line Results From Long-Term Phase 3 Study of Tanezumab in Patients With Osteoarthritis",
                -2.4371392873
            ],
            [
                1555545600000,
                "Pfizer Invites Public to Listen to Webcast of April 25 Annual Meeting of Shareholders",
                -2.4371392873
            ],
            [
                1555113600000,
                "Pfizer Announces Presentation of Data from a Phase 2 Study of its 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older",
                -2.2971624148
            ],
            [
                1554336000000,
                "U.S. FDA Approves IBRANCE® (palbociclib) for the Treatment of Men with HR+, HER2- Metastatic Breast Cancer",
                0.4652598181
            ],
            [
                1554249600000,
                "VIZIMPRO® (dacomitinib) Receives Marketing Authorization in European Union (EU) for the First-Line Treatment of Adult Patients with EGFR-Mutated Non-Small Cell Lung Cancer",
                -0.5849612397
            ],
            [
                1554163200000,
                "Sangamo and Pfizer Announce Phase 1/2 Interim Data for Investigational Hemophilia A Gene Therapy",
                -0.2567657528
            ],
            [
                1553040000000,
                "Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics",
                0.3542011419
            ],
            [
                1552953600000,
                "Merck KGaA, Darmstadt, Germany, and Pfizer Announce Discontinuation of Phase III JAVELIN Ovarian PARP 100 Trial in Previously Untreated Advanced Ovarian Cancer",
                0.4742752149
            ],
            [
                1552953600000,
                "Pfizer Invites Public to View and Listen to Webcast of April 30 Conference Call with Analysts",
                0.4742752149
            ],
            [
                1552867200000,
                "Hospira, Inc. Issues A Voluntary Nationwide Recall of 8.4% Sodium Bicarbonate Injection, USP Due To The Presence of Particulate  Matter",
                1.2529380029
            ],
            [
                1552780800000,
                "AUGUSTUS Demonstrates Favorable Safety Results of Eliquis® Versus Vitamin K Antagonists in Non-Valvular Atrial Fibrillation Patients with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention",
                1.2529380029
            ],
            [
                1552262400000,
                "U.S. FDA Approves Pfizer’s Oncology Biosimilar TRAZIMERA™ (trastuzumab-qyyp), a Biosimilar to Herceptin®1",
                1.5096987811
            ],
            [
                1552003200000,
                "European Medicines Agency Validates Application for BAVENCIO® (avelumab) Plus INLYTA® (axitinib) for the Treatment of Advanced Renal Cell Carcinoma",
                0.4096323716
            ],
            [
                1551744000000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference",
                -2.9383591701
            ],
            [
                1551657600000,
                "Pfizer Prices $5,000,000,000 Debt Offering",
                -1.2823768134
            ],
            [
                1551398400000,
                "Pfizer Receives Positive CHMP Opinion for LORVIQUA® (lorlatinib) for Certain Adult Patients with Previously-Treated ALK-Positive Advanced Non-Small Cell Lung Cancer",
                -1.253762958
            ],
            [
                1551312000000,
                "Pfizer Announces Serotypes Included in 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older",
                0.9455839704
            ],
            [
                1550534400000,
                "Pfizer Announces Modification To Ongoing Tofacitinib FDA Post-Marketing Requirement Study In Patients With Rheumatoid Arthritis",
                -0.0947821429
            ],
            [
                1550534400000,
                "Ochsner Health System and Pfizer Partner to Develop Innovative Models for Clinical Trials",
                -0.0947821429
            ],
            [
                1550534400000,
                "Pfizer Receives European Approval for ZIRABEV™ (bevacizumab), a Biosimilar to Avastin®*",
                -0.0947821429
            ],
            [
                1550534400000,
                "Pfizer and Lilly Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain",
                -0.0947821429
            ],
            [
                1550275200000,
                "Pivotal Phase III Data for BAVENCIO® (avelumab) Plus INLYTA® (axitinib) in Advanced Renal Cell Carcinoma Published in The New England Journal of Medicine",
                -0.0947821429
            ],
            [
                1549929600000,
                "G-CON Manufacturing Delivers New PCMM POD® With Tablet Coating Capability to Pfizer Inc.’s  Groton, Conn. Site",
                -0.0239817064
            ],
            [
                1549843200000,
                "FDA Accepts sBLA and Grants Priority Review for BAVENCIO® (avelumab) Plus INLYTA® (axitinib) for the Treatment of Advanced Renal Cell Carcinoma",
                -0.9792218811
            ],
            [
                1549843200000,
                "Phase 3 ARCHES Trial Shows XTANDI® (enzalutamide) Significantly Improved Radiographic Progression-Free Survival in Men with Metastatic Hormone-Sensitive Prostate Cancer",
                -0.9792218811
            ],
            [
                1549238400000,
                "The Union For International Cancer Control And Pfizer Announce New Phase Of Global Grants Initiative Supporting Metastatic Breast Cancer Patients",
                -1.7335672132
            ],
            [
                1548979200000,
                "Pfizer Receives Positive CHMP Opinion for Vizimpro® (dacomitinib) for the First-line Treatment of Adult Patients with Locally Advanced Or Metastatic Non-Small Cell Lung Cancer with EGFR-Activating Mutations",
                -1.0132040104
            ],
            [
                1548720000000,
                "PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2018 RESULTS",
                5.0024279823
            ],
            [
                1548720000000,
                "Pfizer and Lilly Announce Top-Line Results From Second Phase 3 Study of Tanezumab in Osteoarthritis Pain",
                5.0024279823
            ],
            [
                1547424000000,
                "US FDA Accepts Regulatory Submissions for Review of Tafamidis to Treat Transthyretin Amyloid Cardiomyopathy",
                0.4212522819
            ],
            [
                1546992000000,
                "eFFECTOR Enters Into Agreement with Pfizer Inc. to Develop Novel First-inClass Inhibitors of eIF4E to Treat Multiple Cancer Types",
                -2.7180525723
            ],
            [
                1546819200000,
                "CytoReason Signs Collaboration Agreement with Pfizer Inc. To Utilize CytoReason’s Machine Learning Model  of the Immune System for Drug Discovery",
                0.8289299446
            ],
            [
                1546473600000,
                "Pfizer Initiates Phase 2b/3 Clinical Trial for PF-06651600, an Oral JAK3 Inhibitor, for the Treatment of Patients with Moderate to Severe Alopecia Areata",
                -0.5581693953
            ],
            [
                1545350400000,
                "Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on JAVELIN Ovarian 100 Trial of Avelumab in Previously Untreated Advanced Ovarian Cancer",
                -2.6880406227
            ],
            [
                1545264000000,
                "Independent Data Monitoring Committee Recommends Discontinuation of the Phase 2b STRIVE Clinical Trial of Staphylococcus aureus Vaccine Following Planned Interim Analysis",
                0.5246694662
            ],
            [
                1545264000000,
                "Astellas and Pfizer Announce Positive Top-Line Results from Phase 3 ARCHES Trial of XTANDI® (enzalutamide) in Men with Metastatic Hormone-Sensitive Prostate Cancer",
                0.5246694662
            ],
            [
                1545091200000,
                "Pfizer and GlaxoSmithKline Announce Joint Venture to Create a Premier Global Consumer Healthcare Company",
                -3.5740014658
            ],
            [
                1545091200000,
                "Pfizer Invites Public to View and Listen to Webcast of January 29 Conference Call with Analysts",
                -3.5740014658
            ],
            [
                1545004800000,
                "Kineta Enters Research Collaboration and License Agreement  with Pfizer to Develop New Cancer Immunotherapies",
                -2.5943226634
            ],
            [
                1544745600000,
                "Pfizer Declares First-Quarter 2019 Dividend",
                -2.2500778628
            ],
            [
                1544745600000,
                "Pfizer Receives Positive CHMP Opinion for Oncology Biosimilar, ZIRABEV™ (bevacizumab)",
                -2.2500778628
            ],
            [
                1544745600000,
                "Pfizer Initiates Phase 3 Program for 20-Valent Pneumococcal Conjugate Vaccine for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older",
                -2.2500778628
            ],
            [
                1543708800000,
                "Pfizer Presents Positive 26-Week Data For PF-05280586, A Potential Biosimilar To Rituximab, At The American Society Of Hematology Annual Meeting",
                -2.7248807603
            ],
            [
                1543536000000,
                "Pfizer Reaches a Global Agreement with AbbVie",
                1.3915956022
            ],
            [
                1543276800000,
                "Pfizer Receives Six Months Pediatric Exclusivity for LYRICA® (pregabalin)",
                3.7861771879
            ],
            [
                1543190400000,
                "Pfizer Inc. Issues A Voluntary Nationwide Consumer Level Recall Of Six Lots Of ThermaCare® HeatWraps Due To Leaking Wraps with  the Potential For Skin Injuries",
                1.7018228411
            ],
            [
                1542758400000,
                "U.S. FDA Approves DAURISMO™ (glasdegib) for Adult Patients with Newly-Diagnosed Acute Myeloid Leukemia (AML) for Whom Intensive Chemotherapy is Not an Option",
                -0.3691676439
            ],
            [
                1542585600000,
                "Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer",
                -0.2067845976
            ],
            [
                1542326400000,
                "Pfizer Provides Transparency On Drug Prices In The U.S. 90 Percent Of Company’s Prices Will Remain Unchanged",
                2.4445663483
            ],
            [
                1541894400000,
                "Real-World Evidence on Patients Aged 80 and Older Presented From ARISTOPHANES,  the Largest Real-World Data Study Evaluating Oral Anticoagulants Among Patients with  Non-Valvular Atrial Fibrillation",
                -1.7463526145
            ],
            [
                1541721600000,
                "Data From Phase 2 PALLET Study of IBRANCE® (palbociclib)in Early Breast  Cancer to be Presented at San Antonio Breast Cancer Symposium",
                0.8841796676
            ],
            [
                1541116800000,
                "U.S. FDA Approves LORBRENA® (lorlatinib) for Previously-Treated ALK-Positive Metastatic NSCLC",
                -0.5514837771
            ],
            [
                1540857600000,
                "PFIZER REPORTS THIRD-QUARTER 2018 RESULTS",
                2.5777897572
            ],
            [
                1540684800000,
                "Pfizer Announces Clinical Development Agreement with Novartis to Advance the Treatment of NASH",
                -0.1398758703
            ],
            [
                1540425600000,
                "CANCER THERAPEUTICS CRC SIGNS AGREEMENT TO ENABLE PFIZER TO DEVELOP NOVEL  CANCER DRUGS",
                0.4929477626
            ],
            [
                1540252800000,
                "Complete Results from First Study in Ongoing Phase 3 Program for Tanezumab Demonstrated Significant Improvement in Pain and Function in Osteoarthritis Patients",
                -3.3192106138
            ],
            [
                1540252800000,
                "Bain Capital and Pfizer Create Cerevel Therapeutics, New CNS Company",
                -3.3192106138
            ],
            [
                1539993600000,
                "Pfizer Presents Overall Survival Data From PALOMA-3 Trial of IBRANCE® (palbociclib) in Patients With HR+, HER2- Metastatic Breast Cancer",
                -0.7709796551
            ],
            [
                1539820800000,
                "Pfizer Announces Initiation of Phase 3 Trial of Tofacitinib in  Patients with Ankylosing Spondylitis",
                0.3595594376
            ],
            [
                1539648000000,
                "U.S. FDA Approves TALZENNA® (talazoparib)",
                2.7372919427
            ],
            [
                1539043200000,
                "Pfizer Announces Executive Leadership Team",
                -1.0784066048
            ],
            [
                1538611200000,
                "Pfizer to Award More Than $3 Million in Grants to Further Breast Cancer Research",
                0.8461580826
            ],
            [
                1538352000000,
                "Pfizer Announces CEO Succession",
                0.429658264
            ],
            [
                1538006400000,
                "U.S. FDA Approves VIZIMPRO® (dacomitinib) for the First-Line Treatment of Patients with EGFR-Mutated Metastatic Non-Small Cell Lung Cancer",
                0.6353367325
            ],
            [
                1538006400000,
                "Pfizer Declares 34-Cent Fourth-Quarter 2018 Dividend",
                0.6353367325
            ],
            [
                1537401600000,
                "Pfizer Granted FDA Breakthrough Therapy Designation for 20-Valent Pneumococcal Conjugate Vaccine for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older",
                1.5660640472
            ],
            [
                1537228800000,
                "Pfizer Invites Public to View and Listen to Webcast of October 30 Conference Call with Analysts",
                0.6010109056
            ],
            [
                1537228800000,
                "New Sub-group Analyses from the Tafamidis Phase 3 Transthyretin Amyloid Cardiomyopathy (ATTR-ACT) Study Presented at 2018 HFSA Annual Scientific Meeting",
                0.6010109056
            ],
            [
                1537142400000,
                "ATOMWISE ENTERS INTO AN EVALUATION AGREEMENT WITH PFIZER",
                1.126161324
            ],
            [
                1536883200000,
                "Pfizer Presents Positive Phase 2 Data in Alopecia Areata During Late-Breaker Session at the 27th European Academy of Dermatology and Venereology (EADV) Congress",
                0.6045311695
            ],
            [
                1536710400000,
                "System1 Announces a $25 Million Series A Funding to Advance  Integrated Technology Platform for Neurotherapeutics Discovery",
                1.2835458236
            ],
            [
                1536710400000,
                "Terry Bradshaw and Pfizer Encourage Boomers to Understand Their Risk  for Pneumococcal Pneumonia and Take Action to Help Prevent It",
                1.2835458236
            ],
            [
                1536624000000,
                "BAVENCIO® (avelumab) Plus INLYTA® (axitinib) Significantly Improved Progression-Free Survival in Previously Untreated Patients with Advanced Renal Cell Carcinoma in Phase III Study",
                0.9667456138
            ],
            [
                1536192000000,
                "CYTOO enters into Research and Option Agreement with Pfizer to develop a  target discovery platform for Duchenne Muscular Dystrophy",
                0.8293898718
            ],
            [
                1536105600000,
                "4D Molecular Therapeutics Raises $90 Million Series B Financing",
                1.1728318622
            ],
            [
                1536105600000,
                "Pfizer Receives Breakthrough Therapy Designation from FDA for PF-06651600, an oral JAK3 Inhibitor, for the Treatment of Patients with Alopecia Areata",
                1.1728318622
            ],
            [
                1536019200000,
                "Pfizer Prices $5,000,000,000 Debt Offering",
                0.8840787008
            ],
            [
                1535587200000,
                "Pfizer Terminates Domagrozumab (PF-06252616) Clinical Studies for the Treatment of Duchenne Muscular Dystrophy",
                0.6984472986
            ],
            [
                1535328000000,
                "Pfizer, Inc. Issues A Voluntary Nationwide Recall Of One Lot Of Children’s Advil® Suspension Bubble Gum Flavored 4 FL OZ Bottle",
                -2.4578436741
            ],
            [
                1535328000000,
                "Tafamidis Phase 3 Transthyretin Amyloid Cardiomyopathy (ATTR-ACT) Study Results Presented as Late-Breaking Data at the ESC Congress 2018",
                -2.4578436741
            ],
            [
                1534896000000,
                "Pfizer and Astellas Amend Clinical Research Protocols for Two Phase 3 Trials of Enzalutamide in Patients with Hormone-Sensitive Prostate Cancer",
                0.1184899256
            ],
            [
                1534896000000,
                "Exact Sciences and Pfizer Enter into U.S. Promotion Agreement for Cologuard®",
                0.1184899256
            ],
            [
                1534809600000,
                "Important Notice Regarding EpiPen Auto-Injector U.S. supply",
                -0.6180388374
            ],
            [
                1534723200000,
                "Bristol-Myers Squibb-Pfizer Alliance ACROPOLIS™ Real-World Data Program Grows to Sample  Size of Nearly One Million Lives Worldwide",
                -0.0948490499
            ],
            [
                1534723200000,
                "Pfizer Invites Public To View And Listen To Webcast Of August 27 Conference Call With Analysts And Investors To Review Tafamidis Data Presentation At ESC Congress 2018",
                -0.0948490499
            ],
            [
                1534377600000,
                "BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza",
                2.0432367338
            ],
            [
                1533686400000,
                "SANGAMO ANNOUNCES POSITIVE PRELIMINARY DATA FROM THE PHASE 1/2  ALTA STUDY EVALUATING SB-525 GENE THERAPY FOR HEMOPHILIA A",
                0.7073197996
            ],
            [
                1533081600000,
                "XELJANZ® (tofacitinib citrate) Receives Marketing Authorization in the European Union for Moderately to Severely Active Ulcerative Colitis",
                0.8943352561
            ],
            [
                1532995200000,
                "PFIZER REPORTS SECOND-QUARTER 2018 RESULTS",
                5.115468673
            ],
            [
                1532995200000,
                "Pfizer Receives European Approval for Oncology Biosimilar, TRAZIMERA™ (trastuzumab)",
                5.115468673
            ],
            [
                1532476800000,
                "Pfizer Clarifies Incorrect Media Reports Regarding Amsterdam UMC Clinical Trial",
                1.2840698628
            ],
            [
                1532390400000,
                "Pfizer to Build Cutting-Edge Sterile Injectable Facility in Michigan, Investing Nearly Half a Billion Dollars in U.S. Manufacturing, Creating More than 450 Jobs",
                1.6320155635
            ],
            [
                1532304000000,
                "Dr. Seng Hing Cheng Appointed Chief Scientific Officer of Pfizer Rare Disease Research Unit",
                0.9549187848
            ],
            [
                1532044800000,
                "U.S. FDA Approves Pfizer’s Biosimilar NIVESTYM™ (filgrastim-aafi)",
                0.0268820965
            ],
            [
                1531872000000,
                "Pfizer And Lilly Announce Positive Top-Line Results From Phase 3 Trial Of Tanezumab For The Treatment Of Osteoarthritis (OA) Pain",
                -0.6156390739
            ],
            [
                1531699200000,
                "Pfizer Initiates Pivotal Phase 3 Program for Investigational Hemophilia B Gene Therapy",
                0.4515214175
            ],
            [
                1531440000000,
                "U.S. FDA Approves XTANDI® (enzalutamide) for the Treatment of Men with Non-Metastatic Castration-Resistant Prostate Cancer (CRPC)",
                -0.3210290068
            ],
            [
                1531267200000,
                "Pfizer to Organize for Future Growth",
                0.7196234576
            ],
            [
                1531180800000,
                "Pfizer Announces it Will Defer Company’s Price Increases",
                -0.2418854008
            ],
            [
                1530576000000,
                "RESOLUTE:13 academic & industry partners join forces to unlock SLCs for new therapies",
                1.9401945462
            ],
            [
                1530230400000,
                "Hospira Issues Voluntary Nationwide Recall Of Daptomycin For  Injection Lyophilized Powder For Solution, Due to Infusion Reactions",
                -0.3302906839
            ],
            [
                1530144000000,
                "XELJANZ® (tofacitinib citrate) Receives Marketing Authorisation in the European Union for Active Psoriatic Arthritis",
                0.4685793587
            ],
            [
                1530144000000,
                "Pfizer Declares 34-Cent Third-Quarter 2018 Dividend",
                0.4685793587
            ],
            [
                1530057600000,
                "U.S. FDA Grants Priority Review for Pfizer’s New Drug Application for Glasdegib in Patients with Previously Untreated Acute Myeloid Leukemia",
                0.1650207303
            ],
            [
                1529884800000,
                "Pfizer Announces Overall Survival Results from Phase 3 PALOMA-3 Trial of IBRANCE® (Palbociclib) in HR+, HER2- Metastatic Breast Cancer",
                0.1649279039
            ],
            [
                1529366400000,
                "Pfizer Invites Public To View And Listen To Webcast Of July 31 Conference Call With Analysts",
                1.5633272053
            ],
            [
                1528761600000,
                "Pfizer Announces Extension of Zithromax® Antibiotic Donation Program through 2025 to Help Eliminate World’s Leading Infectious Cause of Blindness",
                -0.469350302
            ],
            [
                1528329600000,
                "U.S. FDA and European Medicines Agency Accept Regulatory Submissions for Review of Talazoparib for Metastatic Breast Cancer Patients with an Inherited BRCA Mutation",
                0.4908341015
            ],
            [
                1528243200000,
                "Pfizer to Expand Venture Investing with $600 Million Commitment to Pfizer Ventures",
                0.2466580537
            ],
            [
                1528070400000,
                "Hospira Issues A Voluntary Nationwide Recall For Two Lots of  Naloxone Hydrochloride Injection, USP, in the Carpuject™ Syringe  System Due To The Potential Presence of Particulate Matter.",
                0.0822992288
            ],
            [
                1528070400000,
                "Dacomitinib Shows More than Seven-Month Improvement in Overall Survival Compared to an Established Therapy in Advanced NSCLC with EGFR-Activating Mutations",
                0.0822992288
            ],
            [
                1528070400000,
                "Two-Year Update of Pivotal JAVELIN Merkel 200 Trial Shows Continued Durable Responses with BAVENCIO® (avelumab)",
                0.0822992288
            ],
            [
                1527811200000,
                "Pfizer Receives Positive CHMP Opinion for Oncology Biosimilar, TRAZIMERA™ (trastuzumab)",
                0.5212853038
            ],
            [
                1527724800000,
                "Cortexyme Completes $76 Million Series B Financing and Provides Update on Clinical Development Progress",
                0.827584344
            ],
            [
                1527638400000,
                "Pfizer Announces U.S. FDA Approves XELJANZ® (tofacitinib) for the Treatment of Moderately to Severely Active Ulcerative Colitis",
                -0.0556645921
            ],
            [
                1527638400000,
                "The Pfizer Foundation Announces $5 Million in Grants to Support Women and Families",
                -0.0556645921
            ],
            [
                1527552000000,
                "Pfizer’s XALKORI® (crizotinib) Receives FDA Breakthrough Therapy Designation in Two New Indications",
                1.8862595064
            ],
            [
                1527120000000,
                "Pfizer Reaches $23.85 Million Settlement Agreement To Resolve  Allegations Related To Patient Assistance Charities",
                -0.784756608
            ],
            [
                1527033600000,
                "FDA Grants Breakthrough Therapy Designation for Tafamidis for the Treatment of Patients with Transthyretin Cardiomyopathy",
                0.5851168436
            ],
            [
                1526947200000,
                "A Study Analyzing Observational Data Shows Real-World Effectiveness of Prevnar® 13 in Adults Age 65+",
                0.4726288101
            ],
            [
                1526947200000,
                "Pfizer Begins a Phase 1/2 Study to Evaluate Respiratory Syncytial Virus (RSV) Vaccine",
                0.4726288101
            ],
            [
                1526860800000,
                "Spark Therapeutics and Pfizer Announce Data from 15 Participants with Hemophilia B Showing Persistent and Sustained Factor IX Levels with No Serious Adverse Events",
                0.028001038
            ],
            [
                1526515200000,
                "Around the World, People Living with Ulcerative Colitis Share Common Perspectives and Experiences",
                0.0280477191
            ],
            [
                1526515200000,
                "LYRICA® (pregabalin) Oral Solution CV Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint",
                0.0280477191
            ],
            [
                1526428800000,
                "Pfizer Oncology to Showcase Clinical Advances from its Growing Portfolio and Research Pipeline at ASCO",
                -0.0559853803
            ],
            [
                1526342400000,
                "Pfizer’s Biosimilar RETACRIT® (epoetin alfa-epbx) Approved by U.S. FDA",
                0.4764548674
            ],
            [
                1525824000000,
                "Important Notice Regarding EpiPen auto-injector supply",
                1.0232612057
            ],
            [
                1525737600000,
                "XtalPi Inc. Announces Strategic Research Collaboration with Pfizer Inc. to Develop  Artificial Intelligence-Powered Molecular Modeling Technology for Drug Discovery",
                0.7392730071
            ],
            [
                1525737600000,
                "New project to enhance nanomedicine development",
                0.7392730071
            ],
            [
                1525651200000,
                "Wave Life Sciences Highlights Progress on Hepatic Collaboration with Pfizer",
                0.5431517133
            ],
            [
                1525132800000,
                "HUB Announces Collaboration with Pfizer Inc. on Human Gut Organoids for  IBD",
                -1.9776431531
            ],
            [
                1525132800000,
                "Pfizer Reports First-Quarter 2018 Results",
                -1.9776431531
            ],
            [
                1525046400000,
                "Dawn Rogers Appointed Executive Vice President of Pfizer Worldwide Human Resources",
                -4.8869987428
            ],
            [
                1524700800000,
                "Pfizer Hosts Annual Meeting of Shareholders",
                0.5405561289
            ],
            [
                1524441600000,
                "Pfizer Granted FDA Breakthrough Therapy Designation for TRUMENBA® (Meningococcal Group B Vaccine) for the Prevention of Invasive Meningococcal B Disease in Children Ages 1 to 9 Years",
                1.0523742636
            ],
            [
                1524441600000,
                "Pfizer Provides Update on Proposed Trastuzumab Biosimilar",
                1.0523742636
            ],
            [
                1524441600000,
                "MYLOTARG™ Approved In The EU For The Treatment Of Previously Untreated, De Novo, CD33-positive Acute Myeloid Leukemia In Combination With Chemotherapy",
                1.0523742636
            ],
            [
                1524096000000,
                "Pfizer Invites Public to Listen to Webcast of April 26 Annual Meeting of Shareholders",
                0.6551976558
            ],
            [
                1523491200000,
                "Pfizer Doses First Patient Using Investigational Mini-Dystrophin Gene Therapy for the Treatment of Duchenne Muscular Dystrophy",
                0.7984592074
            ],
            [
                1523318400000,
                "Pfizer Provides Update on Phase 3 Trial of Axitinib as Adjuvant Treatment for Patients at High Risk of Renal Cell Carcinoma Recurrence After Surgery",
                -0.5867487608
            ],
            [
                1523318400000,
                "Pfizer Signs Lease for The Spiral at Hudson Yards in Manhattan",
                -0.5867487608
            ],
            [
                1522800000000,
                "U.S. FDA and European Medicines Agency Accept Regulatory Submissions for Review of Dacomitinib to Treat Metastatic Non-Small Cell Lung Cancer with EGFR-Activating Mutations",
                1.1475132846
            ],
            [
                1522713600000,
                "Pfizer and Allogene Therapeutics Enter into Asset Contribution Agreement for Pfizer’s Allogeneic CAR T Immuno-oncology Portfolio",
                2.8231394835
            ],
            [
                1522281600000,
                "Pfizer Announces Positive Topline Results From Phase 3 ATTR-ACT Study Of Tafamidis In Patients With Transthyretin Cardiomyopathy",
                -1.3409535581
            ],
            [
                1521763200000,
                "Pfizer Reports Top-Line Results from a Study of CHANTIX®/CHAMPIX® (varenicline) in Adolescent Smokers",
                -1.2842276162
            ],
            [
                1521417600000,
                "U.S. FDA Grants Priority Review for a Supplemental New Drug Application (sNDA) for XTANDI® (enzalutamide) in Non-Metastatic Castration-Resistant Prostate Cancer (CRPC)",
                -1.2936929164
            ],
            [
                1521417600000,
                "BioDuro Collaboration with Pfizer Inc. Leads to Creation of a Shelf-Stable  Fluorosulfation Reagent",
                -1.2936929164
            ],
            [
                1520812800000,
                "BIOGEN TO ACQUIRE FROM PFIZER FIRST-IN-CLASS PHASE 2b READY ASSET  FOR COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA",
                -0.4625917579
            ],
            [
                1520726400000,
                "Findings Released from Largest Real-World Data Analysis of Non-Valvular Atrial Fibrillation Patients Receiving Direct Oral Anticoagulants",
                -0.4625917579
            ],
            [
                1520553600000,
                "AM‐Pharma announces Phase II study results of recAP in sepsis‐associated Acute  Kidney Injury",
                9.0623e-06
            ],
            [
                1520467200000,
                "Pfizer Announces Favorable Outcome of FDA Advisory Committee Meeting on XELJANZ® (tofacitinib) for Moderately to Severely Active Ulcerative Colitis",
                2.1212801123
            ],
            [
                1520380800000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference",
                2.4657523373
            ],
            [
                1520208000000,
                "Hospira Issues A Voluntary Nationwide Recall For Hydromorphone HCL Injection, USP CII Due To The Potential For Empty Or Cracked Glass Vials",
                0.167236684
            ],
            [
                1520208000000,
                "Dan R. Littman Elected to Pfizer’s Board of Directors",
                0.167236684
            ],
            [
                1519948800000,
                "Neofluidics Announces Collaboration with Pfizer Inc.",
                1.5780899234
            ],
            [
                1519776000000,
                "Inserm announces research agreement with Pfizer Inc. to study rare neuromuscular  disease",
                -3.9292679436
            ],
            [
                1519344000000,
                "Hospira Issues A Voluntary Nationwide Recall For Labetalol  Hydrochloride Injection, USP, Due To The Potential Of Cracked  Glass At The Rim Surface Of The Vials",
                3.1275545941
            ],
            [
                1519344000000,
                "Pfizer Receives Positive CHMP Opinion for Two Hematology Medicines, MYLOTARG™ and BOSULIF®",
                3.1275545941
            ],
            [
                1519344000000,
                "Pfizer Announces Update on European Marketing Authorization Application for SUTENT® (sunitinib) in Adult Patients at High Risk of Recurrent Renal Cell Carcinoma",
                3.1275545941
            ],
            [
                1519344000000,
                "Albert Bourla Elected to Pfizer’s Board of Directors",
                3.1275545941
            ],
            [
                1518566400000,
                "Pfizer Receives Breakthrough Therapy Designation from FDA for PF-04965842, an oral JAK1 Inhibitor, for the Treatment of Patients with Moderate-to-Severe Atopic Dermatitis",
                2.8283399645
            ],
            [
                1518393600000,
                "U.S., EU and Japan Health Authorities Accept Regulatory Submissions for Review of Pfizer’s Third-Generation ALK Inhibitor Lorlatinib",
                1.4024018587
            ],
            [
                1517788800000,
                "Phase 3 PROSPER Trial Shows XTANDI® (enzalutamide) Significantly Reduced the Risk of Metastasis or Death by 71 Percent in Men with Non-Metastatic Castration-Resistant Prostate Cancer",
                -3.4013823162
            ],
            [
                1517270400000,
                "Pfizer Reports Fourth-Quarter and Full-Year 2017 Results",
                -3.1587363776
            ],
            [
                1516752000000,
                "Pfizer Announces Positive Top-Line Results For Potential Biosimilar To Rituxan®/MabThera®",
                0.6446376576
            ],
            [
                1516579200000,
                "MINDIMMUNE THERAPEUTICS TO CONDUCT RESEARCH ON SPECIALIZED IMMUNE CELLS WITH PFIZER INC.",
                -0.19010856
            ],
            [
                1516320000000,
                "Survey of Ulcerative Colitis Patients and Gastroenterologists Indicates that Symptoms May Create a New Reality for Patients",
                -0.7040167127
            ],
            [
                1516147200000,
                "Circle Pharma announces publication in Journal of Medicinal Chemistry of results from  collaboration with Pfizer Inc.",
                0.4595515635
            ],
            [
                1515456000000,
                "Adapsyn Bioscience Completes Financing to Advance its Small Molecule Natural Products  Platform and Pipeline; Announces Research Collaboration with Pfizer Inc.",
                0.0822266246
            ],
            [
                1515369600000,
                "Imcyse announces a research collaboration with  Pfizer Inc. in rheumatoid arthritis (RA)",
                -0.8514091026
            ],
            [
                1515369600000,
                "Regeneron Forms Consortium of Leading Life Sciences Companies to  Accelerate Largest Widely-Available ‘Big Data’ Human Sequencing Resource with UK Biobank",
                -0.8514091026
            ],
            [
                1515369600000,
                "Alexandria Venture Investments Launches the Alexandria Seed Capital Platform, a Novel  and Innovative Seed-Stage Life Science Funding Model and a Natural Extension of  Alexandria LaunchLabs",
                -0.8514091026
            ],
            [
                1515369600000,
                "Pfizer Inc. Announces Expiration and Results of its Tender Offer for its 5.750 per cent. Notes due 2021 and Related Solicitation of Consents",
                -0.8514091026
            ],
            [
                1515369600000,
                "Pfizer Establishes New Partnering Model for Early-Stage Academic Research",
                -0.8514091026
            ],
            [
                1515110400000,
                "Distributed Bio Announces SuperHuman  Platform License Agreement with Pfizer Inc.",
                -1.0150842776
            ],
            [
                1515110400000,
                "Distributed Bio Announces SuperHuman  Platform License Agreement with Pfizer Inc.",
                -1.0150842776
            ],
            [
                1515024000000,
                "Berkeley Lights Announces Research Collaboration and License Agreement with Pfizer",
                0.4069398747
            ],
            [
                1514937600000,
                "Sangamo and Pfizer announce collaboration for development of zinc finger protein gene therapy for ALS",
                0.9241644767
            ],
            [
                1513900800000,
                "FDA Approves SGLT2 Inhibitor STEGLATRO™ (ertugliflozin) and Fixed-Dose Combination STEGLUJAN™ (ertugliflozin and sitagliptin) for Adults with Type 2 Diabetes",
                -0.1657141215
            ],
            [
                1513814400000,
                "FDA Grants Breakthrough Therapy Designation for Avelumab in Combination with INLYTA® in Advanced Renal Cell Carcinoma",
                -1.1067930738
            ],
            [
                1513641600000,
                "U.S. FDA Approves Pfizer’s BOSULIF® (bosutinib) for the Treatment of Patients with Newly-Diagnosed Ph+ Chronic Myelogenous Leukemia (CML)",
                -2.0296319238
            ],
            [
                1513555200000,
                "CMAC Medicines Manufacturing Consortium Welcomes Pfizer as  Newest Partner",
                -0.7579780597
            ],
            [
                1513555200000,
                "Pfizer Declares First-Quarter 2018 Dividend",
                -0.7579780597
            ],
            [
                1513296000000,
                "Pfizer Inc. Announces Expiration and Results of its Private Exchange Offer for its 6.500 per cent. Notes due 2038 and Related Tender Offer",
                0.9426377465
            ],
            [
                1513209600000,
                "Pfizer Announces FDA Approval of XELJANZ® (tofacitinib) and XELJANZ® XR for the Treatment of Active Psoriatic Arthritis",
                1.2634361256
            ],
            [
                1513209600000,
                "Pfizer Inc. Announces Pricing Terms of Private Exchange Offer for its 6.500 per cent. Notes due 2038 Open to Certain Investors and Related Tender Offer Open to All Investors",
                1.2634361256
            ],
            [
                1513209600000,
                "Pfizer Initiates Phase 3 Program for PF-04965842, a JAK1 Inhibitor in Development for Moderate-to-Severe Atopic Dermatitis",
                1.2634361256
            ],
            [
                1513123200000,
                "FDA Approves New Pfizer Biosimilar",
                -0.3017349635
            ],
            [
                1513123200000,
                "Phase 3 TRUMENBA® (Meningococcal Group B Vaccine) Data Published in New England Journal of Medicine Demonstrate the Vaccine’s Immunogenicity",
                -0.3017349635
            ],
            [
                1513036800000,
                "U.S. Food And Drug Administration Extends Action Date For XELJANZ® (Tofacitinib) Supplemental New Drug Application In Ulcerative Colitis By Three Months",
                0.7642348676
            ],
            [
                1512950400000,
                "Spark Therapeutics and Pfizer Announce Longer-term Preliminary Data Showing Consistent and Sustained Factor IX Levels in Hemophilia B at 59th American Society of Hematology (ASH) Annual Meeting and Exposition",
                1.47622066
            ],
            [
                1512691200000,
                "Talazoparib Significantly Extends Progression-Free Survival in Phase 3 EMBRACA Trial of Patients with Metastatic Breast Cancer",
                2.4578539577
            ],
            [
                1512604800000,
                "Pfizer Inc. Announces (i) Private Exchange Offer for its 6.500 per cent.",
                0.5036670717
            ],
            [
                1512518400000,
                "Spark Therapeutics and Pfizer Announce Publication in The New England Journal of Medicine of Interim Data from Phase 1/2 Clinical Trial of Investigational Gene Therapy for Hemophilia B",
                -0.2253794155
            ],
            [
                1512518400000,
                "Updated Data from Phase 3 Trial of IBRANCE® (palbociclib) Plus Letrozole in ER+, HER2- Metastatic Breast Cancer Confirm Improvement in Progression-Free Survival",
                -0.2253794155
            ],
            [
                1512432000000,
                "Bristol-Myers Squibb and Pfizer Alliance Urge People to ‘Tune in to AFib, Take Note of Stroke Risk’",
                -1.0123767207
            ],
            [
                1512432000000,
                "Pfizer Unveils 2017 ASPIRE Oncology/Hematology Clinical Research Awards Winners; Grants Totaling More than $6M in 2017",
                -1.0123767207
            ],
            [
                1512000000000,
                "Pfizer Enters into Agreement to Develop and Commercialize CRESEMBA® (isavuconazole) in China and Asia Pacific Region",
                0.38512885
            ],
            [
                1511827200000,
                "Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Phase III JAVELIN Gastric 300 Study in Patients with Pre-Treated Advanced Gastric Cancer",
                1.7122232966
            ],
            [
                1511222400000,
                "Ground-breaking €34 million project to develop better test for liver disease",
                0.0846756904
            ],
            [
                1510790400000,
                "Pfizer Receives FDA Approval for SUTENT® (sunitinib malate) as First and Only Adjuvant Treatment for Adult Patients at High Risk of Recurrent Renal Cell Carcinoma",
                0.0848238555
            ],
            [
                1510704000000,
                "COMBACTE Adds a New Project to its Consortium: COMBACTE-CDI",
                0.7874147686
            ],
            [
                1510704000000,
                "UC San Diego Center for Microbiome Innovation Announces Pfizer as Corporate Member",
                0.7874147686
            ],
            [
                1510531200000,
                "Pfizer Names Albert Bourla Chief Operating Officer",
                0.4522060934
            ],
            [
                1510272000000,
                "BMS-Pfizer Alliance To Unveil Real-World Data Analyses - Cost, Safety and Comparative Effectiveness Findings Associated with Oral Anticoagulants in Non-Valvular Atrial Fibrillation",
                0.5665976526
            ],
            [
                1510272000000,
                "Pfizer Sells Its 49% Equity Share in Hisun-Pfizer Pharmaceuticals",
                0.5665976526
            ],
            [
                1510012800000,
                "Spark Therapeutics and Pfizer Amend License Agreement for Investigational SPK-9001 in Hemophilia B",
                0.1132032246
            ],
            [
                1509494400000,
                "Encycle\tTherapeutics\tannounces discovery\tcollaboration with\tPfizer\tInc.",
                1.2690396894
            ],
            [
                1509408000000,
                "Pfizer Reports Third-Quarter 2017 Results",
                0.5955826677
            ],
            [
                1509235200000,
                "One Year Maintenance and Switching Data in Patients with Crohn’s Disease Support the Use of INFLECTRA®* (infliximab CT-P13) in IBD1",
                -1.0553671878
            ],
            [
                1508112000000,
                "New Ulcerative Colitis Data for XELJANZ® (tofacitinib) at Upcoming Gastroenterology Congresses",
                -0.4143685968
            ],
            [
                1508112000000,
                "Pfizer Presents Full Results from Phase 2 Study of Next-Generation Investigational ALK-Inhibitor Lorlatinib in ALK-Positive and ROS1-Positive Advanced Non-Small Cell Lung Cancer",
                -0.4143685968
            ],
            [
                1507852800000,
                "The Union for International Cancer Control and Pfizer award new round of grants totalling US$500,000 to organisations in 19 countries to address the needs of metastatic breast cancer patients worldwide",
                -1.0839489615
            ],
            [
                1507766400000,
                "U.S. FDA Approves LYRICA® CR (pregabalin) Extended-Release Tablets CV",
                -0.3852471202
            ],
            [
                1507593600000,
                "Pfizer Reviewing Strategic Alternatives for Consumer Healthcare Business",
                0.192051364
            ],
            [
                1507161600000,
                "Pfizer Launches Novel Programs to Put Important Support Services at the Fingertips of Cancer Patients",
                0.4715820807
            ],
            [
                1507075200000,
                "AmerisourceBergen, Blue Cross Blue Shield Association, Pfizer and Prime Therapeutics Join Walgreens to Combat Prescription Drug Abuse by Expanding Safe Medication Disposal Program",
                -0.5000222877
            ],
            [
                1506470400000,
                "Pfizer Declares 32-Cent Fourth-Quarter 2017 Dividend",
                0.983147103
            ],
            [
                1506470400000,
                "Bavencio (avelumab) Approved for Merkel Cell Carcinoma in Japan",
                0.983147103
            ],
            [
                1506384000000,
                "Patti LaBelle and Pfizer Work Together to Educate Baby Boomers About the Risk of Pneumococcal Pneumonia",
                -0.1692594103
            ],
            [
                1505952000000,
                "LabCentral to Open Next-Stage Facility for Growing Life Science Companies, Supported by Pfizer",
                -0.2780782851
            ],
            [
                1505952000000,
                "National Sickle Cell Disease Poll of African Americans Dispels Long-Held Views",
                -0.2780782851
            ],
            [
                1505952000000,
                "New Global Report Finds Majority of People at High Risk of Stroke Not Being Screened for Common Risk Factors",
                -0.2780782851
            ],
            [
                1505865600000,
                "European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma",
                0.1112044125
            ],
            [
                1505865600000,
                "Pfizer Goes To Court To Allow Competition For Biologics And Expand Options For Patients",
                0.1112044125
            ],
            [
                1505779200000,
                "Pfizer Announces Outcome of FDA Advisory Committee Meeting for SUTENT® in Patients at High Risk of Recurrent Renal Cell Carcinoma after Surgery",
                0.9169167345
            ],
            [
                1505347200000,
                "Pfizer and Astellas Announce Positive Top-Line Results from Phase 3 PROSPER Trial of XTANDI (enzalutamide) in Patients with Non-Metastatic Castration-Resistant Prostate Cancer",
                0.876687501
            ],
            [
                1505088000000,
                "Pfizer Presents Overall Survival Data of XALKORI in Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer",
                3.6188958491
            ],
            [
                1504915200000,
                "Pfizer Presents Positive Pivotal Data for PF-05280014, an Investigational Biosimilar to Herceptin® (trastuzumab), at the European Society for Medical Oncology (ESMO) 2017 Congress",
                3.6188958491
            ],
            [
                1504224000000,
                "Pfizer Receives FDA Approval for MYLOTARG™ (gemtuzumab ozogamicin)",
                -0.4141980909
            ],
            [
                1504137600000,
                "Amyloid Publishes Long-Term Data Analysis from Pfizer Suggesting Tafamidis Delays Progression of TTR-FAP, a Rare Disease",
                1.3545431656
            ],
            [
                1503964800000,
                "Bristol-Myers Squibb and Pfizer Alliance Announce Real-World Observational Analysis of the Effectiveness and Safety of Direct Oral Anticoagulants Compared to Warfarin in Elderly Patients with Non-Valvular Atrial Fibrillation",
                0.0598166884
            ],
            [
                1503964800000,
                "U.S. FDA and European Medicines Agency Accept Regulatory Submissions for BOSULIF® (bosutinib) for the Treatment of Patients with Newly Diagnosed Ph+ Chronic Myeloid Leukemia",
                0.0598166884
            ],
            [
                1503878400000,
                "Bristol-Myers Squibb and Pfizer Present Investigational Eliquis® (apixaban) Data for Patients with Non-Valvular Atrial Fibrillation (NVAF) Undergoing Cardioversion",
                -1.33799e-05
            ],
            [
                1503792000000,
                "Bristol-Myers Squibb and Pfizer Present Observational Real-World Data Analysis on the Effectiveness and Safety of Eliquis® (apixaban) Compared to Warfarin in Select High-Risk Patients with Non-Valvular Atrial Fibrillation",
                -1.33799e-05
            ],
            [
                1503532800000,
                "Pfizer Rare Disease Launches Two First-of-Its-Kind Innovative Technologies for People Living with Hemophilia at National Hemophilia Foundation Annual Meeting",
                0.0598950449
            ],
            [
                1503360000000,
                "Alliance Foundation Trials Opens Global Trial Investigating First-in-Class Palbociclib in HR+, HER2+ Metastatic Breast Cancer",
                1.4440620801
            ],
            [
                1503014400000,
                "Bristol-Myers Squibb and Pfizer to Highlight Commitment to Reducing the Risk of Stroke Caused by Non-Valvular Atrial Fibrillation (NVAF) and Treating Deep Vein Thrombosis/Pulmonary Embolism (DVT/PE) at...",
                -0.4578938463
            ],
            [
                1502928000000,
                "Pfizer Receives U.S. FDA Approval for BESPONSA® (inotuzumab ozogamicin)",
                -1.8977728397
            ],
            [
                1501718400000,
                "FDA Advisory Committee Votes in Favor of XELJANZ® (tofacitinib citrate) for the Treatment of Active Psoriatic Arthritis",
                2.0511179123
            ],
            [
                1501545600000,
                "Pfizer Reports Second-Quarter 2017 Results",
                0.606385597
            ],
            [
                1500940800000,
                "CONSORTIUM ESTABLISHED TO SUPPORT ICH M7 COMPLIANCE",
                -1.4898302801
            ],
            [
                1500940800000,
                "Interest from startups in the BaseLaunch healthcare accelerator exceeds  expectations",
                -1.4898302801
            ],
            [
                1500854400000,
                "Pfizer Announces Positive Top-Line Results from the Comparative REFLECTIONS B7391003 Study for PF-06439535, a Potential Biosimilar to Avastin®1 (bevacizumab)",
                -0.8458951361
            ],
            [
                1500595200000,
                "EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma",
                -0.4501892093
            ],
            [
                1500508800000,
                "Merck and Pfizer Collaborate with Corning",
                0.0298544623
            ],
            [
                1500422400000,
                "Pfizer Completes License Agreement For The Exclusive Commercialization Rights In Europe For CRESEMBA (isavuconazole)",
                0.5068590771
            ],
            [
                1499904000000,
                "Pfizer Announces FDA Accepts Supplemental New Drug Application for XELJANZ® (tofacitinib citrate) for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis",
                0.6281916754
            ],
            [
                1499731200000,
                "FDA Advisory Committee Votes in Favor of Pfizer’s MYLOTARG (gemtuzumab ozogamicin) for Acute Myeloid Leukemia",
                -0.5418598061
            ],
            [
                1499644800000,
                "Spark Therapeutics Presents Updated Interim Hemophilia B Data Supporting  Consistent and Sustained Response at the International Society on Thrombosis  and Haemostasis (ISTH) 2017 Congress",
                -0.5728014716
            ],
            [
                1498780800000,
                "BESPONSA® Approved in the EU for Adult Patients with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia",
                0.2661258329
            ],
            [
                1498694400000,
                "Alcyone Lifesciences Enters into a Feasibility Study Agreement with Pfizer to  Evaluate Alcyone’s proprietary PulsarTM Advanced Intrathecal Precision Delivery  Platform Technology for use in Gene Therapy Targeting Central Nervous System  Disorders",
                -0.4763590824
            ],
            [
                1498521600000,
                "Pfizer Breaks Ground on New R&D Facility in Chesterfield, Missouri",
                -1.1259054271
            ],
            [
                1498089600000,
                "Pfizer Declares 32-Cent Third-Quarter 2017 Dividend",
                0.6438348768
            ],
            [
                1497830400000,
                "Pfizer Begins Phase 1 Clinical Trial to Evaluate Investigational Group B Streptococcus Vaccine",
                1.847463477
            ],
            [
                1497571200000,
                "Pfizer Announces Results from XELJANZ® (tofacitinib citrate) ORAL Strategy Study Published in The Lancet and Presented at the EULAR Annual Congress",
                0.7224260195
            ],
            [
                1497398400000,
                "Pfizer Receives Exclusive Commercialization Rights in Europe for CRESEMBA, a Novel Treatment for Potentially Life-Threatening Fungal Infections Among Immunocompromised Patients",
                0.6705291883
            ],
            [
                1497312000000,
                "Nearly One in Four New and Expectant Parents Have Never Heard of Invasive Pneumococcal Disease According to a New Survey",
                -0.0611952292
            ],
            [
                1497312000000,
                "Pfizer and Lilly Receive FDA Fast Track Designation for Tanezumab",
                -0.0611952292
            ],
            [
                1497052800000,
                "Merck and Pfizer Announce that Investigational SGLT-2 Inhibitor Ertugliflozin Met Primary Endpoint in Two Phase 3 Studies",
                -0.5831576852
            ],
            [
                1496966400000,
                "Astellas and Pfizer Announce Amendment to Clinical Research Protocol for Phase 3 PROSPER Trial of enzalutamide in Patients with Non-metastatic Castration-Resistant Prostate Cancer",
                2.7216949015
            ],
            [
                1496793600000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference",
                -1.0393637148
            ],
            [
                1496793600000,
                "Sangamo Therapeutics And Pfizer Announce That Sb-525 Investigational Hemophilia A Gene Therapy Receives Orphan Medicinal Product Designation From The European Medicines Agency",
                -1.0393637148
            ],
            [
                1496707200000,
                "Pfizer Receives FDA Fast Track Designation for Tafamidis for Transthyretin Cardiomyopathy",
                -0.9375105077
            ],
            [
                1496534400000,
                "Spark Therapeutics Presents Updated Preliminary Data From Hemophilia B Phase 1/2 Trial Suggesting Consistent And Sustained Levels Of Factor IX Activity At The Hemostasis And Thrombosis Research Society (HTRS) 2017 Scientific Symposium",
                -1.3720201382
            ],
            [
                1496448000000,
                "Pfizer Presents Final Phase 2 Data on Investigational PARP Inhibitor Talazoparib in Patients with Germline BRCA-Positive Advanced Breast Cancer",
                -1.3720201382
            ],
            [
                1496188800000,
                "Pfizer Announces Acceptance of Regulatory Submissions by U.S. FDA and European Medicines Agency for SUTENT® (sunitinib) for Adjuvant Treatment of Adult Patients at High Risk of Recurrent Renal Cell Carcinoma After Surgery",
                1.3145828727
            ],
            [
                1496102400000,
                "European Commission Approves Pfizer’s TRUMENBA® to Help Prevent Meningococcal Group B Disease in Adolescents and Adults",
                1.8070375896
            ],
            [
                1495670400000,
                "FDA Advisory Committee Recommends Approval of Pfizer’s Proposed Biosimilar to Epogen®/Procrit® Across All Indications",
                0.2489206035
            ],
            [
                1495584000000,
                "Pfizer Recommends Shareholders Reject the Below-Market Mini-Tender Offer by TRC Capital Corporation",
                -0.0311046155
            ],
            [
                1495411200000,
                "Pharma Completes Patient Recruitment Of Recombinant Human Alkaline  Phosphatase (Recap) Phase II Trial In Acute Kidney Injury",
                -1.1201199681
            ],
            [
                1494979200000,
                "Pfizer Oncology to Present Data Across 13 Different Types of Cancer at ASCO 2017 Annual Meeting",
                -1.1793894867
            ],
            [
                1494979200000,
                "Merck KGaA, Darmstadt, Germany, and Pfizer to Present Data Highlighting Potential of Avelumab in Challenging Cancers at ASCO 2017",
                -1.1793894867
            ],
            [
                1494979200000,
                "Pfizer Invites Public to View and Listen to Webcast of June 9 Conference Call with Analysts to Review Oncology Business and ASCO Data Presentations",
                -1.1793894867
            ],
            [
                1494892800000,
                "Sangamo Receives Fast Track Designation From The Fda For Sb-525 Investigational Hemophilia A Gene Therapy",
                -1.0238860216
            ],
            [
                1494892800000,
                "Sangamo Receives Fast Track Designation From The Fda For Sb-525 Investigational Hemophilia A Gene Therapy",
                -1.0238860216
            ],
            [
                1494547200000,
                "TNO Starts Research Initiative With Industrial Partners To Combat Obesity-Associated Liver Disease",
                0.694445405
            ],
            [
                1494374400000,
                "SANGAMO THERAPEUTICS AND PFIZER ANNOUNCE COLLABORATION FOR HEMOPHILIA A GENE THERAPY",
                0.1210702862
            ],
            [
                1494288000000,
                "FDA Grants BAVENCIO® (avelumab) Approval for a Common Type of Advanced Bladder Cancer",
                -0.3007052738
            ],
            [
                1494288000000,
                "FDA Grants Second Approval for BAVENCIO® (avelumab)",
                -0.3007052738
            ],
            [
                1494288000000,
                "New Smartphone App May Enable Lupus Patients to Report Symptoms More Easily and Accurately",
                -0.3007052738
            ],
            [
                1494201600000,
                "Collaboration Helps Broaden Access to Pfizer’s Contraceptive, Sayana® Press (medroxyprogesterone acetate), for Women in Some of the World’s Poorest Countries",
                -0.0599190093
            ],
            [
                1493769600000,
                "Phase 3 OCTAVE Studies of Oral Tofacitinib in Ulcerative Colitis Results Published in The New England Journal of Medicine",
                -0.0896868473
            ],
            [
                1493769600000,
                "Pfizer Announces U.S. FDA Filing Acceptance of Supplemental New Drug Application for XELJANZ® (tofacitinib citrate) for the Treatment of Adult Patients with Active Psoriatic Arthritis",
                -0.0896868473
            ],
            [
                1493683200000,
                "Pfizer Reports First-Quarter 2017 Results",
                -0.3286604397
            ],
            [
                1493251200000,
                "Pfizer Hosts Annual Meeting of Shareholders",
                -0.117895665
            ],
            [
                1493251200000,
                "Insphero Announces Agreement With Pfizer To Develop Novel Assays For Predicting Drug-Induced Liver Injury",
                -0.117895665
            ],
            [
                1493251200000,
                "Pfizer’s Next-Generation ALK/ROS1 Inhibitor, Lorlatinib, Granted Breakthrough Therapy Designation from FDA for ALK-Positive Metastatic Non-Small Cell Lung Cancer",
                -0.117895665
            ],
            [
                1493078400000,
                "Aquinnah Pharmaceuticals Receives $10 Million Investment  from Pfizer and AbbVie to Research Breakthrough Approach to  Neurodegenerative Disease",
                0.0886197596
            ],
            [
                1493078400000,
                "Circle Pharma Announces Expansion Of Series A Financing And Appointment Of James C. Lu To Its Board",
                0.0886197596
            ],
            [
                1493078400000,
                "Domain Therapeutics And Pfizer Inc. Enter Into Collaboration Agreement On Biosensall™",
                0.0886197596
            ],
            [
                1492992000000,
                "Pivotal Phase III Study Underscores Efficacy Of Zavicefta™ (ceftazidime-avibactam) For Treatment Of Hospital-Acquired Pneumonia, A Leading Cause Of Mortality In Hospitals",
                -0.6516834656
            ],
            [
                1492732800000,
                "Pfizer Receives Positive CHMP Opinion for BESPONSA® (Inotuzumab Ozogamicin) for the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia",
                0.2964106131
            ],
            [
                1492732800000,
                "Pfizer Unveils ATLAS®, An Interactive, User-Friendly Website That Provides Global Antibiotic Resistance Surveillance Data Across 60 Countries",
                0.2964106131
            ],
            [
                1492646400000,
                "Pfizer Invites Public To Listen To Webcast Of April 27 Annual Meeting Of Shareholders",
                0.0297061203
            ],
            [
                1492646400000,
                "PSI And Pfizer Partner To Address Hypertension In Vietnam And Myanmar",
                0.0297061203
            ],
            [
                1490918400000,
                "IBRANCE® (palbociclib) Receives FDA Regular Approval and Expanded Indication for First-Line HR+, HER2- Metastatic Breast Cancer",
                0.0876129632
            ],
            [
                1490572800000,
                "XELJANZ® (tofacitinib citrate) Receives Marketing Authorisation in the European Union for the Treatment of Moderate to Severe Active Rheumatoid Arthritis (RA)",
                1.2295211599
            ],
            [
                1490313600000,
                "Pfizer Receives Positive CHMP Opinion for TRUMENBA® for Prevention of Meningococcal Group B Disease",
                -0.2633099176
            ],
            [
                1490227200000,
                "FDA Grants Approval for BAVENCIO® (avelumab), the First Immunotherapy Approved for Metastatic Merkel Cell Carcinoma",
                -0.9411760308
            ],
            [
                1490054400000,
                "NephCure Kidney International® Launches the NephCure Accelerating Cures Institute® Aims to accelerate treatments and a cure for glomerular kidney diseases",
                -0.0290134313
            ],
            [
                1490054400000,
                "New drug strategy: target the ribosome to halt protein production",
                -0.0290134313
            ],
            [
                1489708800000,
                "DILIsym Services, Inc. Evaluates Prospective NAFLD Treatment,  Utilizing Its Flagship Technology in Collaboration with Pfizer, Inc.",
                -0.2326878461
            ],
            [
                1489708800000,
                "Bristol-Myers Squibb and Pfizer Present Large Real-World Observational Analysis of the Effectiveness and Safety of Direct Oral Anticoagulants Compared to Warfarin in Patients with Non-Valvular Atrial Fibrillation",
                -0.2326878461
            ],
            [
                1489536000000,
                "Pfizer Announces Approval By The China Food And Drug Administration Of XELJANZ®, The First Oral JAK Inhibitor For Adult Patients With Moderately To Severely Active Rheumatoid Arthritis",
                0.6099476503
            ],
            [
                1488931200000,
                "Servier and Pfizer Announce FDA Clearance of IND Application for UCART19 in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia",
                0.4111836179
            ],
            [
                1488931200000,
                "The Union for International Cancer Control and Pfizer Announce Next Phase of Global Grants Initiative Supporting Metastatic Breast Cancer Patients",
                0.4111836179
            ],
            [
                1488758400000,
                "Bristol-Myers Squibb and Pfizer to Present New Analyses of Eliquis™ (apixaban) Clinical and Real-World Data at the American College of Cardiology 2017 Scientific Session",
                -1.0002907818
            ],
            [
                1488758400000,
                "Merck and Pfizer Announce U.S. FDA and EMA Filing Acceptances of Three Marketing Applications for Ertugliflozin-Containing Medicines for Adults with Type 2 Diabetes",
                -1.0002907818
            ],
            [
                1488326400000,
                "Spark Therapeutics and Pfizer Announce that SPK-9001, an Investigational  Hemophilia B Medicine, has been Granted Access to the PRIority MEdicines  (PRIME) Program by the European Medicines Agency",
                0.6954389516
            ],
            [
                1488240000000,
                "Pfizer Prices €4,000,000,000 Debt Offering",
                0.9297131682
            ],
            [
                1488240000000,
                "Pfizer Commits $4M to North Carolina Biotechnology Center Gene Therapy  Fellowship Program",
                0.9297131682
            ],
            [
                1488240000000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference",
                0.9297131682
            ],
            [
                1488240000000,
                "FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Urothelial Carcinoma for Priority Review",
                0.9297131682
            ],
            [
                1488153600000,
                "Arrakis Therapeutics Announces $38M Series A Financing To Target RNA with  Small-Molecule Medicines And Names Michael Gilman Chairman and CEO",
                -0.3223916161
            ],
            [
                1487894400000,
                "Pfizer Prices $1,065,000,000 Debt Offering",
                0.3208837712
            ],
            [
                1487808000000,
                "Ronald E. Blaylock Elected to Pfizer’s Board of Directors",
                1.634562098
            ],
            [
                1487721600000,
                "Startup accelerator BaseLaunch aims to attract promising  healthcare ventures to Basel, Europe’s leading life sciences hub.",
                1.4386595719
            ],
            [
                1487635200000,
                "Pfizer Announces Acceptance of Regulatory Submission for Inotuzumab Ozogamicin by the U.S. Food and Drug Administration",
                0.0595210216
            ],
            [
                1487289600000,
                "New Data in Crohn’s Disease Patients Shows Similar Efficacy and Safety Profiles for INFLECTRA® and REMICADE®a",
                0.0892337451
            ],
            [
                1487203200000,
                "Pfizer Announces Top-Line Results from the Oral Strategy Trial of XELJANZ® (tofacitinib citrate) Compared to Humira® (adalimumab)",
                0.5056539022
            ],
            [
                1486512000000,
                "Pfizer Receives FDA Approval for EUCRISA™ (crisaborole)",
                1.4206288918
            ],
            [
                1486512000000,
                "Relationship Expert Teams Up with Pfizer to Address Intimacy and Relationship Issues for People Living with Chronic Diseases",
                1.4206288918
            ],
            [
                1485820800000,
                "Edelris Announces Research Collaboration Agreement with Pfizer Inc.",
                3.0714877842
            ],
            [
                1485820800000,
                "PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2016 RESULTS",
                3.0714877842
            ],
            [
                1485475200000,
                "Pfizer Receives Positive CHMP Opinion in Europe for XELJANZ® (tofacitinib citrate) for the Treatment of Moderate to Severe Active Rheumatoid Arthritis",
                -0.5110311958
            ],
            [
                1485388800000,
                "Pfizer Announces Positive Top-Line Results from Phase 2 Study of Investigational Clostridium difficile Vaccine for the Prevention of C. difficile Infection",
                0.0636722267
            ],
            [
                1484784000000,
                "Milner Therapeutics Institute announces new partnership with US pharmaceutical company Pfizer",
                -0.912812285
            ],
            [
                1484006400000,
                "The Scripps Research Institute Signs Collaboration Agreement with Pfizer to Advance DNA-Encoded Library  Technology",
                -2.3149601352
            ],
            [
                1483660800000,
                "Guardant Health to create a new 500-plus-gene liquid biopsy panel with several leading  pharmaceutical companies to accelerate clinical trials and drug development",
                -0.567691961
            ],
            [
                1483574400000,
                "Iterum Announces Sulopenem in Development for Treatment of  Gram-Negative, Multi-drug Resistant Infections",
                0.3285825313
            ],
            [
                1483574400000,
                "Molecular Stethoscope Completes $8.2M Seed Financing to Advance Circulating Cell-Free RNA Liquid  Biopsy Platform; Announces Research Collaboration with Pfizer",
                0.3285825313
            ],
            [
                1483574400000,
                "AbCellera Announces Multi-Target Research Collaboration with Pfizer",
                0.3285825313
            ],
            [
                1483574400000,
                "Pfizer Announces Positive Top-Line Results from the Comparative REFLECTIONS B538-02 Study for PF-06410293, a Potential Biosimilar to Humira®1 (adalimumab)",
                0.3285825313
            ],
            [
                1483488000000,
                "Arvinas Announces Research Collaboration and License Agreement  with Pfizer Inc. for the Discovery and Development of Protein  Degradation Drug Candidates",
                1.4281144632
            ],
            [
                1483488000000,
                "Spark Therapeutics Announces $15 Million Milestone Payment from Pfizer  for Progress in Hemophilia B Gene Therapy Program",
                1.4281144632
            ],
            [
                1483401600000,
                "Pfizer Invites Public To View And Listen To Webcast Of January 31 Conference Call With Analysts",
                1.7723233784
            ],
            [
                1482364800000,
                "Pfizer Completes Acquisition of Small Molecule Anti-Infective Business From AstraZeneca",
                0.5849896127
            ],
            [
                1482278400000,
                "BioInvent announces Cancer Immunotherapy Research Collaboration and  License Agreement with Pfizer and issues new shares to Pfizer",
                -1.205950405
            ],
            [
                1482278400000,
                "Circle Pharma, developer of macrocyclic peptide therapeutics, announces Series A financing and  appoints Walter H. Moos, Ph.D., to its board",
                -1.205950405
            ],
            [
                1482278400000,
                "FDA Accepts Supplemental New Drug Application for Pfizer’s IBRANCE® (palbociclib) in HR+, HER2- Metastatic Breast Cancer",
                -1.205950405
            ],
            [
                1482192000000,
                "Draper to Build Preclinical Microphysiological Systems with Pfizer to Help Predict Clinical Outcomes",
                -1.1728359848
            ],
            [
                1482105600000,
                "Pfizer Presents Data from PALOMA-2 Phase 3 Study Demonstrating Clinical Benefit of IBRANCE® (palbociclib) in Asian Women with ER+, HER2- Metastatic Breast Cancer at ESMO Asia Congress",
                0.2739569523
            ],
            [
                1482105600000,
                "Pfizer Receives Approval in the European Union for Nimenrix™ (Meningococcal Group A, C, W-135, and Y Conjugate Vaccine) in Infants Six Weeks of Age and Older",
                0.2739569523
            ],
            [
                1481846400000,
                "FDA Approves Removal Of Boxed Warning Regarding Serious Neuropsychiatric Events From CHANTIX® (varenicline) Labeling",
                -0.1522794694
            ],
            [
                1481673600000,
                "Pfizer Receives FDA Approval for EUCRISA™ (crisaborole), a Novel Non-Steroidal Topical Ointment for Mild to Moderate Atopic Dermatitis (Eczema)",
                -0.5190630483
            ],
            [
                1481673600000,
                "Pfizer and Astellas Announce Top-Line Results from Phase 4 PLATO Trial of XTANDI® (enzalutamide) Capsules in Patients with Metastatic Castration-Resistant Prostate Cancer",
                -0.5190630483
            ],
            [
                1481673600000,
                "Pfizer Announces FDA Approval of EUCRISA™ (crisaborole)",
                -0.5190630483
            ],
            [
                1481587200000,
                "Pediatric Open Innovation Challenge Grantees Awarded $50,000 by the Institute for  Pediatric Innovation and Pfizer",
                0.0304301686
            ],
            [
                1481587200000,
                "Ab\tInitio\tAnnounces\tStrategic\tCollaboration with\tPfizer\tto\tDiscover\tGPCR\tActivating\tAntibodies",
                0.0304301686
            ],
            [
                1481587200000,
                "Pfizer Declares First-Quarter 2017 Dividend",
                0.0304301686
            ],
            [
                1481500800000,
                "Pioneers in Oncolytic Virus and Gene Therapy Fields Announce Formation  of IGNITE Immunotherapy Inc., a Company Focused on Oncolytic Cancer  Vaccine Discovery and Development",
                3.441987793
            ],
            [
                1481241600000,
                "Akili and Pfizer Present Positive Data from Digital Biomarker Study to Detect Subtle Cognitive Changes  in Healthy Subjects at Risk of Developing Alzheimer’s Disease",
                3.9814863443
            ],
            [
                1480982400000,
                "Pfizer Announces Expansion of ASPIRE Awards Program for 2017 to Include $5.5M in Funding for Breast and Hematologic Cancers",
                -1.4748118835
            ],
            [
                1480896000000,
                "Pfizer and Avillion Announce Positive Top-Line Results for Phase 3 BFORE Study of BOSULIF for First-Line Treatment of Philadelphia Chromosome Positive Chronic Myeloid Leukemia",
                -0.5703605379
            ],
            [
                1480723200000,
                "Spark Therapeutics and Pfizer Present Updated Data from Hemophilia B Phase  1/2 Trial Suggesting Consistent and Sustained Levels of Factor IX Activity at  Annual ASH Meeting",
                -0.5703605379
            ],
            [
                1480723200000,
                "New Phase 2 Results Show Investigational Compound Glasdegib Improved Overall Survival in Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome",
                -0.5703605379
            ],
            [
                1480550400000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference",
                -1.9601672651
            ],
            [
                1480550400000,
                "IBM and Pfizer to Accelerate Immuno-oncology Research with Watson for Drug Discovery",
                -1.9601672651
            ],
            [
                1480550400000,
                "LYRICA® (pregabalin) Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint",
                -1.9601672651
            ],
            [
                1480464000000,
                "Pfizer Announces Positive Top-Line Results from the Pivotal Comparative REFLECTIONS B3271002 Study for PF-05280014, a Potential Biosimilar to Herceptin®1 (trastuzumab)",
                -1.6528919666
            ],
            [
                1480377600000,
                "FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma for Priority Review",
                0.9023157326
            ],
            [
                1479686400000,
                "Anthony J. Maddaluna, Executive Vice President and President of Pfizer Global Supply to Retire",
                -0.574530613
            ],
            [
                1479686400000,
                "Pfizer Announces Expiration And Results Of Tender Offer For Any And All Of Its 6.200% Senior Notes Due March 15, 2019",
                -0.574530613
            ],
            [
                1479427200000,
                "Pfizer Announces Pricing of Tender Offer for Any and All of its 6.200% Senior Notes Due March 15, 2019",
                -1.2036852485
            ],
            [
                1479254400000,
                "PALOMA-2 Phase 3 Study Published In The New England Journal Of Medicine Demonstrates Clinical Benefit Of Pfizer’s IBRANCE® (palbociclib) In First-Line ER+, HER2- Metastatic Breast Cancer",
                -1.4812275802
            ],
            [
                1479168000000,
                "Pfizer Announces Results from Phase 3 OPAL Clinical Development Program Investigating XELJANZ® (Tofacitinib Citrate) for Psoriatic Arthritis",
                -2.5031415817
            ],
            [
                1479081600000,
                "Pfizer Prices $6,000,000,000 Debt Offering",
                -1.9236737712
            ],
            [
                1479081600000,
                "Pfizer Announces Tender Offer for Any and All of its 6.200% Senior Notes Due March 15, 2019",
                -1.9236737712
            ],
            [
                1479081600000,
                "Pfizer to Collaborate with National Cancer Institute to Study Three Immunotherapy Agents Targeting Multiple Cancers",
                -1.9236737712
            ],
            [
                1478995200000,
                "Landmark Study Demonstrates Pfizer’s Celebrex (Celecoxib)Has Similar Cardiovascular Risk As Compared To Prescription Doses Of Ibuprofen and Naproxen",
                -1.9236737712
            ],
            [
                1478822400000,
                "Pfizer Announces Major Expansion of Humanitarian Assistance Program",
                -2.5941874597
            ],
            [
                1478736000000,
                "Bristol-Myers Squibb and Pfizer to Deliver 12 New Eliquis® (apixaban) Presentations at American Heart Association (AHA) Scientific Sessions 2016",
                -2.2399815205
            ],
            [
                1478649600000,
                "IBRANCE® (palbociclib) Receives Approval in European Union for the Treatment of Women with HR+/HER2- Metastatic Breast Cancer",
                1.4332857456
            ],
            [
                1478476800000,
                "Pfizer to Present Additional Research For XELJANZ® (Tofacitinib Citrate) In Rheumatologic Diseases, Including Rheumatoid Arthritis and Psoriatic Arthritis",
                0.2283998451
            ],
            [
                1478131200000,
                "Spark Therapeutics and Pfizer Announce Updated Data from Hemophilia B Phase 1/2 Trial Suggesting Sustained Therapeutic Levels of Factor IX Activity",
                -2.333334212
            ],
            [
                1478044800000,
                "Pfizer’s Prevenar 13® Receives Approval For Use in Infants and Children in China",
                -3.6801481806
            ],
            [
                1477958400000,
                "Pfizer Reports Third-Quarter 2016 Results",
                -1.0120998185
            ],
            [
                1477958400000,
                "Pfizer Discontinues Global Development of Bococizumab, Its Investigational PCSK9 Inhibitor",
                -1.0120998185
            ],
            [
                1477785600000,
                "European Medicines Agency Validates the Marketing Authorization Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma",
                -3.121971284
            ],
            [
                1477008000000,
                "FDA Approves Supplemental New Drug Application for XTANDI® (enzalutamide) Capsules in Advanced Prostate Cancer",
                -0.9025834403
            ],
            [
                1476835200000,
                "CDC Advisory Committee on Immunization Practices Votes to Recommend New Dosing Schedule for Vaccination with TRUMENBA® (Meningococcal Group B Vaccine)",
                -0.6453503337
            ],
            [
                1476835200000,
                "DILIsym Services, Inc. Utilizes Flagship Technology to Evaluate Prospective NAFLD Treatments in  Collaboration with Pfizer Inc.",
                -0.6453503337
            ],
            [
                1476835200000,
                "Pfizer Awarded Grant to Evaluate Vaccine to Protect Newborns Against Group B Streptococcus Infection",
                -0.6453503337
            ],
            [
                1476662400000,
                "Pfizer Announces The U.S. Availability Of Biosimilar INFLECTRA® (infliximab-dyyb)",
                0.3364880385
            ],
            [
                1476489600000,
                "Pfizer to Present New Data on XELJANZ® (Tofacitinib Citrate) for Ulcerative Colitis at UEG Week 2016",
                0.3364880385
            ],
            [
                1475971200000,
                "First Positive Phase 3 Results In Adjuvant Setting For Renal Cell Carcinoma Show SUTENT® (sunitinib) Extended Disease Free Survival After Surgical Removal",
                -1.5695578762
            ],
            [
                1475971200000,
                "Pfizer Presents Promising New Immunotherapy Combination Data With INLYTA® (axitinib) In Advanced Renal Cell Carcinoma (RCC)",
                -1.5695578762
            ],
            [
                1475712000000,
                "ICU Medical Inc. To Acquire The Hospira Infusion Systems Business From Pfizer Inc. For $1 Billion In Cash And Stock",
                -0.6555492183
            ],
            [
                1475020800000,
                "iTeos Announces Initiation of Phase 1 Clinical Trial of IDO1 inhibitor",
                -1.590611763
            ],
            [
                1475020800000,
                "Pfizer Completes Acquisition of Medivation",
                -1.590611763
            ],
            [
                1475020800000,
                "Pfizer to Showcase Progress of Broad-Based Oncology Portfolio at European Society for Medical Oncology (ESMO) 2016 Congress",
                -1.590611763
            ],
            [
                1474848000000,
                "Pfizer Decides Remaining One Company Best Positions Company To Maximize Future Value Creation",
                -0.2660247339
            ],
            [
                1474588800000,
                "Pfizer Announces Expiration of HSR Waiting Period For Proposed Acquisition of Medivation",
                -1.5457678744
            ],
            [
                1474502400000,
                "Pfizer Declares 30-Cent Fourth-Quarter 2016 Dividend",
                -0.2042980614
            ],
            [
                1474329600000,
                "Pfizer Invites Public To View And Listen To Webcast Of November 1 Conference Call With Analysts",
                1.2835851523
            ],
            [
                1473984000000,
                "Pfizer Announces Positive Top-Line Results from REFLECTIONS B537-02 Study for PF-06438179 (infliximab-Pfizer) a Potential Biosimilar to Remicade® (infliximab)",
                -1.6047458884
            ],
            [
                1473984000000,
                "Pfizer Receives Positive CHMP Opinion For IBRANCE® (palbociclib) In Combination With Endocrine Therapy For The Treatment Of HR+/HER2- Metastatic Breast Cancer In Europe",
                -1.6047458884
            ],
            [
                1473897600000,
                "OncoImmune Announces Option and License Agreement with Pfizer Inc.",
                0.1473102631
            ],
            [
                1473897600000,
                "Merck and Pfizer Announce Investigational Ertugliflozin Met Primary Endpoint of A1C Reduction When Added to Sitagliptin and Metformin in People with Type 2 Diabetes",
                0.1473102631
            ],
            [
                1473811200000,
                "FDA Advisory Committees Recommend to Remove Boxed Warning in Labeling for Pfizer’s Smoking Cessation Therapy, CHANTIX® (varenicline)",
                0.0585796941
            ],
            [
                1473724800000,
                "Pfizer Launches New “Moodivator” App to Help Support, Encourage and Motivate People with Depression",
                -1.4731816326
            ],
            [
                1473638400000,
                "Circle Pharma enters into an agreement with Pfizer to build screening library of macrocyclic  peptides",
                0.1175031299
            ],
            [
                1473292800000,
                "AnTolRx, Inc. Announces Series A Equity Funding from Pfizer,  JDRF and Orion Equity Partners, LLC to Develop Targeted  Nanoparticle Tolerance Therapeutics",
                -1.7888550348
            ],
            [
                1473206400000,
                "Pfizer Appoints Chief Scientific Officer for Neuroscience Research",
                2.1573e-06
            ],
            [
                1473120000000,
                "Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Morgan Stanley Global Healthcare Conference",
                -0.1148140022
            ],
            [
                1472601600000,
                "XALKORI® (Crizotinib) Receives Approval In European Union For The Treatment Of Patients With ROS1-Positive Advanced Non-Small Cell Lung Cancer",
                -0.5189869938
            ],
            [
                1471910400000,
                "Pfizer To Acquire Small Molecule Anti-Infective Business From AstraZeneca",
                -0.516931287
            ],
            [
                1471910400000,
                "Bristol-Myers Squibb and Pfizer to Present New Eliquis (apixaban) Analyses at ESC Congress 2016",
                -0.516931287
            ],
            [
                1471824000000,
                "Pfizer To Acquire Medivation",
                0.8264470037
            ],
            [
                1471564800000,
                "FDA Approves TROXYCA® ER (oxycodone hydrochloride and naltrexone hydrochloride) Extended-Release Capsules CII with Abuse-Deterrent Properties for the Management of Pain",
                -0.6314696572
            ],
            [
                1470614400000,
                "Pfizer Announces Publication of New Analysis Showing Long-Term Therapy with VYNDAQEL (tafamidis) Slowed Progression of Rare Neurodegenerative Disease",
                -0.5701275336
            ],
            [
                1470096000000,
                "PFIZER REPORTS SECOND-QUARTER 2016 RESULTS",
                -3.3067524289
            ],
            [
                1470009600000,
                "PFIZER AIMS TO BECOME INDUSTRY LEADER IN GENE THERAPY WITH AQUISITION OF BAMBOO THERAPEUTICS, INC.",
                -1.7312290481
            ],
            [
                1469664000000,
                "Pfizer Announces Positive Top-Line Results from Pivotal Phase 3 Maintenance Trial of Oral XELJANZ® (Tofacitinib Citrate) in Ulcerative Colitis",
                0.0271091497
            ],
            [
                1469664000000,
                "Pfizer and Western Oncolytics Announce Immuno-Oncology Research Collaboration to Investigate Novel Oncolytic Virus Technology",
                0.0271091497
            ],
            [
                1469491200000,
                "BIND Therapeutics Determines Pfizer’s $40 Million Bid Is Highest and Best in 363 Auction for  Substantially All of BIND’s Assets",
                0.0542705863
            ],
            [
                1469404800000,
                "Spark Therapeutics and Pfizer Announce Updated Data from First Cohort in Hemophilia B Phase 1/2  Trial Demonstrating Consistent, Sustained Therapeutic Levels of Factor IX Activity",
                0.0814285279
            ],
            [
                1469059200000,
                "Spark Therapeutics and Pfizer Announce Receipt of FDA Breakthrough Therapy Designation for SPK-9001 for the Treatment of Hemophilia B",
                0.1905137968
            ],
            [
                1468886400000,
                "Pfizer Receives World Health Organization Prequalification for Multi-Dose Vial Presentation of Prevenar 13®",
                0.0272461473
            ],
            [
                1468368000000,
                "Pfizer Announces the Publication of Final Results from Two Pivotal Phase 3 Studies of Crisaborole Topical Ointment in Patients with Mild to Moderate Atopic Dermatitis",
                1.7334781575
            ],
            [
                1468281600000,
                "Pfizer Receives FDA Approval for Prevnar 13® in Adults Age 18 Through 49",
                0.4406634895
            ],
            [
                1467936000000,
                "Pfizer Announces Positive Top-Line Results From Phase 3 S-TRAC Trial of SUTENT® (sunitinib) as Adjuvant Therapy in Patients at High Risk of Recurrent Renal Cell Carcinoma",
                0.7468911438
            ],
            [
                1467763200000,
                "Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First-line Treatment for Ovarian Cancer",
                -0.1397645146
            ],
            [
                1467331200000,
                "BIND Therapeutics Files Motion for Sale of Assets After Accepting Stalking Horse Bid from Pfizer Inc.",
                1.8430317781
            ],
            [
                1467072000000,
                "Two Additional Phase 3 Lipid-Lowering Studies of Bococizumab Deliver Positive Topline Results",
                2.4564614634
            ],
            [
                1466985600000,
                "Pfizer Advances Biosimilars Leadership with Investment in a New World-Class Global Biotechnology Center in China",
                1.8582964012
            ],
            [
                1466726400000,
                "Pfizer Completes Acquisition of Anacor",
                1.047e-05
            ],
            [
                1466640000000,
                "Pfizer Declares 30-Cent Third-Quarter 2016 Dividend",
                -2.1489449321
            ],
            [
                1466467200000,
                "Pfizer Invites Public To View And Listen To Webcast Of August 2 Conference Call With Analysts",
                -0.1160529301
            ],
            [
                1466035200000,
                "Help Pfizer Change The Future Of Healthy Aging",
                -1.344247803
            ],
            [
                1466035200000,
                "Pfizer Breaks Ground On New Biologics Clinical Manufacturing Facility In Andover, Massachusetts",
                -1.344247803
            ],
            [
                1465862400000,
                "Shire to License PF-00547659 from Pfizer, Adding to Established and  Leading Gastrointestinal Portfolio",
                0.5461385179
            ],
            [
                1465689600000,
                "Pfizer Announces Final Results from Inotuzumab Ozogamicin Pivotal Phase 3 Study in Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia",
                -0.0857507977
            ],
            [
                1465603200000,
                "Merck and Pfizer Announce Two Pivotal Phase 3 Studies for Ertugliflozin, an Investigational SGLT-2 Inhibitor, Met Primary Endpoints, Showing Significant A1C Reductions in Patients with Type 2 Diabetes",
                -0.0857507977
            ],
            [
                1465430400000,
                "Pro Golfer Jim Furyk Teams Up With Pfizer To Raise Awareness For Pneumococcal Pneumonia And The Importance Of Older Adult Vaccination",
                0.6800668768
            ],
            [
                1465344000000,
                "Pfizer Announces FDA Advisory Committees’ Recommend ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride) Extended-Release Capsules for Approval",
                1.5293070212
            ],
            [
                1465344000000,
                "Pfizer Research Advances Body Of Evidence For Tofacitinib Citrate (XELJANZ®) Providing Clinicians With Additional Information For The Treatment Of Moderate to Severe RA",
                1.5293070212
            ],
            [
                1465257600000,
                "A Mother’s Mission to Help Prevent Another Life Lost to MenB",
                1.1631474811
            ],
            [
                1465257600000,
                "Pfizer Announces Positive Top-Line Results from Second Phase 3 Trial of Oral XELJANZ® (Tofacitinib Citrate) in Adults with Psoriatic Arthritis",
                1.1631474811
            ],
            [
                1465171200000,
                "ASCO 2016: Pivotal Avelumab Study Shows Positive Results in Metastatic Merkel Cell Carcinoma",
                0.4018377495
            ],
            [
                1465171200000,
                "Pfizer Presents Promising Data from Next Generation ALK/ROS1 Inhibitor in Advanced Non-Small Cell Lung Cancer",
                0.4018377495
            ],
            [
                1465084800000,
                "Weizmann Institute of Science Announces Visiting Scientist Agreement with Pfizer Inc.",
                0.4018377495
            ],
            [
                1464998400000,
                "Pfizer Presents Data from Phase 1b Trial Investigating Utomilumab (a 4-1BB agonist) in Combination with a Checkpoint Inhibitor",
                0.4018377495
            ],
            [
                1464652800000,
                "BioRap Technologies to enter strategic collaboration with Pfizer Inc. to research and develop novel  immunomodulators",
                0.2302092697
            ],
            [
                1463961600000,
                "CHAMPIX® (varenicline) European Union Label Updated to Include New Safety and Efficacy Data from the EAGLES Clinical Trial Following Endorsement from CHMP",
                0.7917637738
            ],
            [
                1463702400000,
                "Pfizer Announces European Medicines Agency Acceptance for Review of Marketing Authorization Application for TRUMENBA® (Meningococcal Group B Vaccine)",
                0.5643198125
            ],
            [
                1463616000000,
                "Spark Therapeutics and Pfizer Announce Data from Initial Subjects in Hemophilia B Trial Demonstrating Consistent Therapeutic Levels of Factor IX Expression",
                1.7190145617
            ],
            [
                1463529600000,
                "Merck KGaA, Darmstadt, Germany, and Pfizer to Present Avelumab Data in Seven Different Cancers at ASCO Annual Meeting",
                1.1084442026
            ],
            [
                1463529600000,
                "Pfizer to Showcase Diverse and Growing Oncology Portfolio at the American Society of Clinical Oncology (ASCO) 2016 Annual Meeting",
                1.1084442026
            ],
            [
                1463443200000,
                "Global Survey Finds Disconnects Between Physicians and People Living With Rheumatoid Arthritis (RA)",
                -0.3015001484
            ],
            [
                1463356800000,
                "Pfizer to Acquire Anacor",
                0.3027760097
            ],
            [
                1463097600000,
                "Pfizer Presents Results from Two Phase 3 TRUMENBA® (Meningococcal Group B Vaccine) Studies at the European Society for Paediatric Infectious Diseases Meeting",
                0.1497734978
            ],
            [
                1462924800000,
                "Pfizer Awards More Than $1 Million in Metastatic Breast Cancer Research Funding Through Breast Cancer: A Story Half Told Initiative",
                -0.8134721015
            ],
            [
                1462838400000,
                "AM‐Pharma publishes safety and pharmacokinetic data from Phase I recAP trial",
                -1.1150022169
            ],
            [
                1462838400000,
                "First Dosing of Pfizer DART Candidate in Phase 1 Study Triggers  Milestone Payment to MacroGenics",
                -1.1150022169
            ],
            [
                1462406400000,
                "WAVE Life Sciences Enters Collaboration with Pfizer to Develop  Genetically Targeted Therapies for the Treatment of Metabolic Diseases",
                0.625362095
            ],
            [
                1462233600000,
                "PFIZER REPORTS FIRST-QUARTER 2016 RESULTS",
                -0.7485379764
            ],
            [
                1461801600000,
                "Pfizer Hosts Annual Meeting of Shareholders",
                -0.7948532643
            ],
            [
                1461628800000,
                "AM‐Pharma receives FDA fast track designation for recAP in Acute Kidney Injury, and  reports completion of first stage in Phase II trial",
                -0.6060606661
            ],
            [
                1461628800000,
                "Bococizumab SPIRE-2 Cardiovascular Outcome Study Fully Enrolled",
                -0.6060606661
            ],
            [
                1461283200000,
                "CHANTIX®/CHAMPIX® (varenicline) Results from the Largest Global Clinical Trial of Smoking Cessation Medicines Published in The Lancet",
                -0.1204447742
            ],
            [
                1461196800000,
                "Pfizer Invites Public to Listen to Webcast of April 28 Annual Meeting of Shareholders",
                0.6311661608
            ],
            [
                1461024000000,
                "AM-Pharma STOP-AKI Phase II trial nominated for  “Most Innovative Clinical Trial Design” in 2016 CARE Awards",
                1.2939936559
            ],
            [
                1461024000000,
                "Pfizer Announces Positive Top-Line Results for Phase 3 PALOMA-2 Clinical Trial of IBRANCE® (palbociclib)",
                1.2939936559
            ],
            [
                1459987200000,
                "Pfizer Taps IBM for Research Collaboration to Transform Parkinson’s Disease Care",
                -0.153831022
            ],
            [
                1459900800000,
                "Pfizer Receives European Approval for New Multi-Dose Vial Presentation of Prevenar 13®",
                3.7240699141
            ],
            [
                1459900800000,
                "Pfizer Announces Termination of Proposed Combination with Allergan",
                3.7240699141
            ],
            [
                1459814400000,
                "FDA Approves INFLECTRA™ (Biosimilar Infliximab), The First U.S. Biosimilar Monoclonal Antibody, For All Eligible Indications",
                5.2232048983
            ],
            [
                1459814400000,
                "Merck and Pfizer Announce First Patient Treated in Phase III Combination Study with Avelumab and INLYTA® in Renal Cell Carcinom",
                5.2232048983
            ],
            [
                1459814400000,
                "Pfizer Announces Positive Top-Line Results from the First Phase 3 Trial of Investigational Tofacitinib in Adults with Psoriatic Arthritis",
                5.2232048983
            ],
            [
                1459728000000,
                "Pfizer and Allergan Issue Statement",
                4.0497229904
            ],
            [
                1459728000000,
                "Cancer Metabolism Company Metabomed Completes $18 Million Series A  Financing",
                4.0497229904
            ],
            [
                1459468800000,
                "Pfizer Announces Positive Topline Results from Second Phase 3 Lipid-Lowering Study Evaluating Bococizumab",
                4.1666807983
            ],
            [
                1459382400000,
                "Pfizer Inc. (NYSE: PFE) today issued the following statement:",
                -0.0665644913
            ],
            [
                1459296000000,
                "Pfizer and Allergan Receive Request for Additional Information from Federal Trade Commission Regarding Proposed Combination",
                -1.7206548285
            ],
            [
                1459296000000,
                "Bristol-Myers Squibb and Pfizer Announce Global Real-World Data Program and Present New Analyses of Eliquis (apixaban) at the American College of Cardiology’s 65th Annual Scientific Session",
                -1.7206548285
            ],
            [
                1458691200000,
                "Pfizer Announces European Medicines Agency Accepted for Review Its Marketing Authorization Application for XELJANZ® (Tofacitinib Citrate) for the Treatment of Moderate to Severe Rheumatoid Arthritis",
                -1.1635805542
            ],
            [
                1458604800000,
                "Pfizer Invites Public to View and Listen to Webcast of May 3 Conference Call with Analysts",
                0.529991629
            ],
            [
                1458604800000,
                "Pfizer Joins The Human Vaccines Project To Help Decode The Immune System",
                0.529991629
            ],
            [
                1458259200000,
                "Pfizer Announces Oral Tofacitinib, an Investigational JAK Inhibitor, Meets Primary and Key Secondary Endpoints in Two Pivotal Phase 3 Ulcerative Colitis Trials",
                1.8955626207
            ],
            [
                1458086400000,
                "Pfizer to Present New Data on Investigational Tofacitinib in Inflammatory Bowel Disease at the 11th Congress of ECCO",
                -0.613522319
            ],
            [
                1458000000000,
                "Pfizer Celebrates a Year of Achievements in 2015 Annual Review",
                -2.8925640117
            ],
            [
                1457654400000,
                "XALKORI® (crizotinib) Approved by U.S. FDA for the Treatment of Patients with ROS1-Positive Metastatic Non-Small Cell Lung Cancer",
                1.0630991445
            ],
            [
                1457481600000,
                "New Survey Reveals Many Living with Symptoms of Diabetic Nerve Pain Are Undiagnosed Despite Severe and Constant Pain",
                -0.4393333954
            ],
            [
                1457481600000,
                "Pfizer Commences $5 Billion Accelerated Share Repurchase",
                -0.4393333954
            ],
            [
                1457395200000,
                "Pfizer Announces Publication of Study Results of BeneFIX® Coagulation Factor IX (Recombinant) Once-Weekly Prophylaxis for Hemophilia B",
                -0.0336136081
            ],
            [
                1457395200000,
                "Pfizer Consumer Healthcare and frog Launch Design Collaborative",
                -0.0336136081
            ],
            [
                1456790400000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference",
                0.6337554864
            ],
            [
                1456272000000,
                "Pfizer Announces FDA Approval of XELJANZ® XR (tofacitinib citrate) Extended-Release Tablets, the First and Only Once-Daily Oral JAK Inhibitor Treatment for Rheumatoid Arthritis",
                2.5498366877
            ],
            [
                1455840000000,
                "Pfizer Receives Expanded FDA Approval For IBRANCE (palbociclib) In HR+, HER2- Metastatic Breast Cancer",
                1.4975069091
            ],
            [
                1455580800000,
                "WYETH REACHES AGREEMENT IN PRINCIPLE TO RESOLVE MEDICAID DRUG REBATE CLAIMS FOR 2001-2006 PERIOD FOR PROTONIX",
                0.2699990004
            ],
            [
                1454976000000,
                "Pfizer Commends The FDA Advisory Committee’s Vote To Approve Proposed Biosimilar Infliximab, The First Biosimilar Monoclonal Antibody Reviewed, For All Eligible Indications",
                3.4588088627
            ],
            [
                1454889600000,
                "Pfizer Names Executive Leadership Team for Combined Organization Upon Close of Proposed Allergan Transaction",
                1.4432772551
            ],
            [
                1454544000000,
                "UI strikes agreement with Pfizer Inc. to develop potential cystic fibrosis gene  therapy",
                -1.5845858176
            ],
            [
                1454371200000,
                "PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2015 RESULTS PROVIDES 2016 FINANCIAL GUIDANCE",
                -0.6730634307
            ],
            [
                1454284800000,
                "Bristol-Myers Squibb and Pfizer Sign Collaboration with Portola Pharmaceuticals to Develop and Commercialize Investigational Andexanet Alfa in Japan",
                -0.6635685962
            ],
            [
                1453680000000,
                "La Jolla Institute receives $5 million gift from Pfizer",
                -0.5217038638
            ],
            [
                1453248000000,
                "King’s College London signs licence and research agreement with Pfizer Inc. in the field of gene therapy",
                1.2099484095
            ],
            [
                1452643200000,
                "California Institute for Biomedical Research (Calibr) Enters Worldwide Strategic Collaboration with Pfizer Inc.",
                0.0642794553
            ],
            [
                1452470400000,
                "Schrödinger Announces Research Collaboration with Pfizer Inc.",
                -0.4838490444
            ],
            [
                1452470400000,
                "HemoShear Therapeutics Announces Next Stage of Safety  Collaboration with Pfizer Inc.",
                -0.4838490444
            ],
            [
                1452211200000,
                "Pfizer Expands R&D Equity Investment Strategy to Access Early-Stage Scientific Innovations",
                -1.5449209544
            ],
            [
                1452211200000,
                "Pfizer Enters into Translational Research Collaboration with Adaptive Biotechnologies to Help Advance Novel Immuno-Oncology Solutions",
                -1.5449209544
            ],
            [
                1452124800000,
                "PHILOGEN ANNOUNCES EXERCISE OF OPTIONS WITHIN THE LICENSE AGREEMENT  WITH PFIZER INC. FOR THE DEVELOPMENT AND POTENTIAL COMMERCIALIZATION  OF MULTIPLE ANTIBODY DRUG CONJUGATES (ADCs) AND TARGETED  TECHNOLOGIES",
                -0.5161104995
            ],
            [
                1452124800000,
                "4D Molecular Therapeutics Announces Collaboration with Pfizer Inc. for  Cardiac Gene Therapy Vector Discovery and Development",
                -0.5161104995
            ],
            [
                1452038400000,
                "Cortexyme Raises $15 Million Series A",
                -1.0509339442
            ],
            [
                1452038400000,
                "NextCure, Inc., New Immuno-Oncology Firm Announces $67 Million Series A Financing",
                -1.0509339442
            ],
            [
                1451865600000,
                "KineMed Enters Into Strategic Proteomic Biomarker Discovery Collaboration with Pfizer Inc.",
                1.0254725949
            ],
            [
                1451865600000,
                "Absorption Systems Licenses Cell Line to Pfizer",
                1.0254725949
            ],
            [
                1451865600000,
                "Merck KGaA, Darmstadt, Germany, Pfizer and Syndax Announce Collaboration to Evaluate Combination of Avelumab and Entinostat in Ovarian Cancer",
                1.0254725949
            ],
            [
                1450742400000,
                "Pfizer Invites Public To View And Listen To Webcast Of February 2 Conference Call With Analysts",
                -0.1842768865
            ],
            [
                1450742400000,
                "Merck KGaA, Darmstadt, Germany and Pfizer Advance Clinical Development Program with Two Additional Phase III Trials of Avelumab",
                -0.1842768865
            ],
            [
                1450051200000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference",
                0.8369656005
            ],
            [
                1450051200000,
                "Pfizer Declares First-Quarter 2016 Dividend",
                0.8369656005
            ],
            [
                1449705600000,
                "AMPLIFY Post-Hoc Early Time Course Analysis Evaluated Recurrent Venous Thromboembolism (VTE), VTE-Related Death and Major Bleeding in Deep Vein Thrombosis and Pulmonary Embolism Patients Treated with Eliquis (apixaban) or Conventional Therapy",
                -1.1541047484
            ],
            [
                1449705600000,
                "Pfizer Announces FDA Acceptance of IBRANCE® (palbociclib) Supplemental New Drug Application with Priority Review in HR+, HER2- Metastatic Breast Cancer",
                -1.1541047484
            ],
            [
                1449619200000,
                "Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Two Phase III Studies of Investigational Immunotherapy Avelumab in Advanced Gastric and Gastro-esophageal Junction Cancers",
                -0.1853984349
            ],
            [
                1449532800000,
                "BIOATLA ENTERS INTO STRATEGIC LICENSE AND OPTION AGREEMENT WITH PFIZER  FOR A NEW CLASS OF ANTIBODY THERAPEUTICS",
                -0.1858324662
            ],
            [
                1449532800000,
                "Spark Therapeutics Announces $15 Million Milestone Payment from Pfizer for  Progress in Hemophilia B Gene Therapy Program",
                -0.1858324662
            ],
            [
                1449532800000,
                "Pfizer Announces U.S. FDA Acceptance and Priority Review of Supplemental New Drug Application for XALKORI® (crizotinib) for the Treatment of Patients with ROS1-Positive Metastatic Non-Small Cell Lung Cancer",
                -0.1858324662
            ],
            [
                1449532800000,
                "Pfizer Awards More Than $4 Million in Grants to Further Clinical Research in Advanced Breast Cancer for 2015",
                -0.1858324662
            ],
            [
                1449446400000,
                "Pfizer Receives U.S. FDA Approval of New QuilliChew ER™ (methylphenidate hydrochloride) extended-release chewable tablets CII",
                -0.6455292384
            ],
            [
                1448841600000,
                "HEPTARES ENTERS STRATEGIC DRUG DISCOVERY COLLABORATION WITH PFIZER INC. FOCUSED ON GPCR TARGETS ACROSS MULTIPLE THERAPEUTIC AREAS",
                2.1118055095
            ],
            [
                1448841600000,
                "Sosei Subsidiary Heptares Enters Strategic Drug Discovery  Collaboration with Pfizer Inc. Focused on GPCR Targets Across  Multiple Therapeutic Areas",
                2.1118055095
            ],
            [
                1448409600000,
                "Pfizer Reports Top-Line Results from a Phase 3 Study of LYRICA® (pregabalin) Capsules CV in Adults with Post-Traumatic Peripheral Neuropathic Pain",
                1.251192836
            ],
            [
                1448323200000,
                "Merck KGaA, Darmstadt, Germany, and Pfizer Receive Positive Opinion for Orphan Drug Designation for Avelumab in Merkel Cell Carcinoma from EMA Committee for Orphan Medicinal Products",
                4.5330079964
            ],
            [
                1448323200000,
                "Pfizer Receives European Approval to Expand Use of XALKORI® (crizotinib) to First-Line Treatment of Adults with ALK-Positive Advanced Non-Small Cell Lung Cancer",
                4.5330079964
            ],
            [
                1448236800000,
                "Pfizer And Allergan To Combine",
                1.7203298276
            ],
            [
                1447804800000,
                "Thermo Fisher Scientific Signs Development Agreement for Next-Generation  Sequencing-Based Companion Diagnostic",
                -2.4465698102
            ],
            [
                1447804800000,
                "Pfizer Reports Positive Topline Results from Phase 3 Trial Comparing XALKORI® (crizotinib) to Chemotherapy in Previously Untreated East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)",
                -2.4465698102
            ],
            [
                1447804800000,
                "Merck KGaA, Darmstadt, Germany, and Pfizer Receive FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma",
                -2.4465698102
            ],
            [
                1447545600000,
                "Global Partners Announce Donation of 500 Millionth Dose of Azithromycin, Marking Exceptional Progress to Help Alleviate the Suffering from Trachoma",
                -1.2777793529
            ],
            [
                1447113600000,
                "Uwe Schoenbeck from Pfizer Inc. appointed member of CQDM’s Board of Directors",
                -0.2667553376
            ],
            [
                1446768000000,
                "Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis (apixaban) at the American Heart Association (AHA) Scientific Sessions 2015",
                -0.8023803542
            ],
            [
                1446681600000,
                "Pfizer Expands its Patient Assistance Program, Doubling the Income Eligibility Limit to Benefit Even More Patients Taking Pfizer Medicines",
                -0.8841656545
            ],
            [
                1446681600000,
                "Global Analysis Of Metastatic Breast Cancer Landscape Reveals Gaps In Patient Care And Support",
                -0.8841656545
            ],
            [
                1446595200000,
                "Merck KGaA, Darmstadt, Germany, and Pfizer Announce Initiation of Phase III First-Line Trial of Avelumab in Patients with Recurrent or Stage IV Non-Small Cell Lung Cancer",
                -2.2547837981
            ],
            [
                1446422400000,
                "New Data Continue to Characterize the Safety and Efficacy of XELJANZ® (tofacitinib citrate) in the Treatment of Rheumatoid Arthritis",
                2.2876452906
            ],
            [
                1446076800000,
                "GLYCOMIMETICS, INC. ANNOUNCES INITIATION OF FIRST CLINICAL TRIAL  EVALUATING SUBCUTANEOUS ADMINISTRATION OF RIVIPANSEL",
                -1.2714349309
            ],
            [
                1446076800000,
                "HALOZYME ANNOUNCES FIRST CLINICAL DOSING OF PFIZER’S  RIVIPANSEL USING ENHANZE™TECHNOLOGY",
                -1.2714349309
            ],
            [
                1446076800000,
                "Announcement Regarding Allergan plc",
                -1.2714349309
            ],
            [
                1446076800000,
                "Pfizer Announces Collaboration with GSK on Next-Generation Design of Portable, Continuous, Miniature and Modular (PCMM) Oral Solid Dose Development and Manufacturing Units",
                -1.2714349309
            ],
            [
                1445904000000,
                "PFIZER REPORTS THIRD-QUARTER 2015 RESULTS",
                1.2411717236
            ],
            [
                1445212800000,
                "Pfizer’s Inotuzumab Ozogamicin Receives FDA Breakthrough Therapy Designation for Acute Lymphoblastic Leukemia (ALL)",
                -1.2058957172
            ],
            [
                1444780800000,
                "Pfizer Receives Complete Response Letter from FDA for Oral XELJANZ® (tofacitinib citrate) Supplemental New Drug Application for Moderate to Severe Chronic Plaque Psoriasis",
                3.0516418255
            ],
            [
                1444694400000,
                "Pelago Bioscience grants Pfizer Inc. license to the CETSA™ method",
                -0.4237179955
            ],
            [
                1444694400000,
                "Pfizer and the Union for International Cancer Control Award 20 Grants Totaling $760,000 to Address the Needs of Metastatic Breast Cancer Patients Worldwide",
                -0.4237179955
            ],
            [
                1444348800000,
                "Pfizer’s Phase 2 Study Demonstrates Safety, Tolerability and Immunogenicity of TRUMENBA® When Coadministered with Meningococcal A, C, Y and W-135 Polysaccharide Conjugate (MCV4) and Tetanus, Diphtheria and Pertussis (Tdap) Vaccines in Adolescents",
                0.4816383394
            ],
            [
                1444176000000,
                "Merck KGaA, Darmstadt, Germany, and Pfizer Announce Investigational Immunotherapy Avelumab Receives FDA Fast Track Designation for Metastatic Merkel Cell Carcinoma",
                -0.0302386332
            ],
            [
                1443744000000,
                "Pfizer Inc. Announces Final Results of Exchange Offers",
                4.5101659434
            ],
            [
                1443657600000,
                "Pfizer Completes Acquisition Of Nimenrix And Mencevax From GlaxoSmithKline",
                5.3808994077
            ],
            [
                1443571200000,
                "Pfizer Partners with Breast Cancer Leaders to Chronicle the Lives of Women with Metastatic Breast Cancer through the Lenses of Prominent Photographers",
                1.2248715808
            ],
            [
                1443571200000,
                "Pfizer Updates 2015 Financial Guidance Solely to Include Hospira Operations In Financial Results From September 3, 2015 Through Year-End 2015",
                1.2248715808
            ],
            [
                1443571200000,
                "Is 50 Really the New 30? Your Immune System May Not Think So",
                1.2248715808
            ],
            [
                1443139200000,
                "Pfizer Declares 28-Cent Fourth-Quarter 2015 Dividend",
                -6.9435431437
            ],
            [
                1443052800000,
                "BIND\tTherapeutics Announces Pfizer Inc. Exercises Option to Advance Nanoparticle-Based Kinase Inhibitor for Treatment of Solid Tumors",
                -1.4738226765
            ],
            [
                1442966400000,
                "Pfizer’s Sayana® Press Becomes First Injectable Contraceptive In The United Kingdom Available For Administration By Self-Injection",
                1.4678917774
            ],
            [
                1442880000000,
                "New Centrum® VitaMints® Offer a Refreshingly New Way to Take a Multivitamin",
                1.9619854757
            ],
            [
                1442793600000,
                "Pfizer Announces Positive Top-Line Results from Two Phase 3 Trials of Oral Tofacitinib in Adults with Moderate-to-Severe Ulcerative Colitis",
                -2.6038407687
            ],
            [
                1442534400000,
                "Pfizer Inc. Announces Results of Early Tenders and Consents in Exchange Offers",
                -2.0357821084
            ],
            [
                1442361600000,
                "Pfizer Invites Public to View and Listen to Webcast of October 27 Conference Call with Analysts",
                1.4934362648
            ],
            [
                1441929600000,
                "Merck KGaA, Darmstadt, Germany and Pfizer to Present Updates for Avelumab at the European Cancer Congress 2015",
                0.428019393
            ],
            [
                1441756800000,
                "Evotec enters into licence and  collaboration agreement with  Pfizer Inc. in tissue fibrosis",
                -1.1648998481
            ],
            [
                1441756800000,
                "GPCR Consortium Exceeds Goal with Addition of Four New Pharma Members",
                -1.1648998481
            ],
            [
                1441756800000,
                "GPCR Consortium Exceeds Goal with Addition of Four New Pharma Members",
                -1.1648998481
            ],
            [
                1441756800000,
                "Bristol-Myers Squibb and Pfizer Enroll First Patient in Phase 4 AUGUSTUS Trial to Evaluate Safety of Eliquis (apixaban) in Nonvalvular Atrial Fibrillation Patients with a Recent Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention",
                -1.1648998481
            ],
            [
                1441584000000,
                "AMRA announces collaboration with Pfizer to use imaging to potentially help  identify those most at risk from metabolic disease and comorbidities",
                0.4067145563
            ],
            [
                1441238400000,
                "Pfizer Inc. Commences Exchange Offers for Hospira Notes",
                -2.8689939501
            ],
            [
                1441238400000,
                "Pfizer Completes Acquisition of Hospira",
                -2.8689939501
            ],
            [
                1440547200000,
                "Alliance Foundation Trials and Austrian Breast & Colorectal Cancer Study Group Open Largest Global Phase 3 Trial of Targeted Therapy, IBRANCE® (palbociclib), for Patients with Hormone Receptor–Positive Early Breast Cancer",
                3.5477919224
            ],
            [
                1440374400000,
                "Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis (apixaban) at the ESC Congress 2015",
                -2.0102200911
            ],
            [
                1440374400000,
                "Pfizer Receives Clearance from U.S. Federal Trade Commission for Hospira Acquisition",
                -2.0102200911
            ],
            [
                1440115200000,
                "Pfizer Announces Positive Topline Results Of Two Phase 3 Studies Of TRUMENBA® (Meningococcal Group B Vaccine)",
                -6.5670582567
            ],
            [
                1440028800000,
                "Pfizer Announces European Medicines Agency Validates Marketing Authorization Application for IBRANCE® (palbociclib) in Combination with Endocrine Therapy for the Treatment of HR+/HER2- Metastatic Breast Cancer",
                -4.1144929267
            ],
            [
                1439510400000,
                "Pfizer Granted Approval From The Canadian Competition Bureau For Hospira Acquisition",
                0.366187122
            ],
            [
                1439424000000,
                "HiFiBiO SAS Achieves Milestone in Antibody Research Collaboration with Pfizer Inc.",
                -0.1698614922
            ],
            [
                1439424000000,
                "Pfizer Receives Approval from the Australian Competition and Consumer Commission for Pending Acquisition of Hospira",
                -0.1698614922
            ],
            [
                1438646400000,
                "Pfizer Receives Approval From European Commission For Pending Acquisition Of Hospira",
                -0.3326330076
            ],
            [
                1438560000000,
                "Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis",
                -0.4984502732
            ],
            [
                1438041600000,
                "PFIZER REPORTS SECOND-QUARTER 2015 RESULTS",
                2.2930938617
            ],
            [
                1437523200000,
                "Pfizer Announces Expansion of Lease Agreement with Massachusetts Institute of Technology Subsidiary for Kendall Square Research Facility",
                -0.805094898
            ],
            [
                1436313600000,
                "Pfizer’s Centers For Therapeutic Innovation And Jeffrey Modell Foundation Announce Collaboration to Help Advance Immunological Research",
                0.9155150594
            ],
            [
                1436227200000,
                "Pfizer Begins Phase 2b Study Of Its Investigational Multi-antigen Staphylococcus aureus Vaccine In Adults Undergoing Elective Spinal Fusion Surgery",
                0.328854289
            ],
            [
                1435795200000,
                "Pfizer Announces FDA Acceptance for Review of New Drug Application for A Once-Daily Formulation of XELJANZ® (tofacitinib citrate) Modified Release Tablets",
                -1.4736801361
            ],
            [
                1435190400000,
                "Joseph J. Echevarria Elected To Pfizer’s Board Of Directors",
                -0.8549589422
            ],
            [
                1435190400000,
                "Pfizer Declares 28-Cent Third-Quarter 2015 Dividend",
                -0.8549589422
            ],
            [
                1435104000000,
                "CDC Advisory Committee on Immunization Practices Votes to Recommend Serogroup B Meningococcal Disease Vaccination including TRUMENBA® for Adolescents and Young Adults 16 through 23 Years of Age",
                -0.940649195
            ],
            [
                1435017600000,
                "Pfizer Announces Enrollment Of First Patient In Phase 3 Trial In Sickle Cell Disease",
                -0.5258599445
            ],
            [
                1435017600000,
                "Pfizer Invites Public To View And Listen To Webcast Of July 28 Conference Call With Analysts",
                -0.5258599445
            ],
            [
                1435017600000,
                "New Online Community, Quitter’s Circle, Helps Smokers Trade Cigarettes for Real-Time Support",
                -0.5258599445
            ],
            [
                1434931200000,
                "Pfizer Enters Into Agreement To Acquire Nimenrix And Mencevax From GlaxoSmithKline",
                0.4637835505
            ],
            [
                1433980800000,
                "Pfizer Reports Top Line Results from a Phase 3 Study Evaluating Desvenlafaxine Succinate Sustained-Release Formulation in Pediatric Patients with Major Depressive Disorder",
                -0.321548022
            ],
            [
                1433894400000,
                "Pfizer Builds Upon Robust Body Of Knowledge For XELJANZ® (tofacitinib citrate) With Clinical Trial And Real-World Use Data At The European League Against Rheumatism Annual Congress (EULAR 2015)",
                1.10273941
            ],
            [
                1433721600000,
                "Pfizer Announces 12 Presentations Including New Research Data on Tofacitinib for Chronic Plaque Psoriasis and Atopic Dermatitis at World Congress of Dermatology",
                0.1176025042
            ],
            [
                1433376000000,
                "Get Ready. Get Set. Get Old. Pfizer Challenges Conventional Views of Aging Through New Campaign",
                -0.3227025093
            ],
            [
                1432944000000,
                "Pfizer Announces Palbociclib More Than Doubled Progression-Free Survival in Phase 3 Trial for Patients With HR+, HER2- Metastatic Breast Cancer Whose Disease Has Progressed Following Endocrine Therapy",
                -0.8118289676
            ],
            [
                1432857600000,
                "Pfizer’s RAPAMUNE® (sirolimus) Becomes First FDA-Approved Treatment for Lymphangioleiomyomatosis (LAM), A Rare Progressive Lung Disease",
                0.2314864864
            ],
            [
                1432771200000,
                "Pfizer Announces $3 Million Grants Program to Further Clinical Research in Advanced Breast Cancer",
                0.8345402958
            ],
            [
                1432771200000,
                "Pfizer Global Survey Finds Adults with Rheumatoid Arthritis Who Feel Comfortable Speaking Up About Their Concerns Have a More Positive View of Their Health",
                0.8345402958
            ],
            [
                1431993600000,
                "Pfizer Invites Public to View and Listen to Webcast of June 2 Conference Call with Analysts to Review Oncology Business and ASCO Data Presentations",
                1.2536630116
            ],
            [
                1431561600000,
                "Pfizer Receives Request For Additional Information From FTC Regarding Proposed Acquisition Of Hospira",
                0.823767082
            ],
            [
                1431561600000,
                "Bar Ilan University to work with Pfizer Inc. to evaluate  drug delivery via DNA Nanorobots",
                0.823767082
            ],
            [
                1431561600000,
                "Marc Tessier-Lavigne, Ph.D. to Leave Pfizer Board of Directors",
                0.823767082
            ],
            [
                1431475200000,
                "Merck KGaA, Darmstadt, Germany, and Pfizer to Present Data at ASCO for Avelumab, an Investigational Anti-PD-L1 Antibody",
                0.5008787132
            ],
            [
                1431302400000,
                "Pfizer Acquires Minority Interest in AM-Pharma; Secures Option to Acquire Company",
                -0.9176905655
            ],
            [
                1430870400000,
                "Pfizer Appoints New Leaders for  BioTherapeutics Research & Development and Rinat",
                -0.506240949
            ],
            [
                1430784000000,
                "23andMe Launches Lupus Research Community in Collaboration with  Pfizer Inc.",
                -1.8767079907
            ],
            [
                1430179200000,
                "PFIZER REPORTS FIRST-QUARTER 2015 RESULTS",
                -1.3123463666
            ],
            [
                1429747200000,
                "Pfizer Hosts Annual Meeting Of Shareholders",
                1.0774086435
            ],
            [
                1429574400000,
                "Pfizer Receives U.S. FDA Breakthrough Therapy Designation For XALKORI® (crizotinib) For The Treatment Of Patients With ROS1-Positive Non-Small Cell Lung Cancer",
                -0.486710301
            ],
            [
                1429574400000,
                "Pfizer Phase 3 Study Of Inotuzumab Ozogamicin Meets Primary Endpoint In Adult Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia",
                -0.486710301
            ],
            [
                1429488000000,
                "Global Strategic Partners Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Phase III Study with Avelumab* in Patients with Stage IIIb/IV Non-Small Cell Lung Cancer",
                -0.4299332541
            ],
            [
                1429142400000,
                "Pfizer Invites Public to Listen to Webcast of April 23 Annual Meeting of Shareholders",
                -0.0856252592
            ],
            [
                1429142400000,
                "Pfizer Launches 2014 Integrated Annual Review",
                -0.0856252592
            ],
            [
                1429056000000,
                "Pfizer Announces PALOMA-3 Trial For IBRANCE® (Palbociclib) Stopped Early Due To Efficacy Seen In Patients With HR+, HER2- Metastatic Breast Cancer Whose Disease Has Progressed Following Endocrine Therapy",
                -0.5967283409
            ],
            [
                1428969600000,
                "REGiMMUNE Announces Collaboration with JDRF and Pfizer Inc. for Type 1 Diabetes  Prevention and Treatment Promoting Regulatory T-Cells",
                0.4544003168
            ],
            [
                1428537600000,
                "Pfizer Launches First Annual PCSK9 Competitive Grants Program to Advance Cardiovascular Disease Research",
                2.2573437039
            ],
            [
                1428364800000,
                "Global Strategic Partners Merck KGaA, Darmstadt, Germany, and Pfizer Finalize Agreement to Co-Promote XALKORI® (crizotinib)",
                0.0288616545
            ],
            [
                1428278400000,
                "Kathrin U. Jansen, Ph.D., to Lead Pfizer’s Vaccine Research and Development Unit",
                0.3474332419
            ],
            [
                1427673600000,
                "Dr. Charles Reay Mackay To Join Pfizer as Chief Scientific Officer, Inflammation and Immunology Research Unit",
                0.5461354891
            ],
            [
                1427328000000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference",
                1.2163337278
            ],
            [
                1427068800000,
                "Pfizer And Lilly Preparing To Resume Phase 3 Chronic Pain Program For Tanezumab",
                0.0289705703
            ],
            [
                1426809600000,
                "Pfizer Announces Oral Tofacitinib Meets Primary Endpoints In Pivotal Phase 3 Psoriasis Trials",
                2.6248190105
            ],
            [
                1426636800000,
                "Results of Pfizer’s Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA) Published in the New England Journal of Medicine",
                0.351367772
            ],
            [
                1426118400000,
                "Pfizer Reports Top-Line Results From A Phase 4 Study Evaluating LYRICA® Capsules CV As A Treatment For Adolescents With Fibromyalgia",
                0.5588169141
            ],
            [
                1425340800000,
                "Pfizer Receives European Approval for New Indication for Prevenar 13 for Prevention of Vaccine-Type Pneumococcal Pneumonia in Adults",
                -0.3175637191
            ],
            [
                1424908800000,
                "CDC Advisory Committee on Immunization Practices Votes to Recommend Serogroup B Meningococcal Disease Vaccination for Persons at Increased Risk",
                -0.4370601523
            ],
            [
                1424736000000,
                "Pfizer Announces Positive Top-line Results Of A Phase 2 Study Of TRUMENBA® (Meningococcal Group B Vaccine) Co-Administered With Routine Meningococcal (A, C, Y, and W) And Tetanus, Diphtheria And Pertussis (Tdap) Vaccines In Adolescents",
                1.2694686781
            ],
            [
                1424390400000,
                "FDA Accepts Supplemental New Drug Application for Priority Review of RAPAMUNE® (sirolimus) for Treatment of Lymphangioleiomyomatosis (LAM)",
                0.3489133019
            ],
            [
                1423785600000,
                "Pfizer Announces FDA Acceptance for Review of a New Drug Application for ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride)",
                -0.3470080434
            ],
            [
                1423699200000,
                "Safety and Efficacy of ELELYSO® (taliglucerase alfa) for Injection in Pediatric Patients with Type 1 Gaucher Disease in Long-term Outcome Study Presented at the WORLDSymposium 2015",
                1.0392394506
            ],
            [
                1423440000000,
                "Pfizer Commences $5 Billion Accelerated Share Repurchase",
                3.4260423974
            ],
            [
                1423440000000,
                "Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Investor Conference",
                3.4260423974
            ],
            [
                1423094400000,
                "University of Dundee signs agreement with Pfizer Inc. to research potential new therapies  for the treatment of Cystic Fibrosis.",
                0.3919182614
            ],
            [
                1423094400000,
                "Pfizer to Acquire Hospira",
                0.3919182614
            ],
            [
                1423094400000,
                "Pfizer Invites Investors, Analysts And Media To Join Conference Calls Discussing Pfizer's Proposed Acquisition of Hospira",
                0.3919182614
            ],
            [
                1423008000000,
                "Pfizer Announces FDA Acceptance For Review Of Supplemental New Drug Application For Oral XELJANZ® (tofacitinib citrate) For Adult Patients With Moderate To Severe Chronic Plaque Psoriasis",
                3.0918521808
            ],
            [
                1423008000000,
                "Pfizer Marks World Cancer Day With Grant To Union For International Cancer Control To Address The Needs Of Metastatic Breast Cancer Patients",
                3.0918521808
            ],
            [
                1422921600000,
                "Pfizer Receives U.S. FDA Accelerated Approval of IBRANCE® (palbociclib)",
                1.585378367
            ],
            [
                1422316800000,
                "PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2014 RESULTS; PROVIDES 2015 FINANCIAL GUIDANCE",
                -1.2206755086
            ],
            [
                1422230400000,
                "Pfizer Commits to Further Reduce Price for Prevenar 13 in the World’s Poorest Countries Through 2025",
                0.3987815946
            ],
            [
                1422230400000,
                "SANIONA RECEIVES A RESEARCH MILESTONE PAYMENT IN  PFIZER INC. COLLABORATION",
                0.3987815946
            ],
            [
                1421884800000,
                "Prevenar 13®* Receives CHMP Positive Opinion For Prevention Of Vaccine-Type Pneumococcal Pneumonia in Adults",
                -0.6779788386
            ],
            [
                1421798400000,
                "Pfizer and the Avon Foundation for Women Award 23 Grants Totaling $1 Million in Funding to Support Patients Living With Metastatic Breast Cancer",
                -0.3352582877
            ],
            [
                1421020800000,
                "HemoShear\tAnnounces\tCollaboration\twith\tPfizer\tInc. To Help\tIdentify and\tPredict Drug-Induced\tVascular\tInjury for\t Early\tStage\tCompounds",
                -0.7089813896
            ],
            [
                1421020800000,
                "23andMe Announces Collaboration with Pfizer Inc. to Perform Genetic Research Through 23andMe’s Research Platform",
                -0.7089813896
            ],
            [
                1420675200000,
                "Repligen Receives Milestone Payment from Pfizer",
                0.9494520136
            ],
            [
                1420675200000,
                "Pfizer Provides Update on IBRANCE® (palbociclib)",
                0.9494520136
            ],
            [
                1420502400000,
                "Pfizer Invites Public To View And Listen To Webcast Of Pfizer Presentation At Healthcare Conference",
                1.8210520045
            ],
            [
                1420416000000,
                "Pfizer Acquires Redvax GmbH",
                0.2227882922
            ],
            [
                1420416000000,
                "Pfizer Acquires Redvax GmbH",
                0.2227882922
            ],
            [
                1419379200000,
                "Kissei Announces Licensing Agreement with Pfizer Inc. for KUX-1151, a  Novel Investigational Therapy for Gout and Hyperuricemia",
                -0.1592639827
            ],
            [
                1419206400000,
                "PHILOGEN\tANNOUNCES OPTION AND LICENSE AGREEMENT WITH PFIZER INC. TO DEVELOP AND COMMERCIALIZE MULTIPLE ANTIBODY DRUG CONJUGATES AND TARGETED NANOPARTICLES",
                -1.303656302
            ],
            [
                1418860800000,
                "Pfizer Reports Top-Line Results From a Phase 3 Study Evaluating Pregabalin Controlled-Release Formulation as a Treatment for Patients With Postherpetic Neuralgia",
                1.3149915457
            ],
            [
                1418774400000,
                "Pfizer Initiates Phase 2 Study of PF-06252616 in Duchenne Muscular Dystrophy",
                3.9724390008
            ],
            [
                1418688000000,
                "Pfizer Invites Public To View And Listen To Webcast Of January 27 Conference Call With Analysts",
                0.931879372
            ],
            [
                1418688000000,
                "Meningococcal Meningitis Survivor and TV Personality Amy Purdy and Pfizer Launch Take Action Against Meningitis",
                0.931879372
            ],
            [
                1418601600000,
                "Pfizer Announces Palbociclib PALOMA-1 Data Published in The Lancet Oncology",
                -1.4998278007
            ],
            [
                1418601600000,
                "Pfizer Declares First-Quarter 2015 Dividend",
                -1.4998278007
            ],
            [
                1418601600000,
                "OPKO and Pfizer Enter into Global Agreement for OPKO’s Long-Acting Human Growth Hormone (hGH-CTP)",
                -1.4998278007
            ],
            [
                1418169600000,
                "Pfizer employees join the movement to end hunger; Partnering with Stop Hunger Now, Pfizer is slated to package more than 50,000 meals",
                -1.1058694801
            ],
            [
                1418169600000,
                "Pfizer and Brenda Strong Encourage Women to Change the Conversation on Sexual Health Post-Menopause",
                -1.1058694801
            ],
            [
                1418083200000,
                "New Data at ASH 2014 Highlight Progress of Pfizer’s Growing Portfolio in Blood Cancers",
                0.9730300295
            ],
            [
                1417996800000,
                "Anticoagulant Effect of Eliquis (apixaban) Reversed by Two Separate 4-Factor Prothrombin Complex Concentrates in Healthy Subjects",
                0.5321042306
            ],
            [
                1417996800000,
                "iTeos Therapeutics Announces License and Collaboration with Pfizer Inc. for  Discovery and Development of Cancer Immunosuppression Targets",
                0.5321042306
            ],
            [
                1417996800000,
                "Spark Therapeutics Announces Gene Therapy Collaboration in Hemophilia B with Pfizer Inc.",
                0.5321042306
            ],
            [
                1417996800000,
                "Pfizer Expands Rare Disease Research with Establishment of Gene Therapy Platform",
                0.5321042306
            ],
            [
                1417564800000,
                "Phase 3 Results Published in The New England Journal of Medicine Show Superiority of Pfizer’s XALKORI® (crizotinib) Compared to Platinum-Based Chemotherapy in Previously Untreated Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer",
                0.5367547696
            ],
            [
                1417564800000,
                "WADA Signs a Global Collaboration Agreement with Pfizer  Inc.",
                0.5367547696
            ],
            [
                1417478400000,
                "Lpath Completes Enrollment in its Phase 2 Clinical Trial of iSONEP for Wet Age-Related Macular Degeneration",
                0.9764051571
            ],
            [
                1417478400000,
                "New Survey Finds Majority of Women with Breast Cancer Who Work Want to Do So Even While Undergoing Treatment",
                0.9764051571
            ],
            [
                1417392000000,
                "Pfizer Completes Acquisition of Baxter’s Marketed Vaccines",
                2.1856150144
            ],
            [
                1416268800000,
                "Sanguine’s Mobile Application to Assist Recruitment for Pfizer Inc. Chronic  Pain Research",
                -0.1642535436
            ],
            [
                1416268800000,
                "TRUMENBA® (Meningococcal Group B Vaccine) is Now Available",
                -0.1642535436
            ],
            [
                1416182400000,
                "Portola, Bristol-Myers Squibb and Pfizer Announce Statistically Significant Results From the First Part of the Phase 3 ANNEXA(TM)-A Studies of Investigational Andexanet Alfa With Eliquis (apixaban)",
                2.2229506982
            ],
            [
                1416096000000,
                "Pfizer Forms Global Strategic Alliance with Merck KGaA, Germany, to Jointly Develop and Commercialize Anti-PD-L1 to Accelerate Presence in Immuno-Oncology",
                2.2229506982
            ],
            [
                1415836800000,
                "Novel Agreement Expands Access to Pfizer’s Contraceptive,  Sayana® Press, for Women Most in Need  in the World’s Poorest Countries",
                -0.5932520154
            ],
            [
                1415750400000,
                "Pfizer Highlights Leadership in Rheumatology and Inflammation with Data to be Presented at the ACR/ARHP 2014 Annual Meeting",
                0.6245948909
            ],
            [
                1415232000000,
                "Cedric “The Entertainer” Urges People with Diabetic Nerve Pain to “Step On Up” and Seek Relief",
                -0.5347450233
            ],
            [
                1414540800000,
                "Pfizer Receives FDA Accelerated Approval for TRUMENBA® (Meningococcal Group B Vaccine) for the Prevention of Invasive Meningococcal B Disease in Adolescents and Young Adults",
                2.3123284309
            ],
            [
                1414540800000,
                "Pfizer’s PRISTIQ® (desvenlafaxine) Demonstrates Low Potential For Sexual Dysfunction in Adults with Major Depressive Disorder",
                2.3123284309
            ],
            [
                1414454400000,
                "PFIZER REPORTS THIRD-QUARTER 2014 RESULTS",
                1.085125827
            ],
            [
                1414368000000,
                "Pfizer to Discontinue Agreement on REMOXY™ (oxycodone) Extended-Release Capsules CII",
                -7.0584e-06
            ],
            [
                1414022400000,
                "Pfizer Declares 26-Cent Fourth-Quarter 2014 Dividend",
                1.5802062987
            ],
            [
                1414022400000,
                "Pfizer Wins SUTENT® Patent Case In Delaware District Court",
                1.5802062987
            ],
            [
                1413504000000,
                "FDA Approves Abuse Deterrent Labeling for EMBEDA® (morphine sulfate and naltrexone hydrochloride) Extended-Release (ER) Capsules CII",
                0.4296543075
            ],
            [
                1413158400000,
                "Pfizer Announces FDA Acceptance Of Palbociclib New Drug Application With Priority Review",
                -2.4595978356
            ],
            [
                1412899200000,
                "Pfizer to Present New Data Evaluating Safety, Tolerability and Immunogenicity of its Investigational Staphylococcus aureus Vaccine Candidate at IDWeek 2014™",
                -2.2480049256
            ],
            [
                1412726400000,
                "Pfizer and Breast Cancer Leaders Join Together to Increase Understanding and Dispel Myths about Metastatic Breast Cancer",
                0.620926836
            ],
            [
                1412726400000,
                "Pfizer To Present Safety And Immunogenicity Data From A Phase 2 Study Of Its Investigational Meningococcal Group B Vaccine, Bivalent rLP2086, Co-Administered With A Licensed Human Papillomavirus Vaccine",
                0.620926836
            ],
            [
                1411948800000,
                "Pfizer And Kyowa Hakko Kirin To Collaborate On Immuno-Oncology Combination Study",
                -0.338170393
            ],
            [
                1411603200000,
                "Pfizer Completes Acquisition Of InnoPharma",
                -2.0524651589
            ],
            [
                1411603200000,
                "Pfizer Completes Acquisition Of InnoPharma",
                -2.0524651589
            ],
            [
                1411430400000,
                "Pfizer Invites Public to View and Listen to Webcast of October 28 Conference Call with Analysts",
                1.5835907976
            ],
            [
                1411430400000,
                "Kim Cattrall Encourages Women to Embrace Menopause with Style",
                1.5835907976
            ],
            [
                1411344000000,
                "Circle\tPharma\tAnnounces Receipt\tof Seed\tFunding\tand\tInitiation\tof\tTwo\tCollaborations",
                -0.698800584
            ],
            [
                1411344000000,
                "Bristol-Myers Squibb and Pfizer Announce Charitable Donations of More Than $1 Million to Support Cardiovascular Education for Patients and Caregivers",
                -0.698800584
            ],
            [
                1410825600000,
                "MedGenesis Enters Into Agreement with Pfizer Inc. for Potential Treatments for Parkinson’s Disease",
                1.3179405467
            ],
            [
                1409702400000,
                "Pfizer Invites the Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference",
                -0.2723915637
            ],
            [
                1409356800000,
                "Secondary Analysis of AMPLIFY-EXT Examining Predictors of Hospitalization Presented at ESC Congress: Eliquis (apixaban) Significantly Reduced the Risk of All-Cause Hospitalization Versus Placebo in Patients with Venous Thromboembolism (VTE)",
                0.6462868506
            ],
            [
                1409184000000,
                "Pfizer and Protalix BioTherapeutics Announce FDA Approval of Pediatric Indication for ELELYSO™ (taliglucerase alfa) for Injection, for Intravenous Use for the Treatment of Type 1 Gaucher Disease",
                -0.136067975
            ],
            [
                1409184000000,
                "Pfizer’s Investigational Vaccine Candidate for Clostridium difficile Receives U.S. Food and Drug Administration Fast Track Designation",
                -0.136067975
            ],
            [
                1409011200000,
                "Pfizer And Merck To Collaborate On Study Evaluating Novel AntiCancer Combination Regim",
                1.5598438917
            ],
            [
                1409011200000,
                "Pfizer And Merck To Collaborate On Study Evaluating Novel Anti-Cancer Combination Regimen",
                1.5598438917
            ],
            [
                1408579200000,
                "U.S. FDA Approves Eliquis (apixaban) for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and for the Reduction in the Risk of Recurrent DVT and PE Following Initial Therapy",
                1.01107e-05
            ],
            [
                1408579200000,
                "Palbociclib Expanded Access Program Now Open To Eligible U.S. Patients With HR+, HER2- Advanced Breast Cancer",
                1.01107e-05
            ],
            [
                1408492800000,
                "Expanding IBD Research Through Collaboration",
                -0.0347288557
            ],
            [
                1408492800000,
                "Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis® (apixaban) at the ESC Congress 2014",
                -0.0347288557
            ],
            [
                1408320000000,
                "Pfizer Announces Submission of Palbociclib New Drug Application to the FDA",
                0.6565424777
            ],
            [
                1407974400000,
                "Pfizer Announces FDA Acceptance Of And Priority Review Designation For Biologics License Application For Investigational Meningococcal B Vaccine",
                1.3268716953
            ],
            [
                1407888000000,
                "Advisory Committee on Immunization Practices Votes to Recommend Pfizer’s Prevnar 13® Vaccine in Adults Aged 65 Years and Older",
                1.6707215326
            ],
            [
                1407801600000,
                "Pfizer Reports Top-line Results From Postherpetic Neuralgia And Painful Diabetic Peripheral Neuropathy Lyrica® Studies Conducted In China",
                -0.1772497767
            ],
            [
                1407801600000,
                "23andMe Announces Agreement with Pfizer Inc. to  Research Genetics of Ulcerative Colitis and Crohn’s Disease",
                -0.1772497767
            ],
            [
                1407456000000,
                "Epilepsy Foundation Collaborating On Personalized Drug Discovery Platform For Epilepsy With Intellimedix And Pfizer Inc.",
                0.6017932752
            ],
            [
                1407369600000,
                "European Medicines Agency Accepts Application Seeking New Indication For Prevenar 13®1 For Prevention Of Pneumococcal Pneumonia In Adults",
                -0.3528556676
            ],
            [
                1407110400000,
                "Rascal Flatts Joins the Thousands of People Who Choose Nexium® 24HR Every Day for Their Frequent Heartburn",
                -1.9007236884
            ],
            [
                1406678400000,
                "Pfizer Enters Into Agreement To Acquire Baxter’s Portfolio Of  Marketed Vaccines",
                -2.8223075451
            ],
            [
                1406678400000,
                "Pfizer Enters Into Agreement To Acquire Baxter’s Portfolio Of Marketed Vaccines",
                -2.8223075451
            ],
            [
                1406592000000,
                "European Commission Approves Eliquis (apixaban) for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and Prevention of Recurrent DVT and PE",
                -2.7503441635
            ],
            [
                1406592000000,
                "PFIZER REPORTS SECOND-QUARTER 2014 RESULTS",
                -2.7503441635
            ],
            [
                1405987200000,
                "ViiV Healthcare presents phase III data comparing once-daily  maraviroc in combination with darunavir/ritonavir with  emtricitabine/tenofovir plus darunavir/ritonavir in treatment-naïve  adults with HIV-1",
                -0.5264682528
            ],
            [
                1405987200000,
                "Seven pharma companies offer up compounds to UK researchers",
                -0.5264682528
            ],
            [
                1405555200000,
                "Bristol-Myers Squibb and Pfizer Announce Enrollment of First Patient in Phase IV EMANATE Trial to Assess Effectiveness and Safety of Eliquis® (apixaban) in Patients with NVAF Undergoing Cardioversion",
                -0.2277748982
            ],
            [
                1405468800000,
                "Pfizer to Acquire InnoPharma, Inc.",
                0.1309327638
            ],
            [
                1405468800000,
                "#FOGO? – New Survey Reveals 87% of Americans have a Fear of Getting Old (FOGO) – Results Show Top Fear is Decline in Physical Ability1",
                0.1309327638
            ],
            [
                1405468800000,
                "Pfizer to Acquire InnoPharma, Inc.",
                0.1309327638
            ],
            [
                1405468800000,
                "Pfizer Announces Positive Top-Line Results From Phase 3 Study Of NONACOG ALFA (BeneFIX®) Once-Weekly Prophylaxis For Hemophilia B",
                0.1309327638
            ],
            [
                1405382400000,
                "Absorption Systems Announces License Agreement with Pfizer Inc.",
                2.454802432
            ],
            [
                1404172800000,
                "Pfizer Inc. Receives Kosher Certification for Elelyso™ (taliglucerase alfa) for Injection, for the Treatment of Type 1 Gaucher Disease",
                2.5024772768
            ],
            [
                1403827200000,
                "Eliquis® (apixaban) Receives CHMP Positive Opinion for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and Prevention of Recurrent DVT and PE",
                0.0336575519
            ],
            [
                1403740800000,
                "Pfizer Declares 26-Cent Third-Quarter 2014 Dividend",
                -0.1684888544
            ],
            [
                1403740800000,
                "James C. Smith Elected to Pfizer’s Board of Directors",
                -0.1684888544
            ],
            [
                1403568000000,
                "Pfizer Invites Public to View and Listen to Webcast of July 29 Conference Call with Analysts",
                1.2415971917
            ],
            [
                1403222400000,
                "Prevenar 13® Indication Extended in Japan",
                -0.9847410317
            ],
            [
                1403049600000,
                "Two-Year Results From Pfizer’s XELJANZ® (Tofacitinib Citrate) ORAL Start Study Published in The New England Journal of Medicine",
                0.202803547
            ],
            [
                1403049600000,
                "Pfizer And Cellectis Enter Into Global Strategic Cancer  Immunotherapy Collaboration",
                0.202803547
            ],
            [
                1402963200000,
                "Pfizer And Cellectis Enter Into Global Strategic Cancer Immunotherapy Collaboration",
                0.4375055434
            ],
            [
                1402963200000,
                "Pfizer Announces Submission of Biologics License Application to the FDA for Investigational Meningococcal B Vaccine",
                0.4375055434
            ],
            [
                1402444800000,
                "X-Chem Enters into Multi-Target Collaboration with Pfizer Inc.",
                -0.033962451
            ],
            [
                1402444800000,
                "Pfizer Announces Over 10 Abstracts for XELJANZ® (Tofacitinib Citrate) in Rheumatoid Arthritis to be Presented at the European League Against Rheumatism (EULAR) 2014 Annual Meeting",
                -0.033962451
            ],
            [
                1401840000000,
                "KineMed Collaboration with Pfizer Inc. in Diabetes is  Extended",
                0.5040115439
            ],
            [
                1401840000000,
                "Pfizer Invites the Public to Listen to Webcast of Pfizer Discussion at Health Care Conference",
                0.5040115439
            ],
            [
                1401321600000,
                "Dr. Morris J. Birnbaum Joins Pfizer as Chief Scientific Officer, Cardiovascular and Metabolic Disease Research",
                -0.3375117556
            ],
            [
                1401321600000,
                "Pfizer and the Avon Foundation for Women Announce $1 Million Grants Program to Address Gaps in Support for People Living with Metastatic Breast Cancer",
                -0.3375117556
            ],
            [
                1401148800000,
                "Global Investigator Databank expands to five pharmaceutical  company members and announces new investigator website",
                -1.080711737
            ],
            [
                1401148800000,
                "Pfizer Brings Frequent Heartburn Relief Over-the-Counter with New Nexium® 24HR",
                -1.080711737
            ],
            [
                1401062400000,
                "ANNOUNCEMENT REGARDING ASTRAZENECA PLC",
                -1.080711737
            ],
            [
                1400803200000,
                "Pfizer Announces Detailed Results For Phase 3 OPT Retreatment Study Of Tofacitinib In Adults With Moderate-To-Severe Chronic Plaque Psoriasis",
                0.1351056093
            ],
            [
                1400716800000,
                "BioRestorative Therapies Signs Research Agreement with Pfizer Inc.",
                -0.2373892506
            ],
            [
                1400630400000,
                "Roslin Cells Announces New Cell Therapy Manufacturing Contract  with Pfizer Inc.",
                1.3823352564
            ],
            [
                1400630400000,
                "New Survey Highlights The Impact Of Menopausal Symptoms On Women In The Workplace",
                1.3823352564
            ],
            [
                1400457600000,
                "Statement from Pfizer Inc.",
                -1.1281917023
            ],
            [
                1400371200000,
                "PFIZER MAKES FINAL PROPOSAL TO ASTRAZENECA",
                -1.1281917023
            ],
            [
                1400198400000,
                "Pfizer To Submit Palbociclib New Drug Application With FDA Based On Final Results Of PALOMA-1",
                0.956296523
            ],
            [
                1400025600000,
                "American College of Physicians, CECity, and Pfizer collaborate to increase adult immunization rates",
                -0.2752907369
            ],
            [
                1399852800000,
                "STATEMENT FROM PFIZER INC. (“PFIZER”)",
                -0.4794710169
            ],
            [
                1399852800000,
                "Pfizer Prices $4.5 Billion Debt Offering",
                -0.4794710169
            ],
            [
                1399593600000,
                "Pfizer Announces Positive Phase 2 Study Results for Investigational Meningococcal B Vaccine",
                0.1029685338
            ],
            [
                1399248000000,
                "Pfizer Reports First-Quarter 2014 Results",
                -2.8202685721
            ],
            [
                1398988800000,
                "Second Genome Enters Into Agreement with Pfizer  Inc. on Microbiome Research Initiative in Obesity",
                -3.538063998
            ],
            [
                1398902400000,
                "Pfizer Sends Letter to Rt Hon David Cameron MP Regarding Commitments If Proposed Combination with AstraZeneca is Completed",
                -1.0731690568
            ],
            [
                1398902400000,
                "Pfizer Confirms Delivery of Increased Proposal to AstraZeneca",
                -1.0731690568
            ],
            [
                1398902400000,
                "ALO-02 Demonstrates Significant Difference In Pain Scores In Chronic Low Back Pain Patients And Lower Abuse Potential Compared To Immediate-Release Oxycodone In Recreational Opioid Users",
                -1.0731690568
            ],
            [
                1398643200000,
                "Pfizer Invites Investors, Analysts And Media To Join Conference Calls Discussing Possible Combination With AstraZeneca",
                0.5352962103
            ],
            [
                1398297600000,
                "Pfizer Hosts Annual Meeting of Shareholders Declares 26-Cent Second-Quarter 2014 Dividend",
                -0.4877569823
            ],
            [
                1398124800000,
                "Pfizer Announces Positive Top-Line Results From Two Phase 3 Trials Of Tofacitinib In Adults With Moderate-to-Severe Chronic Plaque Psoriasis",
                0.2264013116
            ],
            [
                1397779200000,
                "Pfizer Invites Public To Listen To Webcast Of April 24 Annual Meeting Of Shareholders",
                1.48387701
            ],
            [
                1397433600000,
                "Advil® Relief in Action and Josh Duhamel Celebrate National Volunteer Week with Points of Light & Kick Off a Nationwide \"Relief\" Tour",
                -0.5352955581
            ],
            [
                1396742400000,
                "Pfizer’s Novel CDK 4/6 Inhibitor Palbociclib plus Letrozole Significantly Prolonged Progression-Free Survival in Patients with Advanced Breast Cancer",
                -1.9760285595
            ],
            [
                1396310400000,
                "Merck Serono Enters into Research Agreement with Pfizer and  Broad Institute",
                1.1148979983
            ],
            [
                1396224000000,
                "Lieber Institute Announces Consortium To Identify How Genes Build A Brain With The Goal Of Developing Treatments For Brain Disorders",
                -0.0313164512
            ],
            [
                1395964800000,
                "Pfizer Statement on U.S. FDA Approval of Over-the-Counter Nexium® 24HR",
                -0.2490653017
            ],
            [
                1395878400000,
                "In A Subanalysis, The Benefits Of Eliquis® (apixaban) Vs. Warfarin In Reducing The Risk Of Stroke In Patients With Nonvalvular Atrial Fibrillation Were Consistent, Regardless Of Blood Pressure Control 1",
                -1.2547140507
            ],
            [
                1395878400000,
                "Bococizumab (RN316) Significantly Reduced LDL Cholesterol In Statin-Treated Adults With High Cholesterol In A Phase 2b Study",
                -1.2547140507
            ],
            [
                1395792000000,
                "Pfizer Achieves Primary Endpoint With Phase 3B Top-Line Results Of GENOTROPIN® In Very Young Children Born Small For Gestational Age",
                0.2803979699
            ],
            [
                1395705600000,
                "Pfizer Invites Public To View And Listen To Webcast Of May 5 Conference Call With Analysts",
                1.274072948
            ],
            [
                1395705600000,
                "Pfizer Reports Positive Phase 3 Study Outcome Of XALKORI® (crizotinib) Compared To Chemotherapy In Previously Untreated Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)",
                1.274072948
            ],
            [
                1395446400000,
                "Pfizer Announces Detailed Results of OPT Compare Phase 3 Study of Tofacitinib 5 mg and 10 mg Twice Daily Compared to High-Dose ENBREL® in Adults with Moderate-to-Severe Chronic Plaque Psoriasis",
                0.1571342723
            ],
            [
                1395273600000,
                "Pfizer’s Investigational Vaccine Candidate Bivalent rLP2086 Receives U.S. Food and Drug Administration Breakthrough Therapy Designation for Potential Prevention of Meningococcal B Disease",
                0.1864644015
            ],
            [
                1395100800000,
                "Pfizer Launches 2013 Integrated Annual Review",
                0.7568374271
            ],
            [
                1394755200000,
                "U.S. FDA Approves Eliquis® (apixaban) To Reduce The Risk Of Blood Clots Following Hip Or Knee Replacement Surgery",
                0.859308768
            ],
            [
                1394582400000,
                "Pfizer Will Appeal Court Decision Regarding Celebrex Reissue Patent",
                -3.3097574871
            ],
            [
                1394582400000,
                "Pfizer Announces Webcast Of April 6 Conference Call With Securities Analysts To Review Palbociclib Phase 2 Final Results Following Presentation At AACR Annual Meeting 2014",
                -3.3097574871
            ],
            [
                1394582400000,
                "Pfizer Presents Detailed Results From Landmark Community-Acquired Pneumonia Immunization Trial In Adults (CAPiTA) Evaluating Efficacy Of Prevenar 13*",
                -3.3097574871
            ],
            [
                1394064000000,
                "Pfizer Initiates Nationwide Voluntary Recall Of Two Lots Of Pfizer's Effexor XR® 150 mg Extended-Release Capsules And One Lot Of Greenstone's Venlafaxine HCI 150 mg Extended-Release Capsules Due To The Possible Presence Of Tikosyn® Capsule",
                -1.1409236984
            ],
            [
                1393372800000,
                "Saniona Announces Collaboration With Pfizer To Research And Develop Small Molecule Treatments For Neurological Disorders.",
                1.5203018952
            ],
            [
                1393200000000,
                "Pfizer Announces FDA Approval To Include Radiographic Data On Reduction Of Progression Of Structural Joint Damage For Adults With Moderately To Severely Active Rheumatoid Arthritis In Labeling For XELJANZ® (tofacitinib citrate)",
                -0.3135887437
            ],
            [
                1393200000000,
                "Pfizer Announces Positive Top-Line Results Of Landmark Community-Acquired Pneumonia Immunization Trial In Adults (CAPiTA) Evaluating Efficacy Of Prevenar 13*",
                -0.3135887437
            ],
            [
                1392940800000,
                "In a Subanalysis, Eliquis® (apixaban) Reduced the Risk of Stroke and Demonstrated Fewer Major Bleeding Events Versus Warfarin Consistently Across Age Groups, Including Older Patients with Nonvalvular Atrial Fibrillation[i]",
                0.9690510385
            ],
            [
                1392422400000,
                "Pfizer And Merck To Collaborate On Innovative Anti-Cancer  Combination Studies",
                -1.0482653127
            ],
            [
                1392076800000,
                "Pfizer Statement on Today’s Joint Meeting of FDA Advisory Committees",
                -0.5694277253
            ],
            [
                1392076800000,
                "New Funding For Fundamental Biomedical Research To Be Made Available",
                -0.5694277253
            ],
            [
                1391558400000,
                "Ichor Enters Into An Agreement With Pfizer To Develop Electroporation Devices For Use In Therapeutic Cancer Vaccine Regimens",
                -0.4863963435
            ],
            [
                1391558400000,
                "Pfizer And Merck To Collaborate On Innovative Anti-Cancer Combination Studies",
                -0.4863963435
            ],
            [
                1391385600000,
                "Pfizer Announces Positive Top-Line Results From PALOMA-1 Evaluating Palbociclib Plus Letrozole in Women with Advanced Breast Cancer",
                1.3040516508
            ],
            [
                1390867200000,
                "U.Va. Spinoff Neoantigenics Announces Collaboration with Pfizer,  Investment from CIT to Develop Antibody-based Therapeutics  For Cancer",
                -1.0960197807
            ],
            [
                1390867200000,
                "Pfizer Reports Fourth-Quarter and Full-Year 2013 Results; Provides 2014 Financial Guidance",
                -1.0960197807
            ],
            [
                1390780800000,
                "Pfizer Announces Top-Line Results From Two Phase 3 Trials Of Dacomitinib In Patients With Refractory Advanced Non-Small Cell Lung Cancer",
                1.2491801783
            ],
            [
                1390435200000,
                "Pfizer Reports Top-Line Results From ALO-02 Phase 3 Study",
                -3.0907176391
            ],
            [
                1390348800000,
                "New Survey Reveals What Match.Com Members Think About Smoking Cigarettes And Dating",
                -0.9674306862
            ],
            [
                1390262400000,
                "CHANTIX®/CHAMPIX® (varenicline) Demonstrates Smoking- Cessation Efficacy In Smokers Unwilling or Unable To Quit Abruptly",
                -0.1599043433
            ],
            [
                1389225600000,
                "Akili Interactive Labs Announces Partnership with Pfizer to Test Video Game in People at Risk of Alzheimer’s Disease",
                -1.2707722476
            ],
            [
                1388966400000,
                "MD Anderson teams up with Pfizer to advance cancer immunotherapy",
                -0.09760741
            ],
            [
                1387411200000,
                "FDA Accepts For Review ELIQUIS® (apixaban) Supplemental New Drug Application For The Treatment Of Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE), And For The Reduction In The Risk Of Recurrent DVT And PE",
                -1.7520691495
            ],
            [
                1387324800000,
                "Mylan Announces Acquisition of Rights to Novel LAMA Respiratory Compound from Pfizer",
                1.3350676294
            ],
            [
                1387238400000,
                "Pfizer Settles Viagra® Patent Litigation With Teva",
                1.9174602511
            ],
            [
                1387238400000,
                "Pfizer Names Albert Bourla Group President; Vaccines, Oncology And Consumer Healthcare Business",
                1.9174602511
            ],
            [
                1387152000000,
                "Pfizer Declares First-Quarter 2014 Dividend",
                -0.5308546438
            ],
            [
                1386115200000,
                "Pfizer Expands Clinical Trial Data Access Policy And Launches Data Access Portal",
                0.4479880016
            ],
            [
                1385942400000,
                "Pfizer Acquires Polocard, Poland’s Leading Over-The-Counter Heart Attack Prevention Brand",
                -1.2491985905
            ],
            [
                1385337600000,
                "Just in Time for Peak Travel Season, Introducing New Robitussin® DM Max Liquid-Filled Capsules",
                -0.7211993054
            ],
            [
                1384992000000,
                "Pfizer’s XALKORI® Granted Regular FDA Approval",
                0.8406203682
            ],
            [
                1384992000000,
                "Pfizer And GSK To Initiate Study Of Novel Combination Therapy In Patients With Melanoma",
                0.8406203682
            ],
            [
                1384732800000,
                "Pfizer Announces FDA Approval Of Supplemental Application To Expand XELJANZ® (tofacitinib citrate) Labeling To Include Additional Patient-Reported Outcomes Data For Adults With Moderately To Severely Active Rheumatoid Arthritis",
                -1.3266057953
            ],
            [
                1384387200000,
                "Pfizer Subsidiary, Wyeth LLC, To Redeem 5.500% Notes Due February 1, 2014",
                0.8074502433
            ],
            [
                1383868800000,
                "Pfizer Announces Top-Line Results Of Phase 3B/4 Study Of RAPAMUNE® (sirolimus) In Renal Transplant Recipients",
                1.1523400153
            ],
            [
                1383609600000,
                "Former U.S. President Jimmy Carter And Pfizer Celebrate  15-Year Effort To Help End Blinding Trachoma As A  Public Health Concern",
                0.0633628706
            ],
            [
                1383523200000,
                "Pfizer Receives FDA Approval For A Prior Approval Supplement For EMBEDA® (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII",
                0.2560789354
            ],
            [
                1383523200000,
                "JDRF Teams Up with Pfizer’s Centers for Therapeutic Innovation to  Support Novel Translational Research in Type 1 Diabetes",
                0.2560789354
            ],
            [
                1383004800000,
                "Pfizer Reports Third Quarter 2013 Results",
                0.2909718757
            ],
            [
                1382918400000,
                "Howie Mandel Challenges People To Learn The Fibs And Facts About Atrial Fibrillation And Its Associated Increased Stroke Risk",
                2.5600285864
            ],
            [
                1382572800000,
                "Pfizer Declares 24-Cent Fourth-Quarter 2013 Dividend",
                -0.2286776137
            ],
            [
                1382400000000,
                "Pfizer Inc. Continues Development Program For Remoxy® (oxycodone) Extended-Release Capsules CII",
                0.7189702146
            ],
            [
                1382054400000,
                "Pfizer Reports Top-Line Results From Two Lyrica® Capsules CV Phase 3b Studies",
                0.6907943117
            ],
            [
                1381968000000,
                "Pfizer Receives European Approval For Label Update Regarding The Use Of Prevenar 13 In Certain High-Risk Populations",
                2.261562719
            ],
            [
                1381881600000,
                "Siemens enters into master agreement with  Pfizer for companion diagnostics",
                3.3046953693
            ],
            [
                1381881600000,
                "Grantmakers In Aging receives $1.3 million grant renewal from the Pfizer Foundation to help communities become more “age-friendly”",
                3.3046953693
            ],
            [
                1381276800000,
                "MaRS Innovation and Pfizer Fund Bio-Manufacturing Technology",
                1.8074009011
            ],
            [
                1381276800000,
                "ChapStick® Announces Olympic Gold Medalist Alex Morgan  As New Face Of The Brand",
                1.8074009011
            ],
            [
                1381276800000,
                "Pfizer Announces Top-Line Results Of The First Two Of Five Phase 3 Clinical Trials Of Tofacitinib In Adults With Moderate-To-Severe Chronic Plaque Psoriasis",
                1.8074009011
            ],
            [
                1380758400000,
                "Pfizer Inc. Announces FDA Approval Of DUAVEETM (conjugated estrogens/ bazedoxifene) For The Treatment Of Moderate-To-Severe Vasomotor Symptoms (Hot Flashes) Associated With Menopause And The Prevention Of Postmenopausal Osteoporosis [1]",
                -0.0689541991
            ],
            [
                1380672000000,
                "International Atherosclerosis Society And Pfizer Independent Grants For Learning & Change Collaborate On New Grant Opportunity",
                0.2780542512
            ],
            [
                1380585600000,
                "Pfizer Invites Public To View And Listen To Webcast Of October 29 Conference Call With Analysts",
                1.4822576819
            ],
            [
                1380499200000,
                "Shantanu Narayen Elected To Pfizer’s Board Of Directors",
                0.6230504325
            ],
            [
                1380499200000,
                "ADVIL® BECOMES OFFICIAL PAIN RELIEVER OF THE  NATIONAL HOCKEY LEAGUE AND THE 30 TEAM ATHLETIC TRAINERS",
                0.6230504325
            ],
            [
                1379980800000,
                "Pfizer Announces Data For XELJANZ® (tofacitinib citrate) In Rheumatoid Arthritis To Be Presented At The American College Of Rheumatology 2013 Annual Meeting",
                -0.8423647236
            ],
            [
                1379030400000,
                "Gliknik Enters Into Licensing Agreement With Pfizer For Drug Candidate Targeting Autoimmune Diseases",
                1.114578036
            ],
            [
                1378166400000,
                "Pfizer Invites Public To Listen to Webcast of Pfizer Discussion at Health Care Conference",
                -0.0352595749
            ],
            [
                1378080000000,
                "Subanalysis of Phase III ARISTOTLE Trial of Eliquis® (apixaban) Demonstrated Consistent Results Versus Warfarin in Patients with Nonvalvular Atrial Fibrillation with or without Valvular Heart Disease",
                -0.0352595749
            ],
            [
                1377907200000,
                "New Eliquis® (apixaban) Post-hoc Subanalysis of the Phase III ARISTOTLE trial Demonstrated that within 30 Days of a Procedure, Stroke or Systemic Embolism and Major Bleeding were Uncommon",
                -0.0352595749
            ],
            [
                1377734400000,
                "Pfizer Completes Pneumococcal Pneumonia Case Accrual For CAPiTA,  Adult Vaccine Clinical Trial Of Prevenar 13*",
                0.3190128553
            ],
            [
                1375056000000,
                "Pfizer Reports Second-Quarter 2013 Results",
                0.9100229612
            ],
            [
                1375056000000,
                "Pfizer To Create Separate, Internal, Global Innovative And Value Businesses",
                0.9100229612
            ],
            [
                1375056000000,
                "Pfizer Signs New Agreement With UNICEF To Supply A Total Of Up To 740 Million Doses Of Prevenar 13* For The World’s Poorest Countries Through 2025",
                0.9100229612
            ],
            [
                1374710400000,
                "CHMP Confirms Prior Opinion Regarding Marketing Authorization In Europe For Pfizer’s XELJANZ® (tofacitinib citrate)",
                1.1576175282
            ],
            [
                1374624000000,
                "Pfizer Provides Historical Consolidated Statements of Income with the Animal Health Business (Zoetis) Reported as a Discontinued Operation",
                -0.8564529805
            ],
            [
                1373846400000,
                "Pfizer Provides Update on Global Regulatory Approvals and Launches of XELJANZ® (tofacitinib citrate) for the Treatment of Rheumatoid Arthritis",
                -0.3835870387
            ],
            [
                1373500800000,
                "Is San Diego Ready for an Aging Population? New Local Survey Reveals San Diego-Area Residents Concerned About Rheir City and Themselves as They Get Old; New Website, “By the Decades” Healthy Aging Checklist and Aging Communities Toolkit Offers Help",
                -0.1041666289
            ],
            [
                1373500800000,
                "Is Kansas City Ready for an Aging Population? New Local Survey Reveals Kansas City-Area Residents Concerned About Their City and Themselves as They Get Old; New Website, “By the Decades” Healthy Aging Checklist and Aging Communities Toolkit Offers Help",
                -0.1041666289
            ],
            [
                1373500800000,
                "Is Boston Ready for an Aging Population? New Local Survey Reveals Bostonians’ Concerned About Their City and Themselves as They Get Old; New Website, Healthy Aging “By the Decades” Checklist and Aging Communities Toolkit Offers Help",
                -0.1041666289
            ],
            [
                1373500800000,
                "Is Atlanta Ready for an Aging Population? New Local Survey Reveals Atlanta-Area Residents Concerned About Their City and Themselves as They Get Old; New Website, Healthy Aging “By the Decades” Checklist and Aging Communities Toolkit Offer Help",
                -0.1041666289
            ],
            [
                1373500800000,
                "FDA Accepts Eliquis® (apixaban) Supplemental New Drug Application for Review for Prophylaxis of Deep Vein Thrombosis Following Hip Or Knee Replacement Surgery",
                -0.1041666289
            ],
            [
                1373414400000,
                "New survey on Atlanta Attitudes Toward Aging To Be Released Thursday, July 11",
                1.0427748992
            ],
            [
                1373414400000,
                "Pfizer Receives European Approval To Expand Use Of  Prevenar 13* To Adults Aged 18 To 49 Years For The Prevention Of Invasive Pneumococcal Disease",
                1.0427748992
            ],
            [
                1372550400000,
                "Eliquis® (apixaban) Demonstrated Comparable Efficacy And Significantly Lower Rates Of Major Bleeding In Patients Compared To Current Standard Of Care For The Treatment Of Acute Venous Thromboembolism",
                -0.9747863173
            ],
            [
                1372291200000,
                "Pfizer Declares 24-Cent Third-Quarter 2013 Dividend",
                -1.3566774987
            ],
            [
                1372204800000,
                "Pfizer Announces Final Results of Zoetis Exchange Offer",
                0.3548839001
            ],
            [
                1372118400000,
                "Advil® Is The Official Pain Reliever Of Tough Mudder® Bringing #ReliefinAction  To “Probably The Toughest Event On The Planet”",
                0.0711719694
            ],
            [
                1372032000000,
                "Pfizer Invites Public To View And Listen To Webcast Of July 30 Conference Call With Analysts",
                -0.6073579127
            ],
            [
                1371945600000,
                "Pfizer Announces Preliminary Results of Zoetis Exchange Offer and Adjusts 2013 Financial Guidance(1) Solely to Reflect Impact of Exchange Offer",
                -0.6073579127
            ],
            [
                1371686400000,
                "Pfizer Announces FDA Acceptance For Review Of Application To Expand Labeling For XELJANZ® (tofacitinib citrate) For Adults With Moderately To Severely Active Rheumatoid Arthritis To Include Inhibition Of Progression Of Structural Damage",
                -1.9676770513
            ],
            [
                1371600000000,
                "Pfizer Announces Final Exchange Ratio Of 0.9898 For Zoetis Exchange Offer And  Automatic Extension Of Offer To Midnight On Friday, June 21, 2013",
                -2.5488460035
            ],
            [
                1370908800000,
                "Pfizer Obtains $2.15 Billion Settlement From Teva And Sun For Infringement Of Protonix® Patent",
                1.3717971687
            ],
            [
                1370476800000,
                "CytomX Announces Global Strategic Collaboration with Pfizer to Develop and  Commercialize Multiple Probody™-Drug Conjugates in Oncology",
                2.7601137702
            ],
            [
                1370304000000,
                "Americans Believe Their Communities Are Ill-Prepared For Aging Population, New Survey Reveals; Survey Shows A Fear Of Getting Old Due To Health And Financial Concerns",
                -1.273651265
            ],
            [
                1369699200000,
                "Pfizer Prices $4.0 Billion Debt Offering",
                -3.606812008
            ],
            [
                1369094400000,
                "Pfizer Announces Plan for Split-Off of Zoetis",
                2.013647457
            ],
            [
                1369008000000,
                "Pfizer Discontinues Phase 3 Study of Inotuzumab Ozogamicin in Relapsed or Refractory Aggressive Non-Hodgkin Lymphoma (NHL) Due to Futility",
                -0.6602099083
            ],
            [
                1368316800000,
                "Pfizer Announces 11 Abstracts for Tofacitinib to Be Presented at the European League Against Rheumatism (EULAR) 2013 Annual Meeting",
                2.2108851059
            ],
            [
                1367971200000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference",
                -1.0139755789
            ],
            [
                1367798400000,
                "Bristol-Myers Squibb and Pfizer Announce Publication of ARISTOTLE Subanalysis in Circulation",
                0.3444884401
            ],
            [
                1367712000000,
                "Facing Off Against Counterfeit Online Pharmacies: Pfizer Launches New Purchasing Website To Help Alleviate the Guesswork Around Buying Legitimate Viagra® (sildenafil citrate) Online",
                0.3444884401
            ],
            [
                1367193600000,
                "Pfizer Reports First-Quarter 2013 Results",
                -3.6119736641
            ],
            [
                1367193600000,
                "Merck & Co., Inc. and Pfizer Enter Worldwide Collaboration Agreement to Develop and Commercialize Ertugliflozin, an Investigational Medicine for Type 2 Diabetes",
                -3.6119736641
            ],
            [
                1367107200000,
                "Merck & Co., Inc. and Pfizer Enter Worldwide Collaboration Agreement to Develop and Commercialize Ertugliflozin, an Investigational Medicine for Type 2 Diabetes",
                -3.6119736641
            ],
            [
                1367020800000,
                "Pfizer Presents Phase 3 Safety And Immunogenicity Data On Prevenar 13 In Adults Aged 18 To 49 Years",
                -3.6119736641
            ],
            [
                1366848000000,
                "Pfizer Receives CHMP Negative Opinion Regarding Marketing Authorization In Europe For Rheumatoid Arthritis Treatment XELJANZ® (tofacitinib citrate)",
                -1.8610502937
            ],
            [
                1366761600000,
                "Pfizer Hosts Annual Meeting Of Shareholders",
                -2.7098727815
            ],
            [
                1366761600000,
                "Top-Line Data Show Celecoxib Met Primary Objective In Clinical Trial To Evaluate The Effects On Blood Pressure In Pediatric Patients With Juvenile Idiopathic Arthritis",
                -2.7098727815
            ],
            [
                1366156800000,
                "Pfizer Invites Public To Listen To Webcast Of April 25 Annual Meeting Of Shareholders",
                -0.6865401296
            ],
            [
                1365984000000,
                "Millions of US Teens May Be Missing Out on Annual Checkups, and the Opportunity to be Screened for Potential Health Risks",
                1.0666322356
            ],
            [
                1365465600000,
                "Pfizer’s Palbociclib (PD-0332991) Receives Food And Drug Administration Breakthrough Therapy Designation For Potential Treatment Of Patients With Breast Cancer",
                2.9745777281
            ],
            [
                1365379200000,
                "Pfizer Launches Third Integrated Annual Review",
                0.4466007542
            ],
            [
                1364947200000,
                "Advil® Launches Advil® Relief in Action Campaign Celebrating Active Volunteers Who Don’t Let Pain Hold Them Back",
                -0.2400799944
            ],
            [
                1364947200000,
                "BIND Therapeutics Announces Global Collaboration with Pfizer to Develop and  Commercialize Multiple Accurins",
                -0.2400799944
            ],
            [
                1364947200000,
                "CHOP Collaborates With Pfizer’s Centers For Therapeutic Innovation To Speed Pediatric Research & Development",
                -0.2400799944
            ],
            [
                1364342400000,
                "Pfizer’s BOSULIF® (bosutinib) Receives Conditional Marketing Authorization From The European Commission",
                1.1781136865
            ],
            [
                1364256000000,
                "Pfizer Invites Public to View and Listen to Webcast of April 30 Conference Call with Analysts",
                1.3268150666
            ],
            [
                1364083200000,
                "Over 50? Of Course You’ve Still Got It, and the Y and Pfizer are Launching 50 MOVING FORWARD to Help You Keep It",
                0.5244931511
            ],
            [
                1364083200000,
                "XELJANZ® (tofacitinib citrate) Approved in Japan for the Treatment of Adults with Rheumatoid Arthritis (RA)",
                0.5244931511
            ],
            [
                1362873600000,
                "New trial results support treatment with Inspra (eplerenone) within first 24 hours of symptoms, in addition to standard therapy, in patients with acute STEMI without heart failure.",
                -0.7874148515
            ],
            [
                1362355200000,
                "United States Patent & Trademark Office Grants Pfizer Reissue Patent For Celebrex® (celecoxib capsules)",
                2.7075637353
            ],
            [
                1362355200000,
                "Pfizer Presents Phase 3 Safety And Immunogenicity Data On Prevnar 13® In Adults With HIV",
                2.7075637353
            ],
            [
                1361318400000,
                "Top-Line Data Show Lyrica Met Primary Endpoint in Clinical Trial as Adjunctive Therapy versus Levetiracetam in Patients with Partial Onset Seizures",
                -0.875595941
            ],
            [
                1361232000000,
                "Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference",
                0.6166301032
            ],
            [
                1359590400000,
                "Pfizer Inc. Issues Statement on ZoetisTM IPO",
                0.7600454385
            ],
            [
                1359504000000,
                "Pfizer Wins RAPAMUNE® Patent Case in Delaware District Court",
                -0.9164498563
            ],
            [
                1359331200000,
                "Pfizer Reports Fourth-Quarter and Full-Year 2012 Results; Provides 2013 Financial Guidance",
                2.1660365068
            ],
            [
                1359072000000,
                "Pfizer Receives FDA Approval For The Use Of Prevnar 13 In Vaccine-Naive Children And Adolescents Aged 6 Years Through 17 Years For The Prevention Of Invasive Pneumococcal Disease",
                -0.5216059719
            ],
            [
                1358985600000,
                "ChapStick® Sessions Applies a Spotlight on Musically Talented Lips",
                0.4814817504
            ],
            [
                1358899200000,
                "Study Shows Higher Dose Of Toviaz® (fesoterodine fumarate) Offers Greater Efficacy In Reducing Urge Urinary Incontinence In Patients With Overactive Bladder",
                1.2290446316
            ],
            [
                1358899200000,
                "Pfizer Announces Top-Line Efficacy Results From A Phase 4 Study Of PRISTIQ® (desvenlafaxine) For The Treatment Of Major Depressive Disorder (MDD) In Adults",
                1.2290446316
            ],
            [
                1358899200000,
                "CHANTIX® (varenicline) Demonstrates Efficacy in Smokers Who Previously Attempted to Quit Smoking with CHANTIX",
                1.2290446316
            ],
            [
                1358726400000,
                "Pfizer Partnership Organizations Significantly Benefit From Pfizer’s Global Health Fellows Program",
                0.300211002
            ],
            [
                1358380800000,
                "Pfizer’s Bosutinib Receives Positive Opinion For Conditional Marketing Authorization From The Committee For Medicinal Products For Human Use For The Treatment Of Ph+ Chronic Myelogenous Leukemia With Resistance Or Intolerance To Prior Therapy In Europe",
                -0.7912347006
            ],
            [
                1358035200000,
                "Pfizer Announces Availability Of Quillivant XR™ (methylphenidate hydrochloride) CII For Extended-Release Oral Suspension In The United States",
                0.0375751003
            ],
            [
                1357516800000,
                "Pfizer Receives European Approval To Expand Use Of Prevenar 13 To Older Children And Adolescents Aged 6 To 17 Years For The Prevention Of Pneumococcal Disease",
                0.4227951332
            ],
            [
                1357171200000,
                "Philogen S.p.A. Announces Worldwide Licensing Agreement with Pfizer Inc. for Dekavil, an Investigational Immunoregulatory Therapy for Autoimmune Diseases",
                -0.0770543037
            ],
            [
                1357171200000,
                "Repligen Announces Licensing Agreement with Pfizer for Spinal Muscular Atrophy Program",
                -0.0770543037
            ],
            [
                1357171200000,
                "EMD Serono and Pfizer Announce FDA Approval of Rebif® Rebidose® (interferon beta-1a)",
                -0.0770543037
            ],
            [
                1356998400000,
                "UPDATE: With Multimedia: U.S. FDA Approves ELIQUIS® (apixaban) to Reduce the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation",
                1.237912109
            ],
            [
                1356393600000,
                "ELIQUIS® (apixaban) Approved In Japan For The Prevention Of Stroke And Systemic Embolism In Patients With Nonvalvular Atrial Fibrillation",
                0.3579878784
            ],
            [
                1356048000000,
                "Halozyme Therapeutics And Pfizer Enter Into A Collaboration To Develop  And Commercialize Subcutaneous Biologics Using Recombinant Human  Hyaluronidase",
                -1.2360418062
            ],
            [
                1355961600000,
                "Humedica and Pfizer Form Strategic Alliance",
                -0.956942698
            ],
            [
                1355702400000,
                "Pfizer Invites Public To View And Listen To Webcast Of January 29 Conference Call With Analysts",
                1.8331033523
            ],
            [
                1355702400000,
                "Pfizer Declares First-Quarter 2013 Dividend",
                1.8331033523
            ],
            [
                1355356800000,
                "U.S. Food And Drug Administration (FDA) Accepts New Drug Application For Bazedoxifene/Conjugated Estrogens, An Investigational Treatment For Symptoms Associated With Menopause And Prevention Of Osteoporosis",
                -0.9928463432
            ],
            [
                1355184000000,
                "New Robitussin® COUGHCAST™ Tool Helps Consumers Prepare for Coughs, Colds and the Flu by Tracking Cough Incidence Rates in Their Area",
                -0.0784165361
            ],
            [
                1354924800000,
                "ELIQUIS® (apixaban) Demonstrated Superiority In Reducing A Composite Of Recurrent Venous Thromboembolism And All-Cause Death Without Increasing The Rate Of Major Bleeding Versus Placebo During One Year Of Extended Treatment",
                0.8580736241
            ],
            [
                1354579200000,
                "Tanzania Expands Immunization Program To Include Pfizer’s Prevenar 13 For Prevention Of Pneumococcal Disease",
                2.340111178
            ],
            [
                1354579200000,
                "Pfizer Presents Phase 2 Data Showing Investigational Therapy PD-0332991 Plus Letrozole Significantly Improved Progression Free Survival Compared With Letrozole Alone In Patients With ER Positive, HER2 Negative Advanced Breast Cancer",
                2.340111178
            ],
            [
                1354233600000,
                "Pfizer Completes Sale of Nutrition Business to Nestlé",
                0.7174370885
            ],
            [
                1354233600000,
                "Pfizer Completes Sale of Nutrition Business to Nestlé",
                0.7174370885
            ],
            [
                1354060800000,
                "Pfizer to Present Clinical Data from Its Hematology Portfolio at the 54th Annual Meeting of the American Society of Hematology",
                2.4949621408
            ],
            [
                1354060800000,
                "Pfizer Acquires NextWave Pharmaceuticals, Inc.",
                2.4949621408
            ],
            [
                1353974400000,
                "Pfizer Acquires NextWave Pharmaceuticals, Inc.",
                1.6619398044
            ],
            [
                1353801600000,
                "Pfizer Subsidiary, Wyeth LLC, to Redeem 5.500% Notes Due March 15, 2013",
                -0.3711757096
            ],
            [
                1353283200000,
                "ELIQUIS®(apixaban) Approved in Europe for Prevention of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation",
                1.0296791168
            ],
            [
                1353283200000,
                "Cystic Fibrosis Foundation Therapeutics Announces $58 Million CF Drug Discovery  Agreement with Pfizer",
                1.0296791168
            ],
            [
                1353283200000,
                "Cystic Fibrosis Foundation Therapeutics Announces $58 Million CF Drug Discovery Agreement with Pfizer",
                1.0296791168
            ],
            [
                1353196800000,
                "Pfizer Reports Top-Line Results Of A Phase 3 Study Evaluating Pregabalin Controlled-Release As Treatment For Patients With Fibromyalgia",
                1.0296791168
            ],
            [
                1352937600000,
                "Pfizer Reports Top-Line Results Of A Phase 3 Study Evaluating Pregabalin Controlled-Release Formulation As Adjunctive Treatment In Adult Patients With Partial Onset Seizures",
                0.6286412023
            ],
            [
                1352678400000,
                "Best-Selling Author and Award-Winning Life Coach, Gail Blanke, Leads the Charge for Disease Awareness During National Chronic Obstructive Pulmonary Disease (COPD) Awareness Month",
                -0.4157882355
            ],
            [
                1352678400000,
                "Amgen and Pfizer Highlight Data to be Presented at American College of Rheumatology Meeting",
                -0.4157882355
            ],
            [
                1352246400000,
                "MULTIMEDIA: U.S. Food And Drug Administration Approves Pfizer’s XELJANZ® (tofacitinib citrate) for Adults with Moderately to Severely Active Rheumatoid Arthritis (RA) Who Have Had an Inadequate Response or Intolerance to Methotrexate",
                -1.2417411347
            ],
            [
                1352160000000,
                "Auxilium and Pfizer Will Conclude Agreement on XIAPEX® EU Collaboration",
                -0.9138835939
            ],
            [
                1352160000000,
                "U.S. Food and Drug Administration Approval of XELJANZ® (tofacitinib citrate) and Invitation to Media Briefing from Pfizer",
                -0.9138835939
            ],
            [
                1352160000000,
                "U.S. Food And Drug Administration Approves Pfizer’s XELJANZ® (tofacitinib citrate) for Adults with Moderately to Severely Active Rheumatoid Arthritis (RA) Who Have Had an Inadequate Response or Intolerance to Methotrexate",
                -0.9138835939
            ],
            [
                1351728000000,
                "Bristol-Myers Squibb and Pfizer Announce New Data on Stroke Prevention in Atrial Fibrillation to be Presented at American Heart Association 2012 Scientific Sessions",
                -1.0998023147
            ],
            [
                1351728000000,
                "Portola, Bristol-Myers Squibb and Pfizer Sign Clinical Collaboration Agreement to Study ELIQUIS® and Portola’s Universal Factor Xa Inhibitor Antidote PRT4445",
                -1.0998023147
            ],
            [
                1351641600000,
                "Pfizer Reports Third-Quarter 2012 Results",
                -4.4806317713
            ],
            [
                1351641600000,
                "Grantmakers In Aging Receives $1.3 million from the Pfizer Foundation to Boost ‘Age-friendly’ Communities",
                -4.4806317713
            ],
            [
                1351382400000,
                "Pfizer Reschedules Issuance Of Third Quarter 2012 Performance Report And Associated Conference Call And Webcast to November 1, 2012 Due To Expected Severe Weather Conditions",
                -4.4806317713
            ],
            [
                1351123200000,
                "Pfizer Declares A 22-Cent Fourth-Quarter 2012 Dividend",
                -0.1572750935
            ],
            [
                1351036800000,
                "Pfizer’s XALKORI® Receives Conditional Marketing Authorization from the European Commission for the Treatment of Adults with Previously Treated ALK-Positive Advanced Non-Small Cell Lung Cancer in the EU",
                1.3276071344
            ],
            [
                1350777600000,
                "Pfizer To Acquire NextWave Pharmaceuticals, Inc.",
                -1.9452169278
            ],
            [
                1350432000000,
                "Pfizer Consumer Healthcare Responds to PHS II Findings with Statement and Centrum® Silver® Multivitamin B-roll and Photo Assets",
                0.6912154417
            ],
            [
                1350345600000,
                "Pfizer Announces Top-line Results From Phase 3 Trial Of INLYTA® (axitinib) In Treatment-Naïve Patients With Advanced Renal Cell Carcinoma",
                0.5805131081
            ],
            [
                1350259200000,
                "New Study With CHANTIX®/CHAMPIX® (varenicline) Tablets Suggests Favorable Benefit-Risk Profile In Adult Smokers With Major Depressive Disorder",
                2.4418472765
            ],
            [
                1349827200000,
                "Pfizer Announces Top-Line Results From A Phase 3 Long-Term Safety Study Of ALO-02:",
                -0.8758155814
            ],
            [
                1349740800000,
                "New Report Reveals Programs That Promote Healthy Ageing Can Help Reduce Rising Health Costs1",
                -0.5961792625
            ],
            [
                1349222400000,
                "Pfizer Announces Top-Line Results Of Prevenar 13® Phase 3 Trial In Adults 18 To 49 Years Of Age",
                0.9467587382
            ],
            [
                1349049600000,
                "ELIQUIS® (apixaban) Demonstrates Consistent Reductions in Stroke and Systemic Embolism, Major Bleeding and Mortality Compared to Warfarin in Patients with Nonvalvular Atrial Fibrillation at Varying Risk for Stroke and Bleeding",
                1.2738561388
            ],
            [
                1348617600000,
                "FDA Acknowledges Receipt of Resubmission of the ELIQUIS® (apixaban) New Drug Application to Reduce the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation",
                0.2003251361
            ],
            [
                1348185600000,
                "Pfizer Invites Public To View And Listen To Webcast Of October 30 Conference Call With Analysts",
                1.1716988343
            ],
            [
                1348099200000,
                "ELIQUIS® (apixaban) Receives CHMP Positive Opinion For The Prevention Of Stroke And Systemic Embolism In Patients With Nonvalvular Atrial Fibrillation",
                1.5905186021
            ],
            [
                1347840000000,
                "Pfizer Announces Data For Investigational Compound Tofacitinib In Rheumatoid Arthritis To Be Presented At The American College Of Rheumatology 2012 Annual Meeting",
                1.3744063043
            ],
            [
                1347753600000,
                "Pfizer To Present New Data in Lung And Kidney Cancers at The European Society For Medical Oncology 2012 Congress",
                1.3744063043
            ],
            [
                1347494400000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference",
                -1.0083991566
            ],
            [
                1347494400000,
                "Pfizer Recognized by Carbon Disclosure Project for Carbon Performance",
                -1.0083991566
            ],
            [
                1347408000000,
                "Pfizer And Hisun Announce Launch Of Hisun-Pfizer Pharmaceuticals Co., Ltd.",
                0.3710866572
            ],
            [
                1347408000000,
                "Pfizer and Waste Management Launch Online Pharmaceutical Disposal Guide",
                0.3710866572
            ],
            [
                1347408000000,
                "Pfizer And Hisun Announce Launch Of Hisun-Pfizer Pharmaceuticals Co., Ltd.",
                0.3710866572
            ],
            [
                1347235200000,
                "World Health Organization Grants Expansion To The Prequalification For Prevenar 13 To Include Adults 50 Years Of Age And Older",
                -0.1240934223
            ],
            [
                1346889600000,
                "Pfizer Settles Patent Litigation with Mylan Covering Detrol LA®",
                0.5775217904
            ],
            [
                1346716800000,
                "U.S. Food and Drug Administration Approves BOSULIF® (bosutinib) for Patients with Previously Treated Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia (CML)",
                0.5434307755
            ],
            [
                1346716800000,
                "Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Healthcare Conference",
                0.5434307755
            ],
            [
                1346630400000,
                "Pfizer Receives EU Marketing Authorization for INLYTA® (Axitinib)",
                0.5434307755
            ],
            [
                1346371200000,
                "VLST Corporation Announces In-licensing Agreement with  Pfizer for Anti-CD40 Monoclonal Antibody",
                -0.4204810716
            ],
            [
                1346284800000,
                "Spiriva® HandiHaler® (tiotropium bromide inhalation powder) and COPD Data to be Presented at the 2012 European Respiratory Society (ERS) Congress",
                -0.0419278088
            ],
            [
                1346025600000,
                "Pfizer Announces Conclusion of Consent Solicitation For $22.5 Million of Debt",
                -0.2935009934
            ],
            [
                1345680000000,
                "Pfizer Announces Successful Consent Solicitation Results For Three Series Of Debt",
                0.9995869553
            ],
            [
                1345420800000,
                "U.S. Food And Drug Administration Extends Action Date For Tofacitinib New Drug Application By Three Months",
                -0.0844459816
            ],
            [
                1345420800000,
                "ELIQUIS® (apixaban) Data Analyses To Be Presented At European Society of Cardiology Congress 2012",
                -0.0844459816
            ],
            [
                1344988800000,
                "Pfizer Commences Consent Solicitation for Amendments to Pharmacia Indentures",
                0.1665703126
            ],
            [
                1344816000000,
                "Pfizer And Astrazeneca Enter Into Agreement For Over-The-Counter Nexium",
                0.7089383535
            ],
            [
                1344729600000,
                "Zoetis™ Files IPO Registration Statement",
                0.7089383535
            ],
            [
                1344470400000,
                "Pfizer Reports Results From Phase 3 Study Of Torisel (temsirolimus) In Combination With Bevacizumab In Advanced Renal Cell Carcinoma (RCC)",
                0.459499274
            ],
            [
                1344470400000,
                "Nodality Enters into a Multi-Year Strategic  Collaboration with Pfizer in Autoimmune Disease",
                0.459499274
            ],
            [
                1344384000000,
                "Pfizer Reduces Its Greenhouse Gas Emissions by 20 Percent",
                0.6702778333
            ],
            [
                1344297600000,
                "Pfizer Announces Resolutions with DOJ and SEC Related to Certain International Operations",
                -0.7133749839
            ],
            [
                1344211200000,
                "Pfizer Announces Co-Primary Clinical Endpoints Not Met In Second Phase 3 Bapineuzumab Study In Mild-To-Moderate Alzheimer’s Disease Patients Who Do Not Carry The Apoe4 Genotype",
                -2.106148194
            ],
            [
                1344211200000,
                "Summertime Shines a Light on the Need for Vitamin D",
                -2.106148194
            ],
            [
                1343865600000,
                "Study Shows Toviaz Is Effective In Reducing Urge Urinary Incontinence In Patients With Overactive Bladder After Suboptimal Response To Detrol LA",
                1.9357650605
            ],
            [
                1343692800000,
                "Pfizer Announces Positive Top-Line Results From The ORAL Start Phase 3 Study Of Tofacitinib In Rheumatoid Arthritis",
                1.0393321673
            ],
            [
                1343606400000,
                "Pfizer Reports Second-Quarter 2012 Results",
                1.1230593362
            ],
            [
                1343001600000,
                "Pfizer Announces Topline Results Of First Of Four Studies In Bapineuzumab Phase 3 Program",
                -0.3849168429
            ],
            [
                1342915200000,
                "Pfizer Reports Top-Line Results of EU Post-Authorization Safety and Efficacy Study of Lyrica’s Discontinuation Effects In Patients with Generalized Anxiety Disorder",
                -0.3849168429
            ],
            [
                1342915200000,
                "Pfizer Reports Top-Line Results of Study of Lyrica’s Effect on Male Reproduction Conducted as a Post-Approval Commitment Required by the U.S. Food and Drug Administration",
                -0.3849168429
            ],
            [
                1342656000000,
                "Pfizer’s Crizotinib Receives Positive Opinion For Conditional Marketing Authorization From The Committee For Medicinal Products For Human Use For The Treatment Of Adults With Previously Treated ALK-Positive Advanced Non-Small Cell Lung Cancer In The EU",
                0.421938484
            ],
            [
                1342656000000,
                "Pfizer and Northwestern University Win LYRICA® Patent Case in Delaware District Court",
                0.421938484
            ],
            [
                1342569600000,
                "European Medicines Agency Accepts Regulatory Submission For Bazedoxifene/Conjugated Estrogens For The Treatment Of Symptoms Associated With Menopause And Osteoporosis",
                1.1344447416
            ],
            [
                1341964800000,
                "VERASTEM ACQUIRES CLINICAL-STAGE FAK INHIBITOR FROM PFIZER",
                1.2351213236
            ],
            [
                1340841600000,
                "Pfizer Declares A 22-Cent Third-Quarter 2012 Dividend",
                1.6086923676
            ],
            [
                1340582400000,
                "Pfizer Invites Public to View and Listen to Webcast of July 31 Conference Call with Analysts",
                1.7380039507
            ],
            [
                1340496000000,
                "Bristol-Myers Squibb and Pfizer Receive Complete Response Letter from U.S. Food and Drug Administration for ELIQUIS® (apixaban)",
                1.7380039507
            ],
            [
                1340236800000,
                "EMA Adopts Opinion On Taliglucerase Alfa Marketing Authorization Application",
                -0.1320062237
            ],
            [
                1340150400000,
                "FDA Approves Lyrica For The Management Of Neuropathic Pain Associated With Spinal Cord Injury Based On Priority Review",
                -0.7079508741
            ],
            [
                1340150400000,
                "Pfizer Statement Regarding Prevnar 13® Receiving ACIP Recommendation for Prevention of Pneumococcal Disease in Adults With Immunocompromising Conditions",
                -0.7079508741
            ],
            [
                1339977600000,
                "Pfizer Announces Positive Results From Phase 3 Study PROFILE 1007 Evaluating XALKORI® (crizotinib) In Previously Treated Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer",
                0.6164747647
            ],
            [
                1339977600000,
                "FDA Issues Complete Response Letter For Pfizer’s Tafamidis Meglumine New Drug Application",
                0.6164747647
            ],
            [
                1339891200000,
                "Have Americans Reached a New Era of Optimism about Aging?",
                0.6164747647
            ],
            [
                1338940800000,
                "Pfizer Provides Update On Animal Health Strategic Alternatives Review Process",
                1.0027427169
            ],
            [
                1337817600000,
                "Pfizer’s Axitinib Receives Positive Opinion from the Committee for Human Medicinal Products for the Second-line Treatment of Advanced Kidney Cancer in the EU",
                -0.0903578204
            ],
            [
                1337731200000,
                "FDA Advisory Committee Finds Data Support Effectiveness of Tafamidis Meglumine, Pfizer’s Novel Investigational Treatment for Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP)",
                -1.0840332679
            ],
            [
                1337644800000,
                "Pfizer Names Olivier Brandicourt as President and General Manager, Emerging Markets and Established Products Business Units",
                -1.7655252653
            ],
            [
                1337644800000,
                "Pfizer Invites Public to View and Listen to Webcast of June 3 Pfizer Analyst and Investor Meeting at ASCO",
                -1.7655252653
            ],
            [
                1337212800000,
                "Pfizer Exploratory Study Measures Effects Of Lyrica (pregabalin) On Brain Activity In Fibromyalgia Patients",
                -0.2215378243
            ],
            [
                1337040000000,
                "Pfizer Provides Topline Results From Phase 3 Study Of Torisel® As Second-Line Treatment In Advanced Renal Cell Carcinoma (RCC)",
                0.3533418778
            ],
            [
                1336867200000,
                "Pfizer To Present New Data In Advanced Kidney, Lung And Hematologic Cancers At 2012 ASCO Annual Meeting",
                -0.7174827285
            ],
            [
                1336608000000,
                "Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Healthcare Conference",
                -0.2207820509
            ],
            [
                1336521600000,
                "FDA Arthritis Advisory Committee Recommends Approval of Tofacitinib for Adult Patients with Moderately to Severely Active Rheumatoid Arthritis",
                3.3289563839
            ],
            [
                1336262400000,
                "Pfizer Announces New Long-Term Relapse Prevention Data For PRISTIQ® (desvenlafaxine) 50 mg/day For The Treatment Of Major Depressive Disorder In Adults",
                0.8028932648
            ],
            [
                1336003200000,
                "Pfizer Stops Phase 3 Trial Of Lyrica (pregabalin) Capsules CV In Neuropathic Pain Associated With HIV Neuropathy",
                -1.2958305589
            ],
            [
                1336003200000,
                "Pfizer Reports Top-Line Results From Phase 3 Trial Of Lyrica (pregabalin) Capsules CV In Patients With Inadequately Treated Painful Diabetic Peripheral Neuropathy",
                -1.2958305589
            ],
            [
                1335830400000,
                "Pfizer And Protalix BioTherapeutics Announce FDA Approval Of ELELYSO™ (taliglucerase alfa) For The Treatment Of Gaucher Disease",
                0.132388854
            ],
            [
                1335744000000,
                "Pfizer Inc. Issues Statement Regarding Pending Court Case",
                -1.0535563405
            ],
            [
                1335744000000,
                "Pfizer Reports First-Quarter 2012 Results",
                -1.0535563405
            ],
            [
                1335398400000,
                "Pfizer Hosts Annual Meeting Of Shareholders",
                0.9099058864
            ],
            [
                1335225600000,
                "The Advil® Congestion Relief Project Visits St. Louis To Expand Building Space For More Access To Local Family Social Service Program",
                2.1415872732
            ],
            [
                1335139200000,
                "Quark Pharmaceuticals Announces Phase 2a Study of  PF--04523655 (PF-655) in Patients with Moderate and Advanced OpenAngle Glaucoma (OAG",
                1.148967436
            ],
            [
                1334793600000,
                "The Advil® Congestion Relief Project Visits Dayton To Relieve Community Center Congestion Allowing More Students To Participate In Local Mentorship Program",
                0.132995528
            ],
            [
                1334793600000,
                "Pfizer Invites Public To Listen To Webcast Of April 26 Annual Meeting Of Shareholders",
                0.132995528
            ],
            [
                1334707200000,
                "The Advil® Congestion Relief Project Visits Dayton To Relieve Community Center Congestion Allowing More Students To Participate In Local Mentorship Program",
                0.537189706
            ],
            [
                1334188800000,
                "ADDING MULTIMEDIA The Advil® Congestion Relief Project Relieves Transportation Congestion in Albany to Help Get Students to Afterschool Programs",
                -0.9153162141
            ],
            [
                1333843200000,
                "“MasterChef” Judge Joe Bastianich Cooks With “Heart” At New Chicago Walgreens Flagship Store",
                -0.3638344919
            ],
            [
                1332806400000,
                "Pfizer Invites Public To View And Listen To Webcast Of May 1 Conference Call With Analysts",
                0.5355103042
            ],
            [
                1332633600000,
                "Pfizer to Present New Data Highlighting Ongoing Research at 2012 Meeting of the American Association for Cancer Research",
                2.4444006059
            ],
            [
                1332288000000,
                "Data on ELIQUIS® (apixaban) for the Prevention of Stroke in Atrial Fibrillation To Be Presented At American College of Cardiology’s 61st Annual Scientific Session",
                -0.4601517525
            ],
            [
                1331510400000,
                "Biocon And Pfizer Conclude Commercialization Agreement",
                2.4534408566
            ],
            [
                1331510400000,
                "Biocon And Pfizer Conclude Commercialization Agreement",
                2.4534408566
            ],
            [
                1331424000000,
                "Pfizer’s Prevnar 13® Shown to be Immunogenic in Older Children and Adolescents",
                2.4534408566
            ],
            [
                1330992000000,
                "Pfizer Invites Public To View And Listen To Webcast Of Pfizer Presentation At Healthcare Conference",
                -0.1872015021
            ],
            [
                1330387200000,
                "Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference",
                0.0473233084
            ],
            [
                1330300800000,
                "Pfizer Acquires Alacer Corp., a Leading Vitamin Supplements Company",
                2.1677562477
            ],
            [
                1329868800000,
                "Pfizer Statement Regarding CDC’s ACIP Discussion of Prevnar 13® for Use in Adults",
                -0.6181557388
            ],
            [
                1329436800000,
                "Pfizer And Hisun Announce Progress On Potential Joint Venture  To Increase Access To High Quality Branded Generic Medicines",
                -1.2252566637
            ],
            [
                1329436800000,
                "Pfizer And Hisun Announce Progress On Potential Joint Venture To Increase Access To High Quality Branded Generic Medicines",
                -1.2252566637
            ],
            [
                1329177600000,
                "FDA Accepts Pfizer’s New Drug Application for Tafamidis Meglumine, a Novel, Investigational Treatment for Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP)",
                -0.9000485787
            ],
            [
                1328054400000,
                "Pfizer Issues Statement On Voluntary Recall",
                -0.6632104765
            ],
            [
                1328054400000,
                "Pfizer Announces Voluntary Nationwide Recall Of Lo/Ovral®-28 And Norgestrel/Ethinyl Estradiol Tablets Due To Possibility Of Inexact Tablet Counts Or Out Of Sequence Tablets",
                -0.6632104765
            ],
            [
                1327881600000,
                "Pfizer Reports Fourth-Quarter and Full-Year 2011 Results; Updates 2012 Financial Guidance",
                0.046699059
            ],
            [
                1327795200000,
                "Private and Public Partners Unite to Combat 10 Neglected Tropical Diseases by 2020",
                0.046699059
            ],
            [
                1327622400000,
                "U.S. Food And Drug Administration Approves Pfizer’s INLYTA® (axitinib) For Patients With Previously Treated Advanced Renal Cell Carcinoma (RCC)",
                -0.0926974522
            ],
            [
                1327536000000,
                "Pfizer Announces FDA Acceptance Of New Drug Application For Bosutinib For Patients With Previously Treated Ph+ Chronic Myeloid Leukemia",
                -1.3500771847
            ],
            [
                1327449600000,
                "Alzheimer's Challenge 2012: Seeking New Tools To Help Improve Alzheimer’s Care",
                0.5547590574
            ],
            [
                1327449600000,
                "KineMed announced a non-exclusive research collaboration with Pfizer for the advancement of novel approaches towards metabolic disease, in particular Type II Diabetes.",
                0.5547590574
            ],
            [
                1327190400000,
                "MS LifeLines® Earns J.D. Power and Associates Call Center Certification for Customer Service Excellence in Providing Support Services to the MS Community",
                -1.2926999895
            ],
            [
                1326672000000,
                "Medivation and Pfizer Announce Results from Phase 3 Concert Trial of Dimebon in Alzheimer’s Disease",
                -0.0910715833
            ],
            [
                1326153600000,
                "Ventana to collaborate with Pfizer and CST on companion  diagnostic to identify lung cancer patients with ALK gene rearrangements",
                -0.1826786168
            ],
            [
                1326067200000,
                "Introducing nutritionpossible.com – A New Resource That Offers Personalized Nutritional Guidance to Achieve Better Health",
                1.7320244256
            ],
            [
                1326067200000,
                "SFJ Pharma Ltd. II, Announces Agreement With Pfizer to Develop Axitinib for Adjuvant Treatment of Renal Cell Carcinoma",
                1.7320244256
            ],
            [
                1325721600000,
                "PFIZER INITIATES PHASE 1 CLINICAL TRIAL FOR FVIIa HEMOPHILIA  DRUG CANDIDATE DEVELOPED BY CATALYST BIOSCIENCES",
                -0.6953890656
            ],
            [
                1325462400000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference",
                -0.4134261686
            ],
            [
                1325203200000,
                "Pfizer Receives FDA Approval to Extend Use of Prevnar 13® for Prevention of Pneumococcal Pneumonia and Invasive Disease in Adults 50 Years and Older",
                2.1848053504
            ],
            [
                1324771200000,
                "CollPlant to develop orthopedic product  with Pfizer",
                -1.0218140956
            ],
            [
                1324684800000,
                "Karo Bio AB announced that it has entered into a research collaboration agreement with Pfizer to discover and develop novel small molecule RORgamma modulators for the treatment of autoimmune diseases.",
                -1.0218140956
            ],
            [
                1324425600000,
                "Pfizer Reports Results From Three Phase 4 Studies Demonstrating EMBEDA® (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII Impact On Drug Liking And Withdrawal Symptoms",
                0.4160851451
            ],
            [
                1324339200000,
                "Antares Pharma Enters Licensing Agreement With Pfizer Consumer Healthcare",
                1.7066358341
            ],
            [
                1324252800000,
                "Pfizer Invites Public To View And Listen To Webcast Of January 31 Conference Call With Analysts",
                1.5377382572
            ],
            [
                1324252800000,
                "Pfizer Announces FDA Acceptance For Review Of New Drug Application For Tofacitinib For Adult Patients With Moderately To Severely Active Rheumatoid Arthritis",
                1.5377382572
            ],
            [
                1324252800000,
                "Sanofi joins Systems-based Pharmaceutics Alliance",
                1.5377382572
            ],
            [
                1323907200000,
                "Pfizer Reports Positive Results From Phase 3 Trial Of Lyrica (pregabaline) Capsules CV In Restless Legs Syndrome",
                0.3804097424
            ],
            [
                1323907200000,
                "Pfizer Broadens and Extends Commitment to Help Prevent Pneumococcal Disease in Infants and Young Children in the World’s Poorest Countries",
                0.3804097424
            ],
            [
                1323734400000,
                "Progress of GlycoMimetics’ Novel Compounds  Highlighted at 2011 Annual Meeting of the American Society of Hematology",
                1.3902358141
            ],
            [
                1323648000000,
                "New Survey Reveals Top Misperceptions Parents Have When Treating Their Child’s Fever",
                1.8304519091
            ],
            [
                1323648000000,
                "Pfizer Elects CEO Ian Read As Chairman Of The Board",
                1.8304519091
            ],
            [
                1323648000000,
                "Pfizer Declares A 22-Cent First-Quarter 2012 Dividend",
                1.8304519091
            ],
            [
                1323302400000,
                "Jon Bon Jovi Reveals His True Advil® Story",
                1.1673465204
            ],
            [
                1323216000000,
                "The Advil® Congestion Relief Project Tackles Congestion in Chicago, the Country’s #1 City for Traffic Congestion*",
                0.3466965208
            ],
            [
                1323216000000,
                "FDA Advisory Committee Finds The Benefit/Risk Profile Of Axitinib In Previously Treated Advanced Renal Cell Carcinoma (RCC) To Be Favorable",
                0.3466965208
            ],
            [
                1323043200000,
                "Pfizer’s Toviaz Shows Positive Top-Line Primary Endpoint Result In Study Of Overactive Bladder In Vulnerable Elderly Patients",
                0.5437928038
            ],
            [
                1322697600000,
                "Pfizer Completes Acquisition of Excaliard",
                -0.703912122
            ],
            [
                1322697600000,
                "KineMed announces research collaboration with Pfizer for the  advancement of novel approaches in metabolic disease",
                -0.703912122
            ],
            [
                1322697600000,
                "Karo Bio Enters Collaboration With Pfizer To Discover And Develop Innovative Drugs For Autoimmune Diseases",
                -0.703912122
            ],
            [
                1322611200000,
                "Pfizer Completes Acquisition of Ferrosan Consumer Health’s Business",
                2.3464946589
            ],
            [
                1322611200000,
                "New Research Initiative Examines Economic Impact of Smoke-free Policies on Restaurants and Bars",
                2.3464946589
            ],
            [
                1322438400000,
                "FDA Accepts ELIQUIS® (apixaban) New Drug Application for Review for the Prevention of Stroke and Systemic Embolism in Patients with Atrial Fibrillation",
                3.0412313145
            ],
            [
                1321833600000,
                "Pfizer to Acquire Excaliard Pharmaceuticals",
                -1.5873013753
            ],
            [
                1321833600000,
                "Pfizer And MIT Break Ground On New Research Units In Kendall Square",
                -1.5873013753
            ],
            [
                1321747200000,
                "Pfizer Announces European Medicines Agency Acceptance Of Regulatory Submission For Tofacitinib For The Treatment Of Rheumatoid Arthritis",
                -1.5873013753
            ],
            [
                1321488000000,
                "Pfizer Wins Corporate Citizenship Award For Global Health Partnerships Program",
                -0.2048247113
            ],
            [
                1321401600000,
                "Pfizer’s Vyndaqel® (tafamidis) First Therapy Approved in the European Union for the Rare and Fatal Neurodegenerative Disease Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP)",
                -0.924476514
            ],
            [
                1321401600000,
                "The Advil® Congestion Relief Project Hits the Road to Relieve Congestion in Communities",
                -0.924476514
            ],
            [
                1321228800000,
                "Kathryn Joosten Speaks Out About Lung Cancer Profiles; ‘Desperate’ to Share Her Personal Lung Cancer Story to Help Others",
                1.2581781495
            ],
            [
                1321056000000,
                "New Data Presented On Phase 3 Trial Of ELIQUIS® (apixaban) In The Prevention Of Venous Thromboembolism In Patients With Acute Medical Illness",
                1.2581781495
            ],
            [
                1320796800000,
                "Children's Hospital Boston and Pfizer enter into novel collaborative research agreement for muscular dystrophy therapeutics",
                1.0611549822
            ],
            [
                1320624000000,
                "Toviaz Top-Line Primary Endpoint Results Positive In Overactive Bladder Study Of Nocturnal Urinary Urgency",
                3.4124275383
            ],
            [
                1320624000000,
                "Pfizer To Present Clinical Data From Its Hematology Portfolio At The 53rd Annual Meeting Of The American Society Of Hematology",
                3.4124275383
            ],
            [
                1320451200000,
                "Treatment with Enbrel® (etanercept) Shows Significant and Sustained Clinical Benefits in Rheumatoid Arthritis (RA) Patients with Moderately Active Disease",
                3.4124275383
            ],
            [
                1320019200000,
                "Pfizer Reports Third-Quarter 2011 Results",
                -1.2933114711
            ],
            [
                1319760000000,
                "Pfizer Completes Acquisition Of Icagen",
                -3.1671896457
            ],
            [
                1319673600000,
                "Pfizer Completes Acquisition Of Icagen",
                0.9586256743
            ],
            [
                1319673600000,
                "Pfizer Declares A 20-Cent Fourth-Quarter 2011 Dividend",
                0.9586256743
            ],
            [
                1319587200000,
                "Pfizer Receives European Approval to Extend Use of Prevenar 13 to Adults 50 Years and Older for the Prevention of Invasive Pneumococcal Disease",
                4.0322755566
            ],
            [
                1319587200000,
                "Pfizer Establishes Precision Medicine Research Collaboration With Medco",
                4.0322755566
            ],
            [
                1319500800000,
                "Peggy Fleming and the Makers of Robitussin® Provide Relief this Cold and Flu Season with a Simple Question: \"Does Your Last Name Sound Contagious?\"",
                0.2593198425
            ],
            [
                1319500800000,
                "Leading Pharmaceutical Companies & Research Institutions Offer IP and Expertise for use in Treating Neglected Tropical Diseases as Part of WIPO Re:Search",
                0.2593198425
            ],
            [
                1319414400000,
                "Pfizer Invites Public to View and Listen to Webcast of November 6 Pfizer Analyst and Investor Meeting at ACR",
                -0.4769521703
            ],
            [
                1319068800000,
                "Additional Data From Pfizer’s Prevnar 13® Clinical Trials In Adults 50 Years And Older To Be Presented At The 49th Annual Meeting Of The Infectious Diseases Society Of America",
                1.4690809694
            ],
            [
                1318809600000,
                "Pfizer Animal Health and the Resource Foundation Expand Initiative to Increase Productivity of Small Family Farms in Latin America and India",
                0.15813978
            ],
            [
                1318550400000,
                "Findings from DiaGenic, Pfizer R&D Collaboration  Show Promising Early Results for Blood-based Test for  Early Alzheimer Disease",
                -1.6585995231
            ],
            [
                1318464000000,
                "Humana and Pfizer Form Research Partnership to Improve Health Care Delivery for Seniors",
                1.6806570268
            ],
            [
                1318377600000,
                "deCODE Announces Agreement with Pfizer to Search  for Variants in the Human Genome that Confer Risk of  Systemic Lupus Erythematosis",
                -0.6929990349
            ],
            [
                1318204800000,
                "Exonhit enters into Research Agreement with Pfizer to  identify Alzheimer’s disease biomarkers",
                0.636611241
            ],
            [
                1317772800000,
                "Pfizer Announces Licensing Agreement  With Puma Biotechnology, Inc. For The  Development And Commercialization Of  Neratinib, An Investigational Pan-HER  Inhibitor",
                3.7849730834
            ],
            [
                1317772800000,
                "Lpath Granted Two Additional U.S. Patents Related to  iSONEP and ASONEP Drug Programs",
                3.7849730834
            ],
            [
                1317772800000,
                "Pfizer Announces Licensing Agreement With Puma Biotechnology, Inc. For The Development And Commercialization Of Neratinib, An Investigational Pan-HER Inhibitor",
                3.7849730834
            ],
            [
                1317600000000,
                "Medimmune'in(Licenses'cancer'immunotherapy'tremelimumab'from'pfizer",
                -0.5685250434
            ],
            [
                1317600000000,
                "Pfizer Invites Public To View And Listen To Webcast Of November 1 Conference Call With Analysts",
                -0.5685250434
            ],
            [
                1317340800000,
                "Excellence in Scientific Innovation and Humanitarian Efforts Honored at 2011 Prix Galien Award Ceremony",
                -2.4812341964
            ],
            [
                1317254400000,
                "Pfizer Reports Top-Line Results Of A Phase 3 Clinical Trial Comparing The Efficacy And Safety Of VFEND® (voriconazole) And ERAXISTM (anidulafungin) Combination Therapy To VFEND Alone In Invasive Aspergillosis",
                -0.6221864654
            ],
            [
                1317168000000,
                "The National Association Of Boards Of Pharmacy And Pfizer Partner To Educate Patients About The Flood Of Counterfeit Medicines Online",
                1.2236190413
            ],
            [
                1317168000000,
                "International Structural Genomics Consortium Announces $48.9 MILLION in Additional Funding to  Continue the Search for New Medicines",
                1.2236190413
            ],
            [
                1316649600000,
                "Even Famous Faces Have an Advil® Story to Share",
                -0.6876666239
            ],
            [
                1316563200000,
                "New Phase 3 Safety Data For Bazedoxifene/Conjugated Estrogens, An Investigational Therapy Being Studied For The Treatment Of Menopausal Symptoms, Show Less Than One Percent Incidence Of Endometrial Hyperplasia",
                -3.4305688292
            ],
            [
                1316390400000,
                "Pfizer Announces Expiration of Subsequent Offering Period and Completion of Tender Offer for Shares of Icagen, Inc.",
                1.6447658607
            ],
            [
                1315785600000,
                "Pfizer Extends Subsequent Offering Period of Tender Offer to Acquire Icagen, Inc.",
                2.5095925567
            ],
            [
                1315785600000,
                "Pfizer to Present Clinical Data from Oncology Portfolio at the 2011 European Multidisciplinary Cancer Congress",
                2.5095925567
            ],
            [
                1315526400000,
                "Lpath Initiates Dosing of iSONEP in First of Two Proof-ofConcept Trials",
                -1.8082461056
            ],
            [
                1315440000000,
                "Pfizer And Guoyuan Form Joint Venture To Expand Development, Manufacture And Distribution Of Animal Vaccines In China",
                -3.2822732483
            ],
            [
                1315440000000,
                "Introducing ProNutrients™, A New Line Of Dietary Supplements From The Makers Of Centrum",
                -3.2822732483
            ],
            [
                1315353600000,
                "Pfizer Announces Detailed Pivotal Data for Investigational Compound Tofacitinib in Rheumatoid Arthritis to be Presented at American College of Rheumatology 2011 Annual Scientific Meeting",
                -0.9032814906
            ],
            [
                1315353600000,
                "Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Healthcare Conference",
                -0.9032814906
            ],
            [
                1315180800000,
                "Pfizer Announces Successful Completion of Initial Cash Tender Offer for Outstanding Shares of Icagen, Inc. and Commencement of Subsequent Offering Period",
                4.103085093
            ],
            [
                1314921600000,
                "Pfizer Extends Tender Offer To Acquire Icagen, Inc.",
                0.160856196
            ],
            [
                1314835200000,
                "Pfizer Signs Agreement With MIT For Future Cambridge Research Center",
                -2.4377012919
            ],
            [
                1314576000000,
                "Jennewein Biotechnologie and Pfizer Nutrition Collaborate  on Human Milk Components",
                0.6355907839
            ],
            [
                1314576000000,
                "FDA Approval of XALKORI (crizotinib) and Invitation to Media Briefing from Pfizer",
                0.6355907839
            ],
            [
                1314403200000,
                "ELIQUIS® (apixaban) was Superior to Warfarin for the Reduction of Stroke or Systemic Embolism with Significantly Less Major Bleeding in Patients with Atrial Fibrillation in Phase 3 ARISTOTLE Trial",
                0.6355907839
            ],
            [
                1314316800000,
                "U.S. Food And Drug Administration Approves Pfizer’s XALKORI® (crizotinib) As First And Only Therapy Specifically For Patients With Locally Advanced Or Metastatic ALK-Positive Non-Small Cell Lung Cancer",
                5.5614771732
            ],
            [
                1313971200000,
                "Bristol-Myers Squibb And Pfizer Announce Data Presentations For Apixaban At European Society of Cardiology Congress 2011",
                1.4254722151
            ],
            [
                1313539200000,
                "Pfizer Announces European Medicines Agency Acceptance of Regulatory Submissions For Two Investigational Cancer Therapies",
                -4.0090441316
            ],
            [
                1313452800000,
                "QIAGEN and Pfizer partner to develop  companion diagnostic for novel  compound in global clinical trials for lung Cancer",
                1.2979990763
            ],
            [
                1313280000000,
                "Pfizer Wins Viagra Patent Trial",
                0.7100028043
            ],
            [
                1312761600000,
                "Pfizer Expands California Centers For Therapeutic Innovation Five Year Partnership With UC San Diego Health Sciences To Accelerate Drug Discovery and Development",
                2.7840526751
            ],
            [
                1312329600000,
                "Biotica regains worldwide rights to its  rapamycin analogue program",
                -3.8018446968
            ],
            [
                1312329600000,
                "Dana Delany Partners with Caltrate® to Celebrate Women and How They Move the World Every Day through Their Amazing Strength and Contributions",
                -3.8018446968
            ],
            [
                1312329600000,
                "NCCN Receives $2M Educational Grant from Pfizer to Support Tailored Quality Improvement Plans at Leading Cancer Centers",
                -3.8018446968
            ],
            [
                1312156800000,
                "Pfizer Reports Second-Quarter 2011 Results",
                -7.1664957195
            ],
            [
                1312156800000,
                "Pfizer Completes Sale Of Capsugel Business To KKR",
                -7.1664957195
            ],
            [
                1311897600000,
                "Pfizer Provides U.S. Regulatory Update on Prevnar 13® for Use in Adults 50 Years and Older",
                -1.0520464187
            ],
            [
                1311033600000,
                "Pfizer To Acquire Icagen",
                1.2562473916
            ],
            [
                1309996800000,
                "Pfizer To Explore Strategic Alternatives  For Its Animal Health And Nutrition  Businesses",
                -2.3810313149
            ],
            [
                1309910400000,
                "Pfizer To Explore Strategic Alternatives For Its Animal Health And Nutrition Businesses",
                -2.7186784171
            ],
            [
                1309824000000,
                "Positive Top-Line Results For Pfizer’s Lyrica In Phase 3 Study Of Patients With Fibromyalgia In Japan",
                0.4812349055
            ],
            [
                1309824000000,
                "A prototype Handheld Device that Analyses DNA to Predict How  Patients May Respond to their Prescription Medication has  Performed Well in a Preliminary Pilot Study, Researchers  Announce Today.",
                0.4812349055
            ],
            [
                1309824000000,
                "Cell Signaling Technology, Inc. Grants a Patent License  to Pfizer",
                0.4812349055
            ],
            [
                1309737600000,
                "Pfizer Affirms CHANTIX/CHAMPIX as Important Treatment Option for Smokers Wanting to Quit",
                0.4812349055
            ],
            [
                1309219200000,
                "Pfizer and ChemRar High Tech Center Announce Plans to Explore Innovative Medical Research and Development Partnership in Russia",
                2.4673060129
            ],
            [
                1309219200000,
                "Pfizer Nutrition Data Demonstrate that Appropriate Early Child Nutrition May Be Linked to Long-Term Health Outcomes in At-Risk Populations and Picky Eaters",
                2.4673060129
            ],
            [
                1309219200000,
                "Pfizer Invites Public To View And Listen To Webcast Of August 2 Conference Call With Analysts",
                2.4673060129
            ],
            [
                1309132800000,
                "Pfizer Files With The FDA For Review Of Axitinib For Patients With Advanced Renal Cell Carcinoma",
                2.1897989484
            ],
            [
                1309132800000,
                "Pfizer Announces Data Presentations For Investigational Compounds In Its Lung Cancer Portfolio",
                2.1897989484
            ],
            [
                1308787200000,
                "FDA Complete Response Letter Received for REMOXY",
                -4.183250551
            ],
            [
                1308787200000,
                "Pfizer Declares A 20-Cent Third-Quarter 2011 Dividend",
                -4.183250551
            ],
            [
                1308700800000,
                "ELIQUIS® (apixaban) Meets Primary and Key Secondary Endpoints in Phase 3 ARISTOTLE Study",
                1.4528013237
            ],
            [
                1308528000000,
                "Pfizer’s Lyrica Top-Line Results Positive In Global Phase 3 Study Of Central Neuropathic Pain Following Spinal Cord Injury",
                1.6642023915
            ],
            [
                1308441600000,
                "Pfizer and Acura Announce FDA Approval of Oxectatm (Oxycodone HCL, USP) CII",
                1.6642023915
            ],
            [
                1308096000000,
                "Pfizer Injectables Adds Doxorubicin Hydrochloride Injection, USP to Its Portfolio of Off-Patent Oncology Products",
                -0.790517331
            ],
            [
                1308009600000,
                "pSivida Announces Phase I/II Clinical Study Evaluating  Bioerodible, Sustained Release Latanoprost Device in Ocular  Hypertension and Glaucoma",
                -1.7830841177
            ],
            [
                1307577600000,
                "Lpath Granted 22nd Patent Related to Lipidomics-Based Drug  Development Program",
                -2.5857972179
            ],
            [
                1307491200000,
                "Pfizer Recognized By CIO Magazine As One Of The CIO 100 Award Honorees",
                -0.5783033553
            ],
            [
                1307491200000,
                "Boston’s Top Academic Medical Centers Join Pfizer’s Centers For Therapeutic Innovation",
                -0.5783033553
            ],
            [
                1307404800000,
                "Pfizer Launches “Migraines at Work” Web Site to Educate Employers and Workers about the Condition",
                -1.2572689639
            ],
            [
                1307404800000,
                "Pfizer Conducts First “Virtual” Clinical Trial Allowing Patients to Participate Regardless Of Geography",
                -1.2572689639
            ],
            [
                1307318400000,
                "Pfizer to Announce New Boston-Area Research Partnerships Wednesday, June 8, 2011 2:00 p.m.",
                -0.3857265475
            ],
            [
                1306972800000,
                "Pfizer and Hisun Sign MOU to Increase  Access to Quality and Low-Cost  Medicines for Patients in China",
                -0.9117065495
            ],
            [
                1306972800000,
                "Clovis Oncology, Inc. Receives License for Worldwide  Development and Commercialization Rights to Pfizer’s Oral  and IV PARP Inhibitor PF-01367338",
                -0.9117065495
            ],
            [
                1306886400000,
                "Pfizer and Hisun Sign MOU to Increase Access to Quality and Low-Cost Medicines for Patients in China",
                -1.6190492475
            ],
            [
                1306800000000,
                "Pfizer Files For European Regulatory Review Of Axitinib For Patients With Advanced Renal Cell Carcinoma",
                0.2375370114
            ],
            [
                1306800000000,
                "Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference",
                0.2375370114
            ],
            [
                1306800000000,
                "Pfizer Invites Public to View and Listen to Webcast of June 6 Pfizer Analyst and Investor Meeting at ASCO",
                0.2375370114
            ],
            [
                1306281600000,
                "Pfizer Announces New Strategic Partnerships With ICON And PAREXEL International Corporation",
                2.6315625422
            ],
            [
                1306195200000,
                "Data Presented at Two Global Medical Congresses Reinforce Benefit of Enbrel® (etanercept) for Patients with Chronic Inflammatory Conditions",
                1.347442937
            ],
            [
                1306195200000,
                "Pfizer Announces Detailed Results Of ORAL Sync Showing Investigational Compound Tofacitinib Reduces Signs And Symptoms And Improves Physical Function In Patients With Moderate-To-Severe Active Rheumatoid Arthritis, With Results Seen As Early As Two Weeks",
                1.347442937
            ],
            [
                1305936000000,
                "Adding Inspra® (eplerenone) To Standard Therapy Reduces The Incidence Of New Onset Atrial Fibrillation/Flutter (AF/F) In Patients With Systolic Heart Failure, Sub-Analysis Shows",
                0.1461855944
            ],
            [
                1305849600000,
                "SUTENT® Receives U.S. FDA Approval For Advanced Pancreatic Neuroendocrine Tumors",
                -1.8455374852
            ],
            [
                1305849600000,
                "ELIQUIS® (apixaban) Approved In Europe For Preventing Venous Thromboembolism After Elective Hip Or Knee Replacement",
                -1.8455374852
            ],
            [
                1305676800000,
                "Pfizer Presents New Phase 3 Data Showing Axitinib Significantly Extended Progression-Free Survival Compared With Sorafenib In Patients With Previously-Treated Advanced Renal Cell Carcinoma",
                -0.3804219982
            ],
            [
                1305504000000,
                "Pfizer Announces Simultaneous Filing Of New Drug Applications For Crizotinib With U.S. Food And Drug Administration And Japanese Ministry Of Health, Labour And Welfare",
                1.4191433679
            ],
            [
                1305417600000,
                "Pfizer To Present New Research From Fifteen Compounds Highlighting Multiple Approaches To Targeting Cancer At 2011 ASCO Annual Meeting",
                1.4191433679
            ],
            [
                1304985600000,
                "Pfizer Animal Health And American Humane Association Partner To Conduct Research On The Power Of The Human-Animal Bond In Pediatric Cancer Patients",
                0.574278071
            ],
            [
                1304985600000,
                "Foundation for the NIH Launches Trial to  Develop Diabetes Diagnostic Tools",
                0.574278071
            ],
            [
                1304985600000,
                "Cellzome to Study Epigenetic Factors  with Neusentis",
                0.574278071
            ],
            [
                1304899200000,
                "Alzheimer’s Association Salutes Advocate And Mountaineer Now Climbing Everest As Part Of The 7 Summits Climb For Alzheimer’s",
                1.5819866469
            ],
            [
                1304899200000,
                "Staphylococcus aureus Investigational Vaccine Elicits a Positive  Immune Response in Phase 1 Study",
                1.5819866469
            ],
            [
                1304812800000,
                "Pfizer’s Prevnar 13® Meets All Study Endpoints In Two Pivotal Phase 3 Trials In Adults Aged 50 And Older Presented Today",
                1.5819866469
            ],
            [
                1304467200000,
                "The European Commission Approves Pfizer’s Revatio® (sildenafil) for the Treatment of Pulmonary Arterial Hypertension in Children",
                -0.1961474306
            ],
            [
                1304467200000,
                "Oxford BioMedica Broadens 5T4  Antibody Collaboration With Pfizer",
                -0.1961474306
            ],
            [
                1304380800000,
                "PRISTIQ® (desvenlafaxine) Extended Release Tablets Shown To Significantly Reduce Number And Severity Of Moderate-To-Severe Hot Flashes Associated With Menopause",
                -1.598878637
            ],
            [
                1304294400000,
                "Pfizer Reports First-Quarter 2011 Results",
                -3.4246340483
            ],
            [
                1304294400000,
                "Pfizer Invites Public To View And Listen To Webcast Of Pfizer Presentation At Healthcare Conference",
                -3.4246340483
            ],
            [
                1304208000000,
                "Centrum® multivitamins and Celebrity Personal Trainer Harley Pasternak Share Star-Tested Secrets to Shape up for Summer",
                -3.4246340483
            ],
            [
                1303948800000,
                "Pfizer Hosts Annual Meeting of Shareholders",
                1.5259842348
            ],
            [
                1303862400000,
                "Pfizer Announces Top-Line Results Of Final Two Pivotal Phase 3 Trials Of Tofacitinib (CP-690,550) In Patients With Active Rheumatoid Arthritis",
                2.7364692823
            ],
            [
                1303776000000,
                "Pfizer Launches New Advanced GOLD Range Of Early Child Nutrition Products",
                2.2782001948
            ],
            [
                1303344000000,
                "Pfizer Comments on ORAL Sync Tofacitinib Data in EULAR Abstract LB0005",
                -1.6385176793
            ],
            [
                1303344000000,
                "Pfizer Invites Public To Listen To Webcast Of April 28 Annual Meeting Of Shareholders",
                -1.6385176793
            ],
            [
                1303257600000,
                "Pfizer and Shanghai Pharmaceutical Sign Memorandum of Understanding for Potential Strategic Partnership",
                -4.4972449465
            ],
            [
                1302739200000,
                "Pfizer Announces Top-Line Results Of Third Phase 3 Clinical Trial Of Tofacitinib (CP-690,550) In Patients With Active Rheumatoid Arthritis",
                0.43832998
            ],
            [
                1302566400000,
                "Tafamidis, An Oral, Investigational Compound For The Treatment Of Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP) Sustained A Slowing Of Disease Progression Over 30 Months",
                -0.6353910225
            ],
            [
                1302566400000,
                "FDA Advisory Committee Finds Data Support The Favorable Benefit-Risk Profile Of SUTENT® In Unresectable Pancreatic Neuroendocrine Tumors (NET)",
                -0.6353910225
            ],
            [
                1302393600000,
                "Pfizer and Medivation Announce Results from Phase 3 HORIZON Trial of Dimebon in Huntington Disease",
                -0.4398631278
            ],
            [
                1302134400000,
                "Zacharon Pharmaceuticals Announces Research and Development  Collaboration with Pfizer to Develop Drugs for Multiple Rare Disorders",
                0.8797711371
            ],
            [
                1301961600000,
                "Pfizer Invites Public To View And Listen To Webcast Of May 3 Conference Call With Analysts",
                -0.9857590431
            ],
            [
                1301875200000,
                "Rigel Assumes Development Responsibility",
                -0.4889952991
            ],
            [
                1301875200000,
                "Pfizer to Sell Capsugel to KKR",
                -0.4889952991
            ],
            [
                1301875200000,
                "Pfizer and Shanghai Pharmaceutical Sign  Memorandum of Understanding for  Potential Strategic Partnership",
                -0.4889952991
            ],
            [
                1301788800000,
                "Pfizer Receives Refusal To File Letter From U.S. FDA On Tafamidis New Drug Application",
                -0.4889952991
            ],
            [
                1301788800000,
                "Pfizer to Sell Capsugel to KKR",
                -0.4889952991
            ],
            [
                1301529600000,
                "Pfizer Oncology To Present Broad Array Of New Pre-Clinical And Clinical Data From Early And Late Stage Compounds",
                0.5397291236
            ],
            [
                1301529600000,
                "Pfizer Posts Details Of Interactions With U.S. Health Care Professionals And Researchers In 2010",
                0.5397291236
            ],
            [
                1301097600000,
                "Greenstone Announces Voluntary Nationwide Recall of Citalopram and Finasteride Due to Possible Mislabeling",
                -0.1962821104
            ],
            [
                1300924800000,
                "Pfizer Animal Health Continues to Invest in the Future of Veterinarians with Announcement of 2011 Veterinary Scholarship Recipients",
                1.7199032783
            ],
            [
                1300838400000,
                "SPIRIVA HandiHaler Prolonged Time To First COPD Exacerbation, New Study In NEJM Shows",
                2.06892511
            ],
            [
                1299628800000,
                "Pfizer Invites Public To View And Listen To Webcast Of Pfizer Presentation At Healthcare Conference",
                -1.2913146905
            ],
            [
                1299110400000,
                "Pfizer Announces Primary Endpoints Met In Second Phase 3 Clinical Trial Of Tofacitinib (CP-690,550) In Patients With Active Rheumatoid Arthritis",
                1.3733507809
            ],
            [
                1299110400000,
                "Charles River Announces Agreement To Supply Pfizer’s Genetically Modified Research Models",
                1.3733507809
            ],
            [
                1298937600000,
                "World-Class Professional Golfer Phil Mickelson Launches “On Course with Phil” for People with Certain Inflammatory Joint and Skin Conditions",
                -0.8337767679
            ],
            [
                1298937600000,
                "King Pharmaceuticals, Inc. Announces Final Results of Its Offer to Purchase Convertible Notes",
                -0.8337767679
            ],
            [
                1298851200000,
                "Pfizer Completes Acquisition Of King Pharmaceuticals, Inc.",
                0.9926720262
            ],
            [
                1298851200000,
                "Pfizer Announces Updated, Interactive Development Pipeline",
                0.9926720262
            ],
            [
                1298851200000,
                "XIAPEX® (Collagenase Clostridium Histolyticum) Authorized in the European Union (EU) For Dupuytren’s Contracture",
                0.9926720262
            ],
            [
                1298419200000,
                "NH Citizens Health Initiative to Premiere Mini-Documentaries on NH Multi-Stakeholder Patient Centered Medical Home Pilot",
                0.6348918748
            ],
            [
                1298332800000,
                "U.S. Supreme Court Decision In Bruesewitz V. Wyeth A Win For Public Health",
                -0.6396694004
            ],
            [
                1297296000000,
                "New AVERROES Data Demonstrate Investigational Apixaban Superior to Aspirin in Reducing Stroke and Systemic Embolism in Patients with Atrial Fibrillation Unsuitable for Warfarin Therapy",
                -0.9558936175
            ],
            [
                1296950400000,
                "Pfizer To Acquire Ferrosan’s Consumer Healthcare Business",
                -0.5741158803
            ],
            [
                1296691200000,
                "Enbrel® (etanercept) Significantly Improved Scalp Involvement in Patients with Moderate to Severe Plaque Psoriasis",
                2.2798088769
            ],
            [
                1296691200000,
                "New Co-Promotion Agreements For Rheumatoid Arthritis Products In Japan",
                2.2798088769
            ],
            [
                1296604800000,
                "National Family Caregivers Association Supports Advocate in His Mission to Raise Awareness of the Burden of Alzheimer’s Disease",
                0.4173492986
            ],
            [
                1296432000000,
                "Pfizer Announces New $5 Billion Share Repurchase Program",
                5.3590230251
            ],
            [
                1296432000000,
                "Pfizer Reports Fourth-Quarter and Full-Year 2010 Results; Provides 2011 Financial Guidance and Updates 2012 Financial Targets",
                5.3590230251
            ],
            [
                1296432000000,
                "Pfizer Completes Tender Offer For Shares Of King Pharmaceuticals, Inc.",
                5.3590230251
            ],
            [
                1296345600000,
                "Dr. Yvonne Greenstreet Joins Pfizer As Senior Vice President And Head Of Medicines Development, Specialty Care Business Unit",
                5.3590230251
            ],
            [
                1296086400000,
                "Pfizer Chief Medical Officer Freda Lewis-Hall Named 2011 Woman Of The Year",
                -1.2121574241
            ],
            [
                1296086400000,
                "Pfizer Announces HSR Clearance for the Acquisition of King Pharmaceuticals",
                -1.2121574241
            ],
            [
                1295913600000,
                "Pfizer Inc and Progenics Alert Physicians and Patients to Information Related to Triad Group Alcohol Prep Products Included In U.S. RELISTOR Kit Packaging",
                -1.3616536812
            ],
            [
                1295827200000,
                "Pfizer Announces Seven Of New York City’s Top Research Hospitals Join Global Centers For Therapeutic Innovation",
                0.757979915
            ],
            [
                1295481600000,
                "Pfizer Extends Tender Offer to Acquire King Pharmaceuticals, Inc. to January 28, 2011",
                0.2178454756
            ],
            [
                1295481600000,
                "Pfizer Inc. UK Regulatory Announcement: Pfizer Extends Tender Offer to Acquire King Pharmaceuticals, Inc. to January 28, 2011",
                0.2178454756
            ],
            [
                1294704000000,
                "Pfizer Initiates Rolling Submission For A New Drug Application In The U.S. For Its Fast-Tracked Investigational Compound Crizotinib (PF-02341066) For Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer",
                1.0343105913
            ],
            [
                1294704000000,
                "Pfizer Inc. UK Regulatory Announcement: Pfizer Initiates Rolling Submission For A New Drug Application In The U.S. For Its Fast-Tracked Investigational Compound Crizotinib (PF-02341066) For Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer",
                1.0343105913
            ],
            [
                1294099200000,
                "Pfizer Invites Public to View and Listen to Webcast of February 1 Conference Call with Analysts",
                1.7669993748
            ],
            [
                1294099200000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference",
                1.7669993748
            ],
            [
                1294012800000,
                "Pfizer Animal Health Completes Acquisition of Synbiotics Corporation",
                1.6120006723
            ],
            [
                1292371200000,
                "Pfizer Extends Tender Offer To Acquire King Pharmaceuticals, Inc.",
                0.9871885881
            ],
            [
                1292198400000,
                "Pfizer Declares A 20-Cent First-Quarter 2011 Dividend",
                -0.2922278016
            ],
            [
                1292198400000,
                "Pfizer Board of Directors Elects George A. Lorch Non-Executive Chairman",
                -0.2922278016
            ],
            [
                1292025600000,
                "Young Children In Developing World Receive Accelerated Access to Pfizer's Prevenar 13 Vaccine",
                -0.2922278016
            ],
            [
                1291852800000,
                "Pfizer Stops Clinical Trials of Thelin® and Initiates Voluntary Product Withdrawal in the Interest of Patient Safety",
                1.4101244078
            ],
            [
                1291593600000,
                "Angie Harmon and Children's Advil® Invite Families to Sing Away the Cold and Flu Season Blues",
                0.4174294609
            ],
            [
                1291507200000,
                "National Initiative Urges 10 Million At-Risk Boomers to 'Face Alzheimer's'",
                0.4174294609
            ],
            [
                1291507200000,
                "Pfizer Announces Phase 3 Results of Investigational Compound Bosutinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia",
                0.4174294609
            ],
            [
                1291507200000,
                "Pfizer Board of Directors Names Ian C. Read President and Chief Executive Officer",
                0.4174294609
            ],
            [
                1291334400000,
                "Pfizer Plans Regulatory Submissions of Bosutinib in Chronic Myeloid Leukemia",
                0.5353876808
            ],
            [
                1291161600000,
                "AVERROES Study of Investigational Agent Apixaban Closes Early Due to Clear Evidence of Efficacy",
                1.1983283701
            ],
            [
                1291161600000,
                "Centrum® and Molly Shannon Search for 'America's Most Amazingly Energized Woman' This Holiday Season",
                1.1983283701
            ],
            [
                1291161600000,
                "SUTENT® Receives European Approval for a New Indication in Progressive Pancreatic Neuroendocrine Tumors (NET)",
                1.1983283701
            ],
            [
                1290988800000,
                "Caltrate® Soft Chews Offer A New and Delicious Way to Help Americans Reach Their Recommended Daily Calcium and Vitamin D Intake",
                -0.6748435313
            ],
            [
                1290902400000,
                "Pfizer to Present Data from Its Hematology Portfolio at the 52nd Annual Meeting of the American Society of Hematology",
                -0.6748435313
            ],
            [
                1290902400000,
                "Pfizer and Protalix BioTherapeutics Announce Submission of taliglucerase alfa for European Marketing Authorization for the Treatment of Gaucher Disease",
                -0.6748435313
            ],
            [
                1290297600000,
                "Pfizer Extends Tender Offer to Acquire King Pharmaceuticals, Inc.",
                -0.5431348279
            ],
            [
                1290038400000,
                "Pfizer Announces Positive Phase 3 Trial Results for Axitinib in Patients With Previously-Treated Metastatic Renal Cell Carcinoma (mRCC)",
                1.4880451914
            ],
            [
                1290038400000,
                "APPRAISE-2 Study with Investigational Compound Apixaban in Acute Coronary Syndrome Discontinued",
                1.4880451914
            ],
            [
                1289865600000,
                "Pfizer Launches Global Centers for Therapeutic Innovation, a Network of Research Partnerships, With University of California, San Francisco",
                -0.8495477229
            ],
            [
                1289779200000,
                "Pfizer Launches New Advil® Congestion Relief and Offers 100 Holiday Shoppers Literal Decongestion From Black Friday Crowds",
                -2.2288708867
            ],
            [
                1289606400000,
                "Adding INSPRA® (eplerenone) to Standard Therapy Significantly Reduces the Risk of CV Mortality and Morbidity in Patients With Chronic Heart Failure With Mild Symptoms, Study Shows",
                -2.2288708867
            ],
            [
                1289260800000,
                "Lower Protein in Infant Formula Supports Growth Rate Similar to Breast Milk, New Study Shows",
                -1.4259824108
            ],
            [
                1289174400000,
                "Alpine Mountaineer and Alzheimer's Advocate to Climb Highest Peak on Each Continent to Raise Awareness of Growing Prevalence and Burden of Alzheimer's Disease",
                -0.4120016869
            ],
            [
                1289088000000,
                "In First Phase 3 Trial, Tasocitinib (CP-690,550), an Oral JAK Inhibitor, Administered as Monotherapy, Reduces Signs and Symptoms of Active Rheumatoid Arthritis and Improves Physical Function",
                -0.4120016869
            ],
            [
                1288742400000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference",
                0.282998473
            ],
            [
                1288569600000,
                "Pfizer Reports Third-Quarter 2010 Results",
                -1.031531917
            ],
            [
                1288224000000,
                "Pfizer's Lyrica® (Pregabalin) Capsules CV Receives Approval for Treatment of Peripheral Neuropathic Pain In Japan",
                0.057420326
            ],
            [
                1288224000000,
                "Pfizer Declares an 18-Cent Fourth-Quarter 2010 Dividend",
                0.057420326
            ],
            [
                1288137600000,
                "Results From an Expanded Cohort Phase 1 Study Published in the New England Journal of Medicine Demonstrate a Majority of Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer Responded to Crizotinib (PF-02341066)",
                0.9675609154
            ],
            [
                1287619200000,
                "Pfizer Commences Tender Offer for All Outstanding Shares of King Pharmaceuticals, Inc.",
                -0.74282151
            ],
            [
                1287532800000,
                "New Phase 4 Study Shows Higher Rates of Clinical and Microbiological Success for Zyvox Versus Vancomycin in MRSA Nosocomial Pneumonia",
                0.9642361452
            ],
            [
                1287446400000,
                "Pfizer Enters Into Agreement to Acquire 40 Percent Stake in Teuto in Brazil",
                0.0566145362
            ],
            [
                1287273600000,
                "Biocon and Pfizer Enter Into Global Commercialization Agreement",
                -1.9551553384
            ],
            [
                1286928000000,
                "Alzheimer's Disease Caregivers Identify Memory Loss, Personal Safety and Confusion as Top Three Concerns Related to Progression of Their Loved One's Disease",
                0.3963651432
            ],
            [
                1286755200000,
                "Pfizer to Acquire King Pharmaceuticals, Inc.",
                0.1144028653
            ],
            [
                1286323200000,
                "Pfizer Oncology To Present New Clinical Data Across Ten Tumor Types and Multiple Molecular Targets",
                0.8055212407
            ],
            [
                1286323200000,
                "Oral Tasocitinib Demonstrates Statistically Significant Response by 12 Weeks in Phase 2 Study of People With Moderate to Severe Plaque Psoriasis",
                0.8055212407
            ],
            [
                1281312000000,
                "Pfizer Receives FDA Approval for Prefilled Dual-Chamber Syringe for Use in the Treatment of Hemophilia A",
                1.6897814934
            ],
            [
                1280707200000,
                "Pfizer Reports Second-Quarter 2010 Results",
                7.2215625193
            ],
            [
                1280361600000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference",
                -1.1999900552
            ],
            [
                1279756800000,
                "Eisai Inc. and Pfizer Inc Announce U.S. FDA Approval for New Higher-Dose Aricept® (donepezil HCl) 23 mg Tablet for the Treatment of Moderate-to-Severe Alzheimer’s Disease",
                -0.2057116911
            ],
            [
                1279670400000,
                "Pfizer To Offer Free Public Access To Mental Health Assessment Tools To Improve Diagnosis And Patient Care",
                1.7555459102
            ],
            [
                1279411200000,
                "Pfizer Suspends Chronic Pain Studies In Tanezumab Clinical Trial Program; Some Studies Continue In Areas Of Unmet Medical Need",
                -0.4810765948
            ],
            [
                1278979200000,
                "Pfizer And SMC Collaborate On Liver Cancer",
                -1.0782125282
            ],
            [
                1278892800000,
                "New Research Presented At Alzheimer’s Association International Conference On Alzheimer's Disease Indicates Alzheimer’s Disease May Lead To Increased Comorbid Conditions And Economic Burden",
                0.4056997664
            ],
            [
                1278460800000,
                "Pfizer To Present More Than 40 Abstracts On Pre-Clinical, Clinical And Outcomes Research At Alzheimer's Association International Conference On Alzheimer’s Disease",
                3.4412620462
            ],
            [
                1278374400000,
                "Pfizer Strengthens Manufacturing Capabilities In Asia With Expansion Of Singapore Nutrition Plant",
                1.9835951313
            ],
            [
                1278288000000,
                "Pfizer Announces European Union Approval Of A New Form Of Lipitor (atorvastatin) For Use In Children",
                1.9835951313
            ],
            [
                1277683200000,
                "Pfizer Invites Public To View And Listen To Webcast Of August 3 Conference Call With Analysts",
                -2.8711668377
            ],
            [
                1277251200000,
                "Pfizer Declares An 18-Cent Third-Quarter 2010 Dividend",
                -3.5961535127
            ],
            [
                1277164800000,
                "Pfizer Suspends Tanezumab Osteoarthritis Clinical Trial Program",
                -1.8145220951
            ],
            [
                1276992000000,
                "Pfizer Enters Into Agreement With Ergonex Pharma To Acquire Investigational Treatment For Pulmonary Arterial Hypertension",
                -2.605246288
            ],
            [
                1276992000000,
                "Caduet Reduces 10-Year Calculated Risk Of Coronary Heart Disease, Fatal Cardiovascular Disease",
                -2.605246288
            ],
            [
                1276646400000,
                "New CELEBREX® (celecoxib) Study Using Novel Endpoint, Published By The Lancet, Contributes to Knowledge Of NSAID-Associated Gastrointestinal Adverse Events",
                0.3231909397
            ],
            [
                1275868800000,
                "Pfizer Invites Public To View And Listen To Webcast Of Pfizer Presentation At Healthcare Conference",
                -1.9931256463
            ],
            [
                1275609600000,
                "Phase 3 Study Showed MACUGEN® Improved Vision Over Standard Of Care In Patients With Diabetic Macular Edema",
                -3.3746584189
            ],
            [
                1275350400000,
                "Pfizer And Epocrates Partner To Give Healthcare Providers Access To Medical Information Specialists For Medication Questions",
                0.2631731041
            ],
            [
                1274832000000,
                "Pfizer Announces EMPHASIS-HF Trial To Halt Recruitment Due To Significant Benefit Observed In Patients Treated With Inspra® (Eplerenone)",
                1.6915822494
            ],
            [
                1274745600000,
                "Pfizer Appoints Mikael Dolsten President Of Worldwide Research And Development",
                1.0588981716
            ],
            [
                1274659200000,
                "Pfizer Animal Health Expands Global Commitment To A Safe Food Supply With A New Focus On Healthy Fish",
                -1.4608033942
            ],
            [
                1274227200000,
                "Pfizer Oncology To Present New Clinical Data From Ten Molecules Across Multiple Tumor Types",
                -3.4143392585
            ],
            [
                1274140800000,
                "Pfizer Invites Public To View And Listen To Webcast Of Pfizer Presentation At Healthcare Conference",
                -2.0227436052
            ],
            [
                1274140800000,
                "Pfizer Global Manufacturing Announces Plans To Reconfigure Its Global Plant Network",
                -2.0227436052
            ],
            [
                1274054400000,
                "Pfizer, Washington University Announce Groundbreaking Collaboration",
                -2.4667525199
            ],
            [
                1273017600000,
                "Pfizer Animal Health Announces First Recipients of New $2 Million Veterinary Scholarship Program",
                -1.3739750181
            ],
            [
                1272844800000,
                "Pfizer Reports First-Quarter 2010 Results; Reaffirms 2010 Financial Guidance",
                2.6651541015
            ],
            [
                1271980800000,
                "World Bank And Pfizer Announce Initiative To Help Improve Healthcare Delivery In Developing Countries",
                2.318676838
            ],
            [
                1271894400000,
                "Pfizer And Medicines For Malaria Venture Seek To Expand Fight Against Malaria With Intermittent Preventive Treatment Option For Pregnant Women",
                2.4246106029
            ],
            [
                1271894400000,
                "Pfizer Discontinues Phase 3 Trial of Sutent® in Advanced Hepatocellular Carcinoma",
                2.4246106029
            ],
            [
                1271894400000,
                "Pfizer Hosts Annual Meeting Of Shareholders; Declares 18-Cent Second-Quarter 2010 Dividend",
                2.4246106029
            ],
            [
                1271289600000,
                "Pfizer Invites Public To Listen To Webcast Of April 22 Annual Meeting Of Shareholders",
                -1.4880887555
            ],
            [
                1271289600000,
                "Stemgent and Pfizer Announce Collaboration",
                -1.4880887555
            ],
            [
                1271116800000,
                "Pfizer Oncology To Present Over 30 Abstracts On Pre-Clinical And Clinical Research At The American Association For Cancer Research Annual Meeting",
                -0.820196533
            ],
            [
                1270080000000,
                "Pfizer And Acacia Living Partner To Support Seniors In Living Independently",
                -1.8342821116
            ],
            [
                1269993600000,
                "Pfizer Posts Details About Interactions With U.S. Physicians, Other Healthcare Professionals And Clinical Research Partners",
                -0.5854648863
            ],
            [
                1269820800000,
                "Pfizer Invites Public to View and Listen to Webcast of May 4 Conference Call with Analysts",
                0.3476263086
            ],
            [
                1269302400000,
                "Pfizer Signs Long-Term Agreement To Supply Prevenar 13* To The World’s Poorest Countries",
                1.8739433995
            ],
            [
                1269216000000,
                "Pfizer Animal Health Encourages Pet Owners to Consult Their Veterinarian for Safe, Effective Flea-and-Tick Control Recommendations",
                3.0787046053
            ],
            [
                1268697600000,
                "Study Shows Prevenar 13* Is Immunogenic In Young Children Previously Vaccinated With Prevenar*",
                -0.6391918858
            ],
            [
                1268611200000,
                "Intensive Lipitor Therapy Was Associated With Reduced Risk Of Cardiovascular Events In Two High-Risk Patient Groups",
                1.3325585467
            ],
            [
                1268265600000,
                "Pfizer Discontinues A Phase 3 Study Of Figitumumab In Previously Treated Patients With Advanced Non-Small Cell Lung Cancer",
                -0.2341823374
            ],
            [
                1268265600000,
                "Two Phase 3 Trials Of Sunitinib With Commonly Used Chemotherapies In Advanced Breast Cancer Did Not Meet The Primary Endpoint",
                -0.2341823374
            ],
            [
                1267660800000,
                "ADVANCE-2 Study Results Demonstrate Investigational Anticoagulant Apixaban Was Statistically Superior To Enoxaparin In The Prevention Of Venous Thromboembolism Following Knee Replacement Surgery",
                0.7436799713
            ],
            [
                1267574400000,
                "“Project Runway’s” Tim Gunn Returns to Address Psoriasis™ and Empower Patients to be Confident in Their Personal Style",
                -0.6924226536
            ],
            [
                1267488000000,
                "Pfizer And Medivation Announce Results From Two Phase 3 Studies In Dimebon (latrepirdine*) Alzheimer’s Disease Clinical Development Program",
                -3.1755037863
            ],
            [
                1267401600000,
                "Pfizer Invites Public To View And Listen To Webcast Of Investor Breakfast At Healthcare Conference",
                -0.0568695227
            ],
            [
                1267056000000,
                "William Ringo, Pfizer’s Senior Vice President, Worldwide Business Development, Strategy And Innovation, To Retire",
                -0.1139267204
            ],
            [
                1266969600000,
                "CDC’s Advisory Committee On Immunization Practices Recommends Pfizer’s Prevnar 13™ Vaccine For The Prevention Of Invasive Pneumococcal Disease In Infants And Young Children In The U.S.",
                -0.2826599569
            ],
            [
                1266969600000,
                "Pfizer Receives FDA Approval for Prevnar 13™ for the Prevention of Invasive Pneumococcal Disease in Infants and Young Children",
                -0.2826599569
            ],
            [
                1266883200000,
                "Lilly, Merck, And Pfizer Join Forces To Accelerate Research And Improve Treatment Of Lung And Gastric Cancers In Asia",
                -0.1684188843
            ],
            [
                1265500800000,
                "Pfizer and Keas Partner to Help Consumers Take a More Active Role in Their Health and Wellness",
                -0.1678207071
            ],
            [
                1265241600000,
                "QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients",
                -2.171486773
            ],
            [
                1265068800000,
                "Pfizer Reports Fourth-Quarter and Full-Year 2009 Results; Provides 2010 Financial Guidance and 2012 Financial Targets",
                -0.3945280958
            ],
            [
                1264550400000,
                "New Pfizer Pipeline Shows Progress And Growth In Vaccines, Biologics And High-Priority Disease Areas",
                -0.8051404153
            ],
            [
                1264032000000,
                "Data Show Progression-Free Survival Advantage With Sutent® In Patients With Pancreatic Neuroendocrine Tumors",
                -5.6962053002
            ],
            [
                1263945600000,
                "Pfizer and Auxilium Announce Commencement of European Regulatory Review of XIAFLEXTM for the Treatment of Dupuytren’s Contracture",
                -4.2099575097
            ],
            [
                1262736000000,
                "Pfizer And Debiopharm Collaborate To Co-Develop Investigational Compound Tremelimumab (CP-675,206) In Advanced Melanoma",
                -0.7015686921
            ],
            [
                1262649600000,
                "Pfizer and Strides Arcolab to Collaborate on Generic Products",
                -1.7204385078
            ],
            [
                1262563200000,
                "Pfizer Invites Public To View And Listen To Webcast Of Pfizer Presentation At Healthcare Conference",
                2.0900534068
            ],
            [
                1262563200000,
                "Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Healthcare Conference",
                2.0900534068
            ],
            [
                1262563200000,
                "European Commission Approves New Intravenous Formulation Of Pfizer’s Revatio® (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension",
                2.0900534068
            ],
            [
                1262131200000,
                "Pfizer Provides U.S. Regulatory Update On Prevnar 13™ Vaccine",
                -1.5942862246
            ],
            [
                1262044800000,
                "Pfizer Discontinues A Phase 3 Trial Of Figitumumab In Non-Small Cell Lung Cancer (NSCLC) For Futility",
                -0.5945548982
            ],
            [
                1261526400000,
                "Pfizer’s Lyrica Receives Complete Response Letter From FDA For Generalized Anxiety Disorder Monotherapy Treatment",
                -0.8601991093
            ],
            [
                1261440000000,
                "Pfizer Invites Public to View and Listen to Webcast of February 3 Conference Call with Analysts",
                -1.1841030665
            ],
            [
                1261094400000,
                "Despite Stresses of Today, Survey Finds Women and Men Set Health and Wellness Goals – But Sex Often Influences Success",
                1.3971260489
            ],
            [
                1261008000000,
                "FDA Approves SPIRIVA® HandiHaler® for the Reduction of COPD Exacerbations",
                -0.4371465726
            ],
            [
                1260921600000,
                "Toviaz 8 Mg Was More Effective Than Detrol LA In Treating Urge Urinary Incontinence In Patients With Overactive Bladder",
                -0.8232887045
            ],
            [
                1260748800000,
                "Takeda and Pfizer to Co-Promote Takeda’s Actos® (Pioglitazone HCl) for the Treatment of Type 2 Diabetes in China",
                -0.9841447731
            ],
            [
                1260748800000,
                "Pfizer Declares an 18-Cent First-Quarter 2010 Dividend",
                -0.9841447731
            ],
            [
                1260748800000,
                "New pH1N1 Vaccine Available for Swine",
                -0.9841447731
            ],
            [
                1260576000000,
                "Pfizer Inc. Affirms Confidence In Its Hormone Therapy Medicines As Important Treatment Options",
                -0.9841447731
            ],
            [
                1260576000000,
                "Pfizer Announces Neratinib Data In HER2 Positive Breast Cancer",
                -0.9841447731
            ],
            [
                1260403200000,
                "Prevenar 13 to provide the broadest coverage of any pneumococcal conjugate vaccine for infants and young children",
                -0.9289611189
            ],
            [
                1260403200000,
                "Adele Gulfo joins Pfizer as U.S. President, Primary Care",
                -0.9289611189
            ],
            [
                1260403200000,
                "Pfizer Extends Commitment to Help Unemployed Americans",
                -0.9289611189
            ],
            [
                1260316800000,
                "Pfizer Announces Updated Trial Results for AROMASIN® (exemestane tablets) In Switch And Upfront Settings",
                1.5830079092
            ],
            [
                1260230400000,
                "Physicians More Likely To Report Drug Safety Information Through Electronic Health Records System",
                1.0416094635
            ],
            [
                1260230400000,
                "CORRECTING and REPLACING Pfizer And Crown Bioscience Announce A Collaboration To Research And Develop New Treatments For Asian Cancers",
                1.0416094635
            ],
            [
                1259798400000,
                "Pfizer To Present Clinical Data From Expanded Breast Cancer Portfolio At The San Antonio Breast Cancer Symposium",
                -1.8388206413
            ],
            [
                1259539200000,
                "Pfizer And Protalix Enter Into Agreement To Develop And Commercialize Gaucher’s Disease Treatment",
                2.8647126755
            ],
            [
                1258588800000,
                "Pfizer Receives FDA Approval For Geodon® (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults",
                1.5795442352
            ],
            [
                1258588800000,
                "FDA Approves Intravenous Formulation Of Pfizer’s Revatio® (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension",
                1.5795442352
            ],
            [
                1258588800000,
                "FDA Advisory Committee Finds Data Support the Claim That SPIRIVA® HandiHaler® Reduces COPD Exacerbations",
                1.5795442352
            ],
            [
                1258502400000,
                "Pfizer Encourages Families To Bring Their Dogs To This Year’s Holiday Celebration",
                0.9939355059
            ],
            [
                1258502400000,
                "FDA Advisory Committee Finds Data Support the Safety and Effectiveness of Prevnar 13™ Vaccine for the Prevention of Invasive Pneumococcal Disease in Infants and Young Children",
                0.9939355059
            ],
            [
                1258416000000,
                "Pfizer and DNDi Advancing International Research Efforts In The Fight Against Neglected Tropical Diseases",
                1.869188178
            ],
            [
                1258416000000,
                "Pfizer Submits New Pediatric Data For Lipitor® (Atorvastatin) To The European Medicines Agency (EMEA)",
                1.869188178
            ],
            [
                1257638400000,
                "Pfizer Announces Global Research Network",
                2.619562751
            ],
            [
                1257292800000,
                "Significantly More Smokers With Mild-To-Moderate COPD Quit Smoking Using CHANTIX/CHAMPIX® (Varenicline) Compared With Placebo",
                0.5287794296
            ],
            [
                1257120000000,
                "Pfizer And Medivation Initiate Two Phase 3 Trials Of Dimebon In Patients With Moderate-To-Severe Alzheimer’s Disease",
                -0.9472911987
            ],
            [
                1256774400000,
                "Pfizer Completes Consent Solicitation",
                -1.2331425085
            ],
            [
                1256774400000,
                "Pfizer’s Board Of Directors Approves Shareholder Advisory Vote On Executive Compensation",
                -1.2331425085
            ],
            [
                1256169600000,
                "Pfizer Declares a 16-Cent Fourth-Quarter 2009 Dividend",
                -0.7536278929
            ],
            [
                1255910400000,
                "Pfizer Reports Third-Quarter 2009 Results",
                1.561627272
            ],
            [
                1255910400000,
                "New Pfizer Animal Health is Unveiled with Acquisition of Wyeth",
                1.561627272
            ],
            [
                1255737600000,
                "CP-690,550, Pfizer’s Oral JAK Inhibitor, Demonstrates Response Both Alone And In Combination With Methotrexate At 24 Weeks In Patients With Active Rheumatoid Arthritis",
                1.561627272
            ],
            [
                1255564800000,
                "Pfizer Commences Consent Solicitation for Amendments to Wyeth Indenture",
                2.2509994897
            ],
            [
                1255564800000,
                "Pfizer And Wyeth Become One: Working Together For A Healthier World™",
                2.2509994897
            ],
            [
                1255478400000,
                "Pfizer Completes Acquisition Of Wyeth",
                4.4733785153
            ],
            [
                1255392000000,
                "Pfizer Receives Clearance From The U.S. Federal Trade Commission And The Canadian Competition Bureau For Wyeth Acquisition",
                2.7634033641
            ],
            [
                1255392000000,
                "Pfizer Announces Settlement And License Agreement With Mylan Related To Vfend®",
                2.7634033641
            ],
            [
                1254960000000,
                "FDA Advisory Committee Recommends Approval of Pfizer’s Selzentry for Use in Patients Starting HIV Therapy for the First Time",
                7.0781e-06
            ],
            [
                1254182400000,
                "Pfizer Receives Approval From Australian Competition And Consumer Commission (ACCC) For Pending Acquisition Of Wyeth",
                -0.1208723179
            ],
            [
                1254096000000,
                "Pfizer Receives Approval from China’s Ministry of Commerce for Pending Wyeth Acquisition",
                1.9678295893
            ],
            [
                1254096000000,
                "Frances D. Fergusson And John P. Mascotte Elected To Pfizer’s Board Of Directors",
                1.9678295893
            ],
            [
                1253750400000,
                "Pfizer and Eisai Continue Aricept Collaboration",
                -0.2439066424
            ],
            [
                1253664000000,
                "Pfizer Launches Phase 3 Clinical Trial With Novel Alk Inhibitor In Non-Small Cell Lung Cancer Patients With Specific Gene Mutation",
                -2.554761473
            ],
            [
                1253664000000,
                "New Survey of People with Diabetic Nerve Pain Shows the Condition Significantly Impacts Daily Activities Such as Exercise and Sleep Yet Often Goes Untreated",
                -2.554761473
            ],
            [
                1253491200000,
                "Pfizer Again Named To Working Mother 100 Best Companies List",
                1.5475979105
            ],
            [
                1253491200000,
                "Survival Benefit Maintained in Long Term Follow-up of IES with Pfizer’s AROMASIN® (Exemestane Tablets)",
                1.5475979105
            ],
            [
                1253491200000,
                "Pfizer and Wyeth to Divest Certain Animal Health Assets to Boehringer Ingelheim",
                1.5475979105
            ],
            [
                1253491200000,
                "Pfizer Commended For Leadership In Addressing Climate Change For Third Consecutive Year",
                1.5475979105
            ],
            [
                1253232000000,
                "Pfizer To Present Research On Established Therapies And New Approaches To Cancer Treatment Using Investigational Agents",
                1.0216347552
            ],
            [
                1251763200000,
                "Pfizer Concludes Previously Disclosed Settlement Agreement With U.S. Department Of Justice Regarding Past Promotional Practices",
                -1.5970593019
            ],
            [
                1251676800000,
                "Heading Back to School: Veterinarians Combine Stethoscopes with Microscopes",
                -1.5262087606
            ],
            [
                1251676800000,
                "Novel Biomarkers, Including CRP, Did Not Predict Risk Of Cardiovascular Events In Patients With Heart Disease Who Were Treated With A Statin",
                -1.5262087606
            ],
            [
                1251158400000,
                "Pfizer Inc Sponsors 7th Biennial U.S.–Africa Business Summit",
                -0.119229928
            ],
            [
                1250899200000,
                "For Sixth Consecutive Year, Pfizer Earns Highest Score In Human Rights Campaign Foundation LGBT Ranking",
                0.4166665437
            ],
            [
                1250553600000,
                "Pfizer And Private Access Announce Plans To Develop Online Community To Accelerate Clinical Research",
                2.9932509784
            ],
            [
                1249430400000,
                "President Clinton, Pfizer, and Mylan Announce New Agreements to Lower Prices of Medicines for Patients with Drug-Resistant HIV in Developing Countries",
                -1.2032812502
            ],
            [
                1248825600000,
                "Pfizer, Kano State Reach Settlement Of Trovan Cases",
                -0.3764599151
            ],
            [
                1248825600000,
                "Pfizer And Medivation Initiate Phase 3 Trial Of Dimebon In Patients With Huntington Disease",
                -0.3764599151
            ],
            [
                1248739200000,
                "Pfizer and Fudan University Announce Joint Graduate Program in Clinical Research",
                -4.6983806407
            ],
            [
                1248739200000,
                "Pfizer Announces Partnership With Shanghai Institutes For Biological Sciences For Drug Discovery Activities",
                -4.6983806407
            ],
            [
                1248134400000,
                "Pfizer Reports Second-Quarter 2009 Results; Increases Full-Year 2009 Adjusted Diluted EPS(1) Guidance",
                2.8355235797
            ],
            [
                1248048000000,
                "96-Week MERIT ES Analysis Shows Efficacy Of Pfizer’s HIV/AIDS Treatment Celsentri/Selzentry (Maraviroc) In Treatment-Naïve HIV Patients; Results Consistent With 48-Week Analysis",
                4.2674826785
            ],
            [
                1247788800000,
                "Pfizer Receives Approval From European Commission For Pending Acquisition Of Wyeth",
                1.1795653177
            ],
            [
                1247529600000,
                "Pfizer Announces New Phase 1 Data From Two Novel Compounds For Alzheimer’s Disease At ICAD Annual Meeting",
                2.396827607
            ],
            [
                1247097600000,
                "Pfizer To Appeal Canadian Federal Court Decision On Company’s Norvasc® Patent",
                -2.9577460592
            ],
            [
                1246406400000,
                "Graceway Pharmaceuticals Acquires Early-stage Dermatological Molecules from Pfizer",
                -3.3839662483
            ],
            [
                1246406400000,
                "Pfizer Invites Public to Listen to Teleconference on Important Update Related to Chantix ® (varenicline)",
                -3.3839662483
            ],
            [
                1246320000000,
                "Pfizer Discontinues Phase 3 Trial of Sutent® in Metastatic Colorectal Cancer",
                -2.4832579293
            ],
            [
                1245888000000,
                "Pfizer Declares a 16-Cent Third-Quarter 2009 Dividend",
                3.6208094303
            ],
            [
                1245801600000,
                "Sutent Significantly Improved Progression-Free Survival for Patients with Advanced Pancreatic Islet Cell Tumors",
                3.3920588376
            ],
            [
                1245196800000,
                "Pfizer Invites Public to View and Listen to Webcast of July 22 Conference Call with Analysts",
                4.6246127431
            ],
            [
                1245196800000,
                "Pfizer Registration Statement Relating To Pending Wyeth Acquisition Declared Effective By SEC",
                4.6246127431
            ],
            [
                1244592000000,
                "Pfizer’s Oral JAK-3 Inhibitor Demonstrates Statistically Significant Response For Patients with Rheumatoid Arthritis, New Phase 2 Studies Show",
                3.417617306
            ],
            [
                1243900800000,
                "Pfizer Announces Completion Of European Debt Offering",
                -0.6044643491
            ],
            [
                1243900800000,
                "FDA Approves First Canine Cancer Therapy",
                -0.6044643491
            ],
            [
                1243814400000,
                "Pfizer Introduces New Treatment And Support Plan For Patients With Overactive Bladder",
                -2.5366968685
            ],
            [
                1243814400000,
                "Pfizer Discontinues SUN 1094 Trial of Sunitinib plus Paclitaxel in Advanced Breast Cancer",
                -2.5366968685
            ],
            [
                1243641600000,
                "Pfizer Data Identify Certain Lung Cancer Patients Who May Benefit from Treatment with Figitumumab",
                -2.5366968685
            ],
            [
                1243555200000,
                "Pfizer Presents Data With Novel Investigational Agents In Select Patient Groups With Non-Small Cell Lung Cancer",
                -0.2710138217
            ],
            [
                1243555200000,
                "New Pfizer Data Helps to Identify Kidney Cancer Patients Who May Be Most Likely to Benefit from Treatment",
                -0.2710138217
            ],
            [
                1243555200000,
                "Pfizer Invites Public to View and Listen to Webcast of June 12 Conference Call with Analysts at EULAR",
                -0.2710138217
            ],
            [
                1243382400000,
                "Pfizer’s Sutent is Recommended for Reimbursement for Gastrointestinal Stromal Tumor Patients by British Health Agency",
                -2.110261993
            ],
            [
                1242691200000,
                "Pfizer Expands Its Generics Portfolio Through Innovative Licensing Deals, Increasing Access To Medicines For Billions Worldwide",
                -0.5294840033
            ],
            [
                1242691200000,
                "Addition of Lyrica Significantly Improved Generalized Anxiety Disorder Symptoms in Patients Who Responded Only Partially to Previous GAD Treatments",
                -0.5294840033
            ],
            [
                1242691200000,
                "EU Commission Approves Pfizer Animal Health’s Vaccine Against Boar Taint",
                -0.5294840033
            ],
            [
                1242172800000,
                "Pfizer Launches Free Medicines Program For Newly Unemployed Americans",
                1.6297243278
            ],
            [
                1242172800000,
                "Pfizer to Present New Clinical Data Highlighting Customized Treatment Approaches For Difficult-To-Treat Cancers",
                1.6297243278
            ],
            [
                1242086400000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference",
                6.7452627424
            ],
            [
                1242086400000,
                "Greg Simon, Noted Leader In Health And Science Policy, Joins Pfizer",
                6.7452627424
            ],
            [
                1241481600000,
                "Pfizer And Wisconsin Alumni Research Foundation (WARF) Sign License Agreement For Human Embryonic Stem Cells",
                0.5517687114
            ],
            [
                1241395200000,
                "Dr. Freda Lewis-Hall Joins Pfizer As Chief Medical Officer",
                4.0616029472
            ],
            [
                1240963200000,
                "Lyrica Significantly Reduced Pain and Improved Other Symptoms of Post-Traumatic Peripheral Nerve Pain, New Data Show",
                0.0748676764
            ],
            [
                1240963200000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference",
                0.0748676764
            ],
            [
                1240790400000,
                "Pfizer Reports First-Quarter 2009 Results; Reaffirms Full-Year 2009 Financial Guidance for Revenues and Adjusted Results(1)",
                0.2240710058
            ],
            [
                1240444800000,
                "Pfizer Supports The Global Fight Against Malaria And Commemorates World Malaria Day – “Counting Malaria Out”",
                0.4555573277
            ],
            [
                1240444800000,
                "Pfizer And University College London Announce Collaboration To Advance Development Of Stem Cell-Based Therapies",
                0.4555573277
            ],
            [
                1240444800000,
                "Pfizer Hosts Annual Meeting Of Shareholders; Declares A 16-Cent Second-Quarter 2009 Dividend",
                0.4555573277
            ],
            [
                1240358400000,
                "Pfizer and Medicines for Malaria Venture Advancing International Research Efforts in the Fight against Malaria",
                -1.1294786809
            ],
            [
                1240358400000,
                "New Findings from Global Survey of Women Living with Metastatic Breast Cancer Highlight Strategies to Improve Patient Enrollment in Clinical Trials",
                -1.1294786809
            ],
            [
                1240185600000,
                "Pfizer Invites Public to Listen to Webcast of April 23 Annual Meeting of Shareholders",
                -3.3284109794
            ],
            [
                1239494400000,
                "Pfizer To Make A Tender Offer To Increase Stake In Pfizer Limited",
                -1.4242812264
            ],
            [
                1239321600000,
                "Pfizer’s Oncology Business Unit Appoints Vice President of Medical Affairs",
                -1.4242812264
            ],
            [
                1238976000000,
                "Pfizer Announces Operating Structure and Select Senior Leadership Posts to Be Effective Immediately Upon Close of Wyeth Acquisition",
                -0.3700922899
            ],
            [
                1238716800000,
                "Pfizer Receives Request for Additional Information from FTC Regarding Proposed Acquisition of Wyeth",
                0.8752661187
            ],
            [
                1238716800000,
                "Pfizer Becomes The First Pharmaceutical Company To Be Accredited For Protection Of Human Rights In Clinical Research",
                0.8752661187
            ],
            [
                1238630400000,
                "Pfizer Development Pipeline Shows Advances In High-Priority Disease Areas",
                -3.7638334727
            ],
            [
                1238544000000,
                "Pfizer Discontinues One Sunitinib Phase 3 Trial in Advanced Breast Cancer; Other Advanced Breast Cancer Trials Continue",
                1.3072042324
            ],
            [
                1238371200000,
                "Significantly More Patients With Cardiovascular Disease Quit Smoking Using Chantix/Champix(®) (Varenicline) Compared With Placebo",
                -1.908955341
            ],
            [
                1238371200000,
                "Intensive Lipitor Therapy Provided Sustained Risk Reduction Of Cardiovascular Events In Older Patients With Heart Disease",
                -1.908955341
            ],
            [
                1237852800000,
                "Pfizer Announces Completion of $13.5 Billion Debt Offering",
                2.4544559678
            ],
            [
                1237680000000,
                "Pfizer’s Oncology Business Unit Appoints Senior Executive to Head U.S. Region",
                -0.2155404968
            ],
            [
                1237420800000,
                "Pfizer, PlaNet Finance Partner to Study Options for Expanding Access to Healthcare in China",
                -4.6221301205
            ],
            [
                1237334400000,
                "Pfizer-Sponsored Prescription Savings Program - Together Rx Access® - Expands Eligibility Criteria in Response to Challenging Economic Times",
                -3.7226756347
            ],
            [
                1237161600000,
                "U.S. Patent & Trademark Office Grants Reissue Patent Relating to Lipitor",
                -2.5946317517
            ],
            [
                1236816000000,
                "Wide-Reaching Global Survey Reveals Majority of Women Living with Metastatic Breast Cancer Desire Increased Public Attention",
                8.8720554201
            ],
            [
                1236556800000,
                "Pfizer Invites Public to View and Listen to Webcast of Investor Breakfast at Healthcare Conference",
                5.4239387089
            ],
            [
                1235952000000,
                "Pfizer and Bausch & Lomb to Co-Promote Products for the Treatment of Ophthalmic Conditions",
                -1.7691415185
            ],
            [
                1235952000000,
                "Pfizer Expands Portfolio of Generic Medicines in the U.S. and Europe Through Licensing Agreements with Aurobindo",
                -1.7691415185
            ],
            [
                1235347200000,
                "Pfizer Discontinues Development of Two Phase 3 Compounds",
                -0.8093973102
            ],
            [
                1234137600000,
                "Pfizer to Publicly Disclose Payments to U.S. Physicians, Healthcare Professionals and Clinical Investigators",
                -7.4626500667
            ],
            [
                1233705600000,
                "Pfizer and The Pfizer Foundation Recognize \"World Cancer Day\" Award $7 Million in Grants to Support Global Cancer Control Efforts",
                -3.724111666
            ],
            [
                1233619200000,
                "Pfizer’s Sutent is Recommended as First-Line Treatment for Kidney Cancer Patients by British Health Agency",
                3.2474866996
            ],
            [
                1233446400000,
                "Lipitor Significantly Reduced hsCRP Levels in Patients with Stable Coronary Artery Disease, According to New Study",
                3.7499928432
            ],
            [
                1233273600000,
                "Pfizer Discontinues Global Phase III Trial of Axitinib for Futility in Advanced Pancreatic Cancer",
                -1.3431949698
            ],
            [
                1233187200000,
                "Geodon Proven Effective as Adjunctive Maintenance Treatment of Bipolar Disorder",
                -4.869662993
            ],
            [
                1233014400000,
                "Pfizer Invites Public to Listen to Audio-Only Webcast of January 27 Investor Luncheon",
                -1.1010277643
            ],
            [
                1232841600000,
                "MEDIA ADVISORY: Pfizer and Wyeth to Host Live Press Conference in New York",
                -4.1087371555
            ],
            [
                1232841600000,
                "Pfizer Reports Fourth-Quarter and Full-Year 2008 Results and 2009 Financial Guidance",
                -4.1087371555
            ],
            [
                1232841600000,
                "Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company",
                -4.1087371555
            ],
            [
                1232064000000,
                "Pfizer Receives FDA Complete Response Letter for Lasofoxifene",
                -3.3139387638
            ],
            [
                1231804800000,
                "Stephen W. Sanger Elected to Pfizer’s Board of Directors",
                -0.9280794677
            ],
            [
                1231200000000,
                "U.S. Patent and Trademark Office Accepts Pfizer’s Reissue Application on Lipitor Enantiomer Patent",
                -4.7455969734
            ],
            [
                1229817600000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference",
                -2.0552086112
            ],
            [
                1229817600000,
                "Bradley E. Lerman Joins Pfizer as Senior Vice President of Litigation",
                -2.0552086112
            ],
            [
                1229299200000,
                "Pfizer Declares a 32-Cent First-Quarter 2009 Dividend",
                2.5921502176
            ],
            [
                1229212800000,
                "Pfizer Invites Public to View and Listen to Webcast of January 28 Conference Call with Analysts",
                2.5921502176
            ],
            [
                1228953600000,
                "Pfizer Announces Results from Trial of AROMASIN in Postmenopausal Women with Hormone Sensitive Early Breast Cancer",
                3.0142365775
            ],
            [
                1228694400000,
                "Pfizer and Sigma-Tau Announce an Agreement to Market a Potential New Treatment for Malaria in Africa",
                -2.4286784586
            ],
            [
                1228176000000,
                "Patients Taking Lipitor Had a Significantly Reduced Risk of Cardiovascular Events Compared with Patients Taking Simvastatin, New Observational Study Shows",
                5.6558823565
            ],
            [
                1227571200000,
                "Pfizer’s Novel HIV/AIDS Treatment SELZENTRY™ Becomes the Latest Fully Approved Antiretrovial for Treatment-Experienced HIV Patients",
                -1.6802044729
            ],
            [
                1227052800000,
                "Pfizer Withdraws Application to Switch Viagra to Non-Prescription Status in Europe",
                -11.7647593867
            ],
            [
                1226534400000,
                "Pfizer Launches Global Regenerative Medicine Research Unit",
                2.456984299
            ],
            [
                1226361600000,
                "New Analysis Suggests That Improvements in Kidney Function in Patients Treated with Lipitor Strongly Correlate with a Reduced Risk of Major Cardiovascular Events",
                -4.548282319
            ],
            [
                1225843200000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference",
                -10.5070155403
            ],
            [
                1225843200000,
                "Pfizer Discontinues Development Program for Its Phase 3 Obesity Compound (CP-945,598)",
                -10.5070155403
            ],
            [
                1225411200000,
                "Pfizer's TOVIAZ(TM) (fesoterodine fumarate) Receives FDA Approval for the Treatment of Overactive Bladder",
                6.57588e-05
            ],
            [
                1224979200000,
                "Pfizer's Novel HIV/AIDS Treatment Selzentry(TM) (Maraviroc) Demonstrates Increased Efficacy Rate In Treatment-Naive HIV Patients",
                8.5297518765
            ],
            [
                1224892800000,
                "Pfizer to Present Data on New Approaches to Pain and Inflammation Treatment at ACR Meeting",
                8.5297518765
            ],
            [
                1224720000000,
                "Pfizer Declares a 32-Cent Fourth-Quarter 2008 Dividend",
                -1.9311747579
            ],
            [
                1224633600000,
                "Pfizer Completes Settlement Agreements with State Attorneys General Regarding its NSAID Pain Medications",
                0.2923944428
            ],
            [
                1224547200000,
                "Pfizer Names New Head of Clinical Development and Medical Affairs for Its Oncology Business Unit",
                -5.555543196
            ],
            [
                1224460800000,
                "Pfizer Reports Third-Quarter 2008 Results",
                0.5190262276
            ],
            [
                1224374400000,
                "Pfizer and UCB Announce Formation of New Company 'Cyclofluidic' to Accelerate Drug Discovery Process",
                0.5190262276
            ],
            [
                1224115200000,
                "Pfizer Reaches Agreements in Principle to Resolve Litigation Involving Its NSAID Pain Medications",
                2.1289134377
            ],
            [
                1223856000000,
                "New Data across Pfizer's Pain and Inflammation Portfolio to Be Presented at Upcoming ACR Meeting",
                3.8529027007
            ],
            [
                1223510400000,
                "Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements over Four Years",
                -14.2668481294
            ],
            [
                1223510400000,
                "Aetna and Pfizer Present ''State of Motion'' Health Fair in Hartford to Encourage Families to Adopt Healthy Lifestyles",
                -14.2668481294
            ],
            [
                1223424000000,
                "EPA Honors Pfizer for Reducing Greenhouse Gas Emissions",
                -10.8487354559
            ],
            [
                1222992000000,
                "Pfizer Invites Public to View and Listen to Webcast of October 28 Analyst and Investor Meeting at ACR",
                0.0527896601
            ],
            [
                1222819200000,
                "Pfizer Invites Public to View and Listen to Webcast of October 21 Conference Call with Analysts",
                2.820653504
            ],
            [
                1222732800000,
                "Pfizer Shows Accelerating Pipeline with Significant Growth in Late-Stage Clinical Development",
                5.332631123
            ],
            [
                1222214400000,
                "Established Safety Profile of Spiriva(R) Confirmed by 30 Rigorously Controlled Clinical Trials",
                2.5751218819
            ],
            [
                1222128000000,
                "Grameen Health and Pfizer Announce Novel Partnership to Explore Sustainable Healthcare Delivery Models for the Developing World",
                -1.167315952
            ],
            [
                1222041600000,
                "Pfizer Recognized as Leader in Improving Climate Change for Second Consecutive Year",
                -1.6101754852
            ],
            [
                1221436800000,
                "MannKind and Pfizer Announce Collaboration for Certain Exubera Patients to Transition to MannKind's Inhaled Insulin Therapy",
                -1.6844438792
            ],
            [
                1221436800000,
                "Pfizer Launches New Medicine Safety Website to Help Healthcare Professionals and Patients Make Better Informed Decisions about Treatment Options",
                -1.6844438792
            ],
            [
                1221350400000,
                "Pfizer Oncology Presents Safety and Efficacy Results Of CP-751,871 Study At ESMO 2008",
                -1.6844438792
            ],
            [
                1221004800000,
                "Pfizer Animal Health Adds Former Schering-Plough Products to European Portfolio",
                0.6525736813
            ],
            [
                1220832000000,
                "Pfizer Will Withdraw Global Marketing Applications for Dalbavancin to Conduct a New Trial",
                -3.289465055
            ],
            [
                1220832000000,
                "Data to Be Presented At ESMO 2008 Highlight Pfizer Commitment to Cancer Care and Research",
                -3.289465055
            ],
            [
                1220832000000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Participation at Healthcare Conference",
                -3.289465055
            ],
            [
                1220313600000,
                "Pfizer and Medivation Enter into Global Agreement to Co-Develop and Market Dimebon for the Treatment of Alzheimer's and Huntington's Diseases",
                -0.5208369226
            ],
            [
                1220227200000,
                "Lipitor 80 mg Provided Sustained Risk Reduction of Cardiovascular Events in Patients with Heart Disease During the Five-Year TNT Trial",
                -0.5208369226
            ],
            [
                1220227200000,
                "New Data is Presented on Investigational Oral Anticoagulant Apixaban in Acute Coronary Syndrome Patients",
                -0.5208369226
            ],
            [
                1219881600000,
                "Court in Denmark Upholds Two Lipitor Patents, Prevents Launch of Ranbaxy Generic Product before November 2011",
                -0.3140236649
            ],
            [
                1219708800000,
                "Bristol-Myers Squibb and Pfizer Provide Update on Apixaban Clinical Development Program",
                -2.5156958814
            ],
            [
                1218672000000,
                "Pfizer Says Vacation with Your Dog before the Summer Ends",
                1.4522498547
            ],
            [
                1218412800000,
                "IAFF Launches Smoking Cessation Campaign with Pfizer",
                -0.4563778692
            ],
            [
                1217980800000,
                "Lipitor 80 mg Reduced the Risk of Heart Attack and Stroke in Patients with Heart Disease, Type 2 Diabetes and Chronic Kidney Disease",
                -1.093173716
            ],
            [
                1216684800000,
                "Pfizer Reports Second-Quarter 2008 Results",
                5.7157801134
            ],
            [
                1215907200000,
                "Pfizer to Showcase Alzheimer's Research and Pipeline at Upcoming Alzheimer's Disease Medical Meeting",
                -2.5028561035
            ],
            [
                1215561600000,
                "Pfizer Fully Supports Updated PhRMA Code",
                -1.6638925461
            ],
            [
                1215302400000,
                "Patients More Likely to Stay on Lipitor Than Simvastatin, a Large Observational Study Shows",
                2.1440553663
            ],
            [
                1214870400000,
                "Pfizer Changes Its Funding of Continuing Medical Education in the U.S.",
                1.078319731
            ],
            [
                1214697600000,
                "FDA Approves First and Only Single-Dose Antibiotic for Dogs and Cats",
                2.4816868437
            ],
            [
                1214352000000,
                "Pfizer Declares a 32-Cent Third Quarter 2008 Dividend",
                -3.3197362418
            ],
            [
                1214352000000,
                "Pfizer Invites Public to View and Listen to Webcast of July 23 Conference Call with Analysts",
                -3.3197362418
            ],
            [
                1214092800000,
                "Pfizer Invites Public to View and Listen to Webcast of July 28 Pfizer Analyst and Investor Meeting at ICAD",
                1.5263227164
            ],
            [
                1214092800000,
                "EyeCyte, Inc. Secures Series A Funding from Pfizer",
                1.5263227164
            ],
            [
                1213660800000,
                "Pfizer and Ranbaxy Settle Lipitor Patent Litigation Worldwide",
                -0.4501937452
            ],
            [
                1213142400000,
                "Pfizer Celebrates 5 Years of High-Impact Corporate Volunteer MissionsPfizer Celebrates 5 Years of High-Impact Corporate Volunteer Missions",
                -1.0716491514
            ],
            [
                1213142400000,
                "Pfizer Inc. and the University of Pennsylvania Announce $15 Million Partnership",
                -1.0716491514
            ],
            [
                1213056000000,
                "Bristol-Myers Squibb and Pfizer Initiate New Study in the Apixaban Phase 3 Clinical Trial Program",
                -2.1082258513
            ],
            [
                1212969600000,
                "Pfizer and UCSF Form Alliance to Advance a Broad Range of Research",
                -0.8919253742
            ],
            [
                1212969600000,
                "Pfizer Completes Acquisition of Encysive Pharmaceuticals Inc.",
                -0.8919253742
            ],
            [
                1212624000000,
                "Charles E. Triano Joins Pfizer as Head of Investor Relations",
                -4.3429602864
            ],
            [
                1212451200000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Participation at Healthcare Conference",
                -1.6489655026
            ],
            [
                1212364800000,
                "Pfizer Reviews Progress of Oncology Pipeline and New Commercial Business Unit Structure with Analysts",
                -2.2093651478
            ],
            [
                1212364800000,
                "New Pfizer Data Presented on CP-751,871 across Non-Small Cell Lung Cancer and Ewing's Sarcoma",
                -2.2093651478
            ],
            [
                1212278400000,
                "Updated CDX-110 Data in Glioblastoma Multiforme Presented at 44th Annual ASCO Annual Meeting",
                -2.2093651478
            ],
            [
                1212019200000,
                "Pfizer Oncology ASCO 2008 Media Briefing to Discuss Study Results in Broad Range of Cancers",
                0.1032940966
            ],
            [
                1211846400000,
                "Pfizer Names Amy W. Schulman as Senior Vice President and General Counsel",
                -1.4507473925
            ],
            [
                1211846400000,
                "Australian Full Federal Court Upholds Basic Lipitor Patent, Preventing Launch of Generic Ranbaxy Product",
                -1.4507473925
            ],
            [
                1211328000000,
                "Pfizer Invites Public to View and Listen to Webcast of June 2 Pfizer Analyst and Investor Meeting at ASCO",
                -1.6684101131
            ],
            [
                1211328000000,
                "New Analysis Showed That High Dose Lipitor Can Reduce the Risk of Cardiovascular Events in Bypass Surgery Patients",
                -1.6684101131
            ],
            [
                1211155200000,
                "FivePrime and Pfizer Enter Oncology and Diabetes Collaboration",
                4.43553e-05
            ],
            [
                1210809600000,
                "New Pfizer Data in Lung Cancer, Ewing's Sarcoma, Prostate Cancer and Other Difficult-to-Treat Tumor Types to Be Presented at ASCO",
                -0.1497428886
            ],
            [
                1210723200000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Participation at Healthcare Conference",
                0.2988248742
            ],
            [
                1210723200000,
                "Pfizer Names Garry Nicholson to Head New Oncology Business Unit",
                0.2988248742
            ],
            [
                1210723200000,
                "As Part of New Transparency Initiative Pfizer Releases List of Grants and Charitable Contributions Made in the First Quarter of 2008",
                0.2988248742
            ],
            [
                1210550400000,
                "Pfizer Extends 10 Million Yuan to Earthquake Victims and Relief Efforts in China",
                0.6008955909
            ],
            [
                1209513600000,
                "Esperion Therapeutics Completes $22.75 M Series A Financing",
                0.6849347186
            ],
            [
                1209427200000,
                "U.S. Patent and Trademark Office to Confirm Patentability of Lipitor Basic Patent",
                -0.7458578818
            ],
            [
                1209340800000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Participation at Healthcare Conference",
                -1.2351686657
            ],
            [
                1209081600000,
                "Pfizer Enters into Research Consortium to Expand Understanding of Diabetes and Obesity Pathobiology",
                0.296579599
            ],
            [
                1208995200000,
                "Pfizer Declares a 32-Cent Second Quarter, 2008, Dividend",
                2.3494937336
            ],
            [
                1208908800000,
                "Pfizer on Track to Deliver Greater Shareholder Value, CEO Kindler Tells Shareholders",
                0.7983774312
            ],
            [
                1208908800000,
                "Pfizer Animal Health Enters into Agreement to Acquire Animal Health Products from Schering-Plough",
                0.7983774312
            ],
            [
                1208736000000,
                "Pfizer Japan to Launch Champix(R) the First Prescription Oral Smoking Cessation Aid in Japan",
                -2.8802618588
            ],
            [
                1208736000000,
                "Pfizer Invites Public to Listen to Webcast of April 24 Annual Shareholders Meeting",
                -2.8802618588
            ],
            [
                1208649600000,
                "High-Dose Lipitor Reduced the Risk of Heart Attack and Stroke in Patients with Chronic Kidney Disease",
                -2.8802618588
            ],
            [
                1208649600000,
                "Pfizer Japan Receives Manufacturing and Marketing Authorization for SUTENT",
                -2.8802618588
            ],
            [
                1208390400000,
                "Pfizer Opens New Development Centre",
                -0.1465662873
            ],
            [
                1208390400000,
                "Federal Court in Canada Upholds Pfizer's Norvasc Patent; Decision Prevents Launch of Generic Amlodipine Besylate Product by Pharmascience until 2010",
                -0.1465662873
            ],
            [
                1208304000000,
                "Pfizer Reports First-Quarter 2008 Results; Reaffirms Full-Year 2008 Financial Guidance",
                -2.107877513
            ],
            [
                1208304000000,
                "Results from Largest Statin Study of Patients with Alzheimer's Disease Show Lipitor(R) Has No Significant Impact on Disease",
                -2.107877513
            ],
            [
                1208304000000,
                "Pfizer and AVANT Enter into Licensing and Development Agreement for Novel Therapeutic Vaccine Candidate for Brain Cancer",
                -2.107877513
            ],
            [
                1208217600000,
                "Lyrica Reduced Pain of Fibromyalgia in Patients Regardless of Symptoms of Anxiety or Depression",
                2.3697136846
            ],
            [
                1208131200000,
                "Pfizer Completes Tender Offer for Shares of Encysive Pharmaceuticals Inc.",
                0.8208739743
            ],
            [
                1207612800000,
                "Pfizer Statement on Exubera Labeling Update in the United States",
                -2.2019719117
            ],
            [
                1207526400000,
                "Pfizer Extends Subsequent Offering Period of Tender Offer for Shares of Encysive Pharmaceuticals",
                -2.047617134
            ],
            [
                1207440000000,
                "Pfizer Reports Shares of Encysive Pharmaceuticals Inc. Tendered Pursuant to Guaranteed Delivery Procedures",
                -2.047617134
            ],
            [
                1207008000000,
                "Pfizer Announces Discontinuation of Phase III Clinical Trial for Patients with Advanced Melanoma",
                2.1385834219
            ],
            [
                1207008000000,
                "Lipitor Provided an Unexpectedly Potent Heart Benefit in Patients with Chronic Stable Angina, According to New Study",
                2.1385834219
            ],
            [
                1207008000000,
                "Pfizer Invites Public to View and Listen to Webcast of April 17 Conference Call with Analysts",
                2.1385834219
            ],
            [
                1206921600000,
                "Pfizer Successfully Completes Tender Offer for Shares of Encysive Pharmaceuticals Inc. and Announces Subsequent Offer Period",
                3.2272984664
            ],
            [
                1206835200000,
                "Spanish Appellate Court Rules in Pfizer's Favor, Upholds Lipitor Patent",
                3.2272984664
            ],
            [
                1206576000000,
                "Pfizer Obtains Clearance from Federal Cartel Office of Germany for Acquisition of All Outstanding Shares of Encysive Pharmaceuticals Inc.; ``Regulatory Condition'' Now Satisfied",
                -1.2682813144
            ],
            [
                1206489600000,
                "Pfizer Clears U.S. Antitrust Review for Acquisition of All Outstanding Shares of Encysive Pharmaceuticals Inc.",
                -0.7782308277
            ],
            [
                1205971200000,
                "Federal Court of Appeal in Canada Upholds Lipitor Enantiomer Patent, Decision Prevents Launch of Generic Product by Ranbaxy until 2010",
                -0.4367079086
            ],
            [
                1205798400000,
                "Pfizer Animal Health to Acquire Catapult Genetics and Bovigen",
                -1.0674336537
            ],
            [
                1205193600000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Participation at Healthcare Conference",
                -0.2819267451
            ],
            [
                1205193600000,
                "Pfizer's Waxman to Leave",
                -0.2819267451
            ],
            [
                1205107200000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Participation at Healthcare Conference",
                1.6114306917
            ],
            [
                1204761600000,
                "Pfizer Wins Challenge to Two Main U.S. Patents for Celebrex by Generic Manufacturer Teva",
                -2.9507907562
            ],
            [
                1204588800000,
                "Pfizer Presents New Opportunities for Global Growth",
                -0.4535199454
            ],
            [
                1204588800000,
                "Pfizer Announces Commencement of Tender Offer for All Outstanding Shares of Encysive Pharmaceuticals Inc.",
                -0.4535199454
            ],
            [
                1204416000000,
                "Pfizer Names William Ringo Senior Vice President of Strategy and Business Development",
                -0.8093883686
            ],
            [
                1204416000000,
                "Pfizer to Acquire Serenex to Extend Oncology Pipeline and Access Novel Technology Platform",
                -0.8093883686
            ],
            [
                1204070400000,
                "Pfizer to Seek to Appeal Lipitor Enantiomer Patent Ruling in the Netherlands, Company Notes That Ruling Has No Commercial Impact",
                -1.0643104818
            ],
            [
                1203811200000,
                "Pfizer Voluntarily Withdraws Lipitor Advertising Featuring Dr. Robert Jarvik",
                1.4454316834
            ],
            [
                1203465600000,
                "Appellate Court in the Netherlands Upholds Basic Lipitor Patent, Prevents Launch of Ranbaxy Product before November 2011",
                0.3125257856
            ],
            [
                1203379200000,
                "Pfizer to Acquire Encysive Pharmaceuticals",
                -0.1334899961
            ],
            [
                1202774400000,
                "Pan-African Conference Focuses on Keeping the Medicine Supply in Africa Safe",
                1.9348521265
            ],
            [
                1202256000000,
                "Pfizer Presents New Data from HIV/AIDS Portfolio at Conference on Retroviruses and Opportunistic Infections",
                -1.0145610481
            ],
            [
                1201478400000,
                "Pfizer Japan Receives Manufacturing and Marketing Authorization for Champix(R)",
                2.1139383438
            ],
            [
                1200960000000,
                "Pfizer Reports Fourth-Quarter and Full-Year 2007 Results and 2008 Financial Guidance",
                5.1618234072
            ],
            [
                1200873600000,
                "Make a New Year's Resolution to Lose Weight - For Your Dog",
                5.1618234072
            ],
            [
                1200528000000,
                "Pfizer Invites Public to View and Listen to Webcast of March 5 Meeting with Analysts",
                -4.0000218939
            ],
            [
                1200528000000,
                "Pfizer Statement on CHANTIX (varenicline) Labeling Update in the United States",
                -4.0000218939
            ],
            [
                1200355200000,
                "Pfizer Reaffirms Leadership in International Corporate Volunteerism by Deploying the Largest Round of Global Health Fellows",
                -1.7521940875
            ],
            [
                1200355200000,
                "Adding Lipitor Early to Effective Blood Pressure Treatment Provided a Significant Reduction in Heart Attacks or Deaths from Heart Attacks over Five Years",
                -1.7521940875
            ],
            [
                1200355200000,
                "Pfizer and Scil Finalize Agreement for Novel Cartilage Growth Factor",
                -1.7521940875
            ],
            [
                1200268800000,
                "News & Media     Press Releases         Press Release Archive         Press Statements Archive     Featured Stories     Video Gallery     Frequently Requested Info     Press Kits     Download Multimedia     Social Media     Contact Pfizer Media Rela",
                -2.7553803985
            ],
            [
                1200182400000,
                "Patients Treated with Lipitor Were Significantly Less Likely to Have a Cardiovascular Event Than Those Treated with Simvastatin, New Observational Study Shows",
                -2.7553803985
            ],
            [
                1200182400000,
                "Pfizer Receives Initial Communication from U.S. Patent and Trademark Office Regarding Lipitor Basic Patent",
                -2.7553803985
            ],
            [
                1199836800000,
                "Pfizer Wins Key New York State Court Ruling on Celebrex",
                2.4086532942
            ],
            [
                1199750400000,
                "Pfizer Invites Public to View and Listen to Webcast of January 23 Conference Call with Analysts",
                2.5919648896
            ],
            [
                1199664000000,
                "ADDING MULTIMEDIA Pfizer Names Sally Susman Senior Vice President of Worldwide Communications and Chief Communications Officer",
                2.3434188682
            ],
            [
                1199664000000,
                "DoveBid(R) to Conduct Online Auction for Pfizer Japan",
                2.3434188682
            ],
            [
                1199577600000,
                "Pfizer and Taisho Finalize Agreement for Novel Schizophrenia Drug Candidate",
                2.3434188682
            ],
            [
                1199318400000,
                "Pfizer to Appeal Canadian Federal Court Ruling on Lipitor Patent; Court's Decision Will Have No Immediate Commercial Impact",
                -0.6570856346
            ],
            [
                1199232000000,
                "Talking to a Doctor about Smoking Makes Quitting Easier - New Survey Reveals",
                1.811916695
            ],
            [
                1198972800000,
                "Pfizer Inc Announces Completion of the Tender Offer Relating to Outstanding Shares of Coley Pharmaceutical Group, Inc.",
                1.0785393456
            ],
            [
                1198195200000,
                "Pfizer Receives Approvable Letter from FDA for Dalbavancin",
                -0.1714881886
            ],
            [
                1198108800000,
                "Pfizer Statement on Results of Comparative Analysis of Tropism Assays",
                0.6024138887
            ],
            [
                1197849600000,
                "Pfizer to Acquire CovX to Extend Biotherapeutics Investment",
                1.3692781508
            ],
            [
                1197849600000,
                "Pfizer Inc Clears Antitrust Review for Acquisition of All Outstanding Shares of Coley Pharmaceutical Group, Inc.",
                1.3692781508
            ],
            [
                1197849600000,
                "Pfizer Declares a 32-Cent First Quarter, 2008, Dividend",
                1.3692781508
            ],
            [
                1196726400000,
                "Pfizer and Adolor Enter into Exclusive Worldwide Collaboration to Develop and Commercialize Novel Pain Compounds",
                2.5854793702
            ],
            [
                1196294400000,
                "Pfizer Inc Commences Tender Offer for All Outstanding Shares of Coley Pharmaceutical Group, Inc.",
                1.59933035
            ],
            [
                1195171200000,
                "Pfizer Invites Public to View and Listen to Webcast of November 30 Analyst Meeting in Hong Kong",
                -3.4346476697
            ],
            [
                1195084800000,
                "Pfizer to Acquire Coley Pharmaceutical Group",
                -0.7267967835
            ],
            [
                1194825600000,
                "Pfizer and Nektar Reach Agreement on Exubera(R)",
                3.0573828362
            ],
            [
                1194307200000,
                "Lipitor Provides Greater Benefit Compared to simvastatin in Patients with a History of Heart Attacks Who Have Had Subsequent Cardiovascular Events",
                -0.3555194863
            ],
            [
                1194134400000,
                "Post-Stroke Patients Treated with Lipitor Demonstrated Significant Improvement or Stabilization of Kidney Function",
                1.3790349956
            ],
            [
                1194048000000,
                "New Lipitor Data Analyses from Landmark Ideal and SPARCL Trials to Be Presented at Upcoming Annual Scientific Sessions of the American Heart Association",
                1.3790349956
            ],
            [
                1193616000000,
                "Taisho and Pfizer Sign a Letter of Intent for Taisho's Schizophrenia Drug Candidate",
                0.6544195851
            ],
            [
                1193616000000,
                "Pfizer to Appeal German Court Decision in Lipitor Patent Case; Company Notes That Ruling Has No Immediate Commercial Impact",
                0.6544195851
            ],
            [
                1193270400000,
                "Pfizer Announces Retirement of Vice Chairman David L. Shedlarz",
                0.4936619806
            ],
            [
                1193270400000,
                "Pfizer Declares a 29-Cent Fourth-Quarter, 2007, Dividend",
                0.4936619806
            ],
            [
                1193097600000,
                "Spanish Appellate Court Rules in Pfizer's Favor, Upholds Lipitor Patent",
                -0.6255261716
            ],
            [
                1192579200000,
                "Pfizer Reports Third-Quarter 2007 Results; Reconfirms 2007 and 2008 Revenue and Adjusted Diluted EPS(1) Guidance",
                -0.8557035703
            ],
            [
                1192320000000,
                "Pfizer Engages with Nation's Physicians Through Sermo to Improve Patient Care",
                -2.5172617812
            ],
            [
                1192060800000,
                "Research Reveals New Trends and Best Practices among Multinational Corporations Engaging in International Corporate Volunteering Programs",
                -1.2272624626
            ],
            [
                1191542400000,
                "Pfizer Invites Public to View and Listen to Webcast of October 18 Conference Call with Analysts",
                -0.1964702869
            ],
            [
                1191369600000,
                "Dr. Martin Mackay Named President of Pfizer Global Research and Development",
                1.7391251602
            ],
            [
                1191283200000,
                "Pfizer Hires New Vice President and Chief Talent Officer",
                0.7575994624
            ],
            [
                1190937600000,
                "Canadian Federal Court Upholds Viagra Patent",
                0.362110032
            ],
            [
                1190937600000,
                "Pfizer Recognized as Leader in Addressing Climate Change",
                0.362110032
            ],
            [
                1190851200000,
                "Two New Directors Elected to Pfizer Board",
                -0.98239557
            ],
            [
                1190678400000,
                "New Preliminary Phase II Data Show Anti-Tumor Activity of Single-Agent Sunitinib Malate in Advanced Gastric Cancer",
                0.9356451998
            ],
            [
                1190505600000,
                "Pfizer's Celsentri(R) Approved in the European Union, Providing a Novel Treatment Option for Treatment-Experienced HIV Patients",
                -1.7325984781
            ],
            [
                1190332800000,
                "Court Rules for Pfizer in Patent Infringement Case on Neurontin",
                -1.5970523077
            ],
            [
                1190246400000,
                "Pfizer and the European Foundation for the Study of Diabetes Announce a New Research Program Focused on Cardiovascular Risk in Patients with Diabetes",
                -1.3420507214
            ],
            [
                1190160000000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Participation at Healthcare Conference",
                -0.5301866389
            ],
            [
                1190073600000,
                "Long-Term Data Reinforce Safety and Efficacy Profile of Pfizer's New HIV Drug Selzentry(TM) (Maraviroc)",
                2.8537133647
            ],
            [
                1189987200000,
                "New Data Support Long-Term Efficacy and Safety in Patients Who Took Exubera for Eight Years",
                1.5484747376
            ],
            [
                1189641600000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Participation at Healthcare Conference",
                -0.0823758369
            ],
            [
                1189641600000,
                "Pfizer to Share New Data and Portfolio Update on Infectious Disease Portfolio at ICAAC Meeting; Invites Public to View and Listen to Webcast of September 18 Analyst Meeting",
                -0.0823758369
            ],
            [
                1189555200000,
                "Canadian Court Finds Infringement of Lipitor Crystal Form Patent",
                0.4953083966
            ],
            [
                1188950400000,
                "Pfizer Oncology Initiates Global Phase III Trial to Evaluate Sunitinib Malate Combined with Erlotinib in Advanced Non-Small Cell Lung Cancer",
                -1.1372967585
            ],
            [
                1188950400000,
                "Pfizer Launches Five Year, Three Country Initiative for Malaria Treatment and Education - Mobilize Against Malaria",
                -1.1372967585
            ],
            [
                1188950400000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Participation at Healthcare Conference",
                -1.1372967585
            ],
            [
                1188864000000,
                "Patients Who Switched from Established Lipitor Therapy to Simvastatin Experienced a Significant 30 Percent Increase in Relative Risk of Cardiovascular Events or Death, New Observational Study Shows",
                -0.2832680911
            ],
            [
                1188086400000,
                "Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program",
                -1.062500721
            ],
            [
                1187654400000,
                "Pfizer Names Frank A. D'Amelio Chief Financial Officer",
                2.0689216269
            ],
            [
                1186358400000,
                "Pfizer's SelzentryTM (Maraviroc) Tablets, Novel Treatment for HIV, Approved by FDA",
                2.7104699566
            ],
            [
                1186012800000,
                "Breast Cancer Guidelines Confirm Central Role of 'Switch Strategy'; Recommendations of St Gallen Panel Support Exemestane Indication",
                -0.8081457157
            ],
            [
                1185753600000,
                "First Medication to Prevent and Treat Vomiting in Dogs Now Available by Prescription",
                -2.2968784519
            ],
            [
                1185235200000,
                "Spanish Court Rules in Pfizer's Favor, Upholds Lipitor Patent",
                -0.7263939122
            ],
            [
                1185235200000,
                "Maraviroc Reduces HIV Viral Load in Treatment-Naive Patients, 48 Week Data Show",
                -0.7263939122
            ],
            [
                1184803200000,
                "Pfizer Receives Positive Opinion from CHMP for Celsentri(R) (maraviroc) for Treatment-Experienced Patients Infected with CCR5-Tropic HIV-1",
                -1.2851356201
            ],
            [
                1184716800000,
                "Pfizer Announces First Occupant in its Science Incubator",
                -0.7603290797
            ],
            [
                1184630400000,
                "Pfizer Reports Second-Quarter 2007 Results, Reconfirms Full-Year 2007 and 2008 Financial Guidance and Updates Progress on Immediate Business Priorities",
                -3.6211919492
            ],
            [
                1183939200000,
                "High Court in Dublin Rules in Pfizer's Favor in Patent Case, Lipitor Protected from Generic Competition until 2011",
                -1.290027337
            ],
            [
                1183852800000,
                "Pfizer Recommends Rejection of Mini-Tender Offer by TRC Capital Corporation",
                -1.290027337
            ],
            [
                1183075200000,
                "Crystal Trial Confirms Central Role of Irinotecan in Metastatic Colorectal Cancer",
                -0.1555286854
            ],
            [
                1182902400000,
                "Pfizer Declares a 29-cent Third-Quarter, 2007, Dividend",
                0.4292007255
            ],
            [
                1182902400000,
                "Pfizer Board of Directors to Initiate Face-to-Face Meetings with Company's Institutional Investors on Corporate Governance Policies and Practices",
                0.4292007255
            ],
            [
                1182902400000,
                "Pfizer Initiates Phase III Trial to Study Sunitinib Malate in Patients with Metastatic Colorectal Cancer",
                0.4292007255
            ],
            [
                1182643200000,
                "Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke",
                0.3516745464
            ],
            [
                1182470400000,
                "Exubera Demonstrated Pulmonary Safety with Blood Sugar Control in Three-Year Interim Analyses",
                -1.4566838808
            ],
            [
                1182384000000,
                "Pfizer's Lyrica Receives FDA Approval for Fibromyalgia Based on Expedited Review",
                -1.4184231422
            ],
            [
                1182297600000,
                "Pfizer Receives Approvable Letter From FDA For Maraviroc",
                -1.7746947446
            ],
            [
                1182297600000,
                "Pfizer Discontinues Clinical Trials for PF-3512676 Combined with Cytotoxic Chemotherapy in Advanced Non-Small Cell Lung Cancer",
                -1.7746947446
            ],
            [
                1181520000000,
                "Slentrol, First Medication to Combat Canine Obesity, Now Available by Prescription",
                -1.4936814491
            ],
            [
                1181174400000,
                "Pfizer Invites Public to View and Listen to Webcast of Pfizer Participation at June 14 Healthcare Conference",
                -0.8672447072
            ],
            [
                1180915200000,
                "Pfizer to Advance Three Key Oncology Compounds into Phase 3 Trials in 2007, Company Tells Financial Analysts",
                -0.9897508214
            ],
            [
                1180828800000,
                "New Data Show Pfizer's Axitinib Prolonged Overall Survival in Advanced Pancreatic Cancer When Combined with Standard of Care Chemotherapy",
                -0.9897508214
            ],
            [
                1180828800000,
                "Single-Agent SUTENT Prolonged Progression-Free Survival across All Advanced Kidney Cancer Patient Risk Groups, Including Those with Poorest Prognoses, Data Show",
                -0.9897508214
            ],
            [
                1180742400000,
                "New Data Evaluating SUTENT, CP-751,871 and Axitinib in Patients with Non-Small Cell Lung Cancer",
                -0.9897508214
            ],
            [
                1180396800000,
                "Pfizer and Express Scripts Sign Agreement",
                -0.4013102648
            ],
            [
                1180396800000,
                "UK Body Recommends Pfizer's Champix (varenicline) for Smokers",
                -0.4013102648
            ],
            [
                1180310400000,
                "Pfizer Invites Public to View and Listen to Webcast of June 4 Pfizer Analyst Meeting at ASCO",
                -0.4013102648
            ],
            [
                1180310400000,
                "Pfizer's Growing Strength in Oncology",
                -0.4013102648
            ],
            [
                1180310400000,
                "New Pfizer Oncology Data Across Numerous Cancer Types to be Presented at ASCO",
                -0.4013102648
            ],
            [
                1180310400000,
                "Pfizer Will Immediately Seek to Appeal Lipitor Patent Ruling in Norway",
                -0.4013102648
            ],
            [
                1180137600000,
                "Pfizer Animal Health Medicine Used to Treat Whales",
                -0.4013102648
            ],
            [
                1179878400000,
                "Pfizer Supports Complete Smoking Ban in Public Areas and Improved Access to Smoking Cessation Treatments across Europe",
                -0.3299065174
            ],
            [
                1179619200000,
                "Pfizer Says Research and Development Head John LaMattina Will Retire This Year",
                -0.182669106
            ],
            [
                1179187200000,
                "Pharmacia and Upjohn Will Appeal Verdict in Simon Case, 'Ruling is Not Supported by the Evidence'",
                0.4758327677
            ],
            [
                1179014400000,
                "Counterfeit Drugs Put Lives at Risk",
                0.3690178412
            ],
            [
                1178150400000,
                "Pfizer Invites Public to Listen to Webcast of July 18 Conference Call with Analysts",
                1.8094491501
            ],
            [
                1177977600000,
                "Pfizer Launches Online Initiative Disclosing Its U.S. Post-Marketing Commitments",
                0.9022764163
            ],
            [
                1177977600000,
                "Lyrica Significantly Reduced Pain and Helped Patients Manage the Symptoms of Fibromyalgia, Data Show",
                0.9022764163
            ],
            [
                1177891200000,
                "Pfizer Wins Celebrex Patent Decision in Canadian Court, Launch of Generic Product by Novopharm Prohibited until 2014",
                0.1504484198
            ],
            [
                1177804800000,
                "Pfizer Foundation's ConnectHIV Initiative Provides $7.5 Million in Grants to Community-Based AIDS Service Organizations Across 10 States",
                0.1504484198
            ],
            [
                1177545600000,
                "Pfizer Invites Public to View and/or Listen to Webcasts of Pfizer Participation at Healthcare Conferences",
                0.7140272874
            ],
            [
                1177459200000,
                "Pfizer Declares a 29-cent Second-Quarter, 2007, Dividend",
                2.0209768255
            ],
            [
                1177459200000,
                "Pfizer Focused on Delivering the Value Customers Expect and Shareholders Deserve, CEO Kindler Tells Shareholders",
                2.0209768255
            ],
            [
                1177459200000,
                "Bristol-Myers Squibb and Pfizer Announce Worldwide Collaboration to Develop and Commercialize Anticoagulant and Metabolic Compounds",
                2.0209768255
            ],
            [
                1177372800000,
                "FDA Advisory Committee Recommends Accelerated Approval of Pfizer's Maraviroc for Treatment-Experienced Patients Infected with CCR5-tropic HIV-1",
                -0.5699454225
            ],
            [
                1176940800000,
                "Pfizer Delivers Solid First-Quarter 2007 Results, Updates Full-Year Expectations for 2007 and 2008",
                1.2977625486
            ],
            [
                1176940800000,
                "Pfizer Invites Public to Access Webcast of April 26 Annual Meeting of Shareholders",
                1.2977625486
            ],
            [
                1176076800000,
                "Pfizer Invites Public to Listen to Webcast of April 20 Conference Call with Analysts",
                0.2692316406
            ],
            [
                1175472000000,
                "Pharmacia Subsidiaries Reach $34.7 Million Settlement with DOJ; Resolve Allegations of Improper Activities Prior to Acquisition by Pfizer",
                1.7140452078
            ],
            [
                1174867200000,
                "Lipitor Significantly Lowered Hospitalization Costs for Patients with Heart Disease, Two New Analyses Show",
                -0.1569185776
            ],
            [
                1174867200000,
                "Lipitor Provides Unprecedented Cardiovascular Risk Reductions in Diabetes Patients with Metabolic Syndrome and in Stroke Patients",
                -0.1569185776
            ],
            [
                1174780800000,
                "Two New Imaging Studies Show Higher Dose Lipitor Stopped the Progression of Atherosclerosis",
                -0.1569185776
            ],
            [
                1174608000000,
                "Pfizer Announces Launch of Generic Amlodipine Besylate Product by Greenstone",
                0.1947803125
            ],
            [
                1174521600000,
                "Pfizer to Present New Lipitor Data, Including Results from Three Large Atherosclerosis Imaging Trials, at the American College of Cardiology Meeting",
                -0.0390009632
            ],
            [
                1174521600000,
                "Pfizer Statement in Response to Appeals Court Decision in Norvasc Patent Case",
                -0.0390009632
            ],
            [
                1174348800000,
                "Pfizer Wins Celebrex Patent Challenge by Generic Manufacturer Teva",
                2.3984011869
            ]
        ]
    }
]